1	ARTICLES	NNS	O	article	_	0	SENT_1	[p1l1913t81r2067b102],

1	6	CD	NUMBER	6	num	2	SENT_2	[p1l89t291r145b347],
2	Association	NN	O	association	_	0	SENT_2	[p1l164t294r504b341],
3	between	IN	O	between	_	0	SENT_2	[p1l529t294r772b341],
4	presence	NN	O	presence	prep_between	2	SENT_2	[p1l798t306r1060b352],
5	of	IN	O	of	_	0	SENT_2	[p1l1082t294r1137b341],
6	HLA	NN	O	hlum	prep_of	2	SENT_2	[p1l1156t294r1526b351],
7	.	.	O	.	_	0	SENT_2	[p1l1156t294r1526b351],

1	—	NN	O	—	_	0	SENT_3	[p1l1156t294r1526b351],
2	.	.	O	.	_	0	SENT_3	[p1l1156t294r1526b351],

1	B	NN	O	b	_	0	SENT_4	[p1l1156t294r1526b351],
2	*	CD	NUMBER	*	num	1	SENT_4	[p1l1156t294r1526b351],
3	5701	CD	NUMBER	5701	dep	1	SENT_4	[p1l1156t294r1526b351],
4	,	,	O	,	_	0	SENT_4	[p1l1156t294r1526b351],
5	HLA-DR7	NN	O	hla-dr7	dep	1	SENT_4	[p1l1550t296r1818b351],
6	,	,	O	,	_	0	SENT_4	[p1l1550t296r1818b351],
7	and	CC	O	and	_	0	SENT_4	[p1l1840t294r1942b341],
8	HLA-DQ3	NN	O	hla-dq3	conj_and	3	SENT_4	[p1l89t377r340b432],
9	and	CC	O	and	_	0	SENT_4	[p1l362t377r464b424],
10	hypersensitivity	NN	O	hypersensitivity	conj_and	3	SENT_4	[p1l489t376r944b435],
11	to	TO	O	to	_	0	SENT_4	[p1l963t378r1022b424],
12	HIV-1	NN	O	hiv-1	nn	15	SENT_4	[p1l1046t377r1200b423],
13	reverse-transcriptase	NN	O	reverse-transcriptase	nn	15	SENT_4	[p1l1223t376r1836b435],
14	inhibitor	NN	O	inhibitor	nn	15	SENT_4	[p1l91t467r326b515],
15	abacavir	NN	O	abacavir	prep_to	10	SENT_4	[p1l347t467r591b515],

1	S	NN	O	s	nn	2	SENT_5	[p1l87t590r108b617],
2	Mallal	NN	O	mallal	_	0	SENT_5	[p1l120t590r219b622],
3	,	,	O	,	_	0	SENT_5	[p1l120t590r219b622],
4	D	NN	O	d	nn	5	SENT_5	[p1l234t590r257b616],
5	Nolan	NNP	PERSON	Nolan	appos	2	SENT_5	[p1l269t590r365b622],
6	,	,	O	,	_	0	SENT_5	[p1l269t590r365b622],
7	C	NNP	O	C	nn	8	SENT_5	[p1l375t590r396b617],
8	Witt	NNP	PERSON	Witt	appos	2	SENT_5	[p1l408t590r472b622],
9	,	,	O	,	_	0	SENT_5	[p1l408t590r472b622],
10	G	NNP	PERSON	G	nn	11	SENT_5	[p1l487t590r509b617],
11	Masel	NNP	PERSON	Masel	appos	2	SENT_5	[p1l522t590r621b622],
12	,	,	O	,	_	0	SENT_5	[p1l522t590r621b622],
13	A	DT	O	a	det	15	SENT_5	[p1l633t590r653b616],
14	M	NN	O	m	nn	15	SENT_5	[p1l667t590r696b616],
15	Martin	NNP	PERSON	Martin	appos	2	SENT_5	[p1l708t590r815b622],
16	,	,	O	,	_	0	SENT_5	[p1l708t590r815b622],
17	C	NNP	O	C	nn	18	SENT_5	[p1l830t590r850b617],
18	Moore	NNP	PERSON	Moore	appos	2	SENT_5	[p1l861t590r966b622],
19	,	,	O	,	_	0	SENT_5	[p1l861t590r966b622],
20	D	NNP	O	D	nn	21	SENT_5	[p1l981t590r1003b616],
21	Sayer	NNP	PERSON	Sayer	appos	2	SENT_5	[p1l1014t590r1108b623],
22	,	,	O	,	_	0	SENT_5	[p1l1014t590r1108b623],
23	A	NNP	O	A	nn	24	SENT_5	[p1l1121t590r1141b616],
24	Castley	NNP	O	Castley	appos	2	SENT_5	[p1l1155t590r1271b623],
25	,	,	O	,	_	0	SENT_5	[p1l1155t590r1271b623],
26	C	NNP	O	C	nn	27	SENT_5	[p1l1287t590r1307b617],
27	Mamotte	NNP	O	Mamotte	appos	2	SENT_5	[p1l1318t590r1464b622],
28	,	,	O	,	_	0	SENT_5	[p1l1318t590r1464b622],
29	D	NNP	O	D	nn	30	SENT_5	[p1l1479t590r1501b616],
30	Maxwell	NNP	PERSON	Maxwell	appos	2	SENT_5	[p1l1513t590r1645b622],
31	,	,	O	,	_	0	SENT_5	[p1l1513t590r1645b622],
32	IJames	NNP	O	IJames	appos	2	SENT_5	[p1l1660t590r1783b622],
33	,	,	O	,	_	0	SENT_5	[p1l1660t590r1783b622],
34	F	NN	O	f	nn	36	SENT_5	[p1l89t640r108b666],
35	T	NN	O	t	nn	36	SENT_5	[p1l119t640r137b666],
36	Christiansen	NN	PERSON	christiansen	appos	2	SENT_5	[p1l147t640r338b667],

1	Summary	NN	O	summary	_	0	SENT_6	[p1l8t773r421b857],

1	Background	NN	O	background	dep	15	SENT_7	[p1l11t972r423b1042],
2	The	DT	O	the	det	3	SENT_7	[p1l458t972r579b1029],
3	use	NN	O	use	dep	1	SENT_7	[p1l619t985r736b1029],
4	of	IN	O	of	_	0	SENT_7	[p1l774t972r839b1029],
5	abacavir	NN	O	abacavir	prep_of	3	SENT_7	[p1l871t972r1269b1029],
6	—	CD	NUMBER	—	dep	15	SENT_7	[p1l871t972r1269b1029],
7	a	DT	O	a	det	15	SENT_7	[p1l871t972r1269b1029],
8	potent	JJ	O	potent	amod	15	SENT_7	[p1l1311t975r1523b1041],
9	HIV-1	NN	O	hiv-1	nn	15	SENT_7	[p1l1562t972r1732b1028],
10	nuc	NN	O	nuc	nn	15	SENT_7	[p1l1771t972r2151b1029],
11	|	NN	O	|	nn	15	SENT_7	[p1l1771t972r2151b1029],
12	eoside	NN	O	eoside	nn	15	SENT_7	[p1l1771t972r2151b1029],
13	—	CD	NUMBER	—	num	15	SENT_7	[p1l1771t972r2151b1029],
14	analogue	NN	O	analogue	nn	15	SENT_7	[p1l9t1066r315b1136],
15	reverse-transcriptase	NN	O	reverse-transcriptase	dep	19	SENT_7	[p1l359t1066r1064b1135],
16	inhibitor	NN	O	inhibitor	nn	17	SENT_7	[p1l1108t1066r1510b1122],
17	—	NN	O	—	dep	15	SENT_7	[p1l1108t1066r1510b1122],
18	is	VBZ	O	be	auxpass	19	SENT_7	[p1l1108t1066r1510b1122],
19	complicated	VBN	O	complicate	_	0	SENT_7	[p1l1551t1066r1956b1135],
20	by	IN	O	by	_	0	SENT_7	[p1l2001t1066r2073b1136],
21	a	DT	O	a	det	27	SENT_7	[p1l2110t1079r2146b1122],
22	potentially	RB	O	potentially	advmod	25	SENT_7	[p1l13t1160r355b1231],
23	life	NN	O	life	npadvmod	25	SENT_7	[p1l397t1159r894b1232],
24	—	CD	NUMBER	—	num	23	SENT_7	[p1l397t1159r894b1232],
25	threatening	JJ	O	threatening	amod	27	SENT_7	[p1l397t1159r894b1232],
26	hypersensitivity	NN	O	hypersensitivity	nn	27	SENT_7	[p1l936t1160r1452b1231],
27	syndrome	NN	O	syndrome	agent	19	SENT_7	[p1l1492t1160r1817b1231],
28	in	IN	O	in	dep	19	SENT_7	[p1l1864t1160r1914b1216],
29	about	IN	O	about	_	0	SENT_7	[p1l1959t1160r2151b1217],
30	5	CD	PERCENT	5	num	31	SENT_7	[p1l10t1255r108b1312],
31	%	NN	PERCENT	%	prep_about	19	SENT_7	[p1l10t1255r108b1312],
32	of	IN	O	of	_	0	SENT_7	[p1l136t1255r201b1312],
33	cases	NNS	O	case	prep_of	31	SENT_7	[p1l225t1268r442b1312],
34	.	.	O	.	_	0	SENT_7	[p1l225t1268r442b1312],

1	Genetic	JJ	O	genetic	amod	2	SENT_8	[p1l476t1255r729b1312],
2	factors	NNS	O	factor	nsubj	10	SENT_8	[p1l755t1255r987b1312],
3	influencing	VBG	O	influence	partmod	2	SENT_8	[p1l1019t1255r1379b1326],
4	the	DT	O	the	det	6	SENT_8	[p1l1402t1255r1509b1312],
5	immune	JJ	O	immune	amod	6	SENT_8	[p1l1541t1255r1807b1312],
6	response	NN	O	response	dobj	3	SENT_8	[p1l1839t1268r2148b1324],
7	to	TO	O	to	_	0	SENT_8	[p1l7t1352r72b1405],
8	abacavir	NN	O	abacavir	prep_to	3	SENT_8	[p1l129t1349r410b1405],
9	might	MD	O	might	aux	10	SENT_8	[p1l467t1349r651b1419],
10	confer	VB	O	confer	_	0	SENT_8	[p1l705t1348r916b1405],
11	susceptibility	NN	O	susceptibility	dobj	10	SENT_8	[p1l970t1349r1425b1419],
12	.	.	O	.	_	0	SENT_8	[p1l970t1349r1425b1419],

1	We	PRP	O	we	nsubj	2	SENT_9	[p1l1484t1349r1588b1405],
2	aimed	VBD	O	aim	_	0	SENT_9	[p1l1646t1349r1848b1405],
3	to	TO	O	to	aux	4	SENT_9	[p1l1905t1352r1970b1405],
4	find	VB	O	find	xcomp	2	SENT_9	[p1l2025t1348r2146b1405],
5	associations	NNS	O	association	iobj	4	SENT_9	[p1l9t1443r435b1500],
6	between	IN	O	between	_	0	SENT_9	[p1l568t1443r847b1500],
7	MHC	NN	O	mhc	nn	8	SENT_9	[p1l982t1443r1139b1500],
8	alleles	NNS	O	allele	prep_between	5	SENT_9	[p1l1270t1443r1487b1500],
9	and	CC	O	and	_	0	SENT_9	[p1l1617t1443r1737b1500],
10	abacavir	NN	O	abacavir	nn	11	SENT_9	[p1l1870t1443r2152b1500],
11	hypersensitivity	NN	O	hypersensitivity	conj_and	5	SENT_9	[p1l12t1538r527b1608],
12	in	IN	O	in	_	0	SENT_9	[p1l605t1538r656b1594],
13	HlV	NN	O	hlv	prep_in	11	SENT_9	[p1l740t1538r1189b1607],
14	—	CD	NUMBER	—	num	15	SENT_9	[p1l740t1538r1189b1607],
15	1	CD	NUMBER	1	dobj	4	SENT_9	[p1l740t1538r1189b1607],
16	—	NN	O	—	tmod	4	SENT_9	[p1l740t1538r1189b1607],
17	positive	JJ	O	positive	amod	18	SENT_9	[p1l740t1538r1189b1607],
18	individuals	NNS	O	individual	nsubj	19	SENT_9	[p1l1271t1538r1621b1595],
19	treated	VBN	O	treat	rcmod	16	SENT_9	[p1l1697t1538r1935b1595],
20	with	IN	O	with	_	0	SENT_9	[p1l2013t1538r2145b1595],
21	abacavu	NN	O	abacavu	prep_with	19	SENT_9	[p1l9t1632r307b1688],
22	.	.	O	.	_	0	SENT_9	[p1l9t1632r307b1688],

1	Methods	NNS	O	method	nsubjpass	6	SENT_10	[p1l11t1820r312b1877],
2	MHC	NN	O	mhc	nn	4	SENT_10	[p1l343t1820r500b1877],
3	region	NN	O	region	nn	4	SENT_10	[p1l532t1820r730b1891],
4	typing	NN	O	typing	dep	1	SENT_10	[p1l758t1820r958b1891],
5	was	VBD	O	be	auxpass	6	SENT_10	[p1l982t1833r1114b1877],
6	done	VBN	O	do	_	0	SENT_10	[p1l1142t1820r1306b1877],
7	in	IN	O	in	_	0	SENT_10	[p1l1338t1820r1388b1876],
8	the	DT	O	the	det	16	SENT_10	[p1l1416t1820r1523b1877],
9	first	JJ	ORDINAL	first	amod	16	SENT_10	[p1l1550t1820r1681b1877],
10	200	CD	NUMBER	200	num	16	SENT_10	[p1l1707t1820r1843b1877],
11	Western	JJ	MISC	western	amod	16	SENT_10	[p1l1870t1820r2146b1877],
12	Australian	JJ	MISC	australian	amod	16	SENT_10	[p1l7t1913r341b1969],
13	HIV	NN	O	hiv	nn	16	SENT_10	[p1l383t1913r492b1968],
14	Cohort	NN	O	cohort	nn	16	SENT_10	[p1l526t1912r748b1969],
15	Study	NN	O	study	nn	16	SENT_10	[p1l782t1912r970b1983],
16	participants	NNS	O	participant	prep_in	6	SENT_10	[p1l1005t1913r1396b1982],
17	exposed	VBN	O	expose	partmod	16	SENT_10	[p1l1432t1913r1711b1982],
18	to	TO	O	to	_	0	SENT_10	[p1l1746t1916r1811b1969],
19	abacavir	NN	O	abacavir	prep_to	17	SENT_10	[p1l1847t1913r2144b1969],
20	.	.	O	.	_	0	SENT_10	[p1l1847t1913r2144b1969],

1	Definite	JJ	O	definite	amod	3	SENT_11	[p1l13t2005r266b2063],
2	abacavir	NN	O	abacavir	nn	3	SENT_11	[p1l308t2006r589b2063],
3	hypersensitivity	NN	O	hypersensitivity	nsubjpass	12	SENT_11	[p1l629t2006r1144b2076],
4	was	VBD	O	be	auxpass	5	SENT_11	[p1l1179t2019r1311b2063],
5	identified	VBN	O	identify	_	0	SENT_11	[p1l1355t2005r1658b2063],
6	in	IN	O	in	_	0	SENT_11	[p1l1703t2006r1754b2062],
7	18	CD	NUMBER	18	num	8	SENT_11	[p1l1800t2006r1886b2063],
8	cases	NNS	O	case	prep_in	5	SENT_11	[p1l1926t2019r2144b2072],
9	,	,	O	,	_	0	SENT_11	[p1l1926t2019r2144b2072],
10	and	CC	O	and	_	0	SENT_11	[p1l9t2099r130b2156],
11	was	VBD	O	be	auxpass	12	SENT_11	[p1l161t2113r293b2156],
12	excluded	VBN	O	exclude	conj_and	5	SENT_11	[p1l326t2099r620b2156],
13	in	IN	O	in	_	0	SENT_11	[p1l657t2099r707b2155],
14	167	CD	NUMBER	167	num	15	SENT_11	[p1l745t2099r876b2156],
15	individuals	NNS	O	individual	prep_in	12	SENT_11	[p1l913t2099r1263b2156],
16	with	IN	O	with	_	0	SENT_11	[p1l1293t2099r1425b2156],
17	more	JJR	DURATION	more	mwe	18	SENT_11	[p1l1462t2113r1628b2156],
18	than	IN	DURATION	than	quantmod	19	SENT_11	[p1l1658t2099r1805b2156],
19	6	CD	DURATION	6	num	20	SENT_11	[p1l1840t2099r1882b2156],
20	weeks	NNS	NUMBER	week	prep_with	15	SENT_11	[p1l1911t2099r2143b2156],
21	’	JJ	O	’	amod	22	SENT_11	[p1l1911t2099r2143b2156],
22	exposure	NN	O	exposure	tmod	12	SENT_11	[p1l9t2206r315b2262],
23	to	TO	O	to	dep	22	SENT_11	[p1l380t2196r445b2249],
24	the	DT	O	the	det	29	SENT_11	[p1l511t2193r618b2249],
25	drug	NN	O	drug	nn	29	SENT_11	[p1l686t2193r833b2263],
26	(	NN	O	(	nn	29	SENT_11	[p1l899t2193r1202b2262],
27	abacavir	NN	O	abacavir	nn	29	SENT_11	[p1l899t2193r1202b2262],
28	tolerant	JJ	O	tolerant	amod	29	SENT_11	[p1l1264t2193r1565b2262],
29	)	NN	O	)	dep	22	SENT_11	[p1l1264t2193r1565b2262],
30	.	.	O	.	_	0	SENT_11	[p1l1264t2193r1565b2262],

1	15	CD	NUMBER	15	num	2	SENT_12	[p1l1640t2193r1726b2249],
2	individuals	NNS	O	individual	nsubj	9	SENT_12	[p1l1798t2193r2148b2249],
3	experienced	VBD	O	experience	_	0	SENT_12	[p1l9t2286r412b2355],
4	some	DT	O	some	det	5	SENT_12	[p1l467t2299r651b2343],
5	symptoms	NNS	O	symptom	dobj	3	SENT_12	[p1l704t2289r1050b2356],
6	but	CC	O	but	_	0	SENT_12	[p1l1104t2286r1209b2343],
7	did	VBD	O	do	aux	9	SENT_12	[p1l1258t2286r1354b2343],
8	not	RB	O	not	neg	9	SENT_12	[p1l1410t2289r1514b2343],
9	meet	VB	O	meet	conj_but	3	SENT_12	[p1l1566t2289r1736b2343],
10	criteria	NNS	O	criterion	dobj	9	SENT_12	[p1l1784t2286r2010b2343],
11	for	IN	O	for	_	0	SENT_12	[p1l2061t2285r2152b2343],
12	abacavir	NN	O	abacavir	nn	13	SENT_12	[p1l9t2379r291b2436],
13	hypersensitivity	NN	O	hypersensitivity	prep_for	10	SENT_12	[p1l377t2379r907b2449],
14	.	.	O	.	_	0	SENT_12	[p1l377t2379r907b2449],

1	p	NN	O	p	nn	2	SENT_13	[p1l1001t2392r1036b2448],
2	values	NNS	O	value	nsubjpass	4	SENT_13	[p1l1118t2379r1336b2436],
3	were	VBD	O	be	auxpass	4	SENT_13	[p1l1420t2392r1578b2436],
4	corrected	VBN	O	correct	_	0	SENT_13	[p1l1664t2379r1975b2436],
5	for	IN	O	for	_	0	SENT_13	[p1l2061t2379r2151b2436],
6	comparisons	NNS	O	comparison	prep_for	4	SENT_13	[p1l9t2472r441b2541],
7	of	IN	O	of	_	0	SENT_13	[p1l469t2471r535b2528],
8	multiple	JJ	O	multiple	amod	10	SENT_13	[p1l560t2472r822b2541],
9	HLA	NN	O	hlum	nn	10	SENT_13	[p1l851t2473r980b2528],
10	alleles	NNS	O	allele	prep_of	6	SENT_13	[p1l1009t2472r1225b2529],
11	(	CD	NUMBER	(	num	13	SENT_13	[p1l1254t2472r1354b2544],
12	pc	NN	O	pc	nn	13	SENT_13	[p1l1254t2472r1354b2544],
13	)	NN	O	)	dobj	4	SENT_13	[p1l1254t2472r1354b2544],
14	by	IN	O	by	_	0	SENT_13	[p1l1385t2472r1456b2543],
15	multiplication	NN	O	multiplication	agent	4	SENT_13	[p1l1482t2472r1926b2541],
16	of	IN	O	of	_	0	SENT_13	[p1l1956t2471r2022b2528],
17	the	DT	O	the	det	20	SENT_13	[p1l2041t2472r2148b2528],
18	raw	JJ	O	raw	amod	20	SENT_13	[p1l12t2579r126b2623],
19	p	NN	O	p	nn	20	SENT_13	[p1l165t2579r200b2635],
20	value	NN	O	value	prep_of	15	SENT_13	[p1l235t2566r412b2623],
21	by	IN	O	by	_	0	SENT_13	[p1l453t2566r525b2636],
22	the	DT	O	the	det	24	SENT_13	[p1l557t2566r664b2623],
23	estimated	VBN	O	estimate	amod	24	SENT_13	[p1l703t2566r1038b2623],
24	number	NN	O	number	agent	4	SENT_13	[p1l1081t2566r1335b2623],
25	of	IN	O	of	_	0	SENT_13	[p1l1371t2565r1436b2623],
26	HLA	NN	O	hlum	nn	27	SENT_13	[p1l1470t2568r1599b2622],
27	alleles	NNS	O	allele	prep_of	24	SENT_13	[p1l1639t2566r1856b2623],
28	present	JJ	DATE	present	amod	27	SENT_13	[p1l1897t2569r2151b2635],
29	within	IN	O	within	_	0	SENT_13	[p1l7t2659r199b2716],
30	the	DT	O	the	det	31	SENT_13	[p1l226t2659r333b2716],
31	loci	NNS	O	locus	prep_within	28	SENT_13	[p1l364t2659r469b2716],
32	examined	VBN	O	examine	partmod	31	SENT_13	[p1l499t2659r842b2716],
33	.	.	O	.	_	0	SENT_13	[p1l499t2659r842b2716],

1	Findings	NNS	O	finding	_	0	SENT_14	[p1l11t2847r297b2918],
2	HLA	NN	O	hlum	dep	1	SENT_14	[p1l347t2848r766b2905],
3	.	.	O	.	_	0	SENT_14	[p1l347t2848r766b2905],

1	—	NN	O	—	_	0	SENT_15	[p1l347t2848r766b2905],
2	.	.	O	.	_	0	SENT_15	[p1l347t2848r766b2905],

1	B	NN	O	b	nsubj	5	SENT_16	[p1l347t2848r766b2905],
2	*	CD	NUMBER	*	num	3	SENT_16	[p1l347t2848r766b2905],
3	5701	CD	NUMBER	5701	dep	1	SENT_16	[p1l347t2848r766b2905],
4	was	VBD	O	be	cop	5	SENT_16	[p1l815t2861r948b2905],
5	present	JJ	DATE	present	_	0	SENT_16	[p1l1002t2851r1255b2917],
6	in	IN	O	in	_	0	SENT_16	[p1l1306t2848r1357b2904],
7	14	CD	NUMBER	14	num	8	SENT_16	[p1l1413t2848r1501b2904],
8	(	NN	O	(	prep_in	5	SENT_16	[p1l1551t2848r1740b2917],
9	78	CD	PERCENT	78	number	10	SENT_16	[p1l1551t2848r1740b2917],
10	%	NN	PERCENT	%	amod	8	SENT_16	[p1l1551t2848r1740b2917],
11	)	CD	NUMBER	)	tmod	5	SENT_16	[p1l1551t2848r1740b2917],
12	of	IN	O	of	_	0	SENT_16	[p1l1792t2847r1858b2905],
13	the	DT	O	the	det	42	SENT_16	[p1l1901t2848r2008b2905],
14	18	CD	NUMBER	18	num	15	SENT_16	[p1l2062t2848r2149b2905],
15	patients	NNS	O	patient	conj_and	15	SENT_16	[p1l13t2941r281b3010],
16	with	IN	O	with	_	0	SENT_16	[p1l313t2941r445b2998],
17	abacavir	NN	O	abacavir	nn	18	SENT_16	[p1l481t2941r763b2998],
18	hypersensitivity	NN	O	hypersensitivity	prep_with	15	SENT_16	[p1l796t2941r1327b3011],
19	,	,	O	,	_	0	SENT_16	[p1l796t2941r1327b3011],
20	and	CC	O	and	_	0	SENT_16	[p1l1365t2941r1485b2998],
21	in	IN	O	in	_	0	SENT_16	[p1l1524t2941r1574b2997],
22	four	CD	NUMBER	four	num	23	SENT_16	[p1l1608t2941r1741b2998],
23	(	NN	O	(	prep_in	15	SENT_16	[p1l1773t2941r1915b3011],
24	2	CD	PERCENT	2	number	25	SENT_16	[p1l1773t2941r1915b3011],
25	%	NN	PERCENT	%	amod	23	SENT_16	[p1l1773t2941r1915b3011],
26	)	CD	NUMBER	)	dep	37	SENT_16	[p1l1773t2941r1915b3011],
27	of	IN	O	of	_	0	SENT_16	[p1l1949t2941r2015b2998],
28	the	DT	O	the	det	32	SENT_16	[p1l2041t2941r2148b2998],
29	167	CD	NUMBER	167	num	32	SENT_16	[p1l13t3033r144b3090],
30	abacavir	NN	O	abacavir	nn	32	SENT_16	[p1l208t3034r490b3090],
31	tolerant	JJ	O	tolerant	amod	32	SENT_16	[p1l545t3034r807b3090],
32	patients	NNS	O	patient	prep_of	26	SENT_16	[p1l869t3034r1138b3103],
33	(	JJ	O	(	amod	34	SENT_16	[p1l1201t3034r1385b3103],
34	odds	NNS	O	odds	dep	37	SENT_16	[p1l1201t3034r1385b3103],
35	ratio	NN	O	ratio	nn	37	SENT_16	[p1l1450t3034r1594b3090],
36	117	CD	NUMBER	117	num	37	SENT_16	[p1l1659t3034r1791b3090],
37	[	NN	O	[	dep	40	SENT_16	[p1l1857t3033r2024b3103],
38	95	CD	PERCENT	95	num	39	SENT_16	[p1l1857t3033r2024b3103],
39	%	NN	PERCENT	%	dep	37	SENT_16	[p1l1857t3033r2024b3103],
40	Cl	NN	O	cl	dep	15	SENT_16	[p1l2085t3033r2144b3090],
41	29-481	CD	NUMBER	29-481	num	40	SENT_16	[p1l10t3126r321b3196],
42	]	NN	O	]	prep_of	11	SENT_16	[p1l10t3126r321b3196],
43	,	,	O	,	_	0	SENT_16	[p1l10t3126r321b3196],
44	pC	NN	O	pc	appos	42	SENT_16	[p1l408t3126r808b3199],
45	<	JJR	O	<	amod	44	SENT_16	[p1l408t3126r808b3199],
46	O-OOO1	CD	NUMBER	o-ooo1	num	47	SENT_16	[p1l408t3126r808b3199],
47	)	NN	O	)	dep	56	SENT_16	[p1l408t3126r808b3199],
48	,	,	O	,	_	0	SENT_16	[p1l408t3126r808b3199],
49	and	CC	O	and	_	0	SENT_16	[p1l892t3126r1012b3183],
50	the	DT	O	the	det	51	SENT_16	[p1l1091t3126r1198b3183],
51	HLA-DR7	NN	O	hla-dr7	dep	56	SENT_16	[p1l1278t3128r1575b3183],
52	and	CC	O	and	_	0	SENT_16	[p1l1651t3126r1772b3183],
53	HLA-DQ3	NN	O	hla-dq3	dep	56	SENT_16	[p1l1854t3126r2148b3195],
54	combination	NN	O	combination	dep	53	SENT_16	[p1l9t3220r418b3277],
55	was	VBD	O	be	auxpass	56	SENT_16	[p1l452t3233r584b3277],
56	found	VBN	O	find	dep	45	SENT_16	[p1l615t3220r802b3277],
57	in	IN	O	in	_	0	SENT_16	[p1l840t3220r890b3276],
58	13	CD	PERCENT	13	number	59	SENT_16	[p1l929t3220r1015b3277],
59	(	CD	PERCENT	(	prep_in	56	SENT_16	[p1l1050t3220r1238b3290],
60	72	CD	PERCENT	72	num	61	SENT_16	[p1l1050t3220r1238b3290],
61	%	NN	PERCENT	%	dep	59	SENT_16	[p1l1050t3220r1238b3290],
62	)	CD	NUMBER	)	dep	59	SENT_16	[p1l1050t3220r1238b3290],
63	of	IN	O	of	_	0	SENT_16	[p1l1272t3220r1338b3277],
64	hypersensitive	JJ	O	hypersensitive	prep_of	62	SENT_16	[p1l1368t3220r1847b3290],
65	and	CC	O	and	_	0	SENT_16	[p1l1880t3220r2000b3277],
66	five	CD	NUMBER	five	num	67	SENT_16	[p1l2033t3220r2148b3277],
67	(	NN	O	(	conj_and	59	SENT_16	[p1l10t3312r152b3383],
68	3	CD	PERCENT	3	number	69	SENT_16	[p1l10t3312r152b3383],
69	%	NN	PERCENT	%	amod	67	SENT_16	[p1l10t3312r152b3383],
70	)	CD	NUMBER	)	dep	67	SENT_16	[p1l10t3312r152b3383],
71	of	IN	O	of	_	0	SENT_16	[p1l210t3312r276b3369],
72	tolerant	JJ	O	tolerant	amod	73	SENT_16	[p1l325t3313r587b3369],
73	patients	NNS	O	patient	prep_of	70	SENT_16	[p1l645t3313r913b3383],
74	(	IN	O	(	_	0	SENT_16	[p1l972t3312r1082b3383],
75	73	CD	NUMBER	73	num	76	SENT_16	[p1l972t3312r1082b3383],
76	[	CD	NUMBER	[	prep_(	56	SENT_16	[p1l1143t3312r1475b3383],
77	20	CD	NUMBER	20	num	80	SENT_16	[p1l1143t3312r1475b3383],
78	—	NN	O	—	nn	80	SENT_16	[p1l1143t3312r1475b3383],
79	268	CD	NUMBER	268	num	80	SENT_16	[p1l1143t3312r1475b3383],
80	]	NN	O	]	nsubjpass	56	SENT_16	[p1l1143t3312r1475b3383],
81	,	,	O	,	_	0	SENT_16	[p1l1143t3312r1475b3383],
82	pc	NN	O	pc	npadvmod	83	SENT_16	[p1l1539t3312r1939b3385],
83	<	JJR	O	<	dep	45	SENT_16	[p1l1539t3312r1939b3385],
84	O-OOO1	CD	NUMBER	o-ooo1	num	85	SENT_16	[p1l1539t3312r1939b3385],
85	)	NN	O	)	dep	11	SENT_16	[p1l1539t3312r1939b3385],
86	.	.	O	.	_	0	SENT_16	[p1l1539t3312r1939b3385],

1	HLAB	NN	O	hlab	nsubj	10	SENT_17	[p1l2001t3314r2152b3369, p1l10t3407r298b3475],
2	*	CD	NUMBER	*	num	1	SENT_17	[p1l2001t3314r2152b3369, p1l10t3407r298b3475],
3	5701	CD	NUMBER	5701	dep	1	SENT_17	[p1l2001t3314r2152b3369, p1l10t3407r298b3475],
4	,	,	O	,	_	0	SENT_17	[p1l2001t3314r2152b3369, p1l10t3407r298b3475],
5	HLA-DR7	NN	O	hla-dr7	dep	1	SENT_17	[p1l337t3409r645b3475],
6	,	,	O	,	_	0	SENT_17	[p1l337t3409r645b3475],
7	and	CC	O	and	_	0	SENT_17	[p1l684t3407r804b3464],
8	HLA-DQ3	NN	O	hla-dq3	conj_and	3	SENT_17	[p1l840t3407r1134b3476],
9	were	VBD	O	be	cop	10	SENT_17	[p1l1166t3420r1324b3464],
10	present	JJ	DATE	present	_	0	SENT_17	[p1l1362t3410r1615b3476],
11	in	IN	O	in	_	0	SENT_17	[p1l1650t3407r1700b3463],
12	combination	NN	O	combination	prep_in	10	SENT_17	[p1l1736t3407r2146b3464],
13	in	IN	O	in	_	0	SENT_17	[p1l13t3500r63b3556],
14	13	CD	PERCENT	13	num	15	SENT_17	[p1l106t3500r192b3557],
15	(	CD	PERCENT	(	prep_in	12	SENT_17	[p1l232t3500r420b3570],
16	72	CD	PERCENT	72	num	17	SENT_17	[p1l232t3500r420b3570],
17	%	NN	PERCENT	%	dep	12	SENT_17	[p1l232t3500r420b3570],
18	)	CD	NUMBER	)	num	20	SENT_17	[p1l232t3500r420b3570],
19	hypersensitive	JJ	O	hypersensitive	amod	20	SENT_17	[p1l462t3500r940b3570],
20	patients	NNS	O	patient	dep	17	SENT_17	[p1l982t3500r1251b3569],
21	and	CC	O	and	_	0	SENT_17	[p1l1289t3500r1409b3557],
22	none	NN	O	none	conj_and	12	SENT_17	[p1l1451t3513r1613b3557],
23	of	IN	O	of	_	0	SENT_17	[p1l1651t3500r1717b3557],
24	the	DT	O	the	det	26	SENT_17	[p1l1747t3500r1854b3557],
25	tolerant	JJ	O	tolerant	amod	26	SENT_17	[p1l1889t3500r2151b3557],
26	patients	NNS	O	patient	prep_of	22	SENT_17	[p1l13t3593r281b3662],
27	(	IN	O	(	_	0	SENT_17	[p1l319t3592r476b3663],
28	822	CD	NUMBER	822	number	29	SENT_17	[p1l319t3592r476b3663],
29	[	CD	NUMBER	[	prep_(	26	SENT_17	[p1l516t3592r759b3663],
30	43	CD	NUMBER	43	num	31	SENT_17	[p1l516t3592r759b3663],
31	—	NN	O	—	dep	29	SENT_17	[p1l516t3592r759b3663],
32	15	CD	NUMBER	15	number	33	SENT_17	[p1l516t3592r759b3663],
33	675	CD	NUMBER	675	num	34	SENT_17	[p1l797t3592r975b3663],
34	]	NN	O	]	dep	31	SENT_17	[p1l797t3592r975b3663],
35	,	,	O	,	_	0	SENT_17	[p1l797t3592r975b3663],
36	pc	NN	O	pc	npadvmod	37	SENT_17	[p1l1019t3592r1419b3665],
37	<	JJR	O	<	dep	10	SENT_17	[p1l1019t3592r1419b3665],
38	O-0001	CD	NUMBER	o-0001	num	39	SENT_17	[p1l1019t3592r1419b3665],
39	)	NN	O	)	dep	10	SENT_17	[p1l1019t3592r1419b3665],
40	.	.	O	.	_	0	SENT_17	[p1l1019t3592r1419b3665],

1	Other	JJ	O	other	amod	3	SENT_18	[p1l1461t3592r1644b3649],
2	MHC	NN	O	mhc	nn	3	SENT_18	[p1l1681t3592r1838b3649],
3	markers	NNS	O	marker	nsubj	5	SENT_18	[p1l1877t3593r2148b3649],
4	also	RB	O	also	advmod	5	SENT_18	[p1l9t3687r148b3744],
5	present	VBP	DATE	present	_	0	SENT_18	[p1l197t3690r451b3756],
6	on	IN	O	on	_	0	SENT_18	[p1l495t3700r572b3744],
7	the	DT	O	the	det	10	SENT_18	[p1l617t3687r724b3744],
8	57-1	CD	NUMBER	57-1	npadvmod	9	SENT_18	[p1l772t3687r930b3744],
9	ancestral	JJ	O	ancestral	amod	10	SENT_18	[p1l976t3687r1283b3744],
10	haplotype	NN	O	haplotype	prep_on	5	SENT_18	[p1l1335t3687r1655b3757],
11	to	TO	O	to	_	0	SENT_18	[p1l1699t3690r1764b3744],
12	which	WDT	O	which	rel	17	SENT_18	[p1l1808t3687r1995b3744],
13	the	DT	O	the	det	15	SENT_18	[p1l2041t3687r2148b3744],
14	three	CD	NUMBER	three	num	15	SENT_18	[p2l7t18r180b75],
15	markers	NNS	O	marker	nsubj	29	SENT_18	[p2l250t18r520b75],
16	above	IN	O	above	advmod	17	SENT_18	[p2l588t18r786b75],
17	belong	VBP	O	belong	rcmod	10	SENT_18	[p2l855t18r1077b89],
18	confirmed	VBN	O	confirm	dep	17	SENT_18	[p2l1141t18r1471b75],
19	the	DT	O	the	det	20	SENT_18	[p2l1538t18r1644b75],
20	presence	NN	O	presence	dobj	18	SENT_18	[p2l1715t31r2020b87],
21	of	IN	O	of	_	0	SENT_18	[p2l2088t18r2153b75],
22	haplotype	NN	O	haplotype	nn	26	SENT_18	[p2l12t110r609b181],
23	—	CD	NUMBER	—	num	26	SENT_18	[p2l12t110r609b181],
24	specific	JJ	O	specific	amod	26	SENT_18	[p2l12t110r609b181],
25	linkage	NN	O	linkage	nn	26	SENT_18	[p2l637t111r870b181],
26	disequilibrium	NN	O	disequilibrium	prep_of	20	SENT_18	[p2l895t111r1383b180],
27	,	,	O	,	_	0	SENT_18	[p2l895t111r1383b180],
28	and	CC	O	and	_	0	SENT_18	[p2l1412t111r1532b167],
29	mapped	VBD	O	map	rcmod	10	SENT_18	[p2l1562t111r1829b180],
30	potential	JJ	O	potential	amod	32	SENT_18	[p2l1860t111r2144b180],
31	susceptibility	NN	O	susceptibility	nn	32	SENT_18	[p2l10t204r450b274],
32	loci	NNS	O	locus	dobj	29	SENT_18	[p2l495t204r600b260],
33	to	TO	O	to	_	0	SENT_18	[p2l646t207r711b260],
34	a	DT	O	a	det	35	SENT_18	[p2l757t217r793b260],
35	region	NN	O	region	prep_to	29	SENT_18	[p2l843t204r1041b275],
36	bounded	VBN	O	bound	partmod	35	SENT_18	[p2l1092t204r1378b260],
37	by	IN	O	by	_	0	SENT_18	[p2l1428t204r1500b274],
38	C4A6	NN	O	c4a6	agent	36	SENT_18	[p2l1543t204r1722b261],
39	and	CC	O	and	_	0	SENT_18	[p2l1765t204r1885b260],
40	HLA-C	NN	O	hla-c	agent	36	SENT_18	[p2l1933t204r2144b260],
41	.	.	O	.	_	0	SENT_18	[p2l1933t204r2144b260],

1	Within	IN	O	within	_	0	SENT_19	[p2l7t297r213b354],
2	the	DT	O	the	det	5	SENT_19	[p2l238t297r345b354],
3	entire	JJ	O	entire	amod	5	SENT_19	[p2l372t297r561b354],
4	abaoavir	JJ	O	abaoavir	amod	5	SENT_19	[p2l588t297r1167b366],
5	—	NN	O	—	pobj	1	SENT_19	[p2l588t297r1167b366],
6	exposed	VBN	O	expose	partmod	5	SENT_19	[p2l588t297r1167b366],
7	cohort	NN	O	cohort	nn	9	SENT_19	[p2l1195t297r1407b354],
8	(	NN	O	(	nn	9	SENT_19	[p2l1431t297r1721b367],
9	n	NN	O	n	dobj	6	SENT_19	[p2l1431t297r1721b367],
10	=	JJ	O	=	amod	9	SENT_19	[p2l1431t297r1721b367],
11	200	CD	NUMBER	200	num	12	SENT_19	[p2l1431t297r1721b367],
12	)	NN	O	)	tmod	10	SENT_19	[p2l1431t297r1721b367],
13	,	,	O	,	_	0	SENT_19	[p2l1431t297r1721b367],
14	presence	NN	O	presence	appos	12	SENT_19	[p2l1755t310r2060b366],
15	of	IN	O	of	_	0	SENT_19	[p2l2088t297r2153b354],
16	HLA-B	NN	O	hla-b	prep_of	9	SENT_19	[p2l10t390r455b456],
17	*	CD	NUMBER	*	number	18	SENT_19	[p2l10t390r455b456],
18	5701	CD	NUMBER	5701	num	16	SENT_19	[p2l10t390r455b456],
19	,	,	O	,	_	0	SENT_19	[p2l10t390r455b456],
20	HLA	NN	O	hlum	appos	9	SENT_19	[p2l490t391r803b456],
21	.	.	O	.	_	0	SENT_19	[p2l490t391r803b456],

1	—	NN	O	—	_	0	SENT_20	[p2l490t391r803b456],
2	.	.	O	.	_	0	SENT_20	[p2l490t391r803b456],

1	DR7	NN	O	dr7	nsubj	5	SENT_21	[p2l490t391r803b456],
2	,	,	O	,	_	0	SENT_21	[p2l490t391r803b456],
3	and	CC	O	and	_	0	SENT_21	[p2l838t390r958b446],
4	HLA-DQ3	NN	O	hla-dq3	conj_and	1	SENT_21	[p2l991t390r1285b458],
5	had	VBD	O	have	_	0	SENT_21	[p2l1319t390r1437b446],
6	a	DT	O	a	det	9	SENT_21	[p2l1470t403r1506b446],
7	positive	JJ	O	positive	amod	9	SENT_21	[p2l1542t390r1796b459],
8	predictive	JJ	O	predictive	amod	9	SENT_21	[p2l1831t390r2148b459],
9	value	NN	O	value	dobj	5	SENT_21	[p2l7t483r183b540],
10	for	IN	O	for	_	0	SENT_21	[p2l223t482r314b540],
11	hypersensitivity	NN	O	hypersensitivity	prep_for	9	SENT_21	[p2l354t483r869b554],
12	of	IN	O	of	_	0	SENT_21	[p2l907t482r973b540],
13	100	CD	PERCENT	100	num	14	SENT_21	[p2l1011t483r1219b550],
14	%	NN	PERCENT	%	prep_of	11	SENT_21	[p2l1011t483r1219b550],
15	,	,	O	,	_	0	SENT_21	[p2l1011t483r1219b550],
16	and	CC	O	and	_	0	SENT_21	[p2l1264t483r1384b540],
17	a	DT	O	a	det	20	SENT_21	[p2l1428t497r1463b540],
18	negative	JJ	O	negative	amod	20	SENT_21	[p2l1508t483r1786b555],
19	predictive	JJ	O	predictive	amod	20	SENT_21	[p2l1831t483r2148b553],
20	value	NN	O	value	dobj	5	SENT_21	[p2l7t577r183b634],
21	of	IN	O	of	_	0	SENT_21	[p2l211t577r277b634],
22	97	CD	PERCENT	97	num	23	SENT_21	[p2l300t577r462b634],
23	%	NN	PERCENT	%	prep_of	20	SENT_21	[p2l300t577r462b634],
24	.	.	O	.	_	0	SENT_21	[p2l300t577r462b634],

1	Centre	NNP	O	Centre	dep	159	SENT_22	[p2l8t844r215b895],
2	for	IN	O	for	dep	159	SENT_22	[p2l238t844r320b895],
3	Clinical	JJ	O	clinical	dep	159	SENT_22	[p2l343t844r569b895],
4	Immunology	NN	O	immunology	dep	159	SENT_22	[p2l598t845r972b906],
5	and	CC	O	and	dep	159	SENT_22	[p2l995t845r1104b895],
6	Biomedical	NNP	ORGANIZATION	Biomedical	dep	159	SENT_22	[p2l1132t844r1471b894],
7	Statistics	NNPS	ORGANIZATION	Statistics	dep	159	SENT_22	[p2l1496t844r1816b905],
8	,	,	ORGANIZATION	,	_	0	SENT_22	[p2l1496t844r1816b905],
9	Royal	NNP	ORGANIZATION	Royal	dep	159	SENT_22	[p2l1845t845r2011b906],
10	Perth	NNP	ORGANIZATION	Perth	dep	159	SENT_22	[p2l11t933r173b983],
11	Hospital	NNP	ORGANIZATION	Hospital	dep	159	SENT_22	[p2l201t932r451b994],
12	and	CC	O	and	dep	159	SENT_22	[p2l477t933r586b983],
13	Murdoch	NNP	ORGANIZATION	Murdoch	dep	159	SENT_22	[p2l614t933r882b983],
14	University	NNP	ORGANIZATION	University	dep	159	SENT_22	[p2l909t932r1233b994],
15	,	,	O	,	_	0	SENT_22	[p2l909t932r1233b994],
16	Perth	NNP	LOCATION	Perth	dep	159	SENT_22	[p2l1262t933r1444b993],
17	,	,	O	,	_	0	SENT_22	[p2l1262t933r1444b993],
18	Western	NNP	LOCATION	Western	dep	159	SENT_22	[p2l1469t933r1728b983],
19	Australia	NNP	LOCATION	Australia	dep	159	SENT_22	[p2l1752t932r2048b993],
20	,	,	O	,	_	0	SENT_22	[p2l1752t932r2048b993],
21	Australia	NNP	LOCATION	Australia	dep	159	SENT_22	[p2l7t1020r284b1071],
22	(	VBD	O	(	dep	159	SENT_22	[p2l310t1020r451b1082],
23	Prof	NNP	O	Prof	dep	159	SENT_22	[p2l310t1020r451b1082],
24	S	NNP	O	S	dep	159	SENT_22	[p2l472t1021r510b1071],
25	Mallal	NNP	O	Mallal	dep	159	SENT_22	[p2l539t1021r712b1071],
26	FRACP	NNP	O	FRACP	dep	159	SENT_22	[p2l741t1033r899b1079],
27	,	,	O	,	_	0	SENT_22	[p2l741t1033r899b1079],
28	D	NNP	O	D	dep	159	SENT_22	[p2l931t1021r970b1070],
29	Nolan	NNP	PERSON	Nolan	dep	159	SENT_22	[p2l998t1021r1165b1071],
30	FRACP	NNP	PERSON	FRACP	dep	159	SENT_22	[p2l1194t1033r1352b1079],
31	,	,	O	,	_	0	SENT_22	[p2l1194t1033r1352b1079],
32	C	NNP	O	C	dep	159	SENT_22	[p2l1380t1020r1419b1071],
33	Witt	NNP	PERSON	Witt	dep	159	SENT_22	[p2l1443t1021r1561b1071],
34	PhD	NNP	O	PhD	dep	159	SENT_22	[p2l1585t1034r1688b1079],
35	,	,	O	,	_	0	SENT_22	[p2l1585t1034r1688b1079],
36	G	NNP	O	G	dep	159	SENT_22	[p2l1717t1020r1757b1071],
37	Masel	NNP	PERSON	Masel	dep	159	SENT_22	[p2l1786t1021r1963b1071],
38	MBBS	NNP	O	MBBS	dep	159	SENT_22	[p2l1993t1033r2142b1079],
39	,	,	O	,	_	0	SENT_22	[p2l1993t1033r2142b1079],
40	A	DT	O	a	dep	159	SENT_22	[p2l7t1109r46b1159],
41	M	NN	O	m	dep	159	SENT_22	[p2l72t1109r120b1159],
42	Martin	NNP	PERSON	Martin	dep	159	SENT_22	[p2l151t1109r336b1160],
43	PhD	NNP	O	PhD	dep	159	SENT_22	[p2l363t1122r467b1168],
44	,	,	O	,	_	0	SENT_22	[p2l363t1122r467b1168],
45	C	NNP	O	C	dep	159	SENT_22	[p2l496t1109r534b1160],
46	Moore	NNP	PERSON	Moore	dep	159	SENT_22	[p2l563t1109r748b1160],
47	BSc	NNP	O	BSc	dep	159	SENT_22	[p2l775t1122r876b1168],
48	,	,	O	,	_	0	SENT_22	[p2l775t1122r876b1168],
49	D	NNP	O	D	dep	159	SENT_22	[p2l908t1109r946b1159],
50	Sayer	NNP	PERSON	Sayer	dep	159	SENT_22	[p2l972t1108r1141b1172],
51	Bsc	NNP	PERSON	Bsc	dep	159	SENT_22	[p2l1165t1122r1260b1168],
52	,	,	O	,	_	0	SENT_22	[p2l1165t1122r1260b1168],
53	C	NNP	O	C	dep	159	SENT_22	[p2l1288t1109r1327b1160],
54	Mamotte	NNP	O	Mamotte	dep	159	SENT_22	[p2l1355t1109r1621b1160],
55	PhD	NNP	O	PhD	dep	159	SENT_22	[p2l1648t1122r1750b1168],
56	,	,	O	,	_	0	SENT_22	[p2l1648t1122r1750b1168],
57	D	NNP	PERSON	D	dep	159	SENT_22	[p2l13t1197r51b1247],
58	Maxwell	NNP	PERSON	Maxwell	dep	159	SENT_22	[p2l79t1197r333b1256],
59	,	,	O	,	_	0	SENT_22	[p2l79t1197r333b1256],
60	Prof	NNP	O	Prof	dep	159	SENT_22	[p2l363t1197r482b1247],
61	I	PRP	O	I	dep	159	SENT_22	[p2l506t1197r513b1246],
62	James	NNP	PERSON	James	dep	159	SENT_22	[p2l540t1197r735b1247],
63	PhD	NNP	O	PhD	dep	159	SENT_22	[p2l761t1197r886b1258],
64	)	NN	O	)	dep	159	SENT_22	[p2l761t1197r886b1258],
65	;	:	O	;	_	0	SENT_22	[p2l761t1197r886b1258],
66	Department	NNP	ORGANIZATION	Department	dep	159	SENT_22	[p2l915t1197r1280b1258],
67	of	IN	ORGANIZATION	of	dep	159	SENT_22	[p2l1304t1197r1363b1247],
68	Clinical	JJ	ORGANIZATION	clinical	dep	159	SENT_22	[p2l1383t1197r1610b1247],
69	Immunology	NN	ORGANIZATION	immunology	dep	159	SENT_22	[p2l1639t1197r2012b1259],
70	and	CC	ORGANIZATION	and	dep	159	SENT_22	[p2l2035t1197r2144b1247],
71	Biochemical	JJ	ORGANIZATION	biochemical	dep	159	SENT_22	[p2l11t1285r389b1335],
72	Genetics	NNP	ORGANIZATION	Genetics	dep	159	SENT_22	[p2l414t1285r706b1346],
73	,	,	O	,	_	0	SENT_22	[p2l414t1285r706b1346],
74	Royal	NNP	ORGANIZATION	Royal	dep	159	SENT_22	[p2l736t1286r902b1347],
75	Perth	NNP	ORGANIZATION	Perth	dep	159	SENT_22	[p2l931t1285r1093b1335],
76	Hospital	NNP	ORGANIZATION	Hospital	dep	159	SENT_22	[p2l1120t1285r1371b1347],
77	(	CD	NUMBER	(	dep	159	SENT_22	[p2l1398t1285r1457b1347],
78	S	NN	O	s	dep	159	SENT_22	[p2l1398t1285r1457b1347],
79	Mallal	NN	O	mallal	dep	159	SENT_22	[p2l1486t1286r1679b1344],
80	,	,	O	,	_	0	SENT_22	[p2l1486t1286r1679b1344],
81	C	NN	O	c	dep	159	SENT_22	[p2l1708t1285r1746b1335],
82	Witt	NNP	PERSON	Witt	dep	159	SENT_22	[p2l1770t1285r1904b1344],
83	,	,	O	,	_	0	SENT_22	[p2l1770t1285r1904b1344],
84	G	NNP	O	G	dep	159	SENT_22	[p2l10t1373r49b1424],
85	Masel	NNP	PERSON	Masel	dep	159	SENT_22	[p2l79t1374r276b1432],
86	,	,	O	,	_	0	SENT_22	[p2l79t1374r276b1432],
87	D	NNP	PERSON	D	dep	159	SENT_22	[p2l308t1374r346b1423],
88	Sayer	NNP	PERSON	Sayer	dep	159	SENT_22	[p2l372t1373r555b1435],
89	,	,	O	,	_	0	SENT_22	[p2l372t1373r555b1435],
90	A	NNP	O	A	dep	159	SENT_22	[p2l582t1374r621b1423],
91	Castley	NNP	O	Castley	dep	159	SENT_22	[p2l645t1373r866b1435],
92	BSc	NNP	O	BSc	dep	159	SENT_22	[p2l891t1386r991b1432],
93	,	,	O	,	_	0	SENT_22	[p2l891t1386r991b1432],
94	C	NNP	O	C	dep	159	SENT_22	[p2l1019t1373r1058b1423],
95	Mamotte	NNP	O	Mamotte	dep	159	SENT_22	[p2l1086t1374r1370b1432],
96	,	,	O	,	_	0	SENT_22	[p2l1086t1374r1370b1432],
97	F	NN	O	f	dep	159	SENT_22	[p2l1402t1374r1432b1423],
98	T	NN	O	t	dep	159	SENT_22	[p2l1451t1374r1486b1423],
99	Christiansen	NN	PERSON	christiansen	dep	159	SENT_22	[p2l1509t1373r1886b1424],
100	MD	NN	O	md	dep	159	SENT_22	[p2l1915t1374r2025b1435],
101	)	NN	O	)	dep	159	SENT_22	[p2l1915t1374r2025b1435],
102	;	:	O	;	_	0	SENT_22	[p2l1915t1374r2025b1435],
103	and	CC	O	and	dep	159	SENT_22	[p2l8t1462r117b1512],
104	Department	NNP	ORGANIZATION	Department	dep	159	SENT_22	[p2l145t1462r510b1523],
105	of	IN	ORGANIZATION	of	dep	159	SENT_22	[p2l534t1461r593b1512],
106	Pathology	NNP	ORGANIZATION	Pathology	dep	159	SENT_22	[p2l615t1462r940b1523],
107	,	,	O	,	_	0	SENT_22	[p2l615t1462r940b1523],
108	University	NNP	ORGANIZATION	University	dep	159	SENT_22	[p2l969t1461r1276b1523],
109	of	IN	ORGANIZATION	of	dep	159	SENT_22	[p2l1298t1461r1358b1512],
110	Western	NNP	ORGANIZATION	Western	dep	159	SENT_22	[p2l1377t1462r1636b1512],
111	Australia	NNP	ORGANIZATION	Australia	dep	159	SENT_22	[p2l1660t1461r1937b1512],
112	(	CD	NUMBER	(	dep	159	SENT_22	[p2l10t1550r64b1611],
113	F	NN	PERSON	f	dep	159	SENT_22	[p2l10t1550r64b1611],
114	T	NN	PERSON	t	dep	159	SENT_22	[p2l83t1550r117b1599],
115	Christiansen	NN	PERSON	christiansen	dep	159	SENT_22	[p2l141t1550r539b1611],
116	)	CD	NUMBER	)	dep	159	SENT_22	[p2l141t1550r539b1611],
117	Correspondence	NN	O	correspondence	dep	159	SENT_22	[p2l8t1644r512b1705],
118	to	TO	O	to	dep	159	SENT_22	[p2l535t1645r616b1694],
119	:	:	O	:	_	0	SENT_22	[p2l535t1645r616b1694],
120	Prof	NNP	O	Prof	dep	159	SENT_22	[p2l645t1643r764b1694],
121	Simon	NNP	PERSON	Simon	dep	159	SENT_22	[p2l785t1644r972b1694],
122	Mallal	NNP	PERSON	Mallal	dep	159	SENT_22	[p2l1002t1644r1195b1702],
123	,	,	O	,	_	0	SENT_22	[p2l1002t1644r1195b1702],
124	Centre	NNP	O	Centre	dep	159	SENT_22	[p2l1224t1643r1420b1694],
125	for	IN	O	for	dep	159	SENT_22	[p2l1445t1643r1526b1694],
126	Clinical	JJ	O	clinical	dep	159	SENT_22	[p2l1548t1644r1760b1694],
127	Immunology	NN	O	immunology	dep	159	SENT_22	[p2l13t1731r374b1795],
128	and	CC	O	and	dep	159	SENT_22	[p2l396t1731r503b1781],
129	Biomedical	NNP	O	Biomedical	dep	159	SENT_22	[p2l533t1731r859b1782],
130	Statistics	NNPS	O	Statistics	dep	159	SENT_22	[p2l888t1731r1188b1790],
131	,	,	O	,	_	0	SENT_22	[p2l888t1731r1188b1790],
132	2nd	JJ	ORDINAL	2nd	dep	159	SENT_22	[p2l1217t1731r1328b1781],
133	floor	NN	O	floor	dep	159	SENT_22	[p2l1353t1731r1504b1790],
134	,	,	O	,	_	0	SENT_22	[p2l1353t1731r1504b1790],
135	North	NNP	ORGANIZATION	North	dep	159	SENT_22	[p2l1535t1731r1692b1781],
136	Block	NNP	ORGANIZATION	Block	dep	159	SENT_22	[p2l1723t1731r1899b1790],
137	,	,	O	,	_	0	SENT_22	[p2l1723t1731r1899b1790],
138	Royal	NNP	ORGANIZATION	Royal	dep	159	SENT_22	[p2l1931t1731r2086b1794],
139	Perth	NNP	ORGANIZATION	Perth	dep	159	SENT_22	[p2l11t1820r162b1869],
140	Hospital	NNP	ORGANIZATION	Hospital	dep	159	SENT_22	[p2l193t1819r454b1880],
141	,	,	O	,	_	0	SENT_22	[p2l193t1819r454b1880],
142	Perth	NNP	LOCATION	Perth	dep	159	SENT_22	[p2l485t1820r655b1878],
143	,	,	O	,	_	0	SENT_22	[p2l485t1820r655b1878],
144	Western	NNP	LOCATION	Western	dep	159	SENT_22	[p2l682t1819r930b1869],
145	Australia	NNP	LOCATION	Australia	dep	159	SENT_22	[p2l955t1820r1218b1869],
146	6000	CD	NUMBER	6000	dep	159	SENT_22	[p2l1245t1819r1427b1878],
147	,	,	O	,	_	0	SENT_22	[p2l1245t1819r1427b1878],
148	Australia	NNP	LOCATION	Australia	dep	159	SENT_22	[p2l1453t1819r1716b1869],
149	(	CD	NUMBER	(	dep	159	SENT_22	[p2l10t1909r225b1971],
150	e	SYM	O	e	dep	159	SENT_22	[p2l10t1909r225b1971],
151	—	CD	NUMBER	—	dep	159	SENT_22	[p2l10t1909r225b1971],
152	mail	NN	O	mail	dep	159	SENT_22	[p2l10t1909r225b1971],
153	:	:	O	:	_	0	SENT_22	[p2l10t1909r225b1971],
154	ma	FW	O	ma	dep	159	SENT_22	[p2l255t1908r1267b1972],
155	|	FW	O	|	dep	159	SENT_22	[p2l255t1908r1267b1972],
156	la	FW	O	la	dep	159	SENT_22	[p2l255t1908r1267b1972],
157	|	FW	O	|	dep	159	SENT_22	[p2l255t1908r1267b1972],
158	@prodiga	FW	O	@prodiga	dep	159	SENT_22	[p2l255t1908r1267b1972],
159	|	NN	O	|	_	0	SENT_22	[p2l255t1908r1267b1972],
160	.	.	O	.	_	0	SENT_22	[p2l255t1908r1267b1972],

1	murdoch.edu	NN	O	murdoch.edu	_	0	SENT_23	[p2l255t1908r1267b1972],
2	.	.	O	.	_	0	SENT_23	[p2l255t1908r1267b1972],

1	au	NN	O	au	nn	4	SENT_24	[p2l255t1908r1267b1972],
2	)	CD	NUMBER	)	num	4	SENT_24	[p2l255t1908r1267b1972],
3	Interpretation	NNP	O	Interpretation	nn	4	SENT_24	[p2l11t1995r480b2065],
4	Genetic	NNP	O	Genetic	nn	5	SENT_24	[p2l570t1995r822b2052],
5	susceptibility	NN	O	susceptibility	nsubjpass	10	SENT_24	[p2l910t1996r1348b2066],
6	to	TO	O	to	_	0	SENT_24	[p2l1430t1999r1494b2052],
7	abacavir	NN	O	abacavir	nn	8	SENT_24	[p2l1582t1996r1863b2052],
8	hypersensitivity	NN	O	hypersensitivity	prep_to	5	SENT_24	[p2l1949t1996r2145b2066, p2l10t2089r342b2159],
9	is	VBZ	O	be	auxpass	10	SENT_24	[p2l383t2089r434b2146],
10	carried	VBN	O	carry	_	0	SENT_24	[p2l474t2089r698b2146],
11	on	IN	O	on	_	0	SENT_24	[p2l741t2102r818b2146],
12	the	DT	O	the	det	15	SENT_24	[p2l858t2089r965b2146],
13	57-1	CD	NUMBER	57-1	npadvmod	14	SENT_24	[p2l1006t2089r1164b2146],
14	ancestral	JJ	O	ancestral	amod	15	SENT_24	[p2l1205t2089r1510b2146],
15	haplotype	NN	O	haplotype	prep_on	10	SENT_24	[p2l1556t2089r1896b2159],
16	.	.	O	.	_	0	SENT_24	[p2l1556t2089r1896b2159],

1	In	IN	O	in	_	0	SENT_25	[p2l1944t2089r1995b2145],
2	our	PRP$	O	we	poss	3	SENT_25	[p2l2038t2102r2145b2146],
3	population	NN	O	population	pobj	1	SENT_25	[p2l13t2182r379b2251],
4	,	,	O	,	_	0	SENT_25	[p2l13t2182r379b2251],
5	withholding	VBG	O	withhold	partmod	3	SENT_25	[p2l429t2182r810b2253],
6	abacavir	NN	O	abacavir	dobj	5	SENT_25	[p2l856t2182r1137b2239],
7	in	IN	O	in	_	0	SENT_25	[p2l1186t2182r1236b2238],
8	those	DT	O	those	prep_in	5	SENT_25	[p2l1285t2182r1474b2239],
9	with	IN	O	with	_	0	SENT_25	[p2l1521t2182r1653b2239],
10	HLA-B	NN	O	hla-b	prep_with	8	SENT_25	[p2l1705t2182r2138b2250],
11	*	CD	NUMBER	*	number	12	SENT_25	[p2l1705t2182r2138b2250],
12	5701	CD	NUMBER	5701	dep	10	SENT_25	[p2l1705t2182r2138b2250],
13	,	,	O	,	_	0	SENT_25	[p2l1705t2182r2138b2250],
14	HLA	NN	O	hlum	appos	10	SENT_25	[p2l9t2276r317b2342],
15	.	.	O	.	_	0	SENT_25	[p2l9t2276r317b2342],

1	—	NN	O	—	_	0	SENT_26	[p2l9t2276r317b2342],
2	.	.	O	.	_	0	SENT_26	[p2l9t2276r317b2342],

1	DR7	NN	O	dr7	nsubj	6	SENT_27	[p2l9t2276r317b2342],
2	,	,	O	,	_	0	SENT_27	[p2l9t2276r317b2342],
3	and	CC	O	and	_	0	SENT_27	[p2l382t2275r501b2331],
4	HLA-DQ3	NN	O	hla-dq3	conj_and	1	SENT_27	[p2l564t2275r857b2343],
5	should	MD	O	should	aux	6	SENT_27	[p2l920t2275r1140b2331],
6	reduce	VB	O	reduce	_	0	SENT_27	[p2l1207t2275r1429b2331],
7	the	DT	O	the	det	8	SENT_27	[p2l1489t2275r1595b2331],
8	prevalence	NN	O	prevalence	dobj	6	SENT_27	[p2l1661t2275r2019b2344],
9	of	IN	O	of	_	0	SENT_27	[p2l2082t2274r2147b2331],
10	hypersensitivity	NN	O	hypersensitivity	prep_of	8	SENT_27	[p2l12t2368r526b2438],
11	from	IN	O	from	_	0	SENT_27	[p2l589t2367r738b2425],
12	9	CD	PERCENT	9	number	16	SENT_27	[p2l809t2368r907b2425],
13	%	NN	PERCENT	%	dep	16	SENT_27	[p2l809t2368r907b2425],
14	to	TO	O	to	dep	16	SENT_27	[p2l972t2371r1037b2425],
15	2-5	CD	PERCENT	2-5	number	16	SENT_27	[p2l1106t2368r1274b2425],
16	%	NN	PERCENT	%	prep_from	6	SENT_27	[p2l1106t2368r1274b2425],
17	without	IN	O	without	_	0	SENT_27	[p2l1339t2368r1584b2425],
18	inappropriately	RB	O	inappropriately	advmod	19	SENT_27	[p2l1653t2368r2145b2438],
19	denying	VBG	O	deny	prepc_without	6	SENT_27	[p2l9t2461r265b2532],
20	abacavir	NN	O	abacavir	dobj	19	SENT_27	[p2l290t2461r571b2518],
21	to	TO	O	to	_	0	SENT_27	[p2l592t2465r657b2518],
22	any	DT	O	any	det	23	SENT_27	[p2l684t2474r799b2531],
23	patient	NN	O	patient	prep_to	19	SENT_27	[p2l826t2461r1073b2530],
24	.	.	O	.	_	0	SENT_27	[p2l826t2461r1073b2530],

1	Lancet	NNP	O	Lancet	_	0	SENT_28	[p2l9t2651r233b2706],
2	2002	CD	DATE	2002	num	1	SENT_28	[p2l258t2649r459b2715],
3	;	:	O	;	_	0	SENT_28	[p2l258t2649r459b2715],
4	359	CD	NUMBER	359	num	6	SENT_28	[p2l489t2649r647b2706],
5	:	:	O	:	_	0	SENT_28	[p2l489t2649r647b2706],
6	727-32	CD	NUMBER	727-32	dep	1	SENT_28	[p2l679t2649r943b2706],

1	See	VB	O	see	_	0	SENT_29	[p2l7t2761r131b2818],
2	Commentary	JJ	O	commentary	amod	3	SENT_29	[p2l158t2761r580b2830],
3	page	NN	O	page	dobj	1	SENT_29	[p2l598t2769r759b2832],
4	722	CD	NUMBER	722	nsubj	1	SENT_29	[p2l791t2761r919b2817],

1	Introduction	NN	O	introduction	nn	2	SENT_30	[p2l11t2920r542b2987],
2	Abacavir	NN	O	abacavir	nsubj	8	SENT_30	[p2l6t3020r324b3080],
3	is	VBZ	O	be	cop	8	SENT_30	[p2l370t3020r421b3080],
4	a	DT	O	a	det	8	SENT_30	[p2l473t3040r508b3080],
5	commonly	RB	O	commonly	advmod	6	SENT_30	[p2l558t3020r938b3096],
6	used	VBN	O	use	amod	8	SENT_30	[p2l984t3020r1149b3080],
7	nucleoside	JJ	O	nucleoside	amod	8	SENT_30	[p2l1196t3020r1573b3080],
8	analogue	NN	O	analogue	_	0	SENT_30	[p2l1624t3020r1940b3096],
9	with	IN	O	with	_	0	SENT_30	[p2l1988t3020r2144b3080],
10	potent	JJ	O	potent	amod	12	SENT_30	[p2l7t3126r238b3188],
11	antiviral	JJ	O	antiviral	amod	12	SENT_30	[p2l281t3112r565b3173],
12	activity	NN	O	activity	prep_with	8	SENT_30	[p2l610t3112r863b3188],
13	against	IN	O	against	_	0	SENT_30	[p2l904t3112r1150b3188],
14	HIV-1	NN	O	hiv-1	prep_against	12	SENT_30	[p2l1192t3113r1443b3173],
15	.	.	O	.	_	0	SENT_30	[p2l1192t3113r1443b3173],

1	About	IN	O	about	_	0	SENT_31	[p2l1488t3112r1715b3173],
2	5	CD	PERCENT	5	number	3	SENT_31	[p2l1759t3112r1870b3175],
3	%	NN	PERCENT	%	amod	5	SENT_31	[p2l1759t3112r1870b3175],
4	(	CD	NUMBER	(	num	5	SENT_31	[p2l1923t3113r2143b3188],
5	range	NN	O	range	prep_about	16	SENT_31	[p2l1923t3113r2143b3188],
6	0	CD	PERCENT	0	num	7	SENT_31	[p2l10t3206r286b3281],
7	—	CD	PERCENT	—	dep	5	SENT_31	[p2l10t3206r286b3281],
8	14	CD	PERCENT	14	number	9	SENT_31	[p2l10t3206r286b3281],
9	%	NN	PERCENT	%	amod	7	SENT_31	[p2l10t3206r286b3281],
10	)	CD	NUMBER	)	nsubj	16	SENT_31	[p2l10t3206r286b3281],
11	of	IN	O	of	_	0	SENT_31	[p2l365t3205r441b3266],
12	patients	NNS	O	patient	prep_of	10	SENT_31	[p2l501t3206r779b3281],
13	treated	VBN	O	treat	partmod	12	SENT_31	[p2l851t3205r1098b3266],
14	with	IN	O	with	_	0	SENT_31	[p2l1168t3205r1325b3266],
15	abacavir	NN	O	abacavir	prep_with	13	SENT_31	[p2l1397t3205r1690b3266],
16	develop	VBP	O	develop	_	0	SENT_31	[p2l1761t3205r2033b3281],
17	a	DT	O	a	det	19	SENT_31	[p2l2108t3225r2143b3266],
18	hypersensitivity	NN	O	hypersensitivity	nn	19	SENT_31	[p2l7t3299r559b3375],
19	reaction	NN	O	reaction	dobj	16	SENT_31	[p2l636t3299r923b3359],
20	characterised	VBN	O	characterise	partmod	19	SENT_31	[p2l1004t3299r1470b3359],
21	by	IN	O	by	_	0	SENT_31	[p2l1548t3299r1635b3375],
22	multisystem	NN	O	multisystem	nn	23	SENT_31	[p2l1712t3299r2144b3375],
23	involvement	NN	O	involvement	agent	20	SENT_31	[p2l8t3391r446b3452],
24	that	WDT	O	that	nsubj	27	SENT_31	[p2l493t3391r633b3452],
25	can	MD	O	can	aux	27	SENT_31	[p2l683t3411r804b3452],
26	be	VB	O	be	cop	27	SENT_31	[p2l851t3391r935b3452],
27	fatal	JJ	O	fatal	rcmod	23	SENT_31	[p2l985t3391r1136b3452],
28	in	IN	O	in	_	0	SENT_31	[p2l1185t3391r1252b3451],
29	rare	JJ	O	rare	amod	30	SENT_31	[p2l1300t3411r1437b3452],
30	cases	NNS	O	case	prep_in	27	SENT_31	[p2l1488t3392r1708b3452],
31	.	.	O	.	_	0	SENT_31	[p2l1488t3392r1708b3452],

1	‘	NN	O	‘	nn	2	SENT_32	[p2l1488t3392r1708b3452],
2	Symptoms	NNS	O	symptom	nsubj	22	SENT_32	[p2l1764t3391r2142b3467],
3	usually	RB	O	usually	advmod	4	SENT_32	[p2l8t3484r258b3560],
4	appear	VBP	O	appear	_	0	SENT_32	[p2l282t3504r521b3560],
5	within	IN	O	within	_	0	SENT_32	[p2l541t3484r767b3545],
6	the	DT	O	the	det	7	SENT_32	[p2l789t3484r899b3545],
7	ﬁrst	NN	O	ﬁrst	prep_within	4	SENT_32	[p2l924t3484r1060b3545],
8	6	CD	DURATION	6	num	9	SENT_32	[p2l1087t3487r1124b3545],
9	weeks	NNS	NUMBER	week	tmod	7	SENT_32	[p2l1149t3484r1360b3545],
10	of	IN	O	of	_	0	SENT_32	[p2l1387t3484r1463b3545],
11	treatment	NN	O	treatment	prep_of	7	SENT_32	[p2l1476t3499r1824b3545],
12	(	CD	NUMBER	(	num	11	SENT_32	[p2l1853t3484r2144b3560],
13	median	JJ	O	median	amod	14	SENT_32	[p2l1853t3484r2144b3560],
14	time	NN	O	time	tmod	7	SENT_32	[p2l8t3578r165b3638],
15	to	TO	O	to	_	0	SENT_32	[p2l198t3592r267b3638],
16	onset	NN	O	onset	prep_to	7	SENT_32	[p2l303t3592r490b3638],
17	11	CD	DURATION	11	num	18	SENT_32	[p2l532t3580r602b3637],
18	days	NNS	NUMBER	day	tmod	16	SENT_32	[p2l646t3578r827b3654],
19	)	RB	O	)	advmod	4	SENT_32	[p2l646t3578r827b3654],
20	and	CC	O	and	_	0	SENT_32	[p2l867t3578r998b3638],
21	characteristically	RB	O	characteristically	advmod	22	SENT_32	[p2l1032t3578r1624b3654],
22	include	VBP	O	include	conj_and	4	SENT_32	[p2l1656t3578r1916b3638],
23	fever	NN	O	fever	dobj	22	SENT_32	[p2l1949t3578r2140b3651],
24	,	,	O	,	_	0	SENT_32	[p2l1949t3578r2140b3651],
25	rash	NN	O	rash	appos	23	SENT_32	[p2l8t3670r176b3743],
26	,	,	O	,	_	0	SENT_32	[p2l8t3670r176b3743],
27	gastrointestinal	JJ	O	gastrointestinal	amod	28	SENT_32	[p2l285t3670r823b3746],
28	symptoms	NNS	O	symptom	appos	23	SENT_32	[p2l932t3684r1294b3746],
29	(	JJ	O	(	amod	30	SENT_32	[p2l1408t3671r1696b3745],
30	nausea	NN	O	nausea	dep	28	SENT_32	[p2l1408t3671r1696b3745],
31	,	,	O	,	_	0	SENT_32	[p2l1408t3671r1696b3745],
32	vomiting	VBG	O	vomit	appos	28	SENT_32	[p2l1804t3670r2140b3746],
33	,	,	O	,	_	0	SENT_32	[p2l1804t3670r2140b3746],

1	diarrhoea	NN	O	diarrhoea	_	0	SENT_33	[p3l9t15r366b88],
2	,	,	O	,	_	0	SENT_33	[p3l9t15r366b88],
3	or	CC	O	or	_	0	SENT_33	[p3l396t35r470b76],
4	abdominal	JJ	O	abdominal	amod	5	SENT_33	[p3l495t15r872b76],
5	pain	NN	O	pain	conj_or	1	SENT_33	[p3l896t16r1076b91],
6	)	NN	O	)	dep	1	SENT_33	[p3l896t16r1076b91],
7	and	CC	O	and	_	0	SENT_33	[p3l1110t15r1240b76],
8	lethargy	NN	O	lethargy	dep	1	SENT_33	[p3l1266t15r1550b91],
9	or	CC	O	or	_	0	SENT_33	[p3l1576t35r1649b76],
10	malaise	NN	O	malaise	conj_and	6	SENT_33	[p3l1673t15r1955b76],
11	.	.	O	.	_	0	SENT_33	[p3l1673t15r1955b76],

1	Less	RBR	O	less	advmod	3	SENT_34	[p3l1985t16r2142b76],
2	common	JJ	O	common	amod	3	SENT_34	[p3l10t128r327b169],
3	manifestations	NNS	O	manifestation	nsubj	4	SENT_34	[p3l473t109r987b169],
4	include	VBP	O	include	_	0	SENT_34	[p3l1135t109r1396b169],
5	respiratory	JJ	O	respiratory	amod	8	SENT_34	[p3l1543t109r1925b185],
6	or	CC	O	or	_	0	SENT_34	[p3l2071t128r2145b169],
7	musculoskeletal	JJ	O	musculoskeletal	conj_or	5	SENT_34	[p3l8t201r572b262],
8	symptoms	NNS	O	symptom	dobj	4	SENT_34	[p3l698t215r1082b277],
9	,	,	O	,	_	0	SENT_34	[p3l698t215r1082b277],
10	headache	NN	O	headache	amod	19	SENT_34	[p3l1208t201r1562b274],
11	,	,	O	,	_	0	SENT_34	[p3l1208t201r1562b274],
12	paraesthesia	NN	O	paraesthesium	conj_or	10	SENT_34	[p3l1688t201r2140b277],
13	,	,	O	,	_	0	SENT_34	[p3l1688t201r2140b277],
14	oedema	NN	O	oedema	conj_or	10	SENT_34	[p3l10t294r307b367],
15	,	,	O	,	_	0	SENT_34	[p3l10t294r307b367],
16	renal	JJ	O	renal	conj_or	10	SENT_34	[p3l334t294r510b355],
17	or	CC	O	or	_	0	SENT_34	[p3l536t314r609b355],
18	hepatic	JJ	O	hepatic	conj_or	10	SENT_34	[p3l629t294r887b370],
19	failure	NN	O	failure	dobj	4	SENT_34	[p3l911t294r1155b367],
20	,	,	O	,	_	0	SENT_34	[p3l911t294r1155b367],
21	or	CC	O	or	_	0	SENT_34	[p3l1183t314r1257b355],
22	anaphylaxis	NN	O	anaphylaxi	dobj	4	SENT_34	[p3l1280t294r1733b370],
23	.	.	O	.	_	0	SENT_34	[p3l1280t294r1733b370],

1	‘	NN	O	‘	nn	2	SENT_35	[p3l1280t294r1733b370],
2	Symptoms	NNS	O	symptom	nsubj	8	SENT_35	[p3l1765t295r2142b371],
3	related	VBN	O	relate	partmod	2	SENT_35	[p3l8t388r250b448],
4	to	TO	O	to	_	0	SENT_35	[p3l328t402r396b448],
5	the	DT	O	the	det	7	SENT_35	[p3l477t388r586b448],
6	hypersensitivity	NN	O	hypersensitivity	nn	7	SENT_35	[p3l664t388r1216b464],
7	reaction	NN	O	reaction	prep_to	3	SENT_35	[p3l1293t388r1580b448],
8	worsen	VBP	O	worsen	_	0	SENT_35	[p3l1657t407r1911b448],
9	with	IN	O	with	_	0	SENT_35	[p3l1988t388r2144b448],
10	continued	JJ	O	continued	amod	11	SENT_35	[p3l10t480r367b541],
11	therapy	NN	O	therapy	prep_with	8	SENT_35	[p3l418t480r686b556],
12	and	CC	O	and	_	0	SENT_35	[p3l738t480r869b541],
13	usually	RB	O	usually	advmod	14	SENT_35	[p3l920t480r1170b556],
14	improve	VBP	O	improve	conj_and	8	SENT_35	[p3l1220t480r1511b556],
15	within	IN	O	within	_	0	SENT_35	[p3l1562t480r1787b541],
16	24	CD	NUMBER	24	num	17	SENT_35	[p3l1841t483r1926b540],
17	h	NN	O	h	prep_within	14	SENT_35	[p3l1978t480r2024b540],
18	of	IN	O	of	_	0	SENT_35	[p3l2077t480r2154b541],
19	abacavir	NN	O	abacavir	nn	20	SENT_35	[p3l10t573r304b634],
20	discontinuation	NN	O	discontinuation	prep_of	17	SENT_35	[p3l334t573r906b634],
21	.	.	O	.	_	0	SENT_35	[p3l334t573r906b634],

1	Rechallenge	VB	MISC	rechallenge	_	0	SENT_36	[p3l944t573r1373b649],
2	with	IN	O	with	_	0	SENT_36	[p3l1404t573r1560b634],
3	abacavir	NN	O	abacavir	prep_with	1	SENT_36	[p3l1593t573r1886b634],
4	after	IN	O	after	mark	9	SENT_36	[p3l1917t573r2076b634],
5	a	DT	O	a	det	7	SENT_36	[p3l2108t593r2143b634],
6	hypersensitivity	NN	O	hypersensitivity	nn	7	SENT_36	[p3l7t667r559b743],
7	reaction	NN	O	reaction	nsubj	9	SENT_36	[p3l601t667r888b727],
8	typically	RB	O	typically	advmod	9	SENT_36	[p3l931t667r1227b743],
9	results	VBZ	O	result	advcl	1	SENT_36	[p3l1270t667r1497b727],
10	in	IN	O	in	_	0	SENT_36	[p3l1542t667r1610b726],
11	recurrence	NN	O	recurrence	prep_in	9	SENT_36	[p3l1653t686r2031b727],
12	of	IN	O	of	_	0	SENT_36	[p3l2077t667r2153b727],
13	symptoms	NNS	O	symptom	prep_of	11	SENT_36	[p3l9t773r372b835],
14	within	IN	O	within	_	0	SENT_36	[p3l396t759r621b820],
15	hours	NNS	DURATION	hour	prep_within	9	SENT_36	[p3l643t759r865b832],
16	,	,	O	,	_	0	SENT_36	[p3l643t759r865b832],
17	with	IN	O	with	_	0	SENT_36	[p3l891t759r1046b820],
18	the	DT	O	the	det	19	SENT_36	[p3l1070t759r1179b820],
19	potential	JJ	O	potential	prep_with	9	SENT_36	[p3l1203t759r1516b835],
20	to	TO	O	to	aux	21	SENT_36	[p3l1540t773r1609b820],
21	induce	VB	O	induce	xcomp	9	SENT_36	[p3l1634t759r1873b820],
22	a	DT	O	a	det	26	SENT_36	[p3l1899t779r1935b820],
23	more	RBR	O	more	advmod	24	SENT_36	[p3l1959t779r2143b820],
24	severe	JJ	O	severe	amod	26	SENT_36	[p3l9t872r224b913],
25	clinical	JJ	O	clinical	amod	26	SENT_36	[p3l298t852r545b913],
26	syndrome	NN	O	syndrome	dobj	21	SENT_36	[p3l619t852r968b928],
27	with	IN	O	with	_	0	SENT_36	[p3l1039t852r1195b913],
28	increased	VBN	O	increase	amod	29	SENT_36	[p3l1267t852r1600b913],
29	risk	NN	O	risk	prep_with	21	SENT_36	[p3l1672t852r1799b913],
30	of	IN	O	of	_	0	SENT_36	[p3l1870t852r1946b913],
31	lifethreatening	VBG	O	lifethreaten	prepc_of	29	SENT_36	[p3l2008t852r2143b913, p3l8t946r414b1022],
32	hypotension	NN	O	hypotension	dobj	31	SENT_36	[p3l435t946r872b1022],
33	and	CC	O	and	_	0	SENT_36	[p3l898t946r1028b1006],
34	death	NN	O	death	dobj	31	SENT_36	[p3l1054t946r1295b1006],
35	?	.	O	?	_	0	SENT_36	[p3l1054t946r1295b1006],

1	Several	JJ	O	several	amod	2	SENT_37	[p3l96t1038r348b1099],
2	observations	NNS	O	observation	nsubj	3	SENT_37	[p3l388t1038r828b1099],
3	support	VBP	O	support	_	0	SENT_37	[p3l868t1052r1141b1114],
4	the	DT	O	the	det	5	SENT_37	[p3l1177t1038r1287b1099],
5	possibility	NN	O	possibility	dobj	3	SENT_37	[p3l1324t1038r1681b1114],
6	that	IN	O	that	complm	15	SENT_37	[p3l1716t1038r1855b1099],
7	genetic	JJ	O	genetic	amod	9	SENT_37	[p3l1892t1038r2143b1114],
8	susceptibility	NN	O	susceptibility	nn	9	SENT_37	[p3l9t1131r471b1207],
9	factors	NNS	O	factor	nsubj	15	SENT_37	[p3l513t1131r747b1192],
10	for	IN	O	for	_	0	SENT_37	[p3l791t1131r892b1192],
11	this	DT	O	this	det	14	SENT_37	[p3l933t1131r1057b1192],
12	idiosyncratic	JJ	O	idiosyncratic	amod	14	SENT_37	[p3l1102t1131r1551b1207],
13	hypersensitivity	NN	O	hypersensitivity	nn	14	SENT_37	[p3l1593t1131r2145b1207],
14	syndrome	NN	O	syndrome	prep_for	9	SENT_37	[p3l9t1225r358b1301],
15	exist	VBP	O	exist	ccomp	3	SENT_37	[p3l391t1225r569b1298],
16	,	,	O	,	_	0	SENT_37	[p3l391t1225r569b1298],
17	and	CC	O	and	_	0	SENT_37	[p3l604t1225r735b1285],
18	more	RBR	O	more	advmod	15	SENT_37	[p3l765t1244r949b1285],
19	speciﬁcally	RB	O	speciﬁcally	advmod	24	SENT_37	[p3l981t1225r1366b1301],
20	that	IN	O	that	dep	24	SENT_37	[p3l1394t1225r1533b1285],
21	involved	JJ	O	involved	amod	23	SENT_37	[p3l1563t1225r1862b1285],
22	genetic	JJ	O	genetic	amod	23	SENT_37	[p3l1892t1225r2143b1301],
23	loci	NNS	O	locus	nsubj	24	SENT_37	[p3l8t1317r133b1378],
24	lie	VBP	O	lie	ccomp	3	SENT_37	[p3l180t1317r259b1378],
25	within	IN	O	within	_	0	SENT_37	[p3l305t1317r530b1378],
26	the	DT	O	the	det	28	SENT_37	[p3l575t1317r685b1378],
27	MHC	NN	O	mhc	nn	28	SENT_37	[p3l732t1317r948b1378],
28	region	NN	O	region	prep_within	24	SENT_37	[p3l997t1317r1239b1393],
29	.	.	O	.	_	0	SENT_37	[p3l997t1317r1239b1393],

1	First	RB	ORDINAL	first	advmod	33	SENT_38	[p3l1291t1317r1475b1390],
2	,	,	O	,	_	0	SENT_38	[p3l1291t1317r1475b1390],
3	only	RB	O	only	advmod	5	SENT_38	[p3l1527t1317r1678b1393],
4	a	DT	O	a	det	5	SENT_38	[p3l1725t1337r1759b1378],
5	subset	NN	O	subset	nsubj	33	SENT_38	[p3l1808t1317r2030b1378],
6	of	IN	O	of	_	0	SENT_38	[p3l2077t1317r2154b1378],
7	individuals	NNS	O	individual	prep_of	5	SENT_38	[p3l8t1410r393b1471],
8	exposed	VBN	O	expose	partmod	7	SENT_38	[p3l446t1410r732b1486],
9	to	TO	O	to	aux	10	SENT_38	[p3l782t1425r850b1471],
10	abacavir	VB	O	abacavir	xcomp	8	SENT_38	[p3l904t1410r1198b1471],
11	develop	VB	O	develop	xcomp	10	SENT_38	[p3l1247t1410r1518b1486],
12	hypersensitivity	NN	O	hypersensitivity	dobj	11	SENT_38	[p3l1570t1410r2140b1486],
13	,	,	O	,	_	0	SENT_38	[p3l1570t1410r2140b1486],
14	typically	RB	O	typically	advmod	11	SENT_38	[p3l8t1504r304b1580],
15	within	IN	O	within	_	0	SENT_38	[p3l331t1504r556b1564],
16	6	CD	DURATION	6	num	17	SENT_38	[p3l589t1506r627b1564],
17	weeks	NNS	NUMBER	week	prep_within	11	SENT_38	[p3l658t1504r868b1564],
18	of	IN	O	of	_	0	SENT_38	[p3l902t1504r978b1564],
19	starting	VBG	O	start	prepc_of	17	SENT_38	[p3l1000t1504r1265b1580],
20	therapy	NN	O	therapy	dobj	19	SENT_38	[p3l1294t1504r1580b1580],
21	,	,	O	,	_	0	SENT_38	[p3l1294t1504r1580b1580],
22	and	CC	O	and	_	0	SENT_38	[p3l1615t1504r1746b1564],
23	those	DT	O	those	prep_within	11	SENT_38	[p3l1776t1504r1963b1564],
24	who	WP	O	who	nsubj	27	SENT_38	[p3l1992t1504r2142b1564],
25	do	VBP	O	do	aux	27	SENT_38	[p3l9t1596r97b1657],
26	not	RB	O	not	neg	27	SENT_38	[p3l122t1610r241b1657],
27	develop	VB	O	develop	rcmod	23	SENT_38	[p3l266t1596r538b1672],
28	the	DT	O	the	det	29	SENT_38	[p3l564t1596r674b1657],
29	syndrome	NN	O	syndrome	dobj	27	SENT_38	[p3l701t1596r1050b1672],
30	within	IN	O	within	_	0	SENT_38	[p3l1074t1596r1299b1657],
31	this	DT	O	this	det	32	SENT_38	[p3l1323t1596r1448b1657],
32	time	NN	O	time	prep_within	27	SENT_38	[p3l1474t1596r1630b1657],
33	remain	VBP	O	remain	_	0	SENT_38	[p3l1656t1596r1905b1657],
34	at	IN	O	at	_	0	SENT_38	[p3l1931t1610r1994b1657],
35	low	JJ	O	low	amod	36	SENT_38	[p3l2018t1596r2144b1657],
36	risk	NN	O	risk	prep_at	33	SENT_38	[p3l8t1689r135b1750],
37	despite	IN	O	despite	_	0	SENT_38	[p3l169t1689r417b1765],
38	continued	JJ	O	continued	amod	39	SENT_38	[p3l453t1689r811b1750],
39	therapy	NN	O	therapy	prep_despite	33	SENT_38	[p3l844t1689r1129b1765],
40	.	.	O	.	_	0	SENT_38	[p3l844t1689r1129b1765],

1	Second	RB	ORDINAL	second	advmod	12	SENT_39	[p3l1171t1689r1453b1762],
2	,	,	O	,	_	0	SENT_39	[p3l1171t1689r1453b1762],
3	a	DT	O	a	det	4	SENT_39	[p3l1492t1709r1527b1750],
4	meta-analysis	NN	O	meta-analysis	nsubj	12	SENT_39	[p3l1562t1689r2040b1765],
5	of	IN	O	of	_	0	SENT_39	[p3l2077t1689r2153b1750],
6	25	CD	NUMBER	25	num	8	SENT_39	[p3l10t1785r92b1843],
7	clinical	JJ	O	clinical	amod	8	SENT_39	[p3l131t1783r378b1843],
8	studies	NNS	O	study	prep_of	4	SENT_39	[p3l412t1783r655b1843],
9	involving	VBG	O	involve	partmod	8	SENT_39	[p3l688t1783r1013b1859],
10	5248	CD	NUMBER	5248	num	11	SENT_39	[p3l1047t1785r1221b1843],
11	participants	NNS	O	participant	dobj	9	SENT_39	[p3l1255t1783r1671b1859],
12	showed	VBD	O	show	_	0	SENT_39	[p3l1707t1783r1973b1843],
13	that	IN	O	that	complm	17	SENT_39	[p3l2005t1783r2144b1843],
14	ethnic	JJ	O	ethnic	amod	15	SENT_39	[p3l10t1875r225b1936],
15	origin	NN	O	origin	nsubj	17	SENT_39	[p3l254t1875r459b1951],
16	might	MD	O	might	aux	17	SENT_39	[p3l485t1875r693b1951],
17	inﬂuence	VB	O	inﬂuence	ccomp	12	SENT_39	[p3l719t1875r1043b1936],
18	abacavir	NN	O	abacavir	nn	19	SENT_39	[p3l1072t1875r1365b1936],
19	hypersensitivity	NN	O	hypersensitivity	dobj	17	SENT_39	[p3l1389t1875r1960b1951],
20	,	,	O	,	_	0	SENT_39	[p3l1389t1875r1960b1951],
21	with	IN	O	with	_	0	SENT_39	[p3l1988t1875r2144b1936],
22	decreased	VBN	O	decrease	amod	23	SENT_39	[p3l9t1968r358b2029],
23	risk	NN	O	risk	prep_with	12	SENT_39	[p3l437t1968r564b2029],
24	associated	VBN	O	associate	partmod	23	SENT_39	[p3l644t1968r1002b2029],
25	with	IN	O	with	_	0	SENT_39	[p3l1080t1968r1236b2029],
26	black	JJ	O	black	amod	27	SENT_39	[p3l1314t1968r1504b2029],
27	race	NN	O	race	prep_with	24	SENT_39	[p3l1581t1970r1772b2029],
28	.	.	O	.	_	0	SENT_39	[p3l1581t1970r1772b2029],

1	-	:	O	-	_	0	SENT_40	[p3l1581t1970r1772b2029],
2	°	NN	O	°	nsubjpass	9	SENT_40	[p3l1581t1970r1772b2029],
3	’	CD	NUMBER	’	num	5	SENT_40	[p3l1581t1970r1772b2029],
4	Familial	JJ	MISC	familial	amod	5	SENT_40	[p3l1853t1969r2143b2029],
5	predisposition	NN	O	predisposition	dep	2	SENT_40	[p3l7t2062r511b2138],
6	has	VBZ	O	have	aux	9	SENT_40	[p3l566t2062r682b2122],
7	also	RB	O	also	advmod	9	SENT_40	[p3l743t2062r875b2122],
8	been	VBN	O	be	auxpass	9	SENT_40	[p3l933t2062r1104b2122],
9	reported	VBN	O	report	_	0	SENT_40	[p3l1160t2062r1509b2138],
10	.	.	O	.	_	0	SENT_40	[p3l1160t2062r1509b2138],

1	‘‘	NN	O	‘‘	tmod	5	SENT_41	[p3l1160t2062r1509b2138],
2	Third	NNP	ORDINAL	Third	dep	1	SENT_41	[p3l1566t2062r1794b2135],
3	,	,	O	,	_	0	SENT_41	[p3l1566t2062r1794b2135],
4	there	EX	O	there	expl	5	SENT_41	[p3l1854t2062r2033b2122],
5	is	VBZ	O	be	_	0	SENT_41	[p3l2092t2062r2142b2122],
6	evidence	NN	O	evidence	nsubj	5	SENT_41	[p3l10t2154r316b2215],
7	that	IN	O	that	complm	17	SENT_41	[p3l413t2154r552b2215],
8	the	DT	O	the	det	9	SENT_41	[p3l647t2154r757b2215],
9	pathogenesis	NN	O	pathogenesis	nsubj	17	SENT_41	[p3l853t2154r1308b2230],
10	of	IN	O	of	_	0	SENT_41	[p3l1407t2154r1483b2215],
11	several	JJ	O	several	amod	16	SENT_41	[p3l1571t2154r1808b2215],
12	similar	JJ	O	similar	amod	16	SENT_41	[p3l1907t2154r2146b2215],
13	multisystem	NN	O	multisystem	nn	16	SENT_41	[p3l8t2247r439b2323],
14	drug	NN	O	drug	nn	16	SENT_41	[p3l468t2247r633b2323],
15	hypersensitivity	NN	O	hypersensitivity	nn	16	SENT_41	[p3l658t2247r1210b2323],
16	reactions	NNS	O	reaction	prep_of	9	SENT_41	[p3l1236t2248r1553b2308],
17	involves	VBZ	O	involve	ccomp	5	SENT_41	[p3l1583t2247r1865b2308],
18	MHC	NN	O	mhc	npadvmod	20	SENT_41	[p3l1895t2248r2143b2308],
19	—	CD	NUMBER	—	num	18	SENT_41	[p3l1895t2248r2143b2308],
20	restricted	JJ	O	restricted	amod	21	SENT_41	[p3l8t2341r339b2401],
21	presentation	NN	O	presentation	dobj	17	SENT_41	[p3l382t2341r823b2417],
22	of	IN	O	of	_	0	SENT_41	[p3l868t2341r945b2401],
23	drug	NN	O	drug	nn	26	SENT_41	[p3l980t2341r1145b2417],
24	or	CC	O	or	_	0	SENT_41	[p3l1189t2361r1263b2401],
25	drug	NN	O	drug	nn	26	SENT_41	[p3l1306t2341r1471b2417],
26	metabolites	NNS	O	metabolite	prep_of	21	SENT_41	[p3l1513t2341r1942b2414],
27	,	,	O	,	_	0	SENT_41	[p3l1513t2341r1942b2414],
28	with	IN	O	with	_	0	SENT_41	[p3l1988t2341r2144b2401],
29	direct	JJ	O	direct	amod	30	SENT_41	[p3l9t2433r211b2494],
30	binding	NN	O	binding	prep_with	17	SENT_41	[p3l265t2433r540b2509],
31	of	IN	O	of	_	0	SENT_41	[p3l597t2433r673b2494],
32	these	DT	O	these	det	34	SENT_41	[p3l719t2433r900b2494],
33	non-peptide	JJ	O	non-peptide	amod	34	SENT_41	[p3l957t2433r1390b2509],
34	antigens	NNS	O	antigen	prep_of	30	SENT_41	[p3l1450t2433r1740b2509],
35	to	TO	O	to	_	0	SENT_41	[p3l1798t2447r1866b2494],
36	MHC	NN	O	mhc	nn	37	SENT_41	[p3l1924t2433r2140b2494],
37	molecules	NNS	O	molecule	prep_to	34	SENT_41	[p3l8t2526r361b2587],
38	or	CC	O	or	_	0	SENT_41	[p3l391t2546r464b2587],
39	haptenation	NN	O	haptenation	prep_of	30	SENT_41	[p3l488t2526r913b2602],
40	to	TO	O	to	_	0	SENT_41	[p3l939t2541r1007b2587],
41	endogenous	JJ	O	endogenous	amod	42	SENT_41	[p3l1037t2526r1462b2602],
42	proteins	NNS	O	protein	prep_to	39	SENT_41	[p3l1489t2527r1776b2602],
43	before	IN	O	before	_	0	SENT_41	[p3l1802t2526r2025b2587],
44	Tcell	NNP	O	Tcell	nn	45	SENT_41	[p3l2051t2527r2143b2586, p3l10t2620r126b2680],
45	presentation	NN	O	presentation	prep_before	42	SENT_41	[p3l150t2620r680b2696],
46	.	.	O	.	_	0	SENT_41	[p3l150t2620r680b2696],

1	“	NN	O	“	_	0	SENT_42	[p3l150t2620r680b2696],

1	Investigation	NN	O	investigation	nsubjpass	12	SENT_43	[p3l93t2712r551b2788],
2	of	IN	O	of	_	0	SENT_43	[p3l593t2712r669b2773],
3	associations	NNS	O	association	prep_of	1	SENT_43	[p3l702t2712r1119b2773],
4	between	IN	O	between	_	0	SENT_43	[p3l1160t2712r1457b2773],
5	MHC	NN	O	mhc	nn	6	SENT_43	[p3l1498t2712r1714b2773],
6	alleles	NNS	O	allele	prep_between	3	SENT_43	[p3l1760t2712r1969b2773],
7	and	CC	O	and	_	0	SENT_43	[p3l2013t2712r2144b2773],
8	clinical	JJ	O	clinical	amod	9	SENT_43	[p3l10t2805r257b2866],
9	phenotypes	NNS	O	phenotype	prep_between	3	SENT_43	[p3l291t2805r696b2881],
10	can	MD	O	can	aux	12	SENT_43	[p3l735t2825r857b2866],
11	be	VB	O	be	auxpass	12	SENT_43	[p3l890t2805r974b2866],
12	facilitated	VBN	O	facilitate	_	0	SENT_43	[p3l1010t2805r1356b2866],
13	by	IN	O	by	_	0	SENT_43	[p3l1390t2805r1476b2881],
14	an	DT	O	a	det	15	SENT_43	[p3l1511t2825r1595b2866],
15	understanding	NN	O	understanding	agent	12	SENT_43	[p3l1629t2805r2145b2881],
16	of	IN	O	of	_	0	SENT_43	[p3l10t2899r86b2959],
17	expected	VBN	O	expect	amod	19	SENT_43	[p3l147t2899r460b2975],
18	linkage	NN	O	linkage	nn	19	SENT_43	[p3l530t2899r779b2975],
19	disequilibrium	NN	O	disequilibrium	prep_of	15	SENT_43	[p3l851t2899r1366b2975],
20	across	IN	O	across	_	0	SENT_43	[p3l1437t2918r1650b2959],
21	the	DT	O	the	det	22	SENT_43	[p3l1721t2899r1831b2959],
22	MHC	NN	O	mhc	prep_across	19	SENT_43	[p3l1900t2899r2138b2959],
23	.	.	O	.	_	0	SENT_43	[p3l1900t2899r2138b2959],

1	Particular	JJ	O	particular	amod	2	SENT_44	[p3l9t2991r358b3052],
2	arrangements	NNS	O	arrangement	nsubjpass	13	SENT_44	[p3l396t3005r876b3067],
3	of	IN	O	of	_	0	SENT_44	[p3l917t2991r994b3052],
4	alleles	NNS	O	allele	prep_of	2	SENT_44	[p3l1024t2991r1255b3064],
5	,	,	O	,	_	0	SENT_44	[p3l1024t2991r1255b3064],
6	referred	VBN	O	refer	partmod	2	SENT_44	[p3l1296t2991r1575b3052],
7	to	TO	O	to	_	0	SENT_44	[p3l1613t3005r1681b3052],
8	as	IN	O	as	dep	9	SENT_44	[p3l1724t3011r1790b3052],
9	ancestral	JJ	O	ancestral	amod	10	SENT_44	[p3l1831t2991r2143b3052],
10	haplotypes	NNS	O	haplotype	prep_to	6	SENT_44	[p3l7t3084r409b3160],
11	,	,	O	,	_	0	SENT_44	[p3l7t3084r409b3160],
12	are	VBP	O	be	auxpass	13	SENT_44	[p3l455t3104r560b3145],
13	known	VBN	O	know	_	0	SENT_44	[p3l602t3084r843b3145],
14	to	TO	O	to	aux	16	SENT_44	[p3l883t3099r951b3145],
15	be	VB	O	be	auxpass	16	SENT_44	[p3l993t3084r1077b3145],
16	maintained	VBN	O	maintain	xcomp	13	SENT_44	[p3l1118t3084r1519b3145],
17	and	CC	O	and	_	0	SENT_44	[p3l1562t3084r1693b3145],
18	transmitted	VBN	O	transmit	conj_and	16	SENT_44	[p3l1734t3084r2144b3145],
19	through	IN	O	through	_	0	SENT_44	[p3l8t3178r291b3254],
20	generations	NNS	O	generation	prep_through	16	SENT_44	[p3l347t3178r753b3254],
21	en	IN	O	en	_	0	SENT_44	[p3l813t3197r896b3238],
22	bloc	NN	O	bloc	prep_en	20	SENT_44	[p3l951t3178r1122b3251],
23	,	,	O	,	_	0	SENT_44	[p3l951t3178r1122b3251],
24	with	IN	O	with	xcomp	13	SENT_44	[p3l1181t3178r1336b3238],
25	a	DT	O	a	det	27	SENT_44	[p3l1394t3198r1429b3238],
26	low	JJ	O	low	amod	27	SENT_44	[p3l1487t3178r1613b3238],
27	frequency	NN	O	frequency	pobj	24	SENT_44	[p3l1668t3178r2021b3254],
28	of	IN	O	of	prep	27	SENT_44	[p3l2077t3178r2154b3238],

1	THE	DT	O	the	det	2	SENT_45	[p3l92t3355r158b3375],
2	LANCET	NN	O	lancet	_	0	SENT_45	[p3l167t3355r297b3376],
3	-	:	O	-	_	0	SENT_45	[p3l306t3362r314b3369],
4	Vol	NN	O	vol	dep	2	SENT_45	[p3l323t3355r367b3376],
5	359	CD	NUMBER	359	dep	4	SENT_45	[p3l377t3356r422b3376],
6	-	:	O	-	_	0	SENT_45	[p3l434t3362r441b3369],
7	March	NNP	DATE	March	dep	4	SENT_45	[p3l451t3355r535b3376],
8	2	CD	DATE	2	num	7	SENT_45	[p3l544t3356r566b3379],
9	,	,	DATE	,	_	0	SENT_45	[p3l544t3356r566b3379],
10	2002	CD	DATE	2002	num	7	SENT_45	[p3l577t3356r639b3376],
11	-	:	O	-	_	0	SENT_45	[p3l650t3362r657b3369],
12	www.the1ancet.com	NN	O	www.the1ancet.com	dep	7	SENT_45	[p3l667t3355r917b3376],
13	727	CD	NUMBER	727	num	14	SENT_45	[p3l2004t3350r2062b3375],
14	ARTICLES	NNS	O	article	dep	2	SENT_45	[p3l91t3398r244b3419],

1	recombination	NN	O	recombination	nn	2	SENT_46	[p4l7t79r527b140],
2	events	NNS	O	event	_	0	SENT_46	[p4l615t93r834b140],
3	within	IN	O	within	_	0	SENT_46	[p4l920t79r1146b140],
4	these	DT	O	these	det	6	SENT_46	[p4l1232t79r1412b140],
5	genetic	JJ	O	genetic	amod	6	SENT_46	[p4l1500t79r1750b155],
6	blocks	NNS	O	block	prep_within	2	SENT_46	[p4l1837t79r2142b140],
7	.	.	O	.	_	0	SENT_46	[p4l1837t79r2142b140],

1	”	NN	O	”	nn	3	SENT_47	[p4l1837t79r2142b140],
2	Ancestral	JJ	O	ancestral	amod	3	SENT_47	[p4l6t173r341b233],
3	haplotypes	NNS	O	haplotype	nsubj	8	SENT_47	[p4l377t173r758b249],
4	and	CC	O	and	_	0	SENT_47	[p4l798t173r929b233],
5	their	PRP$	O	they	poss	7	SENT_47	[p4l965t173r1130b233],
6	simple	JJ	O	simple	amod	7	SENT_47	[p4l1167t173r1395b249],
7	recombinants	NNS	O	recombinant	nsubj	8	SENT_47	[p4l1433t173r1917b233],
8	(	VBP	O	(	ccomp	26	SENT_47	[p4l1961t173r2066b248],
9	ie	FW	O	ie	dobj	8	SENT_47	[p4l1961t173r2066b248],
10	,	,	O	,	_	0	SENT_47	[p4l1961t173r2066b248],
11	a	DT	O	a	det	12	SENT_47	[p4l2108t192r2143b233],
12	haplotype	NN	O	haplotype	nsubjpass	26	SENT_47	[p4l6t266r355b342],
13	resulting	VBG	O	result	partmod	12	SENT_47	[p4l412t266r720b342],
14	from	IN	O	from	_	0	SENT_47	[p4l775t266r946b326],
15	one	CD	NUMBER	one	num	18	SENT_47	[p4l1004t286r1131b326],
16	historical	JJ	O	historical	amod	18	SENT_47	[p4l1186t266r1510b326],
17	crossover	NN	O	crossover	nn	18	SENT_47	[p4l1569t286r1900b326],
18	event	NN	O	event	prep_from	13	SENT_47	[p4l1955t280r2144b326],
19	between	IN	O	between	_	0	SENT_47	[p4l6t358r304b419],
20	two	CD	NUMBER	two	num	22	SENT_47	[p4l337t372r466b419],
21	ancestral	JJ	O	ancestral	amod	22	SENT_47	[p4l504t358r815b419],
22	haplotypes	NNS	O	haplotype	prep_between	18	SENT_47	[p4l848t358r1256b434],
23	)	RB	O	)	advmod	26	SENT_47	[p4l848t358r1256b434],
24	have	VBP	O	have	aux	26	SENT_47	[p4l1295t358r1457b419],
25	been	VBN	O	be	auxpass	26	SENT_47	[p4l1490t358r1661b419],
26	suggested	VBN	O	suggest	_	0	SENT_47	[p4l1696t358r2039b434],
27	to	TO	O	to	aux	28	SENT_47	[p4l2073t372r2141b419],
28	account	VB	O	account	xcomp	26	SENT_47	[p4l9t466r290b512],
29	for	IN	O	for	_	0	SENT_47	[p4l312t451r413b512],
30	at	IN	O	at	quantmod	32	SENT_47	[p4l436t466r500b512],
31	least	JJS	O	least	mwe	30	SENT_47	[p4l522t451r680b512],
32	70	CD	PERCENT	70	num	33	SENT_47	[p4l705t452r863b514],
33	%	NN	PERCENT	%	prep_for	28	SENT_47	[p4l705t452r863b514],
34	of	IN	O	of	_	0	SENT_47	[p4l893t451r969b512],
35	the	DT	O	the	det	37	SENT_47	[p4l982t451r1092b512],
36	observed	VBN	O	observe	amod	37	SENT_47	[p4l1117t451r1432b512],
37	haplotypes	NNS	O	haplotype	prep_of	33	SENT_47	[p4l1455t451r1835b527],
38	in	IN	O	in	_	0	SENT_47	[p4l1860t452r1928b511],
39	white	JJ	O	white	amod	40	SENT_47	[p4l1949t451r2142b512],
40	populations	NNS	O	population	prep_in	37	SENT_47	[p4l6t545r494b621],
41	.	.	O	.	_	0	SENT_47	[p4l6t545r494b621],

1	”	NN	O	”	nn	3	SENT_48	[p4l6t545r494b621],
2	Individual	NN	O	individual	nn	3	SENT_48	[p4l540t545r903b605],
3	alleles	NNS	O	allele	nsubj	7	SENT_48	[p4l951t545r1160b605],
4	can	MD	O	can	aux	7	SENT_48	[p4l1209t565r1330b605],
5	be	VB	O	be	cop	7	SENT_48	[p4l1374t545r1458b605],
6	haplospeciﬁc	JJ	O	haplospeciﬁc	amod	7	SENT_48	[p4l1503t545r1964b621],
7	(	NN	O	(	dep	26	SENT_48	[p4l2016t545r2140b621],
8	eg	FW	O	eg	dep	7	SENT_48	[p4l2016t545r2140b621],
9	,	,	O	,	_	0	SENT_48	[p4l2016t545r2140b621],
10	HLA-B	NN	O	hla-b	conj_and	7	SENT_48	[p4l6t637r372b698],
11	*	CD	NUMBER	*	num	10	SENT_48	[p4l6t637r372b698],
12	5	CD	NUMBER	5	number	13	SENT_48	[p4l6t637r372b698],
13	701	CD	NUMBER	701	dep	10	SENT_48	[p4l378t639r494b698],
14	and	CC	O	and	_	0	SENT_48	[p4l523t637r654b698],
15	the	DT	O	the	det	19	SENT_48	[p4l676t637r786b698],
16	57-1	CD	NUMBER	57-1	npadvmod	17	SENT_48	[p4l812t640r958b698],
17	ancestral	JJ	O	ancestral	amod	19	SENT_48	[p4l992t637r1303b698],
18	haplotype	NN	O	haplotype	nn	19	SENT_48	[p4l1325t637r1700b713],
19	)	NN	O	)	conj_and	7	SENT_48	[p4l1325t637r1700b713],
20	or	CC	O	or	_	0	SENT_48	[p4l1731t657r1804b698],
21	common	JJ	O	common	amod	23	SENT_48	[p4l1827t657r2143b698],
22	to	TO	O	to	dep	23	SENT_48	[p4l7t745r75b791],
23	multiple	JJ	O	multiple	amod	25	SENT_48	[p4l134t730r429b806],
24	ancestral	JJ	O	ancestral	amod	25	SENT_48	[p4l488t730r800b791],
25	haplotypes	NNS	O	haplotype	conj_or	19	SENT_48	[p4l856t730r1237b806],
26	(	VBP	O	(	_	0	SENT_48	[p4l1302t731r1425b806],
27	eg	FW	O	eg	dobj	26	SENT_48	[p4l1302t731r1425b806],
28	,	,	O	,	_	0	SENT_48	[p4l1302t731r1425b806],
29	HLA-DRB1	NN	O	hla-drb1	appos	27	SENT_48	[p4l1484t731r2138b791],
30	*	CD	NUMBER	*	number	31	SENT_48	[p4l1484t731r2138b791],
31	0701	CD	DATE	0701	dep	29	SENT_48	[p4l1484t731r2138b791],
32	represented	VBN	O	represent	partmod	29	SENT_48	[p4l7t824r423b900],
33	in	IN	O	in	_	0	SENT_48	[p4l447t824r514b883],
34	57-1	CD	NUMBER	57-1	prep_in	32	SENT_48	[p4l541t826r717b897],
35	,	,	O	,	_	0	SENT_48	[p4l541t826r717b897],
36	47.1	CD	NUMBER	47.1	num	34	SENT_48	[p4l746t826r894b883],
37	and	CC	O	and	_	0	SENT_48	[p4l930t824r1061b884],
38	13-1	CD	NUMBER	13-1	conj_and	34	SENT_48	[p4l1094t826r1234b884],
39	haplotypes	NNS	O	haplotype	tmod	32	SENT_48	[p4l1267t824r1792b900],
40	)	CD	NUMBER	)	dep	39	SENT_48	[p4l1267t824r1792b900],
41	.8	CD	NUMBER	.8	num	44	SENT_48	[p4l1267t824r1792b900],
42	“	NN	O	“	nn	44	SENT_48	[p4l1267t824r1792b900],
43	1	CD	NUMBER	1	num	44	SENT_48	[p4l1267t824r1792b900],
44	°	NN	O	°	nsubj	26	SENT_48	[p4l1267t824r1792b900],

1	We	PRP	O	we	nsubj	3	SENT_49	[p4l91t917r212b977],
2	therefore	RB	O	therefore	advmod	3	SENT_49	[p4l250t916r568b977],
3	sought	VBD	O	seek	_	0	SENT_49	[p4l608t916r845b992],
4	associations	NNS	O	association	dobj	3	SENT_49	[p4l884t916r1301b977],
5	between	IN	O	between	_	0	SENT_49	[p4l1339t916r1636b977],
6	MHC	NN	O	mhc	nn	7	SENT_49	[p4l1673t916r1889b977],
7	alleles	NNS	O	allele	prep_between	4	SENT_49	[p4l1932t916r2141b977],
8	and	CC	O	and	_	0	SENT_49	[p4l9t1009r140b1070],
9	abacavir	NN	O	abacavir	nn	10	SENT_49	[p4l188t1009r482b1070],
10	hypersensitivity	NN	O	hypersensitivity	conj_and	4	SENT_49	[p4l525t1009r1078b1085],
11	in	IN	O	in	_	0	SENT_49	[p4l1123t1010r1190b1069],
12	the	DT	O	the	det	15	SENT_49	[p4l1236t1009r1346b1070],
13	first	JJ	ORDINAL	first	amod	15	SENT_49	[p4l1393t1009r1529b1070],
14	200	CD	NUMBER	200	num	15	SENT_49	[p4l1577t1012r1708b1070],
15	individuals	NNS	O	individual	prep_in	10	SENT_49	[p4l1757t1009r2142b1070],
16	treated	VBN	O	treat	partmod	10	SENT_49	[p4l7t1103r255b1163],
17	with	IN	O	with	_	0	SENT_49	[p4l316t1103r472b1163],
18	abacavir	NN	O	abacavir	prep_with	16	SENT_49	[p4l537t1103r830b1163],
19	in	IN	O	in	_	0	SENT_49	[p4l892t1103r959b1162],
20	the	DT	O	the	det	23	SENT_49	[p4l1022t1103r1131b1163],
21	Western	JJ	MISC	western	amod	23	SENT_49	[p4l1194t1104r1492b1163],
22	Australian	JJ	MISC	australian	amod	23	SENT_49	[p4l1554t1103r1921b1163],
23	HIV	NN	O	hiv	prep_in	18	SENT_49	[p4l1985t1104r2145b1163],

1	Cohort	NN	O	cohort	_	0	SENT_50	[p4l11t1195r282b1256],
2	.	.	O	.	_	0	SENT_50	[p4l11t1195r282b1256],

1	Patients	NNS	O	patient	_	0	SENT_51	[p4l10t1377r379b1444],
2	and	CC	O	and	_	0	SENT_51	[p4l406t1378r562b1444],
3	methods	NNS	O	method	conj_and	1	SENT_51	[p4l595t1378r974b1444],

1	Patients	NNS	O	patient	_	0	SENT_52	[p4l9t1478r288b1537],

1	581	CD	NUMBER	581	num	3	SENT_53	[p4l10t1572r133b1630],
2	active	JJ	O	active	amod	3	SENT_53	[p4l199t1570r400b1630],
3	participants	NNS	O	participant	nsubjpass	18	SENT_53	[p4l454t1570r870b1645],
4	in	IN	O	in	_	0	SENT_53	[p4l926t1570r994b1629],
5	the	DT	O	the	det	11	SENT_53	[p4l1048t1569r1157b1630],
6	\	NNP	O	\	nn	11	SENT_53	[p4l1211t1570r1510b1630],
7	Western	NNP	MISC	Western	nn	11	SENT_53	[p4l1211t1570r1510b1630],
8	Australian	NNP	MISC	Australian	nn	11	SENT_53	[p4l1562t1569r1930b1630],
9	HIV	NN	O	hiv	nn	11	SENT_53	[p4l1985t1570r2145b1630],
10	Cohort	NN	O	cohort	nn	11	SENT_53	[p4l11t1663r265b1723],
11	Study	NN	O	study	prep_in	3	SENT_53	[p4l308t1663r515b1739],
12	on	IN	O	on	_	0	SENT_53	[p4l556t1683r645b1723],
13	Dec	NNP	DATE	Dec	prep_on	11	SENT_53	[p4l685t1664r829b1723],
14	31	CD	DATE	31	num	13	SENT_53	[p4l873t1665r981b1736],
15	,	,	DATE	,	_	0	SENT_53	[p4l873t1665r981b1736],
16	2001	CD	DATE	2001	num	13	SENT_53	[p4l1026t1665r1195b1723],
17	were	VBD	O	be	auxpass	18	SENT_53	[p4l1244t1683r1411b1723],
18	considered	VBN	O	consider	_	0	SENT_53	[p4l1453t1663r1838b1723],
19	for	IN	O	for	_	0	SENT_53	[p4l1878t1663r1979b1723],
20	this	DT	O	this	det	21	SENT_53	[p4l2017t1663r2141b1723],
21	study	NN	O	study	prep_for	18	SENT_53	[p4l9t1755r218b1831],
22	.	.	O	.	_	0	SENT_53	[p4l9t1755r218b1831],

1	These	DT	O	these	det	2	SENT_54	[p4l253t1755r470b1816],
2	patients	NNS	O	patient	nsubj	5	SENT_54	[p4l500t1755r778b1831],
3	had	VBD	O	have	aux	5	SENT_54	[p4l808t1755r941b1816],
4	been	VBN	O	be	cop	5	SENT_54	[p4l970t1755r1140b1816],
5	HLA-typed	JJ	O	hla-typed	_	0	SENT_54	[p4l1169t1755r1581b1831],
6	at	IN	O	at	_	0	SENT_54	[p4l1613t1769r1676b1816],
7	the	DT	O	the	det	14	SENT_54	[p4l1706t1755r1815b1816],
8	HLA-A	NN	O	hla-a	nn	14	SENT_54	[p4l1845t1755r2137b1828],
9	,	,	O	,	_	0	SENT_54	[p4l1845t1755r2137b1828],
10	HLA-B	NN	O	hla-b	dep	14	SENT_54	[p4l6t1849r296b1921],
11	,	,	O	,	_	0	SENT_54	[p4l6t1849r296b1921],
12	HLA-C	NN	O	hla-c	dep	14	SENT_54	[p4l323t1849r614b1921],
13	,	,	O	,	_	0	SENT_54	[p4l323t1849r614b1921],
14	HLA-DR	NN	O	hla-dr	prep_at	5	SENT_54	[p4l640t1849r995b1921],
15	,	,	O	,	_	0	SENT_54	[p4l640t1849r995b1921],
16	and	CC	O	and	_	0	SENT_54	[p4l1026t1848r1156b1909],
17	HLA-DQ	NN	O	hla-dq	nn	18	SENT_54	[p4l1176t1849r1522b1924],
18	loci	NNS	O	locus	prep_at	5	SENT_54	[p4l1543t1848r1668b1909],
19	at	IN	O	at	_	0	SENT_54	[p4l1691t1863r1755b1909],
20	enrolment	NN	O	enrolment	prep_at	5	SENT_54	[p4l1778t1848r2144b1909],
21	into	IN	O	into	_	0	SENT_54	[p4l8t1942r145b2002],
22	the	DT	O	the	det	24	SENT_54	[p4l185t1942r295b2002],
23	cohort	NN	O	cohort	nn	24	SENT_54	[p4l336t1942r565b2002],
24	study	NN	O	study	prep_into	5	SENT_54	[p4l605t1942r816b2018],
25	,	,	O	,	_	0	SENT_54	[p4l605t1942r816b2018],
26	and	CC	O	and	_	0	SENT_54	[p4l859t1942r990b2002],
27	had	VBD	O	have	aux	29	SENT_54	[p4l1028t1942r1160b2002],
28	been	VBN	O	be	auxpass	29	SENT_54	[p4l1198t1942r1369b2002],
29	followed	VBN	O	follow	conj_and	5	SENT_54	[p4l1407t1942r1710b2002],
30	up	RP	O	up	prt	29	SENT_54	[p4l1749t1961r1839b2018],
31	at	IN	O	at	_	0	SENT_54	[p4l1881t1956r1945b2002],
32	13monthly	CD	NUMBER	13monthly	num	33	SENT_54	[p4l1992t1944r2143b2002, p4l7t2034r306b2110],
33	intervals	NNS	O	interval	prep_at	29	SENT_54	[p4l368t2034r683b2095],
34	.	.	O	.	_	0	SENT_54	[p4l368t2034r683b2095],

1	A	DT	O	a	det	2	SENT_55	[p4l750t2035r811b2094],
2	clinician	NN	O	clinician	nsubj	3	SENT_55	[p4l875t2034r1171b2095],
3	recorded	VBD	O	record	_	0	SENT_55	[p4l1233t2034r1548b2095],
4	details	NNS	O	detail	dobj	3	SENT_55	[p4l1613t2034r1836b2095],
5	of	IN	O	of	_	0	SENT_55	[p4l1903t2034r1980b2095],
6	the	DT	O	the	det	9	SENT_55	[p4l2033t2034r2142b2095],
7	antiretroviral	JJ	O	antiretroviral	amod	9	SENT_55	[p4l9t2127r466b2188],
8	treatment	NN	O	treatment	nn	9	SENT_55	[p4l497t2142r845b2188],
9	history	NN	O	history	prep_of	4	SENT_55	[p4l873t2127r1117b2203],
10	and	CC	O	and	_	0	SENT_55	[p4l1148t2127r1278b2188],
11	adverse	JJ	O	adverse	amod	13	SENT_55	[p4l1311t2127r1573b2188],
12	drug	NN	O	drug	nn	13	SENT_55	[p4l1606t2127r1771b2203],
13	reactions	NNS	O	reaction	prep_of	4	SENT_55	[p4l1800t2128r2140b2200],
14	,	,	O	,	_	0	SENT_55	[p4l1800t2128r2140b2200],
15	especially	RB	O	especially	advmod	3	SENT_55	[p4l9t2221r347b2297],
16	to	TO	O	to	_	0	SENT_55	[p4l420t2235r488b2281],
17	abacavir	NN	O	abacavir	prep_to	15	SENT_55	[p4l568t2221r880b2294],
18	,	,	O	,	_	0	SENT_55	[p4l568t2221r880b2294],
19	at	IN	O	at	_	0	SENT_55	[p4l960t2235r1024b2281],
20	each	DT	O	each	det	21	SENT_55	[p4l1100t2221r1260b2281],
21	visit	NN	O	visit	prep_at	3	SENT_55	[p4l1333t2221r1494b2281],
22	.	.	O	.	_	0	SENT_55	[p4l1333t2221r1494b2281],

1	The	DT	O	the	det	4	SENT_56	[p4l1575t2221r1721b2281],
2	ﬁrst	NN	O	ﬁrst	nn	4	SENT_56	[p4l1797t2221r1933b2281],
3	200	CD	NUMBER	200	num	4	SENT_56	[p4l2010t2223r2141b2281],
4	participants	NNS	O	participant	nsubjpass	17	SENT_56	[p4l6t2313r423b2389],
5	of	IN	O	of	_	0	SENT_56	[p4l454t2313r530b2374],
6	the	DT	O	the	det	7	SENT_56	[p4l548t2313r658b2374],
7	cohort	NN	O	cohort	prep_of	4	SENT_56	[p4l688t2313r918b2374],
8	prescribed	VBN	O	prescribe	partmod	7	SENT_56	[p4l944t2313r1315b2389],
9	abacavir	NN	O	abacavir	dobj	8	SENT_56	[p4l1345t2313r1639b2374],
10	until	IN	O	until	_	0	SENT_56	[p4l1664t2313r1827b2374],
11	Dec	NNP	DATE	Dec	prep_until	8	SENT_56	[p4l1857t2314r2001b2374],
12	31	CD	DATE	31	num	11	SENT_56	[p4l2032t2316r2140b2386],
13	,	,	DATE	,	_	0	SENT_56	[p4l2032t2316r2140b2386],
14	2001	CD	DATE	2001	num	11	SENT_56	[p4l9t2409r209b2479],
15	,	,	O	,	_	0	SENT_56	[p4l9t2409r209b2479],
16	were	VBD	O	be	auxpass	17	SENT_56	[p4l237t2426r404b2467],
17	included	VBN	O	include	_	0	SENT_56	[p4l432t2406r741b2467],
18	in	IN	O	in	_	0	SENT_56	[p4l767t2407r835b2466],
19	the	DT	O	the	det	20	SENT_56	[p4l861t2406r971b2467],
20	study	NN	O	study	prep_in	17	SENT_56	[p4l1000t2406r1210b2482],
21	;	:	O	;	_	0	SENT_56	[p4l1000t2406r1210b2482],
22	abacavir	NN	O	abacavir	nn	23	SENT_56	[p4l1243t2406r1536b2467],
23	prescription	NN	O	prescription	nsubjpass	25	SENT_56	[p4l1560t2407r1986b2482],
24	was	VBD	O	be	auxpass	25	SENT_56	[p4l2011t2426r2141b2467],
25	validated	VBN	O	validate	parataxis	17	SENT_56	[p4l6t2500r328b2560],
26	in	IN	O	in	_	0	SENT_56	[p4l365t2500r433b2559],
27	all	DT	O	all	det	29	SENT_56	[p4l471t2500r549b2560],
28	cohort	NN	O	cohort	nn	29	SENT_56	[p4l588t2500r818b2560],
29	cases	NNS	O	case	prep_in	25	SENT_56	[p4l855t2520r1032b2560],
30	through	IN	O	through	_	0	SENT_56	[p4l1070t2500r1352b2576],
31	the	DT	O	the	det	32	SENT_56	[p4l1388t2500r1498b2560],
32	use	NN	O	use	prep_through	25	SENT_56	[p4l1535t2520r1651b2560],
33	of	IN	O	of	_	0	SENT_56	[p4l1690t2500r1766b2560],
34	the	DT	O	the	det	39	SENT_56	[p4l1793t2500r1902b2560],
35	Royal	NNP	ORGANIZATION	Royal	nn	39	SENT_56	[p4l1941t2500r2143b2576],
36	Perth	NNP	ORGANIZATION	Perth	nn	39	SENT_56	[p4l8t2592r202b2653],
37	Hospital	NNP	ORGANIZATION	Hospital	nn	39	SENT_56	[p4l231t2592r533b2668],
38	pharmacy	NN	O	pharmacy	nn	39	SENT_56	[p4l561t2592r915b2668],
39	database	NN	O	database	prep_of	32	SENT_56	[p4l943t2592r1268b2653],
40	.	.	O	.	_	0	SENT_56	[p4l943t2592r1268b2653],

1	The	DT	O	the	det	3	SENT_57	[p4l1302t2592r1448b2653],
2	medical	JJ	O	medical	amod	3	SENT_57	[p4l1478t2592r1756b2653],
3	records	NNS	O	record	nsubjpass	8	SENT_57	[p4l1785t2592r2045b2653],
4	of	IN	O	of	_	0	SENT_57	[p4l2077t2592r2153b2653],
5	abacavir-exposed	JJ	O	abacavir-exposed	amod	6	SENT_57	[p4l9t2685r621b2761],
6	individuals	NNS	O	individual	prep_of	3	SENT_57	[p4l676t2685r1061b2746],
7	were	VBD	O	be	auxpass	8	SENT_57	[p4l1116t2705r1284b2746],
8	reviewed	VBN	O	review	_	0	SENT_57	[p4l1340t2685r1654b2746],
9	by	IN	O	by	_	0	SENT_57	[p4l1708t2685r1795b2761],
10	a	DT	O	a	det	12	SENT_57	[p4l1851t2705r1886b2746],
11	single	JJ	O	single	amod	12	SENT_57	[p4l1943t2685r2142b2761],
12	clinician	NN	O	clinician	agent	8	SENT_57	[p4l9t2779r305b2839],
13	(	CD	NUMBER	(	num	15	SENT_57	[p4l348t2779r578b2854],
14	GM	NNP	ORGANIZATION	GM	nn	15	SENT_57	[p4l348t2779r578b2854],
15	)	NNP	O	)	tmod	12	SENT_57	[p4l348t2779r578b2854],
16	,	,	O	,	_	0	SENT_57	[p4l348t2779r578b2854],
17	who	WP	O	who	nsubj	19	SENT_57	[p4l617t2779r767b2839],
18	was	VBD	O	be	cop	19	SENT_57	[p4l805t2799r934b2839],
19	unaware	JJ	O	unaware	rcmod	15	SENT_57	[p4l973t2798r1275b2839],
20	of	IN	O	of	_	0	SENT_57	[p4l1315t2779r1391b2839],
21	HLA	NN	O	hlum	nn	24	SENT_57	[p4l1417t2779r1855b2855],
22	—	CD	NUMBER	—	num	24	SENT_57	[p4l1417t2779r1855b2855],
23	typing	NN	O	typing	nn	24	SENT_57	[p4l1417t2779r1855b2855],
24	results	NNS	O	result	prep_of	19	SENT_57	[p4l1891t2779r2140b2852],
25	,	,	O	,	_	0	SENT_57	[p4l1891t2779r2140b2852],
26	for	IN	O	for	_	0	SENT_57	[p4l7t2871r108b2932],
27	evidence	NN	O	evidence	prep_for	19	SENT_57	[p4l157t2871r463b2932],
28	of	IN	O	of	_	0	SENT_57	[p4l515t2871r591b2932],
29	abacavir	NN	O	abacavir	nn	30	SENT_57	[p4l633t2871r926b2932],
30	hypersensitivity	NN	O	hypersensitivity	prep_of	27	SENT_57	[p4l972t2871r1543b2947],
31	,	,	O	,	_	0	SENT_57	[p4l972t2871r1543b2947],
32	using	VBG	O	use	partmod	27	SENT_57	[p4l1595t2871r1786b2947],
33	standard	JJ	O	standard	amod	35	SENT_57	[p4l1835t2871r2143b2932],
34	diagnostic	JJ	O	diagnostic	amod	35	SENT_57	[p4l9t2964r367b3040],
35	criteria	NNS	O	criterion	dobj	32	SENT_57	[p4l399t2965r662b3025],
36	.	.	O	.	_	0	SENT_57	[p4l399t2965r662b3025],

1	These	DT	O	these	det	2	SENT_58	[p4l696t2964r914b3025],
2	criteria	NNS	O	criterion	nsubj	4	SENT_58	[p4l945t2965r1190b3025],
3	were	VBD	O	be	cop	4	SENT_58	[p4l1219t2984r1386b3025],
4	onset	NN	O	onset	ccomp	48	SENT_58	[p4l1418t2979r1605b3025],
5	of	IN	O	of	_	0	SENT_58	[p4l1636t2964r1712b3025],
6	at	IN	O	at	quantmod	8	SENT_58	[p4l1733t2979r1797b3025],
7	least	JJS	O	least	mwe	6	SENT_58	[p4l1826t2964r1984b3025],
8	two	CD	NUMBER	two	prep_of	4	SENT_58	[p4l2012t2979r2141b3025],
9	of	IN	O	of	_	0	SENT_58	[p4l9t3058r85b3118],
10	the	DT	O	the	det	12	SENT_58	[p4l128t3058r238b3118],
11	following	VBG	O	follow	amod	12	SENT_58	[p4l292t3058r622b3134],
12	symptoms	NNS	O	symptom	prep_of	8	SENT_58	[p4l675t3072r1036b3134],
13	within	IN	O	within	_	0	SENT_58	[p4l1090t3058r1315b3118],
14	6	CD	DURATION	6	num	15	SENT_58	[p4l1371t3060r1409b3118],
15	weeks	NNS	NUMBER	week	prep_within	12	SENT_58	[p4l1464t3058r1673b3118],
16	of	IN	O	of	_	0	SENT_58	[p4l1730t3058r1807b3118],
17	abacavir	NN	O	abacavir	nn	18	SENT_58	[p4l1852t3058r2145b3118],
18	initiation	NN	O	initiation	prep_of	15	SENT_58	[p4l8t3150r345b3211],
19	:	:	O	:	_	0	SENT_58	[p4l8t3150r345b3211],
20	fever	NN	O	fever	dep	4	SENT_58	[p4l395t3150r586b3223],
21	,	,	O	,	_	0	SENT_58	[p4l395t3150r586b3223],
22	rash	NN	O	rash	appos	20	SENT_58	[p4l634t3150r802b3223],
23	,	,	O	,	_	0	SENT_58	[p4l634t3150r802b3223],
24	gastrointestinal	JJ	O	gastrointestinal	amod	25	SENT_58	[p4l850t3150r1389b3226],
25	symptoms	NNS	O	symptom	appos	4	SENT_58	[p4l1436t3164r1798b3226],
26	(	JJ	O	(	amod	27	SENT_58	[p4l1851t3151r2140b3225],
27	nausea	NN	O	nausea	dep	25	SENT_58	[p4l1851t3151r2140b3225],
28	,	,	O	,	_	0	SENT_58	[p4l1851t3151r2140b3225],
29	vomiting	VBG	O	vomit	appos	4	SENT_58	[p4l6t3244r342b3319],
30	,	,	O	,	_	0	SENT_58	[p4l6t3244r342b3319],
31	diarrhoea	NN	O	diarrhoea	nsubj	48	SENT_58	[p4l377t3243r733b3316],
32	,	,	O	,	_	0	SENT_58	[p4l377t3243r733b3316],
33	or	CC	O	or	_	0	SENT_58	[p4l769t3263r842b3304],
34	abdominal	JJ	O	abdominal	amod	36	SENT_58	[p4l873t3243r1249b3304],
35	pain	NN	O	pain	nn	36	SENT_58	[p4l1279t3244r1485b3319],
36	)	NN	O	)	conj_or	31	SENT_58	[p4l1279t3244r1485b3319],
37	,	,	O	,	_	0	SENT_58	[p4l1279t3244r1485b3319],
38	lethargy	NN	O	lethargy	conj_or	31	SENT_58	[p4l1519t3243r1822b3319],
39	,	,	O	,	_	0	SENT_58	[p4l1519t3243r1822b3319],
40	malaise	NN	O	malaise	conj_or	31	SENT_58	[p4l1855t3243r2140b3316],
41	,	,	O	,	_	0	SENT_58	[p4l1855t3243r2140b3316],
42	arthralgia	NN	O	arthralgium	conj_or	31	SENT_58	[p4l9t3337r364b3413],
43	,	,	O	,	_	0	SENT_58	[p4l9t3337r364b3413],
44	myalgia	NN	O	myalgium	conj_or	31	SENT_58	[p4l392t3337r665b3413],
45	or	CC	O	or	_	0	SENT_58	[p4l693t3357r766b3397],
46	respiratory	JJ	O	respiratory	amod	47	SENT_58	[p4l789t3337r1171b3413],
47	symptoms	NNS	O	symptom	conj_or	31	SENT_58	[p4l1196t3351r1558b3413],
48	(	VBP	O	(	_	0	SENT_58	[p4l1590t3337r1971b3413],
49	dyspnoea	NN	O	dyspnoea	dobj	48	SENT_58	[p4l1590t3337r1971b3413],
50	,	,	O	,	_	0	SENT_58	[p4l1590t3337r1971b3413],
51	sore	JJ	O	sore	amod	52	SENT_58	[p4l2000t3357r2142b3397],
52	throat	NN	O	throat	conj_or	49	SENT_58	[p4l7t3429r242b3502],
53	,	,	O	,	_	0	SENT_58	[p4l7t3429r242b3502],
54	or	CC	O	or	_	0	SENT_58	[p4l284t3449r358b3490],
55	cough	NN	O	cough	nn	56	SENT_58	[p4l395t3429r662b3505],
56	)	NN	O	)	conj_or	49	SENT_58	[p4l395t3429r662b3505],
57	;	:	O	;	_	0	SENT_58	[p4l395t3429r662b3505],
58	resolution	NN	O	resolution	conj_or	49	SENT_58	[p4l703t3429r1059b3490],
59	of	IN	O	of	_	0	SENT_58	[p4l1098t3429r1174b3490],
60	symptoms	NNS	O	symptom	prep_of	58	SENT_58	[p4l1203t3443r1565b3505],
61	within	IN	O	within	_	0	SENT_58	[p4l1603t3429r1828b3490],
62	72	CD	NUMBER	72	num	63	SENT_58	[p4l1868t3432r1953b3489],
63	h	NN	O	h	prep_within	60	SENT_58	[p4l1992t3429r2038b3489],
64	of	IN	O	of	_	0	SENT_58	[p4l2077t3429r2153b3490],
65	discontinuation	NN	O	discontinuation	prep_of	63	SENT_58	[p4l9t3521r563b3582],
66	of	IN	O	of	_	0	SENT_58	[p4l601t3521r678b3582],
67	abacavir	NN	O	abacavir	prep_of	65	SENT_58	[p4l707t3521r1019b3593],
68	;	:	O	;	_	0	SENT_58	[p4l707t3521r1019b3593],
69	and	CC	O	and	_	0	SENT_58	[p4l1062t3521r1192b3582],
70	absence	NN	O	absence	dobj	48	SENT_58	[p4l1231t3521r1508b3582],
71	of	IN	O	of	_	0	SENT_58	[p4l1547t3521r1624b3582],
72	an	DT	O	a	det	75	SENT_58	[p4l1653t3541r1737b3582],
73	altemative	JJ	O	altemative	amod	74	SENT_58	[p4l1775t3521r2142b3582],
74	likely	JJ	O	likely	amod	75	SENT_58	[p4l8t3615r193b3691],
75	explanation	NN	O	explanation	prep_of	70	SENT_58	[p4l217t3615r630b3691],
76	for	IN	O	for	_	0	SENT_58	[p4l654t3615r754b3675],
77	the	DT	O	the	det	78	SENT_58	[p4l777t3615r886b3675],
78	symptoms	NNS	O	symptom	prep_for	75	SENT_58	[p4l913t3629r1295b3691],
79	.	.	O	.	_	0	SENT_58	[p4l913t3629r1295b3691],

1	Cases	NNS	O	case	nsubjpass	3	SENT_59	[p4l95t3707r297b3768],
2	were	VBD	O	be	auxpass	3	SENT_59	[p4l335t3727r502b3768],
3	reviewed	VBN	O	review	_	0	SENT_59	[p4l541t3707r856b3768],
4	and	CC	O	and	_	0	SENT_59	[p4l896t3707r1027b3768],
5	classiﬁed	VBN	O	classiﬁed	conj_and	3	SENT_59	[p4l1066t3707r1382b3768],
6	as	IN	O	as	_	0	SENT_59	[p4l1423t3727r1509b3768],
7	:	:	O	:	_	0	SENT_59	[p4l1423t3727r1509b3768],
8	deﬁnite	NN	O	deﬁnite	nn	9	SENT_59	[p4l1554t3707r1818b3768],
9	cases	NNS	O	case	prep_as	3	SENT_59	[p4l1859t3727r2035b3768],
10	of	IN	O	of	_	0	SENT_59	[p4l2077t3707r2153b3768],
11	abacavir	NN	O	abacavir	nn	12	SENT_59	[p5l9t23r303b84],
12	hypersensitivity	NN	O	hypersensitivity	prep_of	9	SENT_59	[p5l401t23r972b99],
13	,	,	O	,	_	0	SENT_59	[p5l401t23r972b99],
14	cases	NNS	O	case	appos	12	SENT_59	[p5l1078t43r1254b84],
15	in	IN	O	in	_	0	SENT_59	[p5l1357t24r1425b83],
16	whom	WP	O	whom	rel	17	SENT_59	[p5l1525t23r1748b84],
17	abacavir	VBP	O	abacavir	rcmod	14	SENT_59	[p5l1852t23r2145b84],
18	hypersensitivity	NN	O	hypersensitivity	nsubjpass	21	SENT_59	[p5l6t117r558b193],
19	could	MD	O	could	aux	21	SENT_59	[p5l592t117r789b177],
20	be	VB	O	be	auxpass	21	SENT_59	[p5l822t117r905b177],
21	excluded	VBN	O	exclude	ccomp	17	SENT_59	[p5l942t117r1423b190],
22	—	RB	O	—	advmod	21	SENT_59	[p5l942t117r1423b190],
23	ie	FW	O	ie	dobj	21	SENT_59	[p5l942t117r1423b190],
24	,	,	O	,	_	0	SENT_59	[p5l942t117r1423b190],
25	for	IN	O	for	_	0	SENT_59	[p5l1461t117r1561b177],
26	whom	WP	O	whom	dobj	31	SENT_59	[p5l1592t117r1816b177],
27	abacavir	NN	O	abacavir	nn	28	SENT_59	[p5l1852t117r2145b177],
28	therapy	NN	O	therapy	nsubj	31	SENT_59	[p5l7t209r276b285],
29	had	VBD	O	have	aux	31	SENT_59	[p5l303t209r435b270],
30	been	VBN	O	be	cop	31	SENT_59	[p5l464t209r635b270],
31	continuous	JJ	O	continuous	prepc_for	21	SENT_59	[p5l667t209r1061b270],
32	for	IN	O	for	_	0	SENT_59	[p5l1092t209r1193b270],
33	at	IN	DURATION	at	quantmod	35	SENT_59	[p5l1223t223r1286b270],
34	least	JJS	DURATION	least	mwe	33	SENT_59	[p5l1316t209r1474b270],
35	6	CD	DURATION	6	num	36	SENT_59	[p5l1507t212r1544b270],
36	weeks	NNS	NUMBER	week	prep_for	31	SENT_59	[p5l1576t209r1786b270],
37	(	CD	NUMBER	(	num	40	SENT_59	[p5l1824t209r2145b284],
38	abacavir	NN	O	abacavir	nn	40	SENT_59	[p5l1824t209r2145b284],
39	tolerant	JJ	O	tolerant	amod	40	SENT_59	[p5l7t302r334b378],
40	)	NN	O	)	dep	17	SENT_59	[p5l7t302r334b378],
41	;	:	O	;	_	0	SENT_59	[p5l7t302r334b378],
42	or	CC	O	or	_	0	SENT_59	[p5l367t322r441b363],
43	cases	NNS	O	case	prep_as	3	SENT_59	[p5l468t322r643b363],
44	for	IN	O	for	_	0	SENT_59	[p5l672t302r773b363],
45	whom	WP	O	whom	nsubj	46	SENT_59	[p5l797t302r1020b363],
46	abacavir	VBP	O	abacavir	prepc_for	43	SENT_59	[p5l1049t302r1343b363],
47	hypersensitivity	NN	O	hypersensitivity	nsubjpass	51	SENT_59	[p5l1367t302r1920b378],
48	could	MD	O	could	aux	51	SENT_59	[p5l1947t302r2143b363],
49	not	RB	O	not	neg	51	SENT_59	[p5l7t410r126b456],
50	be	VB	O	be	auxpass	51	SENT_59	[p5l157t396r240b456],
51	excluded	VBN	O	exclude	ccomp	46	SENT_59	[p5l277t396r595b456],
52	because	IN	O	because	mark	64	SENT_59	[p5l627t396r907b456],
53	symptoms	NNS	O	symptom	nsubj	64	SENT_59	[p5l943t410r1305b472],
54	in	IN	O	in	_	0	SENT_59	[p5l1340t396r1408b455],
55	the	DT	O	the	det	56	SENT_59	[p5l1441t396r1550b456],
56	ﬁrst	NN	O	ﬁrst	prep_in	53	SENT_59	[p5l1585t396r1721b456],
57	6	CD	DURATION	6	num	58	SENT_59	[p5l1757t398r1794b456],
58	weeks	NNS	NUMBER	week	tmod	56	SENT_59	[p5l1829t396r2040b456],
59	of	IN	O	of	_	0	SENT_59	[p5l2077t396r2153b456],
60	abacavir	NN	O	abacavir	nn	61	SENT_59	[p5l9t488r303b549],
61	exposure	NN	O	exposure	prep_of	56	SENT_59	[p5l329t508r645b564],
62	did	VBD	O	do	aux	64	SENT_59	[p5l674t488r787b549],
63	not	RB	O	not	neg	64	SENT_59	[p5l813t502r932b549],
64	meet	VB	O	meet	advcl	51	SENT_59	[p5l957t502r1132b549],
65	diagnostic	JJ	O	diagnostic	amod	66	SENT_59	[p5l1159t488r1517b564],
66	criteria	NNS	O	criterion	dobj	64	SENT_59	[p5l1546t488r1791b549],
67	(	CD	NUMBER	(	num	69	SENT_59	[p5l1824t488r2145b563],
68	abacavir	NN	O	abacavir	nn	69	SENT_59	[p5l1824t488r2145b563],
69	hypersensitivity	NN	O	hypersensitivity	npadvmod	70	SENT_59	[p5l6t581r558b657],
70	not	RB	O	not	advmod	71	SENT_59	[p5l596t596r715b642],
71	excluded	VBN	O	exclude	prep	64	SENT_59	[p5l755t581r1123b657],
72	)	NN	O	)	dep	71	SENT_59	[p5l755t581r1123b657],
73	.	.	O	.	_	0	SENT_59	[p5l755t581r1123b657],

1	Cases	NNS	O	case	nsubjpass	7	SENT_60	[p5l1172t582r1373b642],
2	from	IN	O	from	_	0	SENT_60	[p5l1414t581r1585b642],
3	the	DT	O	the	det	5	SENT_60	[p5l1625t581r1735b642],
4	last	JJ	O	last	amod	5	SENT_60	[p5l1776t581r1895b642],
5	group	NN	O	group	prep_from	1	SENT_60	[p5l1934t601r2141b657],
6	were	VBD	O	be	auxpass	7	SENT_60	[p5l6t694r173b735],
7	excluded	VBN	O	exclude	_	0	SENT_60	[p5l211t675r528b735],
8	from	IN	O	from	_	0	SENT_60	[p5l563t675r734b735],
9	analyses	NNS	O	analysis	prep_from	7	SENT_60	[p5l770t675r1056b751],
10	of	IN	O	of	_	0	SENT_60	[p5l1094t675r1170b735],
11	HLA	NN	O	hlum	nn	13	SENT_60	[p5l1193t675r1373b734],
12	allele	NN	O	allele	nn	13	SENT_60	[p5l1413t675r1590b735],
13	frequency	NN	O	frequency	prep_of	9	SENT_60	[p5l1625t675r1978b751],
14	and	CC	O	and	_	0	SENT_60	[p5l2013t675r2143b735],
15	abacavir	NN	O	abacavir	nn	16	SENT_60	[p5l9t767r303b828],
16	hypersensitivity	NN	O	hypersensitivity	prep_of	9	SENT_60	[p5l331t767r902b843],
17	,	,	O	,	_	0	SENT_60	[p5l331t767r902b843],
18	but	CC	O	but	_	0	SENT_60	[p5l935t767r1056b828],
19	were	VBD	O	be	auxpass	20	SENT_60	[p5l1086t787r1253b828],
20	included	VBN	O	include	conj_but	7	SENT_60	[p5l1286t767r1594b828],
21	in	IN	O	in	_	0	SENT_60	[p5l1625t767r1693b827],
22	calculations	NNS	O	calculation	prep_in	20	SENT_60	[p5l1726t767r2141b828],
23	of	IN	O	of	_	0	SENT_60	[p5l9t860r85b921],
24	positive	JJ	O	positive	amod	28	SENT_60	[p5l102t860r373b936],
25	and	CC	O	and	_	0	SENT_60	[p5l404t860r535b921],
26	negative	JJ	O	negative	conj_and	24	SENT_60	[p5l562t861r853b936],
27	predictive	JJ	O	predictive	amod	28	SENT_60	[p5l881t860r1230b936],
28	values	NNS	O	value	prep_of	22	SENT_60	[p5l1257t860r1474b921],
29	of	IN	O	of	_	0	SENT_60	[p5l1505t860r1582b921],
30	the	DT	O	the	det	31	SENT_60	[p5l1599t860r1709b921],
31	presence	NN	O	presence	prep_of	28	SENT_60	[p5l1736t880r2046b936],
32	of	IN	O	of	_	0	SENT_60	[p5l2077t860r2153b921],
33	HLA	NN	O	hlum	nn	34	SENT_60	[p5l6t954r186b1013],
34	alleles	NNS	O	allele	prep_of	31	SENT_60	[p5l216t954r426b1014],
35	for	IN	O	for	_	0	SENT_60	[p5l453t954r554b1014],
36	abacavir	NN	O	abacavir	nn	37	SENT_60	[p5l580t954r873b1014],
37	hypersensitivity	NN	O	hypersensitivity	prep_for	34	SENT_60	[p5l896t954r1448b1030],
38	so	RB	O	so	advmod	41	SENT_60	[p5l1474t974r1545b1014],
39	as	IN	O	as	dep	41	SENT_60	[p5l1575t974r1642b1014],
40	to	TO	O	to	aux	41	SENT_60	[p5l1669t968r1737b1014],
41	provide	VB	O	provide	ccomp	20	SENT_60	[p5l1764t954r2031b1030],
42	an	DT	O	a	det	45	SENT_60	[p5l2060t973r2143b1014],
43	estimated	VBN	O	estimate	amod	45	SENT_60	[p5l9t1046r350b1107],
44	predictive	JJ	O	predictive	amod	45	SENT_60	[p5l384t1046r733b1122],
45	value	NN	O	value	dobj	41	SENT_60	[p5l767t1046r953b1107],
46	for	IN	O	for	_	0	SENT_60	[p5l989t1046r1090b1107],
47	an	DT	O	a	det	49	SENT_60	[p5l1125t1066r1208b1107],
48	unselected	JJ	O	unselected	amod	49	SENT_60	[p5l1243t1046r1619b1107],
49	population	NN	O	population	prep_for	45	SENT_60	[p5l1653t1046r2040b1122],
50	of	IN	O	of	_	0	SENT_60	[p5l2077t1046r2153b1107],
51	patients	NNS	O	patient	prep_of	49	SENT_60	[p5l6t1140r304b1215],
52	.	.	O	.	_	0	SENT_60	[p5l6t1140r304b1215],

1	Additional	JJ	O	additional	amod	4	SENT_61	[p5l91t1233r469b1293],
2	non-HIV-infected	JJ	O	non-hiv-infected	amod	4	SENT_61	[p5l525t1233r1169b1293],
3	control	NN	O	control	nn	4	SENT_61	[p5l1226t1233r1477b1293],
4	individuals	NNS	O	individual	nsubjpass	6	SENT_61	[p5l1534t1233r1919b1293],
5	were	VBD	O	be	auxpass	6	SENT_61	[p5l1975t1252r2142b1293],
6	recruited	VBN	O	recruit	_	0	SENT_61	[p5l7t1325r327b1385],
7	from	IN	O	from	_	0	SENT_61	[p5l356t1325r527b1385],
8	the	DT	O	the	det	14	SENT_61	[p5l556t1325r665b1385],
9	\	NNP	O	\	nn	14	SENT_61	[p5l694t1326r993b1386],
10	Western	NNP	MISC	Western	nn	14	SENT_61	[p5l694t1326r993b1386],
11	Australian	NNP	MISC	Australian	nn	14	SENT_61	[p5l1020t1325r1388b1385],
12	bone-marrow	NN	O	bone-marrow	nn	14	SENT_61	[p5l1415t1325r1902b1385],
13	donor	NN	O	donor	nn	14	SENT_61	[p5l1931t1325r2145b1385],
14	registry	NN	O	registry	prep_from	6	SENT_61	[p5l7t1419r269b1494],
15	(	CD	NUMBER	(	num	16	SENT_61	[p5l323t1419r682b1494],
16	n	NN	O	n	tmod	6	SENT_61	[p5l323t1419r682b1494],
17	=	JJ	O	=	amod	16	SENT_61	[p5l323t1419r682b1494],
18	3212	CD	NUMBER	3212	number	19	SENT_61	[p5l323t1419r682b1494],
19	)	CD	NUMBER	)	dep	17	SENT_61	[p5l323t1419r682b1494],
20	.	.	O	.	_	0	SENT_61	[p5l323t1419r682b1494],

1	As	IN	O	as	_	0	SENT_62	[p5l735t1419r826b1479],
2	a	DT	O	a	det	3	SENT_62	[p5l879t1438r914b1479],
3	requirement	NN	O	requirement	prep_as	11	SENT_62	[p5l964t1419r1403b1494],
4	of	IN	O	of	_	0	SENT_62	[p5l1453t1418r1530b1479],
5	the	DT	O	the	det	6	SENT_62	[p5l1569t1418r1678b1479],
6	registry	NN	O	registry	prep_of	3	SENT_62	[p5l1728t1419r2009b1494],
7	,	,	O	,	_	0	SENT_62	[p5l1728t1419r2009b1494],
8	all	DT	O	all	det	9	SENT_62	[p5l2064t1418r2143b1479],
9	individuals	NNS	O	individual	nsubjpass	11	SENT_62	[p5l8t1512r392b1572],
10	were	VBD	O	be	auxpass	11	SENT_62	[p5l447t1531r614b1572],
11	typed	VBN	O	type	conj_and	11	SENT_62	[p5l670t1512r867b1588],
12	at	IN	O	at	_	0	SENT_62	[p5l924t1526r987b1572],
13	HLA-A	NN	O	hla-a	nn	16	SENT_62	[p5l1040t1512r1310b1571],
14	and	CC	O	and	_	0	SENT_62	[p5l1370t1512r1500b1572],
15	HLA-B	NN	O	hla-b	nn	16	SENT_62	[p5l1554t1512r1826b1571],
16	loci	NNS	O	locus	prep_at	11	SENT_62	[p5l1880t1512r2005b1572],
17	by	IN	O	by	_	0	SENT_62	[p5l2058t1512r2145b1588],
18	standard	JJ	O	standard	amod	20	SENT_62	[p5l9t1604r317b1665],
19	microcytotoxicity	NN	O	microcytotoxicity	nn	20	SENT_62	[p5l350t1604r970b1680],
20	assays	NNS	O	assay	agent	11	SENT_62	[p5l1003t1624r1235b1680],
21	,	,	O	,	_	0	SENT_62	[p5l1003t1624r1235b1680],
22	and	CC	O	and	_	0	SENT_62	[p5l1273t1604r1404b1665],
23	at	IN	O	at	_	0	SENT_62	[p5l1438t1618r1502b1664],
24	HLA-DR	NN	O	hla-dr	nn	25	SENT_62	[p5l1533t1604r1870b1664],
25	loci	NNS	O	locus	prep_at	11	SENT_62	[p5l1902t1604r2026b1664],
26	by	IN	O	by	_	0	SENT_62	[p5l2058t1604r2145b1680],
27	either	CC	O	either	preconj	28	SENT_62	[p5l9t1697r211b1758],
28	serological	JJ	O	serological	amod	32	SENT_62	[p5l239t1697r611b1773],
29	or	CC	O	or	_	0	SENT_62	[p5l642t1717r716b1758],
30	sequence-based	JJ	O	sequence-based	conj_or	28	SENT_62	[p5l745t1697r1303b1773],
31	typing	NN	O	typing	nn	32	SENT_62	[p5l1332t1698r1556b1773],
32	methods	NNS	O	method	agent	11	SENT_62	[p5l1582t1697r1908b1758],
33	.	.	O	.	_	0	SENT_62	[p5l1582t1697r1908b1758],

1	Allele	NN	O	allele	nn	2	SENT_63	[p5l1940t1697r2142b1758],
2	frequencies	NNS	O	frequency	nsubjpass	5	SENT_63	[p5l7t1791r410b1867],
3	were	VBD	O	be	auxpass	5	SENT_63	[p5l441t1810r608b1851],
4	also	RB	O	also	advmod	5	SENT_63	[p5l642t1791r775b1851],
5	examined	VBN	O	examine	_	0	SENT_63	[p5l809t1791r1152b1851],
6	in	IN	O	in	_	0	SENT_63	[p5l1183t1791r1251b1850],
7	381	CD	NUMBER	381	num	9	SENT_63	[p5l1284t1793r1407b1851],
8	HIV	NN	O	hiv	nn	9	SENT_63	[p5l1448t1791r1941b1864],
9	—	NN	O	—	prep_in	5	SENT_63	[p5l1448t1791r1941b1864],
10	infected	JJ	O	infected	amod	13	SENT_63	[p5l1448t1791r1941b1864],
11	,	,	O	,	_	0	SENT_63	[p5l1448t1791r1941b1864],
12	nonabacavir-treated	JJ	O	nonabacavir-treated	amod	13	SENT_63	[p5l1975t1810r2143b1851, p5l9t1883r580b1944],
13	controls	NNS	O	control	nsubj	14	SENT_63	[p5l613t1883r895b1943],
14	(	VBP	O	(	rcmod	9	SENT_63	[p5l935t1883r1069b1958],
15	the	DT	O	the	det	18	SENT_63	[p5l935t1883r1069b1958],
16	remaining	VBG	O	remain	amod	18	SENT_63	[p5l1101t1883r1462b1959],
17	active	JJ	O	active	amod	18	SENT_63	[p5l1493t1883r1694b1944],
18	participants	NNS	O	participant	dobj	14	SENT_63	[p5l1725t1883r2141b1959],
19	in	IN	O	in	_	0	SENT_63	[p5l8t1977r75b2036],
20	the	DT	O	the	det	26	SENT_63	[p5l99t1976r209b2037],
21	\	NNP	O	\	nn	26	SENT_63	[p5l232t1977r530b2037],
22	Western	NNP	MISC	Western	nn	26	SENT_63	[p5l232t1977r530b2037],
23	Australian	NNP	MISC	Australian	nn	26	SENT_63	[p5l553t1976r921b2037],
24	Cohort	NNP	O	Cohort	nn	26	SENT_63	[p5l948t1976r1202b2037],
25	Study	NNP	O	Study	nn	26	SENT_63	[p5l1229t1976r1484b2052],
26	)	NN	O	)	prep_in	18	SENT_63	[p5l1229t1976r1484b2052],
27	.	.	O	.	_	0	SENT_63	[p5l1229t1976r1484b2052],

1	Procedures	NNS	O	procedure	_	0	SENT_64	[p5l9t2167r399b2226],

1	HLA-A	NN	O	hla-a	nsubjpass	9	SENT_65	[p5l6t2259r299b2331],
2	,	,	O	,	_	0	SENT_65	[p5l6t2259r299b2331],
3	HLA-B	NN	O	hla-b	nsubjpass	9	SENT_65	[p5l331t2259r622b2331],
4	,	,	O	,	_	0	SENT_65	[p5l331t2259r622b2331],
5	and	CC	O	and	_	0	SENT_65	[p5l654t2258r785b2319],
6	HLA-C	NN	O	hla-c	nn	7	SENT_65	[p5l811t2259r1087b2319],
7	typing	NN	O	typing	conj_and	1	SENT_65	[p5l1110t2259r1334b2334],
8	was	VBD	O	be	auxpass	9	SENT_65	[p5l1358t2278r1489b2319],
9	done	VBN	O	do	_	0	SENT_65	[p5l1519t2258r1694b2319],
10	by	IN	O	by	_	0	SENT_65	[p5l1721t2258r1808b2334],
11	standard	JJ	O	standard	amod	13	SENT_65	[p5l1835t2258r2143b2319],
12	microcytotoxicity	NN	O	microcytotoxicity	nn	13	SENT_65	[p5l7t2352r628b2428],
13	assays	NNS	O	assay	agent	9	SENT_65	[p5l669t2372r899b2428],
14	.	.	O	.	_	0	SENT_65	[p5l669t2372r899b2428],

1	HLA-B	NN	O	hla-b	nsubjpass	8	SENT_66	[p5l945t2352r1218b2411],
2	and	CC	O	and	_	0	SENT_66	[p5l1260t2352r1390b2412],
3	HLA-C	NN	O	hla-c	nn	5	SENT_66	[p5l1431t2352r1707b2412],
4	sequencing	NN	O	sequencing	nn	5	SENT_66	[p5l1747t2352r2145b2428],
5	analysis	NN	O	analysis	conj_and	1	SENT_66	[p5l9t2444r279b2520],
6	was	VBD	O	be	auxpass	8	SENT_66	[p5l339t2464r469b2505],
7	also	RB	O	also	advmod	8	SENT_66	[p5l532t2444r665b2504],
8	done	VBN	O	do	_	0	SENT_66	[p5l728t2444r902b2505],
9	in	IN	O	in	_	0	SENT_66	[p5l962t2444r1030b2504],
10	cases	NNS	O	case	prep_in	8	SENT_66	[p5l1091t2464r1267b2505],
11	for	IN	O	for	_	0	SENT_66	[p5l1329t2444r1430b2504],
12	whom	WP	O	whom	dobj	16	SENT_66	[p5l1486t2444r1710b2505],
13	serological	JJ	O	serological	amod	14	SENT_66	[p5l1771t2444r2143b2520],
14	methods	NNS	O	method	nsubj	16	SENT_66	[p5l7t2537r313b2598],
15	were	VBD	O	be	cop	16	SENT_66	[p5l363t2557r530b2598],
16	insufﬁcient	JJ	O	insufﬁcient	prepc_for	10	SENT_66	[p5l581t2537r975b2598],
17	to	TO	O	to	aux	18	SENT_66	[p5l1024t2552r1093b2598],
18	resolve	VB	O	resolve	xcomp	16	SENT_66	[p5l1144t2537r1388b2598],
19	speciﬁc	NN	O	speciﬁc	nn	20	SENT_66	[p5l1441t2537r1700b2613],
20	alleles	NNS	O	allele	nsubj	21	SENT_66	[p5l1752t2537r1962b2598],
21	(	VBP	O	(	ccomp	18	SENT_66	[p5l2019t2537r2145b2613],
22	for	IN	O	for	_	0	SENT_66	[p5l2019t2537r2145b2613],
23	example	NN	O	example	prep_for	21	SENT_66	[p5l9t2631r324b2707],
24	,	,	O	,	_	0	SENT_66	[p5l9t2631r324b2707],
25	HLA-B17	NN	O	hla-b17	nsubjpass	27	SENT_66	[p5l384t2631r747b2691],
26	was	VBD	O	be	auxpass	27	SENT_66	[p5l796t2651r926b2691],
27	resolved	VBN	O	resolve	conj_and	8	SENT_66	[p5l985t2631r1277b2691],
28	to	TO	O	to	_	0	SENT_66	[p5l1334t2645r1403b2691],
29	HLA-B	NN	O	hla-b	nn	31	SENT_66	[p5l1460t2631r1948b2691],
30	*	CD	NUMBER	*	num	31	SENT_66	[p5l1460t2631r1948b2691],
31	570I	NN	O	570us	prep_to	27	SENT_66	[p5l1460t2631r1948b2691],
32	and	CC	O	and	_	0	SENT_66	[p5l2013t2631r2143b2691],
33	HLA-B	NN	O	hla-b	nn	35	SENT_66	[p5l7t2723r493b2784],
34	*	CD	NUMBER	*	num	35	SENT_66	[p5l7t2723r493b2784],
35	580I	NN	O	580us	nsubj	39	SENT_66	[p5l7t2723r493b2784],
36	in	IN	O	in	_	0	SENT_66	[p5l526t2723r593b2783],
37	all	DT	O	all	det	38	SENT_66	[p5l622t2723r700b2784],
38	cases	NNS	O	case	prep_in	35	SENT_66	[p5l729t2724r956b2798],
39	)	VBP	O	)	conj_and	8	SENT_66	[p5l729t2724r956b2798],
40	.	.	O	.	_	0	SENT_66	[p5l729t2724r956b2798],

1	HLA-DRBI	NN	O	hla-drbus	nn	2	SENT_67	[p5l987t2723r1418b2783],
2	typing	NN	O	typing	nsubjpass	4	SENT_67	[p5l1450t2723r1673b2799],
3	was	VBD	O	be	auxpass	4	SENT_67	[p5l1697t2743r1827b2784],
4	done	VBN	O	do	_	0	SENT_67	[p5l1857t2723r2031b2784],
5	by	IN	O	by	_	0	SENT_67	[p5l2058t2723r2144b2799],
6	DNA	NN	O	dna	nn	7	SENT_67	[p5l8t2817r208b2877],
7	sequencing	NN	O	sequencing	agent	4	SENT_67	[p5l234t2817r647b2892],
8	.	.	O	.	_	0	SENT_67	[p5l234t2817r647b2892],

1	HLA	NN	O	hlum	_	0	SENT_68	[p5l707t2817r1060b2892],
2	.	.	O	.	_	0	SENT_68	[p5l707t2817r1060b2892],

1	—	NN	O	—	_	0	SENT_69	[p5l707t2817r1060b2892],
2	.	.	O	.	_	0	SENT_69	[p5l707t2817r1060b2892],

1	DQ	NN	O	dq	nn	2	SENT_70	[p5l707t2817r1060b2892],
2	typing	NN	O	typing	nsubjpass	4	SENT_70	[p5l1114t2817r1336b2892],
3	was	VBD	O	be	auxpass	4	SENT_70	[p5l1388t2836r1518b2877],
4	done	VBN	O	do	_	0	SENT_70	[p5l1575t2816r1748b2877],
5	by	IN	O	by	_	0	SENT_70	[p5l1802t2816r1889b2892],
6	either	CC	O	either	preconj	7	SENT_70	[p5l1943t2816r2144b2877],
7	sequencing	NN	O	sequencing	agent	4	SENT_70	[p5l9t2910r407b2986],
8	or	CC	O	or	_	0	SENT_70	[p5l489t2929r562b2970],
9	PCR	NN	O	pcr	agent	4	SENT_70	[p5l642t2910r821b2970],
10	sequence-speciﬁc	JJ	O	sequence-speciﬁc	amod	12	SENT_70	[p5l900t2910r1515b2986],
11	oligonucleotide	NN	O	oligonucleotide	nn	12	SENT_70	[p5l1599t2910r2142b2986],
12	typing	NN	O	typing	dobj	4	SENT_70	[p5l8t3002r231b3078],
13	in	IN	O	in	_	0	SENT_70	[p5l325t3002r392b3062],
14	HLA-DR7-positive	JJ	O	hla-dr7-positive	amod	15	SENT_70	[p5l488t3002r1178b3078],
15	patients	NNS	O	patient	prep_in	12	SENT_70	[p5l1274t3002r1570b3078],
16	.	.	O	.	_	0	SENT_70	[p5l1274t3002r1570b3078],

1	Complement	NN	O	complement	nn	3	SENT_71	[p5l1675t3002r2143b3078],
2	(	CD	NUMBER	(	num	3	SENT_71	[p5l14t3096r159b3171],
3	C4	NN	O	c4	nsubjpass	9	SENT_71	[p5l14t3096r159b3171],
4	,	,	O	,	_	0	SENT_71	[p5l14t3096r159b3171],
5	Bf	NN	O	bf	appos	3	SENT_71	[p5l256t3096r362b3171],
6	)	CD	NUMBER	)	num	7	SENT_71	[p5l256t3096r362b3171],
7	allotyping	NN	O	allotyping	dep	5	SENT_71	[p5l463t3095r811b3171],
8	was	VBD	O	be	auxpass	9	SENT_71	[p5l901t3115r1031b3156],
9	done	VBN	O	do	_	0	SENT_71	[p5l1127t3095r1300b3156],
10	by	IN	O	by	_	0	SENT_71	[p5l1393t3095r1480b3171],
11	immunoﬁxation	NN	O	immunoﬁxation	nn	12	SENT_71	[p5l1572t3095r2143b3156],
12	electrophoresis	NN	O	electrophoresis	agent	9	SENT_71	[p5l10t3189r557b3265],
13	.	.	O	.	_	0	SENT_71	[p5l10t3189r557b3265],

1	This	DT	O	this	det	2	SENT_72	[p5l92t3281r253b3342],
2	study	NN	O	study	nsubj	3	SENT_72	[p5l288t3281r480b3357],
3	exploits	VBZ	O	exploit	_	0	SENT_72	[p5l512t3281r780b3357],
4	current	JJ	DATE	current	amod	5	SENT_72	[p5l816t3295r1073b3342],
5	knowledge	NN	O	knowledge	dobj	3	SENT_72	[p5l1106t3281r1484b3357],
6	of	IN	O	of	_	0	SENT_72	[p5l1519t3281r1595b3342],
7	the	DT	O	the	det	8	SENT_72	[p5l1617t3281r1726b3342],
8	MHC	NN	O	mhc	prep_of	5	SENT_72	[p5l1759t3281r1975b3342],
9	and	CC	O	and	_	0	SENT_72	[p5l2012t3281r2143b3342],
10	the	DT	O	the	det	11	SENT_72	[p5l8t3374r117b3435],
11	alleles	NNS	O	allele	conj_and	5	SENT_72	[p5l201t3374r410b3435],
12	of	IN	O	of	_	0	SENT_72	[p5l494t3374r570b3435],
13	polymorphic	JJ	O	polymorphic	amod	14	SENT_72	[p5l641t3374r1091b3450],
14	microsatellite	NN	O	microsatellite	prep_of	11	SENT_72	[p5l1173t3374r1646b3435],
15	and	CC	O	and	_	0	SENT_72	[p5l1730t3374r1860b3435],
16	single	JJ	O	single	amod	22	SENT_72	[p5l1943t3374r2142b3450],
17	nucleotide	NN	O	nucleotide	nn	22	SENT_72	[p5l7t3468r378b3528],
18	polymorphism	NN	O	polymorphism	nn	22	SENT_72	[p5l410t3468r928b3544],
19	(	NN	O	(	nn	22	SENT_72	[p5l966t3468r1186b3543],
20	SNP	NN	O	snp	nn	22	SENT_72	[p5l966t3468r1186b3543],
21	)	CD	NUMBER	)	num	22	SENT_72	[p5l966t3468r1186b3543],
22	markers	NNS	O	marker	conj_and	14	SENT_72	[p5l1225t3468r1527b3528],
23	.	.	O	.	_	0	SENT_72	[p5l1225t3468r1527b3528],

1	Since	IN	O	since	mark	5	SENT_73	[p5l1568t3468r1757b3528],
2	our	PRP$	O	we	poss	4	SENT_73	[p5l1792t3488r1913b3528],
3	initial	JJ	O	initial	amod	4	SENT_73	[p5l1944t3468r2142b3528],
4	data	NNS	O	datum	nsubj	5	SENT_73	[p5l9t3560r159b3621],
5	indicated	VBD	O	indicate	advcl	22	SENT_73	[p5l279t3560r605b3621],
6	an	DT	O	a	det	7	SENT_73	[p5l727t3580r810b3621],
7	association	NN	O	association	dobj	5	SENT_73	[p5l931t3560r1317b3621],
8	between	IN	O	between	_	0	SENT_73	[p5l1434t3560r1731b3621],
9	abacavir	NN	O	abacavir	nn	10	SENT_73	[p5l1852t3560r2145b3621],
10	hypersensitivity	NN	O	hypersensitivity	prep_between	7	SENT_73	[p6l7t23r558b99],
11	and	CC	O	and	_	0	SENT_73	[p6l619t23r749b84],
12	HLA	NN	O	hlum	nn	14	SENT_73	[p6l811t24r997b83],
13	alleles	NNS	O	allele	nn	14	SENT_73	[p6l1059t23r1268b84],
14	speciﬁc	NN	O	speciﬁc	conj_and	10	SENT_73	[p6l1333t23r1591b99],
15	for	IN	O	for	_	0	SENT_73	[p6l1653t23r1754b84],
16	the	DT	O	the	det	19	SENT_73	[p6l1813t23r1922b84],
17	57-1	CD	NUMBER	57-1	npadvmod	18	SENT_73	[p6l1988t26r2133b84],
18	ancestral	JJ	O	ancestral	amod	19	SENT_73	[p6l10t117r320b177],
19	haplotype	NN	O	haplotype	prep_for	10	SENT_73	[p6l352t117r721b193],
20	,	,	O	,	_	0	SENT_73	[p6l352t117r721b193],
21	we	PRP	O	we	nsubj	22	SENT_73	[p6l755t137r853b177],
22	sought	VBD	O	seek	_	0	SENT_73	[p6l888t117r1124b193],
23	to	TO	O	to	aux	24	SENT_73	[p6l1155t131r1223b177],
24	deﬁne	VB	O	deﬁne	xcomp	22	SENT_73	[p6l1259t117r1473b177],
25	the	DT	O	the	det	26	SENT_73	[p6l1506t117r1616b177],
26	boundaries	NNS	O	boundary	dobj	24	SENT_73	[p6l1647t117r2041b177],
27	of	IN	O	of	_	0	SENT_73	[p6l2076t117r2153b177],
28	the	DT	O	the	det	32	SENT_73	[p6l8t209r117b270],
29	abacavir	NN	O	abacavir	nn	32	SENT_73	[p6l164t209r457b270],
30	hypersensitivity	NN	O	hypersensitivity	nn	32	SENT_73	[p6l498t209r1049b285],
31	susceptibility	NN	O	susceptibility	nn	32	SENT_73	[p6l1092t209r1553b285],
32	region	NN	O	region	prep_of	26	SENT_73	[p6l1595t209r1817b285],
33	through	IN	O	through	_	0	SENT_73	[p6l1861t209r2143b285],
34	the	DT	O	the	det	35	SENT_73	[p6l8t302r117b363],
35	study	NN	O	study	prep_through	24	SENT_73	[p6l159t302r350b378],
36	of	IN	O	of	_	0	SENT_73	[p6l389t302r465b363],
37	participants	NNS	O	participant	prep_of	35	SENT_73	[p6l493t303r909b378],
38	with	IN	O	with	_	0	SENT_73	[p6l948t302r1104b363],
39	recombinant	JJ	O	recombinant	amod	42	SENT_73	[p6l1142t302r1594b363],
40	57-1	CD	NUMBER	57-1	npadvmod	41	SENT_73	[p6l1636t305r1781b363],
41	ancestral	JJ	O	ancestral	amod	42	SENT_73	[p6l1832t302r2142b363],
42	haplotypes	NNS	O	haplotype	prep_with	37	SENT_73	[p6l7t396r406b472],
43	.	.	O	.	_	0	SENT_73	[p6l7t396r406b472],

1	The	DT	O	the	det	4	SENT_74	[p6l506t396r651b456],
2	57-1	CD	NUMBER	57-1	npadvmod	3	SENT_74	[p6l750t398r896b456],
3	ancestral	JJ	O	ancestral	amod	4	SENT_74	[p6l1002t396r1312b456],
4	haplotype	NN	O	haplotype	nsubj	5	SENT_74	[p6l1406t396r1754b472],
5	includes	VBZ	O	include	_	0	SENT_74	[p6l1850t396r2141b456],
6	HLA-B	NN	O	hla-b	dobj	5	SENT_74	[p6l7t488r517b561],
7	*	CD	NUMBER	*	number	8	SENT_74	[p6l7t488r517b561],
8	5701	CD	NUMBER	5701	dep	6	SENT_74	[p6l7t488r517b561],
9	,	,	O	,	_	0	SENT_74	[p6l7t488r517b561],
10	C4A6	NN	O	c4a6	dobj	5	SENT_74	[p6l552t488r772b561],
11	,	,	O	,	_	0	SENT_74	[p6l552t488r772b561],
12	HLA-DRBI	NN	O	hla-drbus	appos	10	SENT_74	[p6l803t488r1455b549],
13	*	CD	NUMBER	*	num	12	SENT_74	[p6l803t488r1455b549],
14	0701	CD	DATE	0701	number	15	SENT_74	[p6l803t488r1455b549],
15	(	CD	NUMBER	(	num	17	SENT_74	[p6l1496t489r1744b564],
16	DR7	NN	O	dr7	nn	17	SENT_74	[p6l1496t489r1744b564],
17	)	NN	O	)	dep	12	SENT_74	[p6l1496t489r1744b564],
18	,	,	O	,	_	0	SENT_74	[p6l1496t489r1744b564],
19	and	CC	O	and	_	0	SENT_74	[p6l1776t488r1906b549],
20	HLADQB1	NN	O	hladqb1	conj_and	6	SENT_74	[p6l1931t488r2144b548, p6l7t582r460b657],
21	*	CD	NUMBER	*	num	20	SENT_74	[p6l1931t488r2144b548, p6l7t582r460b657],
22	0303	CD	DATE	0303	number	23	SENT_74	[p6l1931t488r2144b548, p6l7t582r460b657],
23	(	CD	NUMBER	(	num	25	SENT_74	[p6l558t582r812b657],
24	DQ3	NN	O	dq3	nn	25	SENT_74	[p6l558t582r812b657],
25	)	NN	O	)	dep	20	SENT_74	[p6l558t582r812b657],
26	.	.	O	.	_	0	SENT_74	[p6l558t582r812b657],

1	HLA-DR-DQ	NN	O	hla-dr-dq	nn	2	SENT_75	[p6l906t582r1403b657],
2	haplotypes	NNS	O	haplotype	nsubj	3	SENT_75	[p6l1490t581r1869b657],
3	show	VBP	O	show	_	0	SENT_75	[p6l1962t581r2144b642],
4	extremely	RB	O	extremely	advmod	5	SENT_75	[p6l10t675r355b751],
5	high	JJ	O	high	amod	7	SENT_75	[p6l376t675r531b751],
6	linkage	NN	O	linkage	nn	7	SENT_75	[p6l554t675r803b751],
7	disequilibrium	NN	O	disequilibrium	dobj	3	SENT_75	[p6l828t675r1342b751],
8	in	IN	O	in	_	0	SENT_75	[p6l1365t675r1433b734],
9	all	DT	O	all	det	10	SENT_75	[p6l1458t675r1536b735],
10	populations	NNS	O	population	prep_in	7	SENT_75	[p6l1559t675r1997b751],
11	,	,	O	,	_	0	SENT_75	[p6l1559t675r1997b751],
12	but	CC	O	but	_	0	SENT_75	[p6l2022t675r2143b735],
13	DR7	NN	O	dr7	nsubjpass	16	SENT_75	[p6l7t768r178b828],
14	can	MD	O	can	aux	16	SENT_75	[p6l228t787r350b828],
15	be	VB	O	be	auxpass	16	SENT_75	[p6l403t767r486b828],
16	associated	VBN	O	associate	conj_but	3	SENT_75	[p6l543t767r901b828],
17	with	IN	O	with	prep	16	SENT_75	[p6l954t767r1109b828],
18	either	CC	O	either	dep	17	SENT_75	[p6l1165t767r1366b828],
19	DQ3	NN	O	dq3	nn	20	SENT_75	[p6l1417t767r1591b843],
20	(	NN	O	(	conj	17	SENT_75	[p6l1651t768r1766b842],
21	on	IN	O	on	_	0	SENT_75	[p6l1651t768r1766b842],
22	the	DT	O	the	det	26	SENT_75	[p6l1820t767r1929b828],
23	57-1	CD	NUMBER	57-1	npadvmod	24	SENT_75	[p6l1988t770r2133b828],
24	ancestral	JJ	O	ancestral	amod	26	SENT_75	[p6l10t860r321b921],
25	haplotype	NN	O	haplotype	nn	26	SENT_75	[p6l396t860r770b936],
26	)	NN	O	)	prep_on	17	SENT_75	[p6l396t860r770b936],
27	or	CC	O	or	_	0	SENT_75	[p6l854t880r927b921],
28	DQ2	NN	O	dq2	nn	29	SENT_75	[p6l1001t861r1174b936],
29	(	NN	O	(	conj_or	26	SENT_75	[p6l1255t861r1371b936],
30	on	IN	O	on	_	0	SENT_75	[p6l1255t861r1371b936],
31	other	JJ	O	other	amod	32	SENT_75	[p6l1449t860r1634b921],
32	haplotypes	NNS	O	haplotype	prep_on	26	SENT_75	[p6l1707t860r2137b936],
33	)	RB	O	)	advmod	16	SENT_75	[p6l1707t860r2137b936],
34	.	.	O	.	_	0	SENT_75	[p6l1707t860r2137b936],

1	Therefore	RB	O	therefore	dep	4	SENT_76	[p6l7t954r383b1027],
2	,	,	O	,	_	0	SENT_76	[p6l7t954r383b1027],
3	the	DT	O	the	det	4	SENT_76	[p6l408t954r517b1014],
4	combination	NN	O	combination	_	0	SENT_76	[p6l542t954r989b1014],
5	of	IN	O	of	_	0	SENT_76	[p6l1013t954r1089b1014],
6	HLA-DR7	NN	O	hla-dr7	prep_of	4	SENT_76	[p6l1100t954r1484b1014],
7	plus	CC	O	plus	prep	6	SENT_76	[p6l1500t954r1645b1030],
8	HLA	NN	O	hlum	dep	7	SENT_76	[p6l1667t954r2054b1030],
9	.	.	O	.	_	0	SENT_76	[p6l1667t954r2054b1030],

1	—	NN	O	—	_	0	SENT_77	[p6l1667t954r2054b1030],
2	.	.	O	.	_	0	SENT_77	[p6l1667t954r2054b1030],

1	DQ3	NN	O	dq3	nsubj	10	SENT_78	[p6l1667t954r2054b1030],
2	in	IN	O	in	_	0	SENT_78	[p6l2076t954r2143b1013],
3	individuals	NNS	O	individual	prep_in	1	SENT_78	[p6l8t1046r392b1107],
4	who	WP	O	who	nsubj	7	SENT_78	[p6l424t1046r574b1107],
5	did	VBD	O	do	aux	7	SENT_78	[p6l609t1046r722b1107],
6	not	RB	O	not	neg	7	SENT_78	[p6l754t1060r873b1107],
7	have	VB	O	have	rcmod	3	SENT_78	[p6l903t1046r1064b1107],
8	HLA-DQ2	NN	O	hla-dq2	dobj	7	SENT_78	[p6l1096t1046r1483b1122],
9	was	VBD	O	be	cop	10	SENT_78	[p6l1513t1066r1643b1107],
10	necessary	JJ	O	necessary	_	0	SENT_78	[p6l1677t1066r2014b1122],
11	for	IN	O	for	_	0	SENT_78	[p6l2044t1046r2145b1107],
12	the	DT	O	the	det	13	SENT_78	[p6l8t1139r117b1200],
13	assignment	NN	O	assignment	prep_for	10	SENT_78	[p6l144t1140r540b1215],
14	of	IN	O	of	_	0	SENT_78	[p6l565t1139r641b1200],
15	a	DT	O	a	det	19	SENT_78	[p6l658t1159r693b1200],
16	recombinant	JJ	O	recombinant	amod	19	SENT_78	[p6l718t1139r1170b1200],
17	57-1	CD	NUMBER	57-1	npadvmod	18	SENT_78	[p6l1196t1142r1342b1200],
18	ancestral	JJ	O	ancestral	amod	19	SENT_78	[p6l1378t1139r1688b1200],
19	haplotype	NN	O	haplotype	prep_of	13	SENT_78	[p6l1712t1139r2079b1215],
20	.	.	O	.	_	0	SENT_78	[p6l1712t1139r2079b1215],

1	Samples	NNS	O	sample	nsubjpass	3	SENT_79	[p6l96t1233r389b1309],
2	were	VBD	O	be	auxpass	3	SENT_79	[p6l428t1252r595b1293],
3	typed	VBN	O	type	_	0	SENT_79	[p6l634t1233r832b1309],
4	for	IN	O	for	_	0	SENT_79	[p6l871t1233r971b1293],
5	the	DT	O	the	det	7	SENT_79	[p6l1008t1233r1117b1293],
6	—	CD	NUMBER	—	num	7	SENT_79	[p6l1155t1233r1546b1293],
7	238G	NN	O	238g	prep_for	3	SENT_79	[p6l1155t1233r1546b1293],
8	—	CD	NUMBER	—	num	7	SENT_79	[p6l1155t1233r1546b1293],
9	>	JJR	O	>	amod	10	SENT_79	[p6l1155t1233r1546b1293],
10	A	NN	O	a	tmod	3	SENT_79	[p6l1155t1233r1546b1293],
11	and	CC	O	and	_	0	SENT_79	[p6l1586t1233r1716b1293],
12	—	NN	O	—	nn	13	SENT_79	[p6l1753t1233r2144b1293],
13	308G	NN	O	308g	conj_and	10	SENT_79	[p6l1753t1233r2144b1293],
14	—	CD	NUMBER	—	num	15	SENT_79	[p6l1753t1233r2144b1293],
15	>	JJR	O	>	dep	10	SENT_79	[p6l1753t1233r2144b1293],
16	A	DT	O	a	det	17	SENT_79	[p6l1753t1233r2144b1293],
17	substitutions	NNS	O	substitution	xcomp	3	SENT_79	[p6l9t1325r459b1386],
18	in	IN	O	in	_	0	SENT_79	[p6l488t1325r555b1385],
19	the	DT	O	the	det	20	SENT_79	[p6l581t1325r690b1386],
20	gene	NN	O	gene	prep_in	17	SENT_79	[p6l718t1345r880b1401],
21	encoding	VBG	O	encode	partmod	20	SENT_79	[p6l910t1325r1234b1401],
22	tumour	NN	O	tumour	nn	33	SENT_79	[p6l1259t1339r1528b1386],
23	necrosis	NN	O	necrosis	nn	33	SENT_79	[p6l1553t1325r1835b1386],
24	factor	NN	O	factor	nn	33	SENT_79	[p6l1864t1325r2069b1386],
25	oz	NN	O	oz	nn	33	SENT_79	[p6l2095t1347r2142b1385],
26	(	NN	O	(	nn	33	SENT_79	[p6l14t1419r369b1494],
27	TNF/1	NN	O	tnf/1	nn	33	SENT_79	[p6l14t1419r369b1494],
28	)	NN	O	)	nn	30	SENT_79	[p6l14t1419r369b1494],
29	,	,	O	,	_	0	SENT_79	[p6l14t1419r369b1494],
30	“	NN	O	“	nn	33	SENT_79	[p6l14t1419r369b1494],
31	and	CC	O	and	_	0	SENT_79	[p6l428t1419r558b1479],
32	four	CD	NUMBER	four	conj_and	30	SENT_79	[p6l610t1418r758b1479],
33	microsatellites	NNS	O	microsatellite	dobj	21	SENT_79	[p6l808t1419r1313b1479],
34	spanning	VBG	O	span	xcomp	21	SENT_79	[p6l1368t1419r1689b1495],
35	the	DT	O	the	det	38	SENT_79	[p6l1739t1419r1849b1479],
36	central	JJ	O	central	amod	38	SENT_79	[p6l1903t1419r2142b1479],
37	MHC	NN	O	mhc	nn	38	SENT_79	[p6l8t1512r223b1572],
38	region	NN	O	region	dobj	34	SENT_79	[p6l260t1512r482b1588],
39	(	CD	NUMBER	(	num	40	SENT_79	[p6l521t1512r912b1587],
40	D6S1014	NN	O	d6s1014	nsubjpass	50	SENT_79	[p6l521t1512r912b1587],
41	,	,	O	,	_	0	SENT_79	[p6l521t1512r912b1587],
42	D6S273	NN	O	d6s273	nsubjpass	50	SENT_79	[p6l949t1512r1268b1585],
43	,	,	O	,	_	0	SENT_79	[p6l949t1512r1268b1585],
44	MIB	NNP	O	MIB	nsubjpass	50	SENT_79	[p6l1304t1513r1495b1585],
45	,	,	O	,	_	0	SENT_79	[p6l1304t1513r1495b1585],
46	and	CC	O	and	_	0	SENT_79	[p6l1533t1512r1663b1572],
47	MICA-TM	NN	O	mica-tm	nn	48	SENT_79	[p6l1697t1512r2136b1587],
48	)	NN	O	)	nsubjpass	50	SENT_79	[p6l1697t1512r2136b1587],
49	were	VBD	O	be	auxpass	50	SENT_79	[p6l7t1624r173b1665],
50	used	VBN	O	use	rcmod	38	SENT_79	[p6l198t1604r362b1665],
51	for	IN	O	for	_	0	SENT_79	[p6l386t1604r487b1665],
52	mapping	NN	O	mapping	prep_for	50	SENT_79	[p6l509t1604r823b1680],
53	of	IN	O	of	_	0	SENT_79	[p6l847t1604r923b1665],
54	this	DT	O	this	det	55	SENT_79	[p6l938t1604r1061b1665],
55	region	NN	O	region	prep_of	52	SENT_79	[p6l1088t1604r1434b1680],
56	.	.	O	.	_	0	SENT_79	[p6l1088t1604r1434b1680],

1	”	NN	O	”	_	0	SENT_80	[p6l1088t1604r1434b1680],
2	-13	CD	NUMBER	-13	num	1	SENT_80	[p6l1088t1604r1434b1680],

1	Statistical	JJ	O	statistical	amod	4	SENT_81	[p6l7t1793r348b1852],
2	analysis	NN	O	analysis	nn	4	SENT_81	[p6l371t1794r648b1865],
3	p	NN	O	p	nn	4	SENT_81	[p6l7t1903r50b1959],
4	values	NNS	O	value	nsubjpass	6	SENT_81	[p6l86t1883r303b1944],
5	were	VBD	O	be	auxpass	6	SENT_81	[p6l340t1903r506b1944],
6	corrected	VBN	O	correct	dep	13	SENT_81	[p6l544t1883r875b1944],
7	for	IN	O	for	_	0	SENT_81	[p6l911t1883r1011b1944],
8	comparisons	NNS	O	comparison	prep_for	6	SENT_81	[p6l1046t1883r1491b1959],
9	of	IN	O	of	_	0	SENT_81	[p6l1530t1883r1606b1944],
10	multiple	JJ	O	multiple	amod	12	SENT_81	[p6l1632t1883r1925b1959],
11	HLA	NN	O	hlum	nn	12	SENT_81	[p6l1960t1883r2140b1943],
12	alleles	NNS	O	allele	prep_of	8	SENT_81	[p6l10t1976r218b2037],
13	(	VBP	O	(	_	0	SENT_81	[p6l275t1977r389b2054],
14	pa	NN	O	pa	nn	15	SENT_81	[p6l275t1977r389b2054],
15	)	NN	O	)	dobj	13	SENT_81	[p6l275t1977r389b2054],
16	by	IN	O	by	_	0	SENT_81	[p6l443t1977r530b2052],
17	multiplication	NN	O	multiplication	prep_by	13	SENT_81	[p6l576t1977r1073b2053],
18	of	IN	O	of	_	0	SENT_81	[p6l1123t1976r1200b2037],
19	the	DT	O	the	det	22	SENT_81	[p6l1238t1977r1347b2037],
20	raw	JJ	O	raw	amod	22	SENT_81	[p6l1397t1996r1527b2037],
21	p	NN	O	p	nn	22	SENT_81	[p6l1573t1996r1616b2053],
22	value	NN	O	value	prep_of	17	SENT_81	[p6l1665t1977r1851b2037],
23	by	IN	O	by	_	0	SENT_81	[p6l1899t1977r1986b2052],
24	the	DT	O	the	det	26	SENT_81	[p6l2032t1977r2142b2037],
25	estimated	VBN	O	estimate	amod	26	SENT_81	[p6l10t2070r350b2130],
26	number	NN	O	number	prep_by	13	SENT_81	[p6l391t2070r674b2130],
27	of	IN	O	of	_	0	SENT_81	[p6l716t2070r792b2130],
28	HLA	NN	O	hlum	nn	29	SENT_81	[p6l823t2070r1001b2129],
29	alleles	NNS	O	allele	prep_of	26	SENT_81	[p6l1048t2070r1257b2130],
30	present	JJ	DATE	present	amod	29	SENT_81	[p6l1300t2084r1560b2146],
31	within	IN	O	within	_	0	SENT_81	[p6l1600t2070r1824b2130],
32	the	DT	O	the	det	33	SENT_81	[p6l1866t2070r1975b2130],
33	loci	NNS	O	locus	prep_within	30	SENT_81	[p6l2018t2070r2143b2130],
34	examined	VBN	O	examine	partmod	33	SENT_81	[p6l10t2162r352b2222],
35	(	RB	O	(	advmod	34	SENT_81	[p6l393t2163r502b2236],
36	35	CD	NUMBER	35	nsubj	13	SENT_81	[p6l393t2163r502b2236],
37	for	IN	O	for	_	0	SENT_81	[p6l542t2162r642b2222],
38	HLA-B	NN	O	hla-b	prep_for	36	SENT_81	[p6l673t2162r963b2234],
39	,	,	O	,	_	0	SENT_81	[p6l673t2162r963b2234],
40	18	CD	NUMBER	18	conj_and	36	SENT_81	[p6l1010t2165r1087b2222],
41	for	IN	O	for	_	0	SENT_81	[p6l1125t2162r1225b2222],
42	HLA-DR	NN	O	hla-dr	prep_for	40	SENT_81	[p6l1256t2162r1612b2234],
43	,	,	O	,	_	0	SENT_81	[p6l1256t2162r1612b2234],
44	and	CC	O	and	_	0	SENT_81	[p6l1651t2162r1781b2222],
45	seven	CD	NUMBER	seven	conj_and	36	SENT_81	[p6l1817t2182r2010b2222],
46	for	IN	O	for	_	0	SENT_81	[p6l2044t2162r2144b2222],
47	HLA-DQ	NN	O	hla-dq	nn	48	SENT_81	[p6l7t2255r399b2330],
48	)	NN	O	)	prep_for	45	SENT_81	[p6l7t2255r399b2330],
49	.	.	O	.	_	0	SENT_81	[p6l7t2255r399b2330],

1	Hence	RB	O	hence	advmod	7	SENT_82	[p6l437t2255r689b2327],
2	,	,	O	,	_	0	SENT_82	[p6l437t2255r689b2327],
3	all	DT	O	all	det	5	SENT_82	[p6l726t2254r804b2315],
4	p	NN	O	p	nn	5	SENT_82	[p6l835t2274r879b2330],
5	values	NNS	O	value	nsubjpass	7	SENT_82	[p6l911t2254r1128b2315],
6	were	VBD	O	be	auxpass	7	SENT_82	[p6l1160t2274r1326b2315],
7	multiplied	VBN	O	multiply	_	0	SENT_82	[p6l1359t2254r1722b2330],
8	by	IN	O	by	_	0	SENT_82	[p6l1753t2254r1840b2330],
9	a	DT	O	a	det	10	SENT_82	[p6l1872t2274r1907b2315],
10	factor	NN	O	factor	agent	7	SENT_82	[p6l1939t2254r2144b2315],
11	of	IN	O	of	_	0	SENT_82	[p6l10t2348r86b2408],
12	4410	CD	NUMBER	4410	prep_of	10	SENT_82	[p6l140t2350r337b2408],
13	.	.	O	.	_	0	SENT_82	[p6l140t2350r337b2408],

1	Odds	NNS	O	odds	nn	2	SENT_83	[p6l408t2348r596b2408],
2	ratios	NNS	O	ratio	nsubjpass	4	SENT_83	[p6l661t2348r853b2408],
3	were	VBD	O	be	auxpass	4	SENT_83	[p6l916t2367r1083b2408],
4	calculated	VBN	O	calculate	_	0	SENT_83	[p6l1149t2348r1504b2408],
5	with	IN	O	with	_	0	SENT_83	[p6l1566t2348r1721b2408],
6	Haldane	NNP	PERSON	Haldane	poss	8	SENT_83	[p6l1785t2348r2141b2408],
7	’s	POS	O	’s	_	0	SENT_83	[p6l1785t2348r2141b2408],
8	modiﬁcation	NN	O	modiﬁcation	prep_with	4	SENT_83	[p6l8t2439r478b2511],
9	,	,	O	,	_	0	SENT_83	[p6l8t2439r478b2511],
10	which	WDT	O	which	nsubj	11	SENT_83	[p6l517t2439r730b2500],
11	adds	VBZ	O	add	rcmod	8	SENT_83	[p6l770t2439r930b2500],
12	0-5	CD	NUMBER	0-5	dobj	11	SENT_83	[p6l972t2442r1078b2500],
13	to	TO	O	to	_	0	SENT_83	[p6l1120t2453r1188b2500],
14	all	DT	O	all	det	15	SENT_83	[p6l1230t2439r1308b2499],
15	cells	NNS	O	cell	prep_to	11	SENT_83	[p6l1348t2439r1495b2500],
16	to	TO	O	to	aux	17	SENT_83	[p6l1535t2453r1603b2500],
17	accommodate	VB	O	accommodate	xcomp	11	SENT_83	[p6l1644t2439r2142b2500],
18	possible	JJ	O	possible	amod	20	SENT_83	[p6l7t2532r289b2608],
19	zero	CD	NUMBER	zero	num	20	SENT_83	[p6l319t2552r466b2593],
20	counts	NNS	O	count	dobj	17	SENT_83	[p6l500t2547r753b2605],
21	;	:	O	;	_	0	SENT_83	[p6l500t2547r753b2605],
22	\	CD	NUMBER	\	num	23	SENT_83	[p6l784t2532r1059b2593],
23	X7oolf	NN	O	x7oolf	poss	25	SENT_83	[p6l784t2532r1059b2593],
24	’s	POS	O	’s	_	0	SENT_83	[p6l784t2532r1059b2593],
25	method	NN	O	method	nsubjpass	27	SENT_83	[p6l1090t2532r1364b2593],
26	was	VBD	O	be	auxpass	27	SENT_83	[p6l1393t2552r1523b2593],
27	used	VBN	O	use	parataxis	4	SENT_83	[p6l1554t2532r1718b2593],
28	to	TO	O	to	aux	29	SENT_83	[p6l1748t2547r1816b2593],
29	estimate	VB	O	estimate	xcomp	27	SENT_83	[p6l1849t2533r2142b2593],
30	SEs	NNS	O	se	dobj	29	SENT_83	[p6l11t2626r142b2686],
31	and	CC	O	and	_	0	SENT_83	[p6l187t2626r318b2686],
32	Cls	NNS	O	cl	conj_and	30	SENT_83	[p6l362t2626r553b2686],
33	.	.	O	.	_	0	SENT_83	[p6l362t2626r553b2686],

1	”	NN	O	”	nn	2	SENT_84	[p6l362t2626r553b2686],
2	Comparisons	NNS	O	comparison	nsubjpass	20	SENT_84	[p6l599t2626r1069b2702],
3	of	IN	O	of	_	0	SENT_84	[p6l1114t2626r1190b2686],
4	demographic	JJ	O	demographic	amod	7	SENT_84	[p6l1223t2626r1685b2702],
5	and	CC	O	and	_	0	SENT_84	[p6l1730t2626r1860b2686],
6	related	JJ	O	related	amod	7	SENT_84	[p6l1901t2626r2143b2686],
7	data	NNS	O	datum	prep_of	2	SENT_84	[p6l9t2718r159b2779],
8	in	IN	O	in	_	0	SENT_84	[p6l193t2718r260b2778],
9	those	DT	O	those	prep_in	7	SENT_84	[p6l293t2718r479b2779],
10	with	IN	O	with	_	0	SENT_84	[p6l512t2718r667b2779],
11	abacavir	NN	O	abacavir	nn	12	SENT_84	[p6l702t2718r995b2779],
12	hypersensitivity	NN	O	hypersensitivity	prep_with	9	SENT_84	[p6l1025t2718r1576b2794],
13	and	CC	O	and	_	0	SENT_84	[p6l1609t2718r1739b2779],
14	those	DT	O	those	conj_and	7	SENT_84	[p6l1773t2718r1959b2779],
15	who	WP	O	who	nsubj	17	SENT_84	[p6l1992t2718r2141b2779],
16	were	VBD	O	be	cop	17	SENT_84	[p6l7t2831r173b2872],
17	abacavir	NN	O	abacavir	rcmod	14	SENT_84	[p6l212t2811r505b2872],
18	tolerant	JJ	O	tolerant	amod	17	SENT_84	[p6l539t2811r814b2872],
19	were	VBD	O	be	auxpass	20	SENT_84	[p6l849t2831r1015b2872],
20	done	VBN	O	do	_	0	SENT_84	[p6l1054t2811r1228b2872],
21	with	IN	O	with	_	0	SENT_84	[p6l1264t2811r1419b2872],
22	Fisher	NNP	PERSON	Fisher	poss	25	SENT_84	[p6l1455t2811r1730b2872],
23	’s	POS	O	’s	_	0	SENT_84	[p6l1455t2811r1730b2872],
24	exact	JJ	O	exact	amod	25	SENT_84	[p6l1770t2825r1952b2872],
25	tests	NNS	O	test	prep_with	20	SENT_84	[p6l1987t2825r2141b2872],
26	for	IN	O	for	_	0	SENT_84	[p6l8t2905r109b2965],
27	dichotomous	JJ	O	dichotomous	amod	28	SENT_84	[p6l171t2905r632b2965],
28	variables	NNS	O	variable	prep_for	25	SENT_84	[p6l694t2905r1024b2977],
29	,	,	O	,	_	0	SENT_84	[p6l694t2905r1024b2977],
30	and	CC	O	and	_	0	SENT_84	[p6l1091t2905r1221b2965],
31	1	CD	NUMBER	1	conj_and	25	SENT_84	[p6l1286t2921r1310b2965],
32	:	:	O	:	_	0	SENT_84	[p6l1286t2921r1310b2965],
33	tests	NNS	O	test	dep	31	SENT_84	[p6l1368t2918r1521b2965],
34	for	IN	O	for	_	0	SENT_84	[p6l1585t2905r1686b2965],
35	continuous	JJ	O	continuous	amod	36	SENT_84	[p6l1748t2905r2141b2965],
36	variables	NNS	O	variable	prep_for	33	SENT_84	[p6l6t2996r333b3057],
37	.	.	O	.	_	0	SENT_84	[p6l6t2996r333b3057],

1	Role	NN	O	role	nsubj	8	SENT_85	[p6l10t3186r161b3244],
2	of	IN	O	of	_	0	SENT_85	[p6l189t3185r261b3244],
3	the	DT	O	the	det	5	SENT_85	[p6l279t3186r387b3244],
4	funding	NN	O	funding	nn	5	SENT_85	[p6l414t3185r678b3259],
5	source	NN	O	source	prep_of	1	SENT_85	[p6l697t3199r931b3244],
6	The	DT	O	the	det	7	SENT_85	[p6l7t3276r153b3337],
7	sponsor	NN	O	sponsor	dep	5	SENT_85	[p6l233t3296r509b3352],
8	had	VBD	O	have	_	0	SENT_85	[p6l584t3276r716b3337],
9	no	DT	O	no	det	10	SENT_85	[p6l793t3296r882b3337],
10	role	NN	O	role	dobj	8	SENT_85	[p6l960t3276r1093b3337],
11	in	IN	O	in	_	0	SENT_85	[p6l1171t3276r1239b3336],
12	the	DT	O	the	det	13	SENT_85	[p6l1316t3276r1425b3337],
13	design	NN	O	design	prep_in	10	SENT_85	[p6l1504t3276r1750b3352],
14	,	,	O	,	_	0	SENT_85	[p6l1504t3276r1750b3352],
15	conduct	NN	O	conduct	conj_or	13	SENT_85	[p6l1832t3276r2140b3349],
16	,	,	O	,	_	0	SENT_85	[p6l1832t3276r2140b3349],
17	interpretation	NN	O	interpretation	conj_or	13	SENT_85	[p6l8t3370r514b3445],
18	,	,	O	,	_	0	SENT_85	[p6l8t3370r514b3445],
19	or	CC	O	or	_	0	SENT_85	[p6l543t3389r617b3430],
20	writing	VBG	O	write	prep_in	10	SENT_85	[p6l638t3370r889b3445],
21	up	RP	O	up	prt	20	SENT_85	[p6l911t3389r1001b3445],
22	of	IN	O	of	_	0	SENT_85	[p6l1029t3369r1105b3430],
23	the	DT	O	the	det	24	SENT_85	[p6l1119t3369r1229b3430],
24	study	NN	O	study	prep_of	20	SENT_85	[p6l1255t3369r1464b3445],
25	.	.	O	.	_	0	SENT_85	[p6l1255t3369r1464b3445],

1	Results	NNS	O	result	_	0	SENT_86	[p6l11t3552r342b3619],

1	Prevalence	NN	O	prevalence	_	0	SENT_87	[p7l10t25r389b83],
2	of	IN	O	of	_	0	SENT_87	[p7l417t24r489b83],
3	abacavir	NN	O	abacavir	nn	4	SENT_87	[p7l505t25r805b83],
4	hypersensitivity	NN	O	hypersensitivity	prep_of	1	SENT_87	[p7l827t25r1361b96],
5	In	IN	O	in	dep	1	SENT_87	[p7l8t116r84b174],
6	the	DT	O	the	det	7	SENT_87	[p7l140t115r249b175],
7	cohort	NN	O	cohort	pobj	5	SENT_87	[p7l308t115r537b175],
8	of	IN	O	of	_	0	SENT_87	[p7l594t115r670b175],
9	200	CD	NUMBER	200	num	10	SENT_87	[p7l719t117r849b175],
10	individuals	NNS	O	individual	prep_of	7	SENT_87	[p7l907t115r1313b187],
11	,	,	O	,	_	0	SENT_87	[p7l907t115r1313b187],
12	18	CD	NUMBER	18	num	14	SENT_87	[p7l1382t117r1458b175],
13	deﬁnite	NN	O	deﬁnite	nn	14	SENT_87	[p7l1519t115r1782b175],
14	cases	NNS	O	case	appos	10	SENT_87	[p7l1841t134r2017b175],
15	of	IN	O	of	_	0	SENT_87	[p7l2076t115r2153b175],
16	abacavir	NN	O	abacavir	nn	17	SENT_87	[p7l10t206r303b267],
17	hypersensitivity	NN	O	hypersensitivity	prep_of	14	SENT_87	[p7l400t206r951b282],
18	were	VBD	O	be	auxpass	19	SENT_87	[p7l1048t226r1215b267],
19	identiﬁed	VBN	O	identiﬁed	rcmod	17	SENT_87	[p7l1317t206r1671b279],
20	,	,	O	,	_	0	SENT_87	[p7l1317t206r1671b279],
21	and	CC	O	and	_	0	SENT_87	[p7l1777t206r1907b267],
22	167	CD	NUMBER	167	conj_and	14	SENT_87	[p7l2017t209r2139b267],

1	Abacavir	NNP	O	Abacavir	nn	4	SENT_88	[p7l713t345r968b392],
2	Abacavir	NNP	O	Abacavir	nn	4	SENT_88	[p7l1458t345r1712b392],
3	tolerant	JJ	O	tolerant	amod	4	SENT_88	[p7l1732t345r1963b392],
4	p	NN	O	p	_	0	SENT_88	[p7l1999t357r2030b403],
5	hypersensitive	JJ	O	hypersensitive	amod	7	SENT_88	[p7l716t424r1135b482],
6	(	NN	O	(	nn	7	SENT_88	[p7l1159t424r1356b482],
7	n	NN	O	n	dep	4	SENT_88	[p7l1159t424r1356b482],
8	=	JJ	O	=	quantmod	10	SENT_88	[p7l1159t424r1356b482],
9	18	CD	NUMBER	18	number	10	SENT_88	[p7l1159t424r1356b482],
10	)	CD	NUMBER	)	num	15	SENT_88	[p7l1159t424r1356b482],
11	(	NN	O	(	nn	15	SENT_88	[p7l1459t424r1696b482],
12	n	NN	O	n	nn	15	SENT_88	[p7l1459t424r1696b482],
13	=	JJ	O	=	amod	15	SENT_88	[p7l1459t424r1696b482],
14	167	CD	NUMBER	167	num	15	SENT_88	[p7l1459t424r1696b482],
15	)	NN	O	)	dep	7	SENT_88	[p7l1459t424r1696b482],

1	Sex	NN	O	sex	_	0	SENT_89	[p7l17t552r119b599],

1	Male	JJ	O	male	amod	2	SENT_90	[p7l78t632r212b678],
2	16	CD	PERCENT	16	dep	17	SENT_90	[p7l766t631r838b678],
3	(	CD	PERCENT	(	number	4	SENT_90	[p7l863t631r1022b689],
4	89	CD	PERCENT	89	num	5	SENT_90	[p7l863t631r1022b689],
5	%	NN	PERCENT	%	dep	2	SENT_90	[p7l863t631r1022b689],
6	)	CD	NUMBER	)	number	7	SENT_90	[p7l863t631r1022b689],
7	145	CD	NUMBER	145	num	8	SENT_90	[p7l1471t632r1582b678],
8	(	NN	O	(	npadvmod	13	SENT_90	[p7l1608t631r1766b689],
9	87	CD	PERCENT	87	number	10	SENT_90	[p7l1608t631r1766b689],
10	%	NN	PERCENT	%	amod	8	SENT_90	[p7l1608t631r1766b689],
11	)	CD	NUMBER	)	number	12	SENT_90	[p7l1608t631r1766b689],
12	1-0	CD	NUMBER	1-0	num	8	SENT_90	[p7l2000t631r2091b678],
13	Female	JJ	O	female	amod	5	SENT_90	[p7l78t711r279b757],
14	2	CD	PERCENT	2	dep	17	SENT_90	[p7l804t710r837b757],
15	(	CD	PERCENT	(	num	17	SENT_90	[p7l863t710r1022b768],
16	11	CD	PERCENT	11	num	17	SENT_90	[p7l863t710r1022b768],
17	%	NN	PERCENT	%	dep	23	SENT_90	[p7l863t710r1022b768],
18	)	CD	PERCENT	)	number	19	SENT_90	[p7l863t710r1022b768],
19	22	CD	PERCENT	22	dep	17	SENT_90	[p7l1509t710r1581b757],
20	(	CD	PERCENT	(	num	22	SENT_90	[p7l1608t710r1766b768],
21	13	CD	PERCENT	13	num	22	SENT_90	[p7l1608t710r1766b768],
22	%	NN	PERCENT	%	dep	19	SENT_90	[p7l1608t710r1766b768],
23	)	CD	NUMBER	)	_	0	SENT_90	[p7l1608t710r1766b768],

1	Ethnic	JJ	O	ethnic	amod	2	SENT_91	[p7l19t790r189b836],
2	origin	NN	O	origin	_	0	SENT_91	[p7l213t790r363b848],

1	Caucasoid	NNP	O	Caucasoid	nn	3	SENT_92	[p7l76t868r370b915],
2	18	CD	PERCENT	18	num	3	SENT_92	[p7l766t868r839b915],
3	(	NN	PERCENT	(	_	0	SENT_92	[p7l863t868r1061b926],
4	100	CD	PERCENT	100	num	5	SENT_92	[p7l863t868r1061b926],
5	%	NN	PERCENT	%	dep	3	SENT_92	[p7l863t868r1061b926],
6	)	CD	NUMBER	)	number	7	SENT_92	[p7l863t868r1061b926],
7	147	CD	NUMBER	147	num	8	SENT_92	[p7l1471t869r1581b915],
8	(	NN	O	(	dep	5	SENT_92	[p7l1608t868r1766b926],
9	88	CD	PERCENT	88	num	10	SENT_92	[p7l1608t868r1766b926],
10	%	NN	PERCENT	%	dep	3	SENT_92	[p7l1608t868r1766b926],
11	)	CD	NUMBER	)	number	12	SENT_92	[p7l1608t868r1766b926],
12	0-23	CD	NUMBER	0-23	num	16	SENT_92	[p7l1997t868r2131b915],
13	Non	NNP	O	Non	nn	16	SENT_92	[p7l78t948r489b994],
14	—	CD	NUMBER	—	num	16	SENT_92	[p7l78t948r489b994],
15	caucasoid	NN	O	caucasoid	nn	16	SENT_92	[p7l78t948r489b994],
16	o	NN	O	o	dep	10	SENT_92	[p7l803t947r838b994],
17	20	CD	PERCENT	20	number	18	SENT_92	[p7l1509t947r1583b994],
18	(	CD	PERCENT	(	dep	3	SENT_92	[p7l1608t947r1766b1005],
19	12	CD	PERCENT	12	num	20	SENT_92	[p7l1608t947r1766b1005],
20	%	NN	PERCENT	%	dep	18	SENT_92	[p7l1608t947r1766b1005],
21	)	CD	NUMBER	)	dep	18	SENT_92	[p7l1608t947r1766b1005],
22	.	.	O	.	_	0	SENT_92	[p7l2002t985r2029b994],

1	.	.	O	.	_	0	SENT_93	[p7l2002t985r2029b994],

1	ART	NN	O	art	_	0	SENT_94	[p7l15t1025r125b1071],
2	naive	JJ	O	naive	amod	1	SENT_94	[p7l149t1023r293b1072],
3	2	CD	PERCENT	2	number	4	SENT_94	[p7l804t1024r837b1071],
4	(	CD	PERCENT	(	prep	2	SENT_94	[p7l863t1024r1022b1082],
5	11	CD	PERCENT	11	num	6	SENT_94	[p7l863t1024r1022b1082],
6	%	NN	PERCENT	%	dep	4	SENT_94	[p7l863t1024r1022b1082],
7	)	CD	PERCENT	)	number	8	SENT_94	[p7l863t1024r1022b1082],
8	27	CD	PERCENT	27	num	9	SENT_94	[p7l1509t1024r1581b1071],
9	(	NN	PERCENT	(	dep	14	SENT_94	[p7l1608t1024r1766b1082],
10	16	CD	PERCENT	16	num	11	SENT_94	[p7l1608t1024r1766b1082],
11	%	NN	PERCENT	%	dep	9	SENT_94	[p7l1608t1024r1766b1082],
12	)	CD	NUMBER	)	dep	14	SENT_94	[p7l1608t1024r1766b1082],
13	1-0	CD	NUMBER	1-0	num	14	SENT_94	[p7l2000t1024r2092b1072],
14	Mean	NN	O	mean	dep	21	SENT_94	[p7l19t1104r171b1150],
15	(	CD	NUMBER	(	num	16	SENT_94	[p7l198t1103r315b1161],
16	SD	NN	O	sd	dep	14	SENT_94	[p7l198t1103r315b1161],
17	)	CD	NUMBER	)	num	18	SENT_94	[p7l198t1103r315b1161],
18	age	NN	O	age	nsubj	21	SENT_94	[p7l340t1110r439b1162],
19	(	CD	NUMBER	(	num	20	SENT_94	[p7l465t1104r652b1162],
20	years	NNS	NUMBER	year	tmod	18	SENT_94	[p7l465t1104r652b1162],
21	)	VBP	O	)	ccomp	2	SENT_94	[p7l465t1104r652b1162],
22	44-8	CD	NUMBER	44-8	number	23	SENT_94	[p7l764t1103r898b1150],
23	(	CD	NUMBER	(	dobj	21	SENT_94	[p7l923t1103r1055b1161],
24	9-0	CD	NUMBER	9-0	num	25	SENT_94	[p7l923t1103r1055b1161],
25	)	NN	O	)	dep	23	SENT_94	[p7l923t1103r1055b1161],
26	42-8	CD	NUMBER	42-8	num	27	SENT_94	[p7l1508t1103r1643b1150],
27	(	CD	NUMBER	(	dep	33	SENT_94	[p7l1667t1103r1839b1161],
28	10-3	CD	NUMBER	10-3	num	29	SENT_94	[p7l1667t1103r1839b1161],
29	)	NN	O	)	dep	27	SENT_94	[p7l1667t1103r1839b1161],
30	0-43	CD	NUMBER	0-43	num	31	SENT_94	[p7l1998t1103r2131b1150],
31	Mean	NN	O	mean	dep	33	SENT_94	[p7l19t1182r171b1228],
32	(	CD	NUMBER	(	num	33	SENT_94	[p7l198t1181r315b1239],
33	SD	NN	O	sd	dep	37	SENT_94	[p7l198t1181r315b1239],
34	)	CD	NUMBER	)	num	35	SENT_94	[p7l198t1181r315b1239],
35	percentage	NN	O	percentage	dep	33	SENT_94	[p7l343t1184r655b1240],
36	19-8	CD	NUMBER	19-8	num	37	SENT_94	[p7l766t1181r898b1228],
37	(	CD	NUMBER	(	dep	41	SENT_94	[p7l923t1181r1055b1239],
38	8-1	CD	NUMBER	8-1	num	39	SENT_94	[p7l923t1181r1055b1239],
39	)	NN	O	)	dep	37	SENT_94	[p7l923t1181r1055b1239],
40	20-7	CD	NUMBER	20-7	num	41	SENT_94	[p7l1509t1181r1641b1228],
41	(	CD	NUMBER	(	dep	45	SENT_94	[p7l1667t1181r1839b1239],
42	10-6	CD	NUMBER	10-6	num	43	SENT_94	[p7l1667t1181r1839b1239],
43	)	NN	O	)	dep	41	SENT_94	[p7l1667t1181r1839b1239],
44	0-71	CD	NUMBER	0-71	num	45	SENT_94	[p7l1998t1181r2131b1228],
45	CD4	NN	O	cd4	dep	46	SENT_94	[p7l17t1258r136b1305],
46	Mean	NN	O	mean	dep	48	SENT_94	[p7l19t1338r171b1384],
47	(	CD	NUMBER	(	num	46	SENT_94	[p7l198t1337r315b1395],
48	SD	NN	O	sd	dep	50	SENT_94	[p7l198t1337r315b1395],
49	)	CD	NUMBER	)	num	48	SENT_94	[p7l198t1337r315b1395],
50	absolute	JJ	O	absolute	dep	52	SENT_94	[p7l340t1338r584b1384],
51	444	CD	NUMBER	444	num	52	SENT_94	[p7l724t1338r839b1384],
52	(	NN	O	(	dep	54	SENT_94	[p7l863t1337r1016b1395],
53	233	CD	NUMBER	233	num	54	SENT_94	[p7l863t1337r1016b1395],
54	)	NN	O	)	dep	56	SENT_94	[p7l863t1337r1016b1395],
55	442	CD	NUMBER	442	num	56	SENT_94	[p7l1469t1337r1581b1384],
56	(	NN	O	(	dep	62	SENT_94	[p7l1608t1337r1760b1395],
57	287	CD	NUMBER	287	number	58	SENT_94	[p7l1608t1337r1760b1395],
58	)	CD	NUMBER	)	dep	56	SENT_94	[p7l1608t1337r1760b1395],
59	0-98	CD	NUMBER	0-98	num	60	SENT_94	[p7l1998t1337r2132b1384],
60	CD4	NN	O	cd4	dep	58	SENT_94	[p7l17t1415r136b1462],
61	(	CD	NUMBER	(	num	62	SENT_94	[p7l161t1415r438b1475],
62	cells/p	NNS	O	cells/p	dep	23	SENT_94	[p7l161t1415r438b1475],
63	.	.	O	.	_	0	SENT_94	[p7l161t1415r438b1475],

1	L	NN	O	l	_	0	SENT_95	[p7l161t1415r438b1475],
2	)	SYM	O	)	dep	1	SENT_95	[p7l161t1415r438b1475],

1	ART	NN	O	art	_	0	SENT_96	[p7l15t1574r483b1617],
2	=	JJ	O	=	amod	4	SENT_96	[p7l15t1574r483b1617],
3	antiretroviral	JJ	O	antiretroviral	amod	4	SENT_96	[p7l15t1574r483b1617],
4	therapy	NN	O	therapy	dep	1	SENT_96	[p7l506t1574r716b1627],
5	.	.	O	.	_	0	SENT_96	[p7l506t1574r716b1627],

1	Table	NNP	O	Table	_	0	SENT_97	[p7l15t1671r189b1725],
2	1	CD	NUMBER	1	num	1	SENT_97	[p7l220t1671r276b1724],
3	:	:	O	:	_	0	SENT_97	[p7l220t1671r276b1724],
4	Demographic	JJ	O	demographic	amod	5	SENT_97	[p7l309t1671r744b1738],
5	variables	NNS	O	variable	dep	1	SENT_97	[p7l770t1671r1088b1736],
6	,	,	O	,	_	0	SENT_97	[p7l770t1671r1088b1736],
7	antiretroviral	JJ	O	antiretroviral	amod	8	SENT_97	[p7l1117t1671r1543b1725],
8	exposure	NN	O	exposure	appos	5	SENT_97	[p7l1571t1684r1894b1737],
9	,	,	O	,	_	0	SENT_97	[p7l1571t1684r1894b1737],
10	and	CC	O	and	_	0	SENT_97	[p7l16t1765r133b1818],
11	immunological	JJ	O	immunological	amod	12	SENT_97	[p7l163t1764r642b1831],
12	status	NN	O	status	conj_and	5	SENT_97	[p7l669t1766r880b1818],
13	in	IN	O	in	_	0	SENT_97	[p7l909t1764r962b1818],
14	abacavir-hypersensitive	JJ	O	abacavir-hypersensitive	amod	17	SENT_97	[p7l990t1764r1773b1831],
15	and	CC	O	and	_	0	SENT_97	[p7l1799t1765r1915b1818],
16	abacavir-tolerant	JJ	O	abacavir-tolerant	conj_and	14	SENT_97	[p7l16t1857r580b1912],
17	groups	NNS	O	group	prep_in	12	SENT_97	[p7l604t1865r829b1924],

1	Abacavir	NNP	O	Abacavir	_	0	SENT_98	[p7l606t2284r860b2331],
2	hypersensitive	JJ	O	hypersensitive	amod	4	SENT_98	[p7l609t2369r1027b2428],
3	(	NN	O	(	nn	4	SENT_98	[p7l607t2446r804b2503],
4	n	NN	O	n	dep	1	SENT_98	[p7l607t2446r804b2503],
5	=	JJ	O	=	amod	7	SENT_98	[p7l607t2446r804b2503],
6	18	CD	NUMBER	18	tmod	5	SENT_98	[p7l607t2446r804b2503],
7	)	NN	O	)	dep	4	SENT_98	[p7l607t2446r804b2503],

1	HLA-B	NN	O	hla-b	_	0	SENT_99	[p7l23t2607r379b2654],
2	*	CD	NUMBER	*	number	3	SENT_99	[p7l23t2607r379b2654],
3	5701	CD	NUMBER	5701	dep	1	SENT_99	[p7l23t2607r379b2654],
4	14	CD	NUMBER	14	num	5	SENT_99	[p7l610t2607r682b2653],
5	(	NN	O	(	dep	3	SENT_99	[p7l707t2607r865b2664],
6	78	CD	PERCENT	78	num	7	SENT_99	[p7l707t2607r865b2664],
7	%	NN	PERCENT	%	dep	1	SENT_99	[p7l707t2607r865b2664],
8	)	CD	NUMBER	)	num	9	SENT_99	[p7l707t2607r865b2664],
9	HLA	NN	O	hlum	dep	7	SENT_99	[p7l23t2685r285b2738],
10	.	.	O	.	_	0	SENT_99	[p7l23t2685r285b2738],

1	—	NN	O	—	_	0	SENT_100	[p7l23t2685r285b2738],
2	.	.	O	.	_	0	SENT_100	[p7l23t2685r285b2738],

1	DR7	NN	O	dr7	_	0	SENT_101	[p7l23t2685r285b2738],
2	,	,	O	,	_	0	SENT_101	[p7l23t2685r285b2738],
3	HLA-DQ3	NN	O	hla-dq3	appos	1	SENT_101	[p7l312t2685r558b2740],
4	13	CD	PERCENT	13	num	3	SENT_101	[p7l610t2684r681b2730],
5	(	CD	PERCENT	(	number	6	SENT_101	[p7l707t2684r865b2741],
6	72	CD	PERCENT	72	num	7	SENT_101	[p7l707t2684r865b2741],
7	%	NN	PERCENT	%	dep	3	SENT_101	[p7l707t2684r865b2741],
8	)	CD	NUMBER	)	num	9	SENT_101	[p7l707t2684r865b2741],
9	HLA	NN	O	hlum	dep	3	SENT_101	[p7l23t2761r396b2815],
10	.	.	O	.	_	0	SENT_101	[p7l23t2761r396b2815],

1	—	NN	O	—	_	0	SENT_102	[p7l23t2761r396b2815],
2	.	.	O	.	_	0	SENT_102	[p7l23t2761r396b2815],

1	B	NN	O	b	_	0	SENT_103	[p7l23t2761r396b2815],
2	*	CD	NUMBER	*	num	3	SENT_103	[p7l23t2761r396b2815],
3	5701	CD	NUMBER	5701	dep	1	SENT_103	[p7l23t2761r396b2815],
4	,	,	O	,	_	0	SENT_103	[p7l23t2761r396b2815],
5	13	CD	PERCENT	13	appos	3	SENT_103	[p7l610t2761r681b2807],
6	(	CD	PERCENT	(	number	7	SENT_103	[p7l707t2761r866b2818],
7	72	CD	PERCENT	72	num	8	SENT_103	[p7l707t2761r866b2818],
8	%	NN	PERCENT	%	dep	1	SENT_103	[p7l707t2761r866b2818],
9	)	CD	NUMBER	)	num	10	SENT_103	[p7l707t2761r866b2818],
10	HLA	NN	O	hlum	dep	8	SENT_103	[p7l23t2839r285b2892],
11	.	.	O	.	_	0	SENT_103	[p7l23t2839r285b2892],

1	—	NN	O	—	_	0	SENT_104	[p7l23t2839r285b2892],
2	.	.	O	.	_	0	SENT_104	[p7l23t2839r285b2892],

1	DR7	NN	O	dr7	_	0	SENT_105	[p7l23t2839r285b2892],
2	,	,	O	,	_	0	SENT_105	[p7l23t2839r285b2892],
3	HLA-DQ3	NN	O	hla-dq3	appos	1	SENT_105	[p7l312t2839r558b2894],
4	.	.	O	.	_	0	SENT_105	[p7l612t2876r639b2884],

1	.	.	O	.	_	0	SENT_106	[p7l612t2876r639b2884],

1	THE	DT	O	the	det	2	SENT_107	[p7l1238t2026r1305b2046],
2	LANCET	NN	O	lancet	_	0	SENT_107	[p7l1314t2026r1443b2047],
3	-	:	O	-	_	0	SENT_107	[p7l1453t2033r1460b2040],
4	Vol	NN	O	vol	dep	2	SENT_107	[p7l1470t2026r1514b2047],
5	359	CD	NUMBER	359	num	4	SENT_107	[p7l1524t2027r1569b2047],
6	-	:	O	-	_	0	SENT_107	[p7l1580t2033r1588b2040],
7	March	NNP	DATE	March	dep	4	SENT_107	[p7l1598t2026r1681b2047],
8	2	CD	DATE	2	num	7	SENT_107	[p7l1691t2027r1713b2050],
9	,	,	DATE	,	_	0	SENT_107	[p7l1691t2027r1713b2050],
10	2002	CD	DATE	2002	num	7	SENT_107	[p7l1724t2027r1786b2047],
11	-	:	O	-	_	0	SENT_107	[p7l1796t2033r1804b2040],
12	www.the1ancet.com	CD	NUMBER	www.the1ancet.com	num	13	SENT_107	[p7l1813t2026r2064b2047],
13	ARTICLES	NNS	O	article	dep	2	SENT_107	[p7l1913t2069r2067b2090],

1	Abacavir	NNP	O	Abacavir	nn	2	SENT_108	[p7l1090t2284r1344b2331],
2	Odds	NNPS	O	Odds	dep	8	SENT_108	[p7l1452t2284r1596b2331],
3	ratio	NN	O	ratio	nn	4	SENT_108	[p7l1621t2284r1751b2331],
4	pc	NN	O	pc	dep	2	SENT_108	[p7l1891t2295r1939b2344],
5	tolerant	JJ	O	tolerant	amod	6	SENT_108	[p7l1089t2370r1319b2417],
6	(	NN	O	(	dep	8	SENT_108	[p7l1453t2369r1600b2427],
7	95	CD	PERCENT	95	num	8	SENT_108	[p7l1453t2369r1600b2427],
8	%	NN	PERCENT	%	_	0	SENT_108	[p7l1453t2369r1600b2427],
9	Cl	NN	O	cl	nn	12	SENT_108	[p7l1622t2369r1704b2427],
10	)	CD	NUMBER	)	num	12	SENT_108	[p7l1622t2369r1704b2427],
11	(	NN	O	(	nn	12	SENT_108	[p7l1092t2446r1327b2503],
12	n	NN	O	n	dep	8	SENT_108	[p7l1092t2446r1327b2503],
13	=	JJ	O	=	amod	15	SENT_108	[p7l1092t2446r1327b2503],
14	167	CD	NUMBER	167	tmod	13	SENT_108	[p7l1092t2446r1327b2503],
15	)	NN	O	)	dep	12	SENT_108	[p7l1092t2446r1327b2503],

1	Table	NNP	O	Table	_	0	SENT_109	[p7l21t2989r194b3041],
2	2	CD	NUMBER	2	num	1	SENT_109	[p7l223t2988r281b3041],
3	:	:	O	:	_	0	SENT_109	[p7l223t2988r281b3041],
4	Contribution	NN	O	contribution	dep	1	SENT_109	[p7l312t2988r721b3041],
5	of	IN	O	of	_	0	SENT_109	[p7l749t2988r812b3041],
6	combined	JJ	O	combined	amod	9	SENT_109	[p7l834t2988r1154b3041],
7	or	CC	O	or	_	0	SENT_109	[p7l1181t3001r1245b3041],
8	individual	JJ	O	individual	amod	9	SENT_109	[p7l1272t2988r1581b3041],
9	loci	NNS	O	locus	nsubj	21	SENT_109	[p7l1611t2988r1724b3041],
10	of	IN	O	of	_	0	SENT_109	[p7l1752t2988r1815b3041],
11	57-1	CD	NUMBER	57-1	num	13	SENT_109	[p7l1838t2989r1993b3041],
12	ancestral	JJ	O	ancestral	amod	13	SENT_109	[p7l22t3081r330b3134],
13	haplotype	NN	O	haplotype	prep_of	9	SENT_109	[p7l360t3081r682b3146],
14	to	TO	O	to	_	0	SENT_109	[p7l707t3082r774b3134],
15	susceptibility	NN	O	susceptibility	prep_to	13	SENT_109	[p7l799t3080r1247b3146],
16	to	TO	O	to	_	0	SENT_109	[p7l1270t3082r1337b3134],
17	abacavir	NN	O	abacavir	nn	19	SENT_109	[p7l1363t3080r1645b3134],
18	hypersensitivity	NN	O	hypersensitivity	nn	19	SENT_109	[p7l24t3170r547b3235],
19	individuals	NNS	O	individual	prep_to	15	SENT_109	[p8l17t74r407b134],
20	had	VBD	O	have	aux	21	SENT_109	[p8l464t74r598b134],
21	had	VBN	O	have	dep	36	SENT_109	[p8l653t74r787b134],
22	more	RBR	DURATION	more	advmod	23	SENT_109	[p8l843t93r1028b134],
23	than	IN	DURATION	than	quantmod	24	SENT_109	[p8l1085t74r1245b134],
24	6	CD	DURATION	6	num	25	SENT_109	[p8l1305t76r1342b134],
25	weeks	NNS	NUMBER	week	tmod	26	SENT_109	[p8l1400t74r1634b134],
26	’	JJ	O	’	amod	27	SENT_109	[p8l1400t74r1634b134],
27	exposure	NN	O	exposure	dobj	21	SENT_109	[p8l1696t93r2015b149],
28	to	TO	O	to	_	0	SENT_109	[p8l2072t87r2141b134],
29	abacavir	NN	O	abacavir	prep_to	27	SENT_109	[p8l19t165r316b225],
30	without	IN	O	without	_	0	SENT_109	[p8l382t165r661b225],
31	developing	VBG	O	develop	amod	34	SENT_109	[p8l730t165r1120b240],
32	hypersensitivity	NN	O	hypersensitivity	nn	34	SENT_109	[p8l1187t165r1747b240],
33	(	NN	O	(	nn	34	SENT_109	[p8l1820t165r2145b239],
34	abacavir	NN	O	abacavir	prep_without	29	SENT_109	[p8l1820t165r2145b239],
35	tolerant	JJ	O	tolerant	amod	36	SENT_109	[p8l17t257r347b332],
36	)	NN	O	)	prep_of	4	SENT_109	[p8l17t257r347b332],
37	.	.	O	.	_	0	SENT_109	[p8l17t257r347b332],

1	Among	IN	O	among	_	0	SENT_110	[p8l391t258r660b332],
2	the	DT	O	the	det	3	SENT_110	[p8l700t257r810b317],
3	patients	NNS	O	patient	prep_among	13	SENT_110	[p8l851t258r1133b332],
4	deﬁned	VBD	O	deﬁned	rcmod	3	SENT_110	[p8l1177t257r1443b318],
5	as	IN	O	as	_	0	SENT_110	[p8l1486t277r1553b317],
6	having	VBG	O	have	prepc_as	4	SENT_110	[p8l1594t257r1833b332],
7	deﬁnite	NN	O	deﬁnite	nn	10	SENT_110	[p8l1875t257r2142b318],
8	abacavir	NN	O	abacavir	nn	10	SENT_110	[p8l19t350r316b410],
9	hypersensitivity	NN	O	hypersensitivity	nn	10	SENT_110	[p8l370t350r930b425],
10	reactions	NNS	O	reaction	dobj	6	SENT_110	[p8l984t350r1328b422],
11	,	,	O	,	_	0	SENT_110	[p8l984t350r1328b422],
12	one	CD	NUMBER	one	nsubj	13	SENT_110	[p8l1389t369r1516b410],
13	started	VBD	O	start	_	0	SENT_110	[p8l1575t350r1818b410],
14	therapy	NN	O	therapy	nsubj	19	SENT_110	[p8l1873t350r2145b425],
15	with	IN	O	with	_	0	SENT_110	[p8l16t441r173b501],
16	efavirenz	NN	O	efavirenz	prep_with	14	SENT_110	[p8l207t441r525b501],
17	and	CC	O	and	_	0	SENT_110	[p8l559t441r690b501],
18	two	CD	NUMBER	two	conj_and	16	SENT_110	[p8l722t455r852b501],
19	started	VBD	O	start	ccomp	13	SENT_110	[p8l888t441r1130b501],
20	nevirapine	NN	O	nevirapine	nn	21	SENT_110	[p8l1163t441r1536b516],
21	(	NN	O	(	nsubjpass	34	SENT_110	[p8l1576t441r1816b515],
22	which	WDT	O	which	nsubj	25	SENT_110	[p8l1576t441r1816b515],
23	can	MD	O	can	aux	25	SENT_110	[p8l1850t461r1973b501],
24	also	RB	O	also	advmod	25	SENT_110	[p8l2007t441r2141b501],
25	cause	VB	O	cause	rcmod	21	SENT_110	[p8l19t553r213b593],
26	hypersensitivity	NN	O	hypersensitivity	nn	27	SENT_110	[p8l249t533r809b608],
27	reactions	NNS	O	reaction	nsubj	28	SENT_110	[p8l843t533r1192b608],
28	)	VBP	O	)	ccomp	25	SENT_110	[p8l843t533r1192b608],
29	at	IN	O	at	_	0	SENT_110	[p8l1237t547r1300b593],
30	the	DT	O	the	det	32	SENT_110	[p8l1336t533r1446b593],
31	time	NN	O	time	nn	32	SENT_110	[p8l1483t534r1642b593],
32	abacavir	NN	O	abacavir	prep_at	28	SENT_110	[p8l1680t533r1977b594],
33	was	VBD	O	be	auxpass	34	SENT_110	[p8l2010t553r2141b594],
34	introduced	VBN	O	introduce	ccomp	19	SENT_110	[p8l17t626r430b686],
35	.	.	O	.	_	0	SENT_110	[p8l17t626r430b686],

1	These	DT	O	these	det	2	SENT_111	[p8l508t626r727b686],
2	individuals	NNS	O	individual	nsubjpass	4	SENT_111	[p8l801t626r1191b686],
3	were	VBD	O	be	auxpass	4	SENT_111	[p8l1264t645r1432b686],
4	included	VBN	O	include	_	0	SENT_111	[p8l1506t626r1818b686],
5	in	IN	O	in	_	0	SENT_111	[p8l1891t626r1959b685],
6	the	DT	O	the	det	7	SENT_111	[p8l2031t626r2142b686],
7	analysis	NN	O	analysis	prep_in	4	SENT_111	[p8l19t718r292b793],
8	because	IN	O	because	mark	10	SENT_111	[p8l357t718r640b778],
9	they	PRP	O	they	nsubj	10	SENT_111	[p8l706t718r859b793],
10	fulﬁlled	VBD	O	fulﬁlled	advcl	4	SENT_111	[p8l923t718r1197b778],
11	the	DT	O	the	det	13	SENT_111	[p8l1261t718r1372b778],
12	diagnostic	JJ	O	diagnostic	amod	13	SENT_111	[p8l1440t718r1802b793],
13	criteria	NNS	O	criterion	dobj	10	SENT_111	[p8l1870t718r2137b778],
14	.	.	O	.	_	0	SENT_111	[p8l1870t718r2137b778],

1	Additionally	RB	O	additionally	advmod	5	SENT_112	[p8l16t810r483b885],
2	,	,	O	,	_	0	SENT_112	[p8l16t810r483b885],
3	15	CD	NUMBER	15	num	4	SENT_112	[p8l542t813r618b871],
4	individuals	NNS	O	individual	nsubj	22	SENT_112	[p8l671t810r1061b871],
5	had	VBD	O	have	_	0	SENT_112	[p8l1109t810r1242b870],
6	non	JJ	O	non	amod	9	SENT_112	[p8l1289t810r1726b885],
7	—	NN	O	—	nn	9	SENT_112	[p8l1289t810r1726b885],
8	speciﬁc	NN	O	speciﬁc	nn	9	SENT_112	[p8l1289t810r1726b885],
9	symptoms	NNS	O	symptom	dobj	5	SENT_112	[p8l1776t824r2141b885],
10	during	IN	O	during	_	0	SENT_112	[p8l19t903r255b978],
11	the	DT	O	the	det	12	SENT_112	[p8l285t903r396b963],
12	ﬁrst	NN	O	ﬁrst	prep_during	5	SENT_112	[p8l429t903r567b963],
13	6	CD	DURATION	6	num	14	SENT_112	[p8l602t905r639b963],
14	weeks	NNS	NUMBER	week	tmod	12	SENT_112	[p8l672t903r884b963],
15	of	IN	O	of	_	0	SENT_112	[p8l920t903r996b963],
16	abacavir	NN	O	abacavir	nn	17	SENT_112	[p8l1021t903r1317b963],
17	exposure	NN	O	exposure	prep_of	12	SENT_112	[p8l1349t922r1690b978],
18	,	,	O	,	_	0	SENT_112	[p8l1349t922r1690b978],
19	but	CC	O	but	_	0	SENT_112	[p8l1724t903r1846b963],
20	did	VBD	O	do	aux	22	SENT_112	[p8l1878t903r1993b963],
21	not	RB	O	not	neg	22	SENT_112	[p8l2024t916r2144b963],
22	meet	VB	O	meet	conj_but	5	SENT_112	[p8l17t1008r194b1054],
23	the	DT	O	the	det	24	SENT_112	[p8l231t994r341b1054],
24	criteria	NNS	O	criterion	dobj	22	SENT_112	[p8l381t994r630b1054],
25	for	IN	O	for	_	0	SENT_112	[p8l668t994r770b1054],
26	deﬁnite	JJ	O	deﬁnite	amod	28	SENT_112	[p8l807t994r1074b1054],
27	abacavir	NN	O	abacavir	nn	28	SENT_112	[p8l1114t994r1412b1054],
28	hypersensitivity	NN	O	hypersensitivity	prep_for	22	SENT_112	[p8l1446t994r2024b1069],
29	.	.	O	.	_	0	SENT_112	[p8l1446t994r2024b1069],

1	In	IN	O	in	_	0	SENT_113	[p8l2067t995r2143b1053],
2	this	DT	O	this	det	3	SENT_113	[p8l17t1086r143b1146],
3	group	NN	O	group	prep_in	8	SENT_113	[p8l197t1106r429b1161],
4	,	,	O	,	_	0	SENT_113	[p8l197t1106r429b1161],
5	eight	CD	NUMBER	eight	num	6	SENT_113	[p8l486t1086r661b1161],
6	patients	NNS	O	patient	nsubjpass	8	SENT_113	[p8l711t1087r993b1161],
7	were	VBD	O	be	auxpass	8	SENT_113	[p8l1046t1106r1214b1147],
8	excluded	VBN	O	exclude	_	0	SENT_113	[p8l1270t1086r1590b1147],
9	because	IN	O	because	mark	13	SENT_113	[p8l1642t1086r1925b1147],
10	their	PRP$	O	they	poss	11	SENT_113	[p8l1978t1086r2145b1146],
11	symptoms	NNS	O	symptom	nsubj	13	SENT_113	[p8l19t1192r384b1254],
12	were	VBD	O	be	cop	13	SENT_113	[p8l437t1198r605b1239],
13	insufﬁcient	JJ	O	insufﬁcient	advcl	8	SENT_113	[p8l659t1179r1058b1239],
14	to	TO	O	to	_	0	SENT_113	[p8l1110t1192r1179b1239],
15	fulﬁl	NN	O	fulﬁl	nn	17	SENT_113	[p8l1234t1179r1397b1239],
16	diagnostic	JJ	O	diagnostic	amod	17	SENT_113	[p8l1452t1179r1814b1254],
17	criteria	NNS	O	criterion	prep_to	13	SENT_113	[p8l1870t1179r2140b1251],
18	,	,	O	,	_	0	SENT_113	[p8l1870t1179r2140b1251],
19	including	VBG	O	include	_	0	SENT_113	[p8l17t1270r356b1345],
20	one	CD	NUMBER	one	prep_including	13	SENT_113	[p8l388t1290r515b1330],
21	in	IN	O	in	_	0	SENT_113	[p8l549t1270r616b1329],
22	whom	WP	O	whom	rel	24	SENT_113	[p8l647t1270r871b1330],
23	symptoms	NNS	O	symptom	nsubj	24	SENT_113	[p8l905t1284r1270b1345],
24	persisted	VBD	O	persist	rcmod	20	SENT_113	[p8l1302t1270r1621b1345],
25	after	IN	O	after	mark	28	SENT_113	[p8l1655t1270r1816b1330],
26	abacavir	NN	O	abacavir	nsubjpass	28	SENT_113	[p8l1848t1270r2145b1330],
27	was	VBD	O	be	auxpass	28	SENT_113	[p8l16t1382r147b1423],
28	withdrawn	VBN	O	withdraw	advcl	24	SENT_113	[p8l200t1362r606b1434],
29	,	,	O	,	_	0	SENT_113	[p8l200t1362r606b1434],
30	and	CC	O	and	_	0	SENT_113	[p8l664t1362r795b1423],
31	one	CD	NUMBER	one	conj_and	20	SENT_113	[p8l850t1382r977b1423],
32	in	IN	O	in	_	0	SENT_113	[p8l1030t1363r1098b1422],
33	whom	WP	O	whom	rel	35	SENT_113	[p8l1149t1362r1374b1423],
34	symptoms	NNS	O	symptom	nsubj	35	SENT_113	[p8l1428t1376r1793b1437],
35	resolved	VBN	O	resolve	rcmod	31	SENT_113	[p8l1847t1362r2143b1423],
36	spontaneously	RB	O	spontaneously	advmod	35	SENT_113	[p8l19t1455r533b1530],
37	despite	IN	O	despite	_	0	SENT_113	[p8l594t1455r845b1530],
38	the	DT	O	the	det	39	SENT_113	[p8l907t1455r1018b1515],
39	fact	NN	O	fact	prep_despite	35	SENT_113	[p8l1080t1455r1211b1515],
40	that	IN	O	that	complm	44	SENT_113	[p8l1272t1455r1412b1515],
41	abacavir	NN	O	abacavir	nsubjpass	44	SENT_113	[p8l1475t1455r1772b1515],
42	was	VBD	O	be	auxpass	44	SENT_113	[p8l1831t1474r1962b1515],
43	not	RB	O	not	neg	44	SENT_113	[p8l2024t1468r2144b1515],
44	stopped	VBN	O	stop	ccomp	35	SENT_113	[p8l19t1546r320b1621],
45	.	.	O	.	_	0	SENT_113	[p8l19t1546r320b1621],

1	In	IN	O	in	_	0	SENT_114	[p8l363t1547r440b1605],
2	the	DT	O	the	det	5	SENT_114	[p8l477t1546r587b1606],
3	other	JJ	O	other	amod	5	SENT_114	[p8l627t1546r815b1606],
4	seven	CD	NUMBER	seven	num	5	SENT_114	[p8l852t1566r1047b1606],
5	patients	NNS	O	patient	prep_in	18	SENT_114	[p8l1083t1546r1387b1621],
6	,	,	O	,	_	0	SENT_114	[p8l1083t1546r1387b1621],
7	whose	WP$	O	whose	poss	8	SENT_114	[p8l1426t1546r1650b1606],
8	features	NNS	O	feature	nsubj	9	SENT_114	[p8l1688t1546r1967b1606],
9	met	VBD	O	meet	rcmod	5	SENT_114	[p8l2006t1560r2144b1606],
10	the	DT	O	the	det	12	SENT_114	[p8l17t1638r128b1698],
11	diagnostic	JJ	O	diagnostic	amod	12	SENT_114	[p8l191t1638r553b1713],
12	criteria	NNS	O	criterion	dobj	9	SENT_114	[p8l616t1639r886b1710],
13	,	,	O	,	_	0	SENT_114	[p8l616t1639r886b1710],
14	an	DT	O	a	det	16	SENT_114	[p8l952t1658r1036b1698],
15	alternative	JJ	O	alternative	amod	16	SENT_114	[p8l1098t1638r1470b1699],
16	explanation	NN	O	explanation	nsubj	18	SENT_114	[p8l1533t1638r1951b1713],
17	was	VBD	O	be	cop	18	SENT_114	[p8l2010t1658r2142b1699],
18	available	JJ	O	available	_	0	SENT_114	[p8l19t1731r347b1791],
19	.	.	O	.	_	0	SENT_114	[p8l19t1731r347b1791],

1	An	DT	O	a	det	3	SENT_115	[p8l406t1732r513b1790],
2	alternative	JJ	O	alternative	amod	3	SENT_115	[p8l570t1731r942b1791],
3	drug	NN	O	drug	nsubjpass	5	SENT_115	[p8l999t1731r1165b1806],
4	was	VBD	O	be	auxpass	5	SENT_115	[p8l1218t1750r1349b1791],
5	implicated	VBN	O	implicate	_	0	SENT_115	[p8l1406t1731r1784b1806],
6	in	IN	O	in	_	0	SENT_115	[p8l1839t1731r1907b1790],
7	three	CD	NUMBER	three	num	8	SENT_115	[p8l1961t1731r2142b1791],
8	patients	NNS	O	patient	prep_in	5	SENT_115	[p8l16t1822r298b1897],
9	(	IN	O	(	_	0	SENT_115	[p8l338t1823r493b1896],
10	one	CD	NUMBER	one	prep_(	8	SENT_115	[p8l338t1823r493b1896],
11	with	IN	O	with	_	0	SENT_115	[p8l526t1822r683b1882],
12	recurrence	NN	O	recurrence	prep_with	5	SENT_115	[p8l716t1842r1098b1882],
13	of	IN	O	of	_	0	SENT_115	[p8l1133t1822r1210b1882],
14	symptoms	NNS	O	symptom	prep_of	12	SENT_115	[p8l1235t1836r1600b1897],
15	with	IN	O	with	_	0	SENT_115	[p8l1634t1822r1791b1882],
16	efavirenz	NN	O	efavirenz	nn	17	SENT_115	[p8l1825t1822r2143b1882],
17	rechallenge	NN	O	rechallenge	prep_with	14	SENT_115	[p8l17t1914r445b1989],
18	,	,	O	,	_	0	SENT_115	[p8l17t1914r445b1989],
19	one	CD	NUMBER	one	prep_with	5	SENT_115	[p8l487t1934r614b1974],
20	with	IN	O	with	_	0	SENT_115	[p8l651t1914r808b1975],
21	probable	JJ	O	probable	amod	23	SENT_115	[p8l843t1914r1160b1989],
22	nevirapine	NN	O	nevirapine	nn	23	SENT_115	[p8l1197t1914r1571b1989],
23	hepatotoxicity	NN	O	hepatotoxicity	prep_with	19	SENT_115	[p8l1608t1914r2140b1989],
24	,	,	O	,	_	0	SENT_115	[p8l1608t1914r2140b1989],
25	and	CC	O	and	_	0	SENT_115	[p8l19t2007r150b2067],
26	one	CD	NUMBER	one	prep_with	5	SENT_115	[p8l215t2026r343b2067],
27	who	WP	O	who	nsubj	29	SENT_115	[p8l406t2007r556b2067],
28	had	VBD	O	have	aux	29	SENT_115	[p8l620t2007r753b2067],
29	developed	VBN	O	develop	rcmod	26	SENT_115	[p8l818t2007r1182b2082],
30	similar	JJ	O	similar	amod	31	SENT_115	[p8l1247t2007r1489b2067],
31	symptoms	NNS	O	symptom	dobj	29	SENT_115	[p8l1551t2020r1917b2082],
32	after	IN	O	after	mark	37	SENT_115	[p8l1984t2007r2145b2067],
33	multiple	JJ	O	multiple	amod	36	SENT_115	[p8l17t2098r315b2173],
34	other	JJ	O	other	amod	36	SENT_115	[p8l348t2098r536b2158],
35	drug	NN	O	drug	nn	36	SENT_115	[p8l565t2098r732b2173],
36	exposures	NNS	O	exposure	nsubj	37	SENT_115	[p8l762t2098r1168b2173],
37	)	VBP	O	)	advcl	29	SENT_115	[p8l762t2098r1168b2173],
38	,	,	O	,	_	0	SENT_115	[p8l762t2098r1168b2173],
39	and	CC	O	and	_	0	SENT_115	[p8l1203t2098r1334b2158],
40	in	IN	O	in	_	0	SENT_115	[p8l1364t2098r1432b2157],
41	the	DT	O	the	det	44	SENT_115	[p8l1461t2098r1572b2158],
42	remaining	VBG	O	remain	amod	44	SENT_115	[p8l1602t2098r1967b2173],
43	four	CD	NUMBER	four	num	44	SENT_115	[p8l1995t2098r2145b2158],
44	individuals	NNS	O	individual	prep_in	56	SENT_115	[p8l17t2190r430b2262],
45	,	,	O	,	_	0	SENT_115	[p8l17t2190r430b2262],
46	the	DT	O	the	det	49	SENT_115	[p8l486t2190r596b2250],
47	likely	JJ	O	likely	amod	49	SENT_115	[p8l650t2190r839b2265],
48	alternative	NN	O	alternative	nn	49	SENT_115	[p8l891t2190r1263b2251],
49	explanation	NN	O	explanation	nsubj	56	SENT_115	[p8l1319t2190r1736b2265],
50	for	IN	O	for	_	0	SENT_115	[p8l1789t2190r1891b2250],
51	(	CD	NUMBER	(	num	54	SENT_115	[p8l1948t2191r2142b2265, p8l19t2283r363b2357],
52	nonobserved	JJ	O	nonobserved	amod	54	SENT_115	[p8l1948t2191r2142b2265, p8l19t2283r363b2357],
53	)	NN	O	)	nn	54	SENT_115	[p8l1948t2191r2142b2265, p8l19t2283r363b2357],
54	symptoms	NNS	O	symptom	prep_for	49	SENT_115	[p8l400t2296r766b2358],
55	was	VBD	O	be	cop	56	SENT_115	[p8l795t2302r927b2343],
56	anxiety	NN	O	anxiety	conj_and	5	SENT_115	[p8l960t2283r1235b2358],
57	;	:	O	;	_	0	SENT_115	[p8l960t2283r1235b2358],
58	one	CD	NUMBER	one	nsubj	64	SENT_115	[p8l1270t2302r1396b2343],
59	of	IN	O	of	_	0	SENT_115	[p8l1429t2283r1506b2343],
60	the	DT	O	the	det	61	SENT_115	[p8l1525t2283r1635b2343],
61	four	CD	NUMBER	four	prep_of	58	SENT_115	[p8l1666t2283r1815b2343],
62	also	RB	O	also	advmod	64	SENT_115	[p8l1845t2283r1980b2343],
63	had	VBD	O	have	aux	64	SENT_115	[p8l2010t2283r2143b2343],
64	localised	VBN	O	localise	parataxis	5	SENT_115	[p8l18t2374r326b2434],
65	abdominal	JJ	O	abdominal	amod	66	SENT_115	[p8l370t2374r750b2434],
66	pain	NN	O	pain	dobj	64	SENT_115	[p8l791t2374r948b2449],
67	suggestive	JJ	O	suggestive	amod	66	SENT_115	[p8l990t2374r1351b2449],
68	of	IN	O	of	_	0	SENT_115	[p8l1395t2374r1472b2434],
69	cholelithiasis	NN	O	cholelithiasis	prep_of	66	SENT_115	[p8l1505t2374r1982b2434],
70	.	.	O	.	_	0	SENT_115	[p8l1505t2374r1982b2434],

1	On	IN	O	on	_	0	SENT_116	[p8l2032t2374r2143b2434],
2	the	DT	O	the	det	3	SENT_116	[p8l17t2466r128b2526],
3	basis	NN	O	basis	prep_on	22	SENT_116	[p8l156t2466r328b2526],
4	of	IN	O	of	_	0	SENT_116	[p8l361t2466r438b2526],
5	the	DT	O	the	det	6	SENT_116	[p8l456t2466r567b2526],
6	application	NN	O	application	prep_of	3	SENT_116	[p8l598t2466r995b2541],
7	of	IN	O	of	_	0	SENT_116	[p8l1026t2466r1103b2526],
8	these	DT	O	these	det	10	SENT_116	[p8l1122t2466r1304b2526],
9	diagnostic	JJ	O	diagnostic	amod	10	SENT_116	[p8l1335t2466r1698b2541],
10	criteria	NNS	O	criterion	prep_of	6	SENT_116	[p8l1730t2467r2000b2538],
11	,	,	O	,	_	0	SENT_116	[p8l1730t2467r2000b2538],
12	the	DT	O	the	det	13	SENT_116	[p8l2031t2466r2142b2526],
13	prevalence	NN	O	prevalence	nsubj	22	SENT_116	[p8l16t2559r398b2634],
14	of	IN	O	of	_	0	SENT_116	[p8l442t2559r518b2619],
15	abacavir	NN	O	abacavir	nn	16	SENT_116	[p8l550t2559r848b2619],
16	hypersensitivity	NN	O	hypersensitivity	prep_of	13	SENT_116	[p8l884t2559r1445b2634],
17	in	IN	O	in	_	0	SENT_116	[p8l1483t2559r1551b2618],
18	our	PRP$	O	we	poss	19	SENT_116	[p8l1592t2578r1715b2619],
19	population	NN	O	population	prep_in	16	SENT_116	[p8l1752t2559r2143b2634],
20	was	VBD	O	be	cop	22	SENT_116	[p8l16t2670r147b2711],
21	9	CD	PERCENT	9	num	22	SENT_116	[p8l177t2650r313b2712],
22	%	NN	PERCENT	%	_	0	SENT_116	[p8l177t2650r313b2712],
23	.	.	O	.	_	0	SENT_116	[p8l177t2650r313b2712],

1	Table	NNP	O	Table	nsubj	3	SENT_117	[p8l101t2743r310b2803],
2	1	CD	NUMBER	1	num	1	SENT_117	[p8l352t2746r377b2802],
3	shows	VBZ	O	show	_	0	SENT_117	[p8l419t2743r632b2804],
4	demographics	NNS	O	demographic	dobj	3	SENT_117	[p8l666t2743r1189b2818],
5	,	,	O	,	_	0	SENT_117	[p8l666t2743r1189b2818],
6	exposure	NN	O	exposure	dobj	3	SENT_117	[p8l1225t2763r1544b2818],
7	to	TO	O	to	_	0	SENT_117	[p8l1576t2757r1645b2803],
8	antiretroviral	JJ	O	antiretroviral	amod	9	SENT_117	[p8l1680t2743r2143b2804],
9	therapy	NN	O	therapy	prep_to	6	SENT_117	[p8l17t2836r307b2911],
10	,	,	O	,	_	0	SENT_117	[p8l17t2836r307b2911],
11	and	CC	O	and	_	0	SENT_117	[p8l336t2836r467b2896],
12	immunological	JJ	O	immunological	amod	13	SENT_117	[p8l491t2836r1029b2911],
13	status	NN	O	status	dobj	3	SENT_117	[p8l1055t2849r1258b2896],
14	(	CD	NUMBER	(	num	17	SENT_117	[p8l1289t2836r1493b2910],
15	CD4	NN	O	cd4	nn	17	SENT_117	[p8l1289t2836r1493b2910],
16	T-cell	NN	MISC	t-cell	nn	17	SENT_117	[p8l1517t2836r1732b2896],
17	proportion	NN	O	proportion	dep	13	SENT_117	[p8l1755t2836r2143b2911],
18	and	CC	O	and	_	0	SENT_117	[p8l19t2927r150b2987],
19	absolute	JJ	O	absolute	amod	20	SENT_117	[p8l186t2927r482b2987],
20	number	NN	O	number	conj_and	4	SENT_117	[p8l516t2927r825b3001],
21	)	CD	NUMBER	)	num	20	SENT_117	[p8l516t2927r825b3001],
22	in	IN	O	in	_	0	SENT_117	[p8l865t2927r933b2986],
23	the	DT	O	the	det	24	SENT_117	[p8l966t2927r1076b2987],
24	group	NN	O	group	prep_in	20	SENT_117	[p8l1111t2947r1319b3002],
25	with	IN	O	with	_	0	SENT_117	[p8l1353t2927r1510b2987],
26	deﬁnite	JJ	O	deﬁnite	amod	28	SENT_117	[p8l1545t2927r1812b2987],
27	abacavir	NN	O	abacavir	nn	28	SENT_117	[p8l1848t2927r2144b2987],
28	hypersensitivity	NN	O	hypersensitivity	prep_with	24	SENT_117	[p8l16t3019r575b3094],
29	and	CC	O	and	_	0	SENT_117	[p8l604t3019r735b3079],
30	the	DT	O	the	det	31	SENT_117	[p8l763t3019r873b3079],
31	group	NN	O	group	conj_and	28	SENT_117	[p8l902t3039r1110b3094],
32	who	WP	O	who	nsubj	34	SENT_117	[p8l1139t3019r1289b3080],
33	were	VBD	O	be	cop	34	SENT_117	[p8l1318t3039r1486b3080],
34	abacavir	NN	O	abacavir	rcmod	20	SENT_117	[p8l1517t3019r1814b3079],
35	tolerant	JJ	O	tolerant	amod	34	SENT_117	[p8l1840t3019r2137b3079],
36	.	.	O	.	_	0	SENT_117	[p8l1840t3019r2137b3079],

1	The	DT	O	the	det	2	SENT_118	[p8l17t3112r164b3172],
2	proportion	NN	O	proportion	nsubj	13	SENT_118	[p8l207t3112r595b3187],
3	of	IN	O	of	_	0	SENT_118	[p8l640t3112r717b3172],
4	caucasoid	JJ	O	caucasoid	amod	5	SENT_118	[p8l752t3112r1102b3172],
5	individuals	NNS	O	individual	prep_of	2	SENT_118	[p8l1146t3112r1536b3172],
6	in	IN	O	in	_	0	SENT_118	[p8l1581t3112r1649b3171],
7	the	DT	O	the	det	10	SENT_118	[p8l1692t3112r1802b3172],
8	abacavir	NN	O	abacavir	nn	10	SENT_118	[p8l1849t3112r2145b3172],
9	hypersensitive	JJ	O	hypersensitive	amod	10	SENT_118	[p8l16t3203r522b3278],
10	group	NN	O	group	prep_in	5	SENT_118	[p8l589t3223r797b3278],
11	was	VBD	O	be	cop	13	SENT_118	[p8l863t3223r994b3263],
12	slightly	RB	O	slightly	advmod	13	SENT_118	[p8l1064t3203r1317b3278],
13	higher	JJR	O	higher	_	0	SENT_118	[p8l1380t3203r1609b3278],
14	than	IN	O	than	prep	13	SENT_118	[p8l1672t3203r1833b3263],
15	in	IN	O	in	pcomp	14	SENT_118	[p8l1898t3203r1966b3262],
16	the	DT	O	the	det	18	SENT_118	[p8l2031t3203r2142b3263],
17	tolerant	JJ	O	tolerant	amod	18	SENT_118	[p8l17t3295r297b3355],
18	group	NN	O	group	pobj	15	SENT_118	[p8l339t3315r571b3370],
19	,	,	O	,	_	0	SENT_118	[p8l339t3315r571b3370],
20	but	CC	O	but	_	0	SENT_118	[p8l616t3295r738b3355],
21	the	DT	O	the	det	22	SENT_118	[p8l781t3295r891b3355],
22	groups	NNS	O	group	nsubj	24	SENT_118	[p8l936t3315r1177b3370],
23	were	VBD	O	be	cop	24	SENT_118	[p8l1221t3315r1389b3356],
24	similar	JJ	O	similar	conj_but	13	SENT_118	[p8l1436t3295r1677b3355],
25	in	IN	O	in	_	0	SENT_118	[p8l1719t3296r1787b3355],
26	terms	NNS	O	term	prep_in	24	SENT_118	[p8l1830t3309r2029b3355],
27	of	IN	O	of	_	0	SENT_118	[p8l2076t3295r2153b3355],
28	other	JJ	O	other	amod	29	SENT_118	[p8l19t3388r207b3448],
29	variables	NNS	O	variable	prep_of	26	SENT_118	[p8l256t3388r568b3448],
30	considered	VBN	O	consider	partmod	29	SENT_118	[p8l625t3388r1032b3448],
31	.	.	O	.	_	0	SENT_118	[p8l625t3388r1032b3448],

1	Within	IN	O	within	_	0	SENT_119	[p8l1090t3388r1340b3448],
2	the	DT	O	the	det	4	SENT_119	[p8l1393t3388r1503b3448],
3	entire	JJ	O	entire	amod	4	SENT_119	[p8l1559t3388r1762b3448],
4	abacavirexposed	JJ	O	abacavirexposed	pobj	1	SENT_119	[p8l1818t3388r2143b3448, p9l19t23r308b98],

1	cohort	NN	O	cohort	nn	3	SENT_120	[p9l347t23r579b83],
2	(	NN	O	(	nn	3	SENT_120	[p9l622t23r940b97],
3	n	NN	O	n	nsubjpass	11	SENT_120	[p9l622t23r940b97],
4	=	JJ	O	=	amod	3	SENT_120	[p9l622t23r940b97],
5	200	CD	NUMBER	200	num	6	SENT_120	[p9l622t23r940b97],
6	)	NN	O	)	tmod	4	SENT_120	[p9l622t23r940b97],
7	,	,	O	,	_	0	SENT_120	[p9l622t23r940b97],
8	176	CD	NUMBER	176	num	9	SENT_120	[p9l990t25r1115b83],
9	participants	NNS	O	participant	appos	6	SENT_120	[p9l1154t23r1575b98],
10	were	VBD	O	be	auxpass	11	SENT_120	[p9l1613t43r1782b83],
11	classiﬁed	VBN	O	classiﬁed	dep	17	SENT_120	[p9l1822t23r2143b83],
12	as	IN	O	as	_	0	SENT_120	[p9l19t135r86b175],
13	caucasoidg	NN	O	caucasoidg	prep_as	11	SENT_120	[p9l123t115r494b187],
14	the	DT	O	the	det	16	SENT_120	[p9l531t115r642b175],
15	non-caucasoid	JJ	O	non-caucasoid	amod	16	SENT_120	[p9l676t115r1200b176],
16	group	NN	O	group	nsubj	17	SENT_120	[p9l1234t135r1442b190],
17	consisted	VBD	O	consist	_	0	SENT_120	[p9l1479t115r1811b176],
18	of	IN	O	of	_	0	SENT_120	[p9l1846t115r1922b175],
19	seven	CD	NUMBER	seven	num	20	SENT_120	[p9l1948t135r2143b176],
20	Africans	NNS	MISC	african	prep_of	17	SENT_120	[p9l16t208r335b280],
21	,	,	O	,	_	0	SENT_120	[p9l16t208r335b280],
22	11	CD	NUMBER	11	num	24	SENT_120	[p9l373t210r444b267],
23	indigenous	JJ	O	indigenous	amod	24	SENT_120	[p9l479t208r870b283],
24	Australians	NNPS	MISC	Australians	conj_and	20	SENT_120	[p9l896t208r1321b280],
25	,	,	O	,	_	0	SENT_120	[p9l896t208r1321b280],
26	and	CC	O	and	_	0	SENT_120	[p9l1352t208r1483b268],
27	six	CD	NUMBER	six	num	28	SENT_120	[p9l1510t208r1604b268],
28	Asians	NNPS	MISC	Asians	conj_and	20	SENT_120	[p9l1627t208r1881b268],
29	.	.	O	.	_	0	SENT_120	[p9l1627t208r1881b268],

1	HLA	NN	O	hlum	nn	4	SENT_121	[p9l10t301r147b359],
2	allele	NN	O	allele	nn	4	SENT_121	[p9l176t301r360b360],
3	frequency	NN	O	frequency	nn	4	SENT_121	[p9l388t300r739b374],
4	HLA-B	NN	O	hla-b	nsubj	8	SENT_121	[p9l7t393r498b453],
5	*	CD	NUMBER	*	num	6	SENT_121	[p9l7t393r498b453],
6	5701	CD	NUMBER	5701	dep	4	SENT_121	[p9l7t393r498b453],
7	was	VBD	O	be	cop	8	SENT_121	[p9l583t412r715b453],
8	present	JJ	DATE	present	_	0	SENT_121	[p9l796t407r1060b468],
9	in	IN	O	in	_	0	SENT_121	[p9l1141t393r1208b452],
10	a	DT	O	a	det	13	SENT_121	[p9l1291t412r1326b453],
11	signiﬁcantly	RB	O	signiﬁcantly	advmod	12	SENT_121	[p9l1409t392r1838b468],
12	higher	JJR	O	higher	amod	13	SENT_121	[p9l1917t392r2145b468],
13	proportion	NN	O	proportion	prep_in	8	SENT_121	[p9l7t486r396b562],
14	of	IN	O	of	_	0	SENT_121	[p9l498t486r574b546],
15	abacavir-hypersensitive	JJ	O	abacavir-hypersensitive	amod	16	SENT_121	[p9l667t486r1499b562],
16	patients	NNS	O	patient	prep_of	13	SENT_121	[p9l1600t486r1881b562],
17	than	IN	O	than	_	0	SENT_121	[p9l1983t486r2144b546],
18	abacavir	NN	O	abacavir	npadvmod	20	SENT_121	[p9l10t578r616b639],
19	—	CD	NUMBER	—	num	18	SENT_121	[p9l10t578r616b639],
20	tolerant	JJ	O	tolerant	amod	21	SENT_121	[p9l10t578r616b639],
21	patients	NNS	O	patient	prep_than	8	SENT_121	[p9l640t578r943b654],
22	,	,	O	,	_	0	SENT_121	[p9l640t578r943b654],
23	as	RB	O	as	advmod	26	SENT_121	[p9l973t598r1040b639],
24	was	VBD	O	be	cop	26	SENT_121	[p9l1065t598r1196b639],
25	the	DT	O	the	det	26	SENT_121	[p9l1222t578r1333b639],
26	combination	NN	O	combination	dep	8	SENT_121	[p9l1360t578r1814b639],
27	of	IN	O	of	_	0	SENT_121	[p9l1839t578r1916b639],
28	HLADR7	NN	O	hladr7	prep_of	26	SENT_121	[p9l1930t578r2145b638, p9l7t672r179b732],
29	and	CC	O	and	_	0	SENT_121	[p9l213t671r344b732],
30	HLA-DQ3	NN	O	hla-dq3	conj_and	28	SENT_121	[p9l380t672r771b747],
31	(	CD	NUMBER	(	num	34	SENT_121	[p9l814t671r1012b746],
32	table	NN	O	table	nn	34	SENT_121	[p9l814t671r1012b746],
33	2	CD	NUMBER	2	num	34	SENT_121	[p9l1053t672r1145b747],
34	)	NN	O	)	nsubj	26	SENT_121	[p9l1053t672r1145b747],
35	.	.	O	.	_	0	SENT_121	[p9l1053t672r1145b747],

1	The	DT	O	the	det	9	SENT_122	[p9l1187t671r1334b732],
2	HLA-B	NN	O	hla-b	nn	9	SENT_122	[p9l1371t672r1888b744],
3	*	CD	NUMBER	*	num	9	SENT_122	[p9l1371t672r1888b744],
4	570I	NN	O	570us	nn	9	SENT_122	[p9l1371t672r1888b744],
5	,	,	O	,	_	0	SENT_122	[p9l1371t672r1888b744],
6	HLADR7	NN	O	hladr7	dep	9	SENT_122	[p9l1930t672r2145b731, p9l7t766r193b838],
7	,	,	O	,	_	0	SENT_122	[p9l1930t672r2145b731, p9l7t766r193b838],
8	HLA-DQ3	NN	O	hla-dq3	dep	9	SENT_122	[p9l272t765r663b841],
9	haplotype	NN	O	haplotype	nsubjpass	11	SENT_122	[p9l735t765r1087b841],
10	was	VBD	O	be	auxpass	11	SENT_122	[p9l1161t785r1293b825],
11	found	VBN	O	find	_	0	SENT_122	[p9l1368t765r1581b825],
12	to	TO	O	to	aux	15	SENT_122	[p9l1655t779r1724b825],
13	be	VB	O	be	cop	15	SENT_122	[p9l1798t765r1883b825],
14	more	RBR	O	more	advmod	15	SENT_122	[p9l1958t785r2143b825],
15	predictive	JJ	O	predictive	xcomp	11	SENT_122	[p9l7t857r360b933],
16	of	IN	O	of	_	0	SENT_122	[p9l412t857r489b918],
17	the	DT	O	the	det	19	SENT_122	[p9l528t857r639b918],
18	clinical	JJ	O	clinical	amod	19	SENT_122	[p9l691t857r941b918],
19	syndrome	NN	O	syndrome	prep_of	15	SENT_122	[p9l993t857r1345b933],
20	than	IN	O	than	_	0	SENT_122	[p9l1394t857r1555b918],
21	its	PRP$	O	its	poss	23	SENT_122	[p9l1605t857r1683b918],
22	component	NN	O	component	nn	23	SENT_122	[p9l1736t871r2144b933],
23	alleles	NNS	O	allele	prep_than	19	SENT_122	[p9l10t950r222b1011],
24	(	RB	O	(	advmod	19	SENT_122	[p9l258t950r456b1026],
25	table	NN	O	table	nn	27	SENT_122	[p9l258t950r456b1026],
26	2	CD	NUMBER	2	num	27	SENT_122	[p9l487t951r580b1026],
27	)	NN	O	)	dep	19	SENT_122	[p9l487t951r580b1026],
28	.	.	O	.	_	0	SENT_122	[p9l487t951r580b1026],

1	Within	IN	O	within	_	0	SENT_123	[p9l611t950r863b1011],
2	the	DT	O	the	det	5	SENT_123	[p9l890t950r1000b1011],
3	entire	JJ	O	entire	amod	5	SENT_123	[p9l1031t951r1233b1011],
4	abacavir	NN	O	abacavir	nn	5	SENT_123	[p9l1264t950r1883b1026],
5	—	NN	O	—	prep_within	30	SENT_123	[p9l1264t950r1883b1026],
6	exposed	VBN	O	expose	partmod	5	SENT_123	[p9l1264t950r1883b1026],
7	cohort	NN	O	cohort	nn	9	SENT_123	[p9l1912t950r2144b1011],
8	(	NN	O	(	nn	9	SENT_123	[p9l14t1044r332b1119],
9	n	NN	O	n	dobj	6	SENT_123	[p9l14t1044r332b1119],
10	=	JJ	O	=	amod	12	SENT_123	[p9l14t1044r332b1119],
11	200	CD	NUMBER	200	tmod	10	SENT_123	[p9l14t1044r332b1119],
12	)	NN	O	)	dep	9	SENT_123	[p9l14t1044r332b1119],
13	,	,	O	,	_	0	SENT_123	[p9l14t1044r332b1119],
14	as	RB	O	as	_	0	SENT_123	[p9l368t1064r434b1104],
15	well	RB	O	well	_	0	SENT_123	[p9l464t1044r607b1104],
16	as	IN	O	as	_	0	SENT_123	[p9l640t1064r707b1104],
17	in	IN	O	in	_	0	SENT_123	[p9l738t1044r806b1103],
18	the	DT	O	the	det	20	SENT_123	[p9l835t1044r946b1104],
19	restricted	JJ	O	restricted	amod	20	SENT_123	[p9l976t1044r1312b1104],
20	dataset	NN	O	dataset	prep_in	21	SENT_123	[p9l1343t1044r1595b1104],
21	including	VBG	O	include	conj_and	9	SENT_123	[p9l1624t1044r1962b1120],
22	only	RB	O	only	advmod	24	SENT_123	[p9l1992t1044r2145b1120],
23	the	DT	O	the	det	24	SENT_123	[p9l8t1136r118b1197],
24	abacavir	NN	O	abacavir	npadvmod	25	SENT_123	[p9l166t1136r463b1197],
25	hypersensitive	JJ	O	hypersensitive	amod	29	SENT_123	[p9l505t1136r1011b1212],
26	and	CC	O	and	_	0	SENT_123	[p9l1058t1136r1190b1197],
27	abacavir	NN	O	abacavir	amod	29	SENT_123	[p9l1237t1136r1534b1197],
28	tolerant	JJ	O	tolerant	amod	29	SENT_123	[p9l1577t1136r1856b1197],
29	groups	NNS	O	group	pobj	21	SENT_123	[p9l1900t1156r2142b1212],
30	(	VBP	O	(	_	0	SENT_123	[p9l14t1230r332b1305],
31	n	NN	O	n	nsubj	32	SENT_123	[p9l14t1230r332b1305],
32	=	JJ	O	=	xcomp	30	SENT_123	[p9l14t1230r332b1305],
33	185	CD	NUMBER	185	num	34	SENT_123	[p9l14t1230r332b1305],
34	)	NN	O	)	nsubj	30	SENT_123	[p9l14t1230r332b1305],
35	,	,	O	,	_	0	SENT_123	[p9l14t1230r332b1305],
36	the	DT	O	the	det	37	SENT_123	[p9l378t1229r489b1290],
37	presence	NN	O	presence	appos	34	SENT_123	[p9l531t1249r845b1305],
38	of	IN	O	of	_	0	SENT_123	[p9l890t1229r967b1290],
39	HLA-B	NN	O	hla-b	prep_of	37	SENT_123	[p9l998t1230r1515b1302],
40	*	CD	NUMBER	*	num	41	SENT_123	[p9l998t1230r1515b1302],
41	5701	CD	NUMBER	5701	nsubj	48	SENT_123	[p9l998t1230r1515b1302],
42	,	,	O	,	_	0	SENT_123	[p9l998t1230r1515b1302],
43	HLA-DR7	NN	O	hla-dr7	nsubj	48	SENT_123	[p9l1562t1230r1964b1302],
44	,	,	O	,	_	0	SENT_123	[p9l1562t1230r1964b1302],
45	and	CC	O	and	_	0	SENT_123	[p9l2012t1229r2144b1290],
46	HLA-DQ3	NN	O	hla-dq3	nn	47	SENT_123	[p9l7t1323r397b1399],
47	alleles	NNS	O	allele	conj_and	41	SENT_123	[p9l462t1323r674b1383],
48	had	VBD	O	have	rcmod	39	SENT_123	[p9l739t1323r872b1383],
49	a	DT	O	a	det	52	SENT_123	[p9l938t1343r974b1383],
50	positive	JJ	O	positive	amod	52	SENT_123	[p9l1037t1323r1311b1399],
51	predictive	JJ	O	predictive	amod	52	SENT_123	[p9l1375t1323r1728b1399],
52	value	NN	O	value	dobj	48	SENT_123	[p9l1791t1323r1979b1383],
53	for	IN	O	for	_	0	SENT_123	[p9l2044t1323r2146b1383],
54	abacavir	NN	O	abacavir	nn	55	SENT_123	[p9l10t1415r307b1476],
55	hypersensitivity	NN	O	hypersensitivity	prep_for	52	SENT_123	[p9l335t1415r895b1491],
56	of	IN	O	of	_	0	SENT_123	[p9l926t1415r1003b1476],
57	100	CD	PERCENT	100	num	58	SENT_123	[p9l1035t1415r1258b1488],
58	%	NN	PERCENT	%	prep_of	55	SENT_123	[p9l1035t1415r1258b1488],
59	,	,	O	,	_	0	SENT_123	[p9l1035t1415r1258b1488],
60	and	CC	O	and	_	0	SENT_123	[p9l1295t1415r1427b1476],
61	the	DT	O	the	det	62	SENT_123	[p9l1458t1415r1569b1476],
62	absence	NN	O	absence	nsubj	68	SENT_123	[p9l1604t1415r1883b1476],
63	of	IN	O	of	_	0	SENT_123	[p9l1917t1415r1995b1476],
64	this	DT	O	this	det	65	SENT_123	[p9l2016t1415r2142b1476],
65	combination	NN	O	combination	prep_of	62	SENT_123	[p9l10t1508r463b1569],
66	of	IN	O	of	_	0	SENT_123	[p9l505t1508r582b1569],
67	alleles	NNS	O	allele	prep_of	65	SENT_123	[p9l614t1508r826b1569],
68	had	VBD	O	have	rcmod	39	SENT_123	[p9l867t1508r1000b1569],
69	a	DT	O	a	det	72	SENT_123	[p9l1043t1528r1078b1569],
70	negative	JJ	O	negative	amod	72	SENT_123	[p9l1118t1509r1413b1584],
71	predictive	JJ	O	predictive	amod	72	SENT_123	[p9l1453t1508r1807b1584],
72	value	NN	O	value	dobj	68	SENT_123	[p9l1846t1508r2034b1569],
73	of	IN	O	of	_	0	SENT_123	[p9l2077t1508r2154b1569],
74	97	CD	PERCENT	97	num	75	SENT_123	[p9l10t1603r193b1665],
75	%	NN	PERCENT	%	prep_of	72	SENT_123	[p9l10t1603r193b1665],
76	.	.	O	.	_	0	SENT_123	[p9l10t1603r193b1665],

1	In	IN	O	in	_	0	SENT_124	[p9l93t1695r170b1754],
2	our	PRP$	O	we	poss	3	SENT_124	[p9l202t1714r324b1755],
3	cohort	NN	O	cohort	prep_in	11	SENT_124	[p9l353t1694r606b1767],
4	,	,	O	,	_	0	SENT_124	[p9l353t1694r606b1767],
5	all	DT	O	all	det	6	SENT_124	[p9l641t1694r721b1755],
6	cases	NNS	O	case	nsubjpass	11	SENT_124	[p9l753t1714r931b1755],
7	of	IN	O	of	_	0	SENT_124	[p9l965t1694r1042b1755],
8	abacavir	NN	O	abacavir	nn	9	SENT_124	[p9l1064t1694r1361b1755],
9	hypersensitivity	NN	O	hypersensitivity	prep_of	6	SENT_124	[p9l1388t1694r1947b1770],
10	were	VBD	O	be	auxpass	11	SENT_124	[p9l1974t1714r2143b1755],
11	seen	VBN	O	see	_	0	SENT_124	[p9l9t1807r165b1848],
12	in	IN	O	in	_	0	SENT_124	[p9l223t1788r291b1847],
13	causasoid	JJ	O	causasoid	amod	14	SENT_124	[p9l351t1787r695b1848],
14	individuals	NNS	O	individual	prep_in	11	SENT_124	[p9l754t1787r1163b1848],
15	.	.	O	.	_	0	SENT_124	[p9l754t1787r1163b1848],

1	The	DT	O	the	det	2	SENT_125	[p9l1226t1787r1373b1848],
2	presence	NN	O	presence	nsubjpass	16	SENT_125	[p9l1432t1807r1745b1863],
3	of	IN	O	of	_	0	SENT_125	[p9l1805t1787r1883b1848],
4	HLAB	NN	O	hlab	prep_of	2	SENT_125	[p9l1930t1788r2145b1847, p9l6t1881r308b1954],
5	*	CD	NUMBER	*	number	6	SENT_125	[p9l1930t1788r2145b1847, p9l6t1881r308b1954],
6	5701	CD	NUMBER	5701	num	4	SENT_125	[p9l1930t1788r2145b1847, p9l6t1881r308b1954],
7	,	,	O	,	_	0	SENT_125	[p9l1930t1788r2145b1847, p9l6t1881r308b1954],
8	HLA-DR7	NN	O	hla-dr7	nn	9	SENT_125	[p9l355t1881r743b1941],
9	alleles	NNS	O	allele	conj_or	2	SENT_125	[p9l780t1881r1015b1954],
10	,	,	O	,	_	0	SENT_125	[p9l780t1881r1015b1954],
11	or	CC	O	or	_	0	SENT_125	[p9l1062t1900r1136b1941],
12	both	DT	O	both	nsubjpass	16	SENT_125	[p9l1175t1881r1341b1941],
13	was	VBD	O	be	auxpass	16	SENT_125	[p9l1381t1901r1512b1941],
14	also	RB	O	also	advmod	16	SENT_125	[p9l1558t1881r1692b1941],
15	only	RB	O	only	advmod	16	SENT_125	[p9l1738t1881r1891b1957],
16	found	VBN	O	find	_	0	SENT_125	[p9l1931t1881r2144b1941],
17	among	IN	O	among	_	0	SENT_125	[p9l10t1993r255b2049],
18	causasoids	NNS	O	causasoid	prep_among	16	SENT_125	[p9l300t1973r695b2034],
19	.	.	O	.	_	0	SENT_125	[p9l300t1973r695b2034],

1	When	WRB	O	when	advmod	3	SENT_126	[p9l743t1973r961b2034],
2	we	PRP	O	we	nsubj	3	SENT_126	[p9l1004t1993r1102b2034],
3	repeated	VBD	O	repeat	advcl	20	SENT_126	[p9l1148t1973r1456b2049],
4	the	DT	O	the	det	5	SENT_126	[p9l1501t1973r1611b2034],
5	analyses	NNS	O	analysis	nsubj	13	SENT_126	[p9l1658t1973r1947b2049],
6	in	IN	O	in	_	0	SENT_126	[p9l1994t1973r2061b2033],
7	a	DT	O	a	det	8	SENT_126	[p9l2108t1993r2143b2034],
8	dataset	NN	O	dataset	prep_in	5	SENT_126	[p9l9t2066r261b2127],
9	restricted	JJ	O	restricted	amod	8	SENT_126	[p9l308t2066r643b2127],
10	to	TO	O	to	_	0	SENT_126	[p9l690t2081r759b2127],
11	causasoid	NN	O	causasoid	nn	12	SENT_126	[p9l810t2066r1154b2127],
12	participants	NNS	O	participant	prep_to	9	SENT_126	[p9l1200t2067r1621b2142],
13	(	VBP	O	(	ccomp	3	SENT_126	[p9l1677t2067r1995b2142],
14	n	NN	O	n	dobj	13	SENT_126	[p9l1677t2067r1995b2142],
15	=	JJ	O	=	advmod	13	SENT_126	[p9l1677t2067r1995b2142],
16	176	CD	NUMBER	176	num	17	SENT_126	[p9l1677t2067r1995b2142],
17	)	NN	O	)	dep	15	SENT_126	[p9l1677t2067r1995b2142],
18	,	,	O	,	_	0	SENT_126	[p9l1677t2067r1995b2142],
19	we	PRP	O	we	nsubj	20	SENT_126	[p9l2044t2086r2143b2127],
20	found	VBD	O	find	_	0	SENT_126	[p9l8t2160r220b2220],
21	a	DT	O	a	det	23	SENT_126	[p9l252t2180r287b2220],
22	higher	JJR	O	higher	amod	23	SENT_126	[p9l316t2160r545b2236],
23	frequency	NN	O	frequency	nn	35	SENT_126	[p9l573t2160r929b2236],
24	of	IN	O	of	_	0	SENT_126	[p9l959t2160r1036b2220],
25	HLA-B	NN	O	hla-b	prep_of	23	SENT_126	[p9l1054t2160r1546b2220],
26	*	CD	NUMBER	*	num	25	SENT_126	[p9l1054t2160r1546b2220],
27	5701	CD	NUMBER	5701	number	28	SENT_126	[p9l1054t2160r1546b2220],
28	(	CD	NUMBER	(	num	29	SENT_126	[p9l1587t2160r1783b2235],
29	odds	NNS	O	odds	dep	23	SENT_126	[p9l1587t2160r1783b2235],
30	ratio	NN	O	ratio	nn	32	SENT_126	[p9l1814t2160r1976b2220],
31	103	CD	NUMBER	103	num	32	SENT_126	[p9l2017t2162r2140b2220],
32	[	NN	O	[	dep	29	SENT_126	[p9l18t2252r201b2327],
33	95	CD	PERCENT	95	number	34	SENT_126	[p9l18t2252r201b2327],
34	%	NN	PERCENT	%	amod	35	SENT_126	[p9l18t2252r201b2327],
35	CI	NN	O	ci	dobj	20	SENT_126	[p9l237t2252r328b2313],
36	25-423	CD	NUMBER	25-423	num	37	SENT_126	[p9l359t2252r679b2327],
37	]	NN	O	]	tmod	20	SENT_126	[p9l359t2252r679b2327],
38	,	,	O	,	_	0	SENT_126	[p9l359t2252r679b2327],
39	pC	NN	O	pc	npadvmod	40	SENT_126	[p9l710t2253r1138b2329],
40	<	JJR	O	<	amod	89	SENT_126	[p9l710t2253r1138b2329],
41	O'OO01	CD	NUMBER	o'oo01	dep	49	SENT_126	[p9l710t2253r1138b2329],
42	)	NN	O	)	dep	41	SENT_126	[p9l710t2253r1138b2329],
43	,	,	O	,	_	0	SENT_126	[p9l710t2253r1138b2329],
44	HLA-DR7	NN	O	hla-dr7	conj_plus	42	SENT_126	[p9l1169t2252r1557b2313],
45	plus	CC	O	plus	_	0	SENT_126	[p9l1578t2252r1725b2328],
46	HLA-DQ3	NN	O	hla-dq3	conj_plus	42	SENT_126	[p9l1754t2252r2145b2328],
47	(	CD	NUMBER	(	dep	49	SENT_126	[p9l14t2346r128b2420],
48	64	CD	NUMBER	64	num	49	SENT_126	[p9l14t2346r128b2420],
49	[	NN	O	[	dep	64	SENT_126	[p9l174t2345r517b2421],
50	17	CD	NUMBER	17	num	51	SENT_126	[p9l174t2345r517b2421],
51	—	NN	O	—	dep	49	SENT_126	[p9l174t2345r517b2421],
52	235	CD	NUMBER	235	num	53	SENT_126	[p9l174t2345r517b2421],
53	]	NN	O	]	nsubj	64	SENT_126	[p9l174t2345r517b2421],
54	,	,	O	,	_	0	SENT_126	[p9l174t2345r517b2421],
55	pc	NN	O	pc	dep	56	SENT_126	[p9l554t2346r982b2423],
56	<	JJR	O	<	appos	53	SENT_126	[p9l554t2346r982b2423],
57	0-0001	CD	NUMBER	0-0001	num	58	SENT_126	[p9l554t2346r982b2423],
58	)	NN	O	)	dep	56	SENT_126	[p9l554t2346r982b2423],
59	,	,	O	,	_	0	SENT_126	[p9l554t2346r982b2423],
60	and	CC	O	and	_	0	SENT_126	[p9l1021t2346r1153b2406],
61	the	DT	O	the	det	63	SENT_126	[p9l1187t2346r1298b2406],
62	combined	JJ	O	combined	amod	63	SENT_126	[p9l1334t2346r1691b2406],
63	alleles	NNS	O	allele	nsubj	64	SENT_126	[p9l1727t2346r1939b2406],
64	(	VBP	O	(	ccomp	40	SENT_126	[p9l1982t2346r2142b2421],
65	724	CD	NUMBER	724	number	66	SENT_126	[p9l1982t2346r2142b2421],
66	[	CD	NUMBER	[	nsubj	68	SENT_126	[p9l18t2439r259b2514],
67	38	CD	NUMBER	38	num	68	SENT_126	[p9l18t2439r259b2514],
68	—	CD	NUMBER	—	ccomp	64	SENT_126	[p9l18t2439r259b2514],
69	13	CD	NUMBER	13	num	71	SENT_126	[p9l18t2439r259b2514],
70	811	CD	NUMBER	811	num	71	SENT_126	[p9l313t2439r497b2514],
71	]	NN	O	]	dobj	68	SENT_126	[p9l313t2439r497b2514],
72	,	,	O	,	_	0	SENT_126	[p9l313t2439r497b2514],
73	pC	NN	O	pc	dep	74	SENT_126	[p9l546t2439r975b2516],
74	<	JJR	O	<	appos	71	SENT_126	[p9l546t2439r975b2516],
75	0-0001	CD	NUMBER	0-0001	num	76	SENT_126	[p9l546t2439r975b2516],
76	)	NN	O	)	dep	74	SENT_126	[p9l546t2439r975b2516],
77	,	,	O	,	_	0	SENT_126	[p9l546t2439r975b2516],
78	among	IN	O	among	_	0	SENT_126	[p9l1027t2458r1271b2515],
79	patients	NNS	O	patient	prep_among	71	SENT_126	[p9l1315t2439r1596b2515],
80	with	IN	O	with	_	0	SENT_126	[p9l1643t2439r1801b2499],
81	abacavir	NN	O	abacavir	nn	82	SENT_126	[p9l1849t2439r2146b2499],
82	hypersensitivity	NN	O	hypersensitivity	prep_with	79	SENT_126	[p9l7t2531r566b2607],
83	than	IN	O	than	prep	68	SENT_126	[p9l608t2531r769b2592],
84	among	IN	O	among	pcomp	83	SENT_126	[p9l814t2551r1059b2607],
85	the	DT	O	the	det	87	SENT_126	[p9l1101t2531r1212b2592],
86	abacavir	NN	O	abacavir	nn	87	SENT_126	[p9l1259t2531r1866b2592],
87	—	NN	O	—	pobj	84	SENT_126	[p9l1259t2531r1866b2592],
88	tolerant	JJ	O	tolerant	amod	89	SENT_126	[p9l1259t2531r1866b2592],
89	group	NN	O	group	appos	37	SENT_126	[p9l1909t2551r2138b2607],
90	.	.	O	.	_	0	SENT_126	[p9l1909t2551r2138b2607],

1	The	DT	O	the	det	2	SENT_127	[p9l7t2624r154b2685],
2	presence	NN	O	presence	nsubjpass	14	SENT_127	[p9l185t2644r497b2700],
3	of	IN	O	of	_	0	SENT_127	[p9l530t2624r607b2685],
4	the	DT	O	the	det	5	SENT_127	[p9l627t2624r737b2685],
5	HLA-B	NN	O	hla-b	prep_of	2	SENT_127	[p9l766t2625r1284b2697],
6	*	CD	NUMBER	*	number	7	SENT_127	[p9l766t2625r1284b2697],
7	5701	CD	NUMBER	5701	num	5	SENT_127	[p9l766t2625r1284b2697],
8	,	,	O	,	_	0	SENT_127	[p9l766t2625r1284b2697],
9	HLA-DR7	NN	O	hla-dr7	appos	5	SENT_127	[p9l1318t2625r1720b2697],
10	,	,	O	,	_	0	SENT_127	[p9l1318t2625r1720b2697],
11	HLA-DQ3	NN	O	hla-dq3	nn	12	SENT_127	[p9l1754t2625r2145b2700],
12	haplotype	NN	O	haplotype	appos	9	SENT_127	[p9l7t2718r359b2794],
13	was	VBD	O	be	auxpass	14	SENT_127	[p9l431t2738r562b2778],
14	associated	VBN	O	associate	_	0	SENT_127	[p9l637t2718r1000b2778],
15	with	IN	O	with	_	0	SENT_127	[p9l1070t2718r1227b2778],
16	positive	JJ	O	positive	amod	20	SENT_127	[p9l1297t2718r1571b2794],
17	and	CC	O	and	_	0	SENT_127	[p9l1645t2718r1777b2778],
18	negative	JJ	O	negative	conj_and	16	SENT_127	[p9l1848t2718r2143b2794],
19	predictive	JJ	O	predictive	amod	20	SENT_127	[p9l7t2810r360b2886],
20	values	NNS	O	value	prep_with	14	SENT_127	[p9l385t2810r604b2871],
21	of	IN	O	of	_	0	SENT_127	[p9l633t2810r710b2871],
22	100	CD	PERCENT	100	number	26	SENT_127	[p9l735t2810r933b2873],
23	%	NN	PERCENT	%	dep	26	SENT_127	[p9l735t2810r933b2873],
24	and	CC	O	and	_	0	SENT_127	[p9l964t2810r1096b2871],
25	97	CD	PERCENT	97	prep_of	20	SENT_127	[p9l1124t2810r1308b2883],
26	%	NN	PERCENT	%	prep_of	20	SENT_127	[p9l1124t2810r1308b2883],
27	,	,	O	,	_	0	SENT_127	[p9l1124t2810r1308b2883],
28	respectively	RB	O	respectively	advmod	14	SENT_127	[p9l1337t2810r1772b2886],
29	.	.	O	.	_	0	SENT_127	[p9l1337t2810r1772b2886],

1	HLA	NN	O	hlum	nn	2	SENT_128	[p9l92t2904r272b2963],
2	typing	NN	O	typing	nsubj	3	SENT_128	[p9l303t2904r529b2979],
3	revealed	VBD	O	reveal	_	0	SENT_128	[p9l556t2903r852b2964],
4	no	DT	O	no	det	6	SENT_128	[p9l880t2923r969b2964],
5	alleles	NNS	O	allele	nn	6	SENT_128	[p9l1001t2903r1213b2964],
6	characteristic	NN	O	characteristic	dobj	3	SENT_128	[p9l1245t2903r1718b2964],
7	of	IN	O	of	_	0	SENT_128	[p9l1749t2903r1826b2964],
8	the	DT	O	the	det	11	SENT_128	[p9l1844t2903r1954b2964],
9	57-1	CD	NUMBER	57-1	npadvmod	10	SENT_128	[p9l1986t2906r2134b2964],
10	ancestral	JJ	O	ancestral	amod	11	SENT_128	[p9l10t2997r325b3057],
11	haplotype	NN	O	haplotype	prep_of	6	SENT_128	[p9l355t2997r708b3073],
12	in	IN	O	in	_	0	SENT_128	[p9l740t2997r809b3056],
13	the	DT	O	the	det	15	SENT_128	[p9l839t2997r949b3057],
14	two	CD	NUMBER	two	num	15	SENT_128	[p9l981t3011r1111b3057],
15	patients	NNS	O	patient	prep_in	11	SENT_128	[p9l1143t2997r1424b3073],
16	with	IN	O	with	_	0	SENT_128	[p9l1456t2997r1613b3057],
17	a	DT	O	a	det	18	SENT_128	[p9l1646t3016r1681b3057],
18	diagnosis	NN	O	diagnosis	prep_with	3	SENT_128	[p9l1715t2997r2042b3073],
19	of	IN	O	of	_	0	SENT_128	[p9l2077t2997r2154b3057],
20	abacavir	NN	O	abacavir	nn	21	SENT_128	[p9l10t3089r307b3150],
21	hypersensitivity	NN	O	hypersensitivity	prep_of	18	SENT_128	[p9l379t3089r939b3165],
22	who	WP	O	who	nsubj	23	SENT_128	[p9l1012t3089r1162b3150],
23	started	VBD	O	start	rcmod	18	SENT_128	[p9l1242t3089r1484b3150],
24	nevirapine	NN	O	nevirapine	nn	27	SENT_128	[p9l1560t3089r1933b3165],
25	and	CC	O	and	_	0	SENT_128	[p9l2012t3089r2143b3150],
26	abacavir	NN	O	abacavir	nn	27	SENT_128	[p9l10t3182r307b3243],
27	therapy	NN	O	therapy	dobj	23	SENT_128	[p9l390t3182r661b3258],
28	concurrently	RB	O	concurrently	advmod	23	SENT_128	[p9l746t3182r1221b3258],
29	,	,	O	,	_	0	SENT_128	[p9l746t3182r1221b3258],
30	although	IN	O	although	mark	44	SENT_128	[p9l1312t3182r1626b3258],
31	the	DT	O	the	det	34	SENT_128	[p9l1710t3182r1821b3243],
32	TNFA	NN	O	tnfa	nn	34	SENT_128	[p9l1915t3183r2141b3242],
33	—	CD	NUMBER	—	num	34	SENT_128	[p9l6t3276r401b3336],
34	308G	NN	O	308g	nsubj	44	SENT_128	[p9l6t3276r401b3336],
35	—	CD	NUMBER	—	num	36	SENT_128	[p9l6t3276r401b3336],
36	>	JJR	O	>	dep	34	SENT_128	[p9l6t3276r401b3336],
37	A	DT	O	a	det	39	SENT_128	[p9l6t3276r401b3336],
38	polymorphism	NN	O	polymorphism	nn	39	SENT_128	[p9l573t3276r1220b3352],
39	—	NN	O	—	dep	34	SENT_128	[p9l573t3276r1220b3352],
40	a	DT	O	a	det	43	SENT_128	[p9l573t3276r1220b3352],
41	TNFA	NN	O	tnfa	nn	43	SENT_128	[p9l1404t3276r1629b3335],
42	promoter	NN	O	promoter	nn	43	SENT_128	[p9l1806t3290r2145b3352],
43	polymorphism	NN	O	polymorphism	dep	39	SENT_128	[p9l7t3368r531b3444],
44	implicated	VBN	O	implicate	advcl	23	SENT_128	[p9l688t3368r1066b3444],
45	in	IN	O	in	_	0	SENT_128	[p9l1223t3368r1292b3428],
46	susceptibility	NN	O	susceptibility	prep_in	44	SENT_128	[p9l1450t3368r1918b3444],
47	to	TO	O	to	_	0	SENT_128	[p9l2073t3382r2142b3429],
48	carbamazepine	NN	O	carbamazepine	nn	49	SENT_128	[p9l10t3461r546b3537],
49	hypersensitivity	NN	O	hypersensitivity	prep_to	44	SENT_128	[p9l616t3461r1436b3537],
50	‘	CD	NUMBER	‘	number	51	SENT_128	[p9l616t3461r1436b3537],
51	5	CD	NUMBER	5	num	52	SENT_128	[p9l616t3461r1436b3537],
52	—	NN	O	—	nsubj	54	SENT_128	[p9l616t3461r1436b3537],
53	was	VBD	O	be	cop	54	SENT_128	[p9l616t3461r1436b3537],
54	present	JJ	DATE	present	rcmod	49	SENT_128	[p9l1507t3476r1772b3538],
55	in	IN	O	in	_	0	SENT_128	[p9l1841t3462r1910b3521],
56	both	DT	O	both	det	57	SENT_128	[p9l1978t3462r2144b3522],
57	patients	NNS	O	patient	prep_in	54	SENT_128	[p9l7t3555r308b3631],
58	.	.	O	.	_	0	SENT_128	[p9l7t3555r308b3631],

1	Frequency	NN	O	frequency	nsubj	48	SENT_129	[p10l10t65r377b137],
2	of	IN	O	of	_	0	SENT_129	[p10l401t63r474b124],
3	complete	JJ	O	complete	amod	8	SENT_129	[p10l492t65r815b137],
4	or	CC	O	or	_	0	SENT_129	[p10l843t78r916b124],
5	partial	JJ	O	partial	conj_or	3	SENT_129	[p10l936t65r1161b137],
6	57-1	CD	NUMBER	57-1	npadvmod	7	SENT_129	[p10l1187t63r1349b123],
7	ancestral	JJ	O	ancestral	amod	8	SENT_129	[p10l1377t65r1705b124],
8	haplotype	NN	O	haplotype	prep_of	1	SENT_129	[p10l1731t65r2072b137],
9	in	IN	O	in	_	0	SENT_129	[p10l9t159r67b216],
10	control	NN	O	control	nn	11	SENT_129	[p10l97t159r339b217],
11	populations	NNS	O	population	prep_in	8	SENT_129	[p10l363t159r773b230],
12	The	DT	O	the	det	13	SENT_129	[p10l7t248r154b309],
13	frequency	NN	O	frequency	nsubjpass	35	SENT_129	[p10l197t248r553b324],
14	of	IN	O	of	_	0	SENT_129	[p10l594t248r671b309],
15	the	DT	O	the	det	17	SENT_129	[p10l702t248r813b309],
16	C4A6	NN	O	c4a6	nn	17	SENT_129	[p10l857t248r1063b309],
17	allele	NN	O	allele	prep_of	13	SENT_129	[p10l1104t248r1305b321],
18	,	,	O	,	_	0	SENT_129	[p10l1104t248r1305b321],
19	an	DT	O	a	det	22	SENT_129	[p10l1351t268r1435b309],
20	additional	JJ	O	additional	amod	22	SENT_129	[p10l1478t248r1836b309],
21	speciﬁc	NN	O	speciﬁc	nn	22	SENT_129	[p10l1880t248r2143b324],
22	marker	NN	O	marker	appos	13	SENT_129	[p10l8t341r264b402],
23	of	IN	O	of	_	0	SENT_129	[p10l300t341r377b402],
24	the	DT	O	the	det	28	SENT_129	[p10l403t341r513b402],
25	57	CD	NUMBER	57	num	28	SENT_129	[p10l554t344r637b402],
26	-1	CD	NUMBER	-1	num	28	SENT_129	[p10l648t344r701b401],
27	ancestral	JJ	O	ancestral	amod	28	SENT_129	[p10l749t341r1064b402],
28	haplotype	NN	O	haplotype	prep_of	22	SENT_129	[p10l1100t341r1452b417],
29	within	IN	O	within	_	0	SENT_129	[p10l1488t341r1715b402],
30	the	DT	O	the	det	32	SENT_129	[p10l1751t341r1862b402],
31	central	JJ	O	central	amod	32	SENT_129	[p10l1901t341r2143b402],
32	MHC	NN	O	mhc	prep_within	28	SENT_129	[p10l8t435r249b508],
33	,	,	O	,	_	0	SENT_129	[p10l8t435r249b508],
34	was	VBD	O	be	auxpass	35	SENT_129	[p10l274t455r405b495],
35	assessed	VBN	O	assess	rcmod	8	SENT_129	[p10l432t435r725b495],
36	in	IN	O	in	_	0	SENT_129	[p10l748t435r817b494],
37	the	DT	O	the	det	39	SENT_129	[p10l839t435r949b495],
38	abacavir-exposed	JJ	O	abacavir-exposed	amod	39	SENT_129	[p10l976t435r1594b511],
39	groups	NNS	O	group	prep_in	35	SENT_129	[p10l1617t454r1881b511],
40	,	,	O	,	_	0	SENT_129	[p10l1617t454r1881b511],
41	as	RB	O	as	_	0	SENT_129	[p10l1909t455r1976b495],
42	well	RB	O	well	_	0	SENT_129	[p10l2000t435r2143b495],
43	as	IN	O	as	_	0	SENT_129	[p10l10t547r77b588],
44	in	IN	O	in	_	0	SENT_129	[p10l116t527r184b587],
45	two	CD	NUMBER	two	num	47	SENT_129	[p10l220t541r350b588],
46	control	JJ	O	control	amod	47	SENT_129	[p10l391t527r644b588],
47	populations	NNS	O	population	prep_in	35	SENT_129	[p10l680t527r1103b603],
48	(	VBP	O	(	_	0	SENT_129	[p10l1147t528r1300b602],
49	381	CD	NUMBER	381	num	51	SENT_129	[p10l1147t528r1300b602],
50	HIV-infected	JJ	O	hiv-infected	amod	51	SENT_129	[p10l1347t527r1825b588],
51	patients	NNS	O	patient	nsubj	61	SENT_129	[p10l1861t527r2142b603],
52	not	RB	O	not	neg	53	SENT_129	[p10l7t635r127b681],
53	exposed	VBN	O	expose	partmod	51	SENT_129	[p10l178t620r467b696],
54	to	TO	O	to	_	0	SENT_129	[p10l516t635r585b681],
55	abacavir	NN	O	abacavir	prep_to	53	SENT_129	[p10l639t620r936b681],
56	and	CC	O	and	_	0	SENT_129	[p10l986t620r1117b681],
57	3212	CD	DATE	3212	num	60	SENT_129	[p10l1169t623r1346b681],
58	HIV-negative	JJ	MISC	hiv-negative	amod	60	SENT_129	[p10l1400t621r1886b696],
59	bonemarrow	NN	O	bonemarrow	nn	60	SENT_129	[p10l1935t620r2143b681, p10l8t734r288b774],
60	donors	NNS	O	donor	prep_to	53	SENT_129	[p10l336t714r633b789],
61	)	VBP	O	)	ccomp	48	SENT_129	[p10l336t714r633b789],
62	.	.	O	.	_	0	SENT_129	[p10l336t714r633b789],

1	The	DT	O	the	det	2	SENT_130	[p10l685t714r832b774],
2	distribution	NN	O	distribution	nsubj	22	SENT_130	[p10l882t714r1301b774],
3	of	IN	O	of	_	0	SENT_130	[p10l1349t714r1426b774],
4	the	DT	O	the	det	5	SENT_130	[p10l1463t714r1574b774],
5	HLA-B	NN	O	hla-b	prep_of	2	SENT_130	[p10l1621t714r2138b787],
6	*	CD	NUMBER	*	number	7	SENT_130	[p10l1621t714r2138b787],
7	5701	CD	NUMBER	5701	num	5	SENT_130	[p10l1621t714r2138b787],
8	,	,	O	,	_	0	SENT_130	[p10l1621t714r2138b787],
9	C4A6	NN	O	c4a6	conj_and	2	SENT_130	[p10l10t806r234b879],
10	,	,	O	,	_	0	SENT_130	[p10l10t806r234b879],
11	and	CC	O	and	_	0	SENT_130	[p10l277t806r409b867],
12	HLA-DR7	NN	O	hla-dr7	nn	15	SENT_130	[p10l445t806r833b867],
13	plus	CC	O	plus	_	0	SENT_130	[p10l863t806r1010b882],
14	HLA-DQ3	NN	O	hla-dq3	nn	15	SENT_130	[p10l1048t806r1439b882],
15	alleles	NNS	O	allele	conj_and	2	SENT_130	[p10l1477t806r1689b867],
16	of	IN	O	of	_	0	SENT_130	[p10l1730t806r1807b867],
17	the	DT	O	the	det	20	SENT_130	[p10l1835t806r1945b867],
18	57-1	CD	NUMBER	57-1	npadvmod	19	SENT_130	[p10l1987t809r2134b867],
19	ancestral	JJ	O	ancestral	amod	20	SENT_130	[p10l10t899r325b960],
20	haplotype	NN	O	haplotype	prep_of	15	SENT_130	[p10l348t899r701b975],
21	was	VBD	O	be	cop	22	SENT_130	[p10l724t919r856b960],
22	similar	JJ	O	similar	_	0	SENT_130	[p10l883t899r1124b960],
23	in	IN	O	in	_	0	SENT_130	[p10l1147t900r1215b959],
24	the	DT	O	the	det	28	SENT_130	[p10l1238t899r1349b960],
25	three	CD	NUMBER	three	num	26	SENT_130	[p10l1373t899r1554b960],
26	groups	NNS	O	group	dep	27	SENT_130	[p10l1579t919r1820b975],
27	(	RB	O	(	amod	28	SENT_130	[p10l1853t899r2051b975],
28	table	NN	O	table	prep_in	22	SENT_130	[p10l1853t899r2051b975],
29	3	CD	NUMBER	3	dep	28	SENT_130	[p10l2078t902r2140b972],
30	,	,	O	,	_	0	SENT_130	[p10l2078t902r2140b972],
31	ﬁgure	NN	O	ﬁgure	nn	33	SENT_130	[p10l8t993r212b1069],
32	1	CD	NUMBER	1	num	33	SENT_130	[p10l291t993r376b1068],
33	)	NN	O	)	attr	22	SENT_130	[p10l291t993r376b1068],
34	.	.	O	.	_	0	SENT_130	[p10l291t993r376b1068],

1	By	IN	O	by	_	0	SENT_131	[p10l452t994r547b1069],
2	contrast	NN	O	contrast	prep_by	12	SENT_131	[p10l616t1007r924b1066],
3	,	,	O	,	_	0	SENT_131	[p10l616t1007r924b1066],
4	alleles	NNS	O	allele	nsubj	12	SENT_131	[p10l998t993r1210b1053],
5	of	IN	O	of	_	0	SENT_131	[p10l1282t993r1359b1053],
6	the	DT	O	the	det	9	SENT_131	[p10l1417t993r1528b1053],
7	57-1	CD	NUMBER	57-1	npadvmod	8	SENT_131	[p10l1600t995r1748b1053],
8	ancestral	JJ	O	ancestral	amod	9	SENT_131	[p10l1828t993r2143b1053],
9	haplotype	NN	O	haplotype	prep_of	4	SENT_131	[p10l7t1085r359b1161],
10	were	VBD	O	be	cop	12	SENT_131	[p10l408t1105r577b1146],
11	greatly	RB	O	greatly	advmod	12	SENT_131	[p10l627t1085r868b1161],
12	oVer	NN	O	over	_	0	SENT_131	[p10l917t1085r1520b1161],
13	—	CD	NUMBER	—	num	12	SENT_131	[p10l917t1085r1520b1161],
14	represented	VBN	O	represent	partmod	12	SENT_131	[p10l917t1085r1520b1161],
15	in	IN	O	in	_	0	SENT_131	[p10l1570t1085r1638b1145],
16	the	DT	O	the	det	19	SENT_131	[p10l1686t1085r1797b1146],
17	abacavir	NN	O	abacavir	nn	19	SENT_131	[p10l1848t1085r2146b1146],
18	hypersensitive	JJ	O	hypersensitive	amod	19	SENT_131	[p10l7t1178r513b1254],
19	group	NN	O	group	prep_in	14	SENT_131	[p10l565t1198r773b1254],
20	compared	VBN	O	compare	_	0	SENT_131	[p10l827t1178r1185b1254],
21	with	IN	O	with	prepc_compared_with	14	SENT_131	[p10l1235t1178r1392b1239],
22	the	DT	O	the	det	24	SENT_131	[p10l1442t1178r1552b1239],
23	tolerant	JJ	O	tolerant	amod	24	SENT_131	[p10l1604t1178r1883b1239],
24	group	NN	O	group	pobj	14	SENT_131	[p10l1933t1198r2142b1254],
25	(	CD	NUMBER	(	num	26	SENT_131	[p10l14t1272r212b1347],
26	table	NN	O	table	dep	24	SENT_131	[p10l14t1272r212b1347],
27	3	CD	NUMBER	3	dep	26	SENT_131	[p10l241t1274r303b1345],
28	,	,	O	,	_	0	SENT_131	[p10l241t1274r303b1345],
29	ﬁgure	NN	O	ﬁgure	nn	31	SENT_131	[p10l332t1272r536b1348],
30	1	CD	NUMBER	1	num	31	SENT_131	[p10l572t1272r657b1347],
31	)	NN	O	)	appos	24	SENT_131	[p10l572t1272r657b1347],
32	.	.	O	.	_	0	SENT_131	[p10l572t1272r657b1347],

1	HIV-seronegative	JJ	O	hiv-seronegative	amod	3	SENT_132	[p10l1444t1409r1999b1474],
2	bone-marrow	NN	O	bone-marrow	nn	3	SENT_132	[p10l1443t1476r1864b1528],
3	donors	NNS	O	donor	nsubj	4	SENT_132	[p10l1888t1476r2107b1528],
4	(	VBP	O	(	_	0	SENT_132	[p10l1442t1565r1753b1630],
5	n	NN	O	n	dobj	4	SENT_132	[p10l1442t1565r1753b1630],
6	=	JJ	O	=	amod	5	SENT_132	[p10l1442t1565r1753b1630],
7	3212	CD	NUMBER	3212	number	8	SENT_132	[p10l1442t1565r1753b1630],
8	)	CD	NUMBER	)	dep	6	SENT_132	[p10l1442t1565r1753b1630],

1	Complete	JJ	O	complete	amod	3	SENT_133	[p10l7t1723r322b1788],
2	haplotype	NN	O	haplotype	nn	3	SENT_133	[p10l349t1724r668b1789],
3	frequency	NN	O	frequency	_	0	SENT_133	[p10l692t1723r1015b1789],
4	HLA-B	NN	O	hla-b	dep	3	SENT_133	[p10l8t1813r281b1866],
5	*	CD	NUMBER	*	num	4	SENT_133	[p10l8t1813r281b1866],
6	5	CD	NUMBER	5	num	7	SENT_133	[p10l8t1813r281b1866],
7	701	CD	NUMBER	701	dep	4	SENT_133	[p10l292t1813r430b1874],
8	,	,	O	,	_	0	SENT_133	[p10l292t1813r430b1874],
9	C4A6	NN	O	c4a6	appos	7	SENT_133	[p10l462t1813r646b1875],
10	,	,	O	,	_	0	SENT_133	[p10l462t1813r646b1875],
11	.	.	O	.	_	0	SENT_133	[p10l674t1814r845b1874],

1	—	NN	O	—	_	0	SENT_134	[p10l674t1814r845b1874],
2	.	.	O	.	_	0	SENT_134	[p10l674t1814r845b1874],

1	DR7	NN	O	dr7	nsubj	9	SENT_135	[p10l674t1814r845b1874],
2	,	,	O	,	_	0	SENT_135	[p10l674t1814r845b1874],
3	-	:	O	-	_	0	SENT_135	[p10l873t1813r1027b1877],
4	DQ3	NN	O	dq3	dep	1	SENT_135	[p10l873t1813r1027b1877],
5	134	CD	PERCENT	134	number	6	SENT_135	[p10l1498t1812r1624b1866],
6	(	CD	PERCENT	(	dep	4	SENT_135	[p10l1652t1812r1853b1877],
7	4-2	CD	PERCENT	4-2	num	8	SENT_135	[p10l1652t1812r1853b1877],
8	%	NN	PERCENT	%	dep	6	SENT_135	[p10l1652t1812r1853b1877],
9	)	CD	NUMBER	)	_	0	SENT_135	[p10l1652t1812r1853b1877],

1	Total	JJ	O	total	amod	2	SENT_136	[p10l6t1946r169b1998],
2	frequency	NN	O	frequency	_	0	SENT_136	[p10l196t1946r519b2011],
3	of	IN	O	of	_	0	SENT_136	[p10l543t1946r606b1998],
4	allele	NN	O	allele	nn	5	SENT_136	[p10l628t1946r803b1998],
5	HLA-B	NN	O	hla-b	prep_of	2	SENT_136	[p10l8t2034r281b2086],
6	*	CD	NUMBER	*	num	5	SENT_136	[p10l8t2034r281b2086],
7	5	CD	NUMBER	5	number	8	SENT_136	[p10l8t2034r281b2086],
8	701	CD	NUMBER	701	dep	2	SENT_136	[p10l292t2034r430b2095],
9	,	,	O	,	_	0	SENT_136	[p10l292t2034r430b2095],
10	.	.	O	.	_	0	SENT_136	[p10l458t2035r629b2095],

1	—	NN	O	—	_	0	SENT_137	[p10l458t2035r629b2095],
2	.	.	O	.	_	0	SENT_137	[p10l458t2035r629b2095],

1	DR7	NN	O	dr7	_	0	SENT_138	[p10l458t2035r629b2095],
2	,	,	O	,	_	0	SENT_138	[p10l458t2035r629b2095],
3	-	:	O	-	_	0	SENT_138	[p10l658t2034r811b2098],
4	DQ3	NN	O	dq3	appos	1	SENT_138	[p10l658t2034r811b2098],
5	137	CD	PERCENT	137	number	6	SENT_138	[p10l1498t2034r1622b2086],
6	(	CD	PERCENT	(	amod	4	SENT_138	[p10l1652t2034r1854b2099],
7	4-3	CD	PERCENT	4-3	num	8	SENT_138	[p10l1652t2034r1854b2099],
8	%	NN	PERCENT	%	dep	6	SENT_138	[p10l1652t2034r1854b2099],
9	)	CD	NUMBER	)	num	10	SENT_138	[p10l1652t2034r1854b2099],
10	HLA-B	NN	O	hla-b	dep	4	SENT_138	[p10l8t2122r430b2183],
11	*	CD	NUMBER	*	number	12	SENT_138	[p10l8t2122r430b2183],
12	5701	CD	NUMBER	5701	dep	10	SENT_138	[p10l8t2122r430b2183],
13	,	,	O	,	_	0	SENT_138	[p10l8t2122r430b2183],
14	C4A6	NN	O	c4a6	appos	4	SENT_138	[p10l463t2122r630b2175],
15	206	CD	PERCENT	206	num	14	SENT_138	[p10l1496t2122r1623b2174],
16	(	CD	PERCENT	(	num	18	SENT_138	[p10l1652t2122r1854b2187],
17	6-4	CD	PERCENT	6-4	num	18	SENT_138	[p10l1652t2122r1854b2187],
18	%	NN	PERCENT	%	dep	14	SENT_138	[p10l1652t2122r1854b2187],
19	)	CD	NUMBER	)	num	20	SENT_138	[p10l1652t2122r1854b2187],
20	HLA-B	NN	O	hla-b	dep	1	SENT_138	[p10l8t2210r281b2262],
21	*	CD	NUMBER	*	number	22	SENT_138	[p10l8t2210r281b2262],
22	5	CD	NUMBER	5	num	23	SENT_138	[p10l8t2210r281b2262],
23	701	CD	NUMBER	701	dep	20	SENT_138	[p10l292t2210r411b2264],
24	totally	RB	O	totally	amod	23	SENT_138	[p10l436t2210r631b2275],
25	279	CD	PERCENT	279	number	26	SENT_138	[p10l1496t2210r1623b2262],
26	(	CD	PERCENT	(	prep	24	SENT_138	[p10l1652t2210r1854b2275],
27	8-7	CD	PERCENT	8-7	num	28	SENT_138	[p10l1652t2210r1854b2275],
28	%	NN	PERCENT	%	dep	26	SENT_138	[p10l1652t2210r1854b2275],
29	)	CD	NUMBER	)	dep	20	SENT_138	[p10l1652t2210r1854b2275],

1	Partial	JJ	O	partial	amod	4	SENT_139	[p10l10t2381r220b2434],
2	haplotype	NN	O	haplotype	nn	4	SENT_139	[p10l249t2382r568b2446],
3	frequency	NN	O	frequency	nn	4	SENT_139	[p10l593t2381r916b2446],
4	HLA-B	NN	O	hla-b	_	0	SENT_139	[p10l8t2469r430b2531],
5	*	CD	NUMBER	*	num	6	SENT_139	[p10l8t2469r430b2531],
6	5701	CD	NUMBER	5701	dep	4	SENT_139	[p10l8t2469r430b2531],
7	,	,	O	,	_	0	SENT_139	[p10l8t2469r430b2531],
8	C4A6	NN	O	c4a6	appos	6	SENT_139	[p10l463t2470r630b2522],
9	only	RB	O	only	quantmod	11	SENT_139	[p10l655t2470r782b2535],
10	72	CD	PERCENT	72	number	11	SENT_139	[p10l1542t2469r1622b2521],
11	(	CD	PERCENT	(	dep	4	SENT_139	[p10l1652t2469r1853b2534],
12	2-2	CD	PERCENT	2-2	num	13	SENT_139	[p10l1652t2469r1853b2534],
13	%	NN	PERCENT	%	dep	11	SENT_139	[p10l1652t2469r1853b2534],
14	)	CD	NUMBER	)	num	15	SENT_139	[p10l1652t2469r1853b2534],
15	HLA-B	NN	O	hla-b	dep	4	SENT_139	[p10l8t2557r430b2619],
16	*	CD	NUMBER	*	number	17	SENT_139	[p10l8t2557r430b2619],
17	5701	CD	NUMBER	5701	dep	15	SENT_139	[p10l8t2557r430b2619],
18	,	,	O	,	_	0	SENT_139	[p10l8t2557r430b2619],
19	.	.	O	.	_	0	SENT_139	[p10l458t2559r630b2619],

1	—	NN	O	—	_	0	SENT_140	[p10l458t2559r630b2619],
2	.	.	O	.	_	0	SENT_140	[p10l458t2559r630b2619],

1	DR7	NN	O	dr7	_	0	SENT_141	[p10l458t2559r630b2619],
2	,	,	O	,	_	0	SENT_141	[p10l458t2559r630b2619],
3	-	:	O	-	_	0	SENT_141	[p10l658t2558r811b2621],
4	DQ3	NN	O	dq3	npadvmod	5	SENT_141	[p10l658t2558r811b2621],
5	only	RB	O	only	dep	11	SENT_141	[p10l839t2558r965b2623],
6	3	CD	NUMBER	3	num	7	SENT_141	[p10l1584t2557r1623b2610],
7	(	NN	O	(	dep	5	SENT_141	[p10l1652t2557r1853b2622],
8	O-1	CD	PERCENT	o-1	num	9	SENT_141	[p10l1652t2557r1853b2622],
9	%	NN	PERCENT	%	dep	5	SENT_141	[p10l1652t2557r1853b2622],
10	)	CD	NUMBER	)	num	11	SENT_141	[p10l1652t2557r1853b2622],
11	HLA-B	NN	O	hla-b	dep	1	SENT_141	[p10l8t2645r411b2699],
12	*	CD	NUMBER	*	number	13	SENT_141	[p10l8t2645r411b2699],
13	5701	CD	NUMBER	5701	num	16	SENT_141	[p10l8t2645r411b2699],
14	only	RB	O	only	quantmod	16	SENT_141	[p10l439t2646r566b2711],
15	70	CD	PERCENT	70	number	16	SENT_141	[p10l1542t2645r1623b2698],
16	(	CD	PERCENT	(	nn	20	SENT_141	[p10l1652t2645r1853b2710],
17	2-2	CD	PERCENT	2-2	num	18	SENT_141	[p10l1652t2645r1853b2710],
18	%	NN	PERCENT	%	dep	16	SENT_141	[p10l1652t2645r1853b2710],
19	)	CD	NUMBER	)	dep	16	SENT_141	[p10l1652t2645r1853b2710],
20	C4A6	NN	O	c4a6	dep	11	SENT_141	[p10l9t2734r193b2795],
21	,	,	O	,	_	0	SENT_141	[p10l9t2734r193b2795],
22	.	.	O	.	_	0	SENT_141	[p10l221t2735r392b2795],

1	—	NN	O	—	_	0	SENT_142	[p10l221t2735r392b2795],
2	.	.	O	.	_	0	SENT_142	[p10l221t2735r392b2795],

1	DR7	NN	O	dr7	_	0	SENT_143	[p10l221t2735r392b2795],
2	,	,	O	,	_	0	SENT_143	[p10l221t2735r392b2795],
3	-	:	O	-	_	0	SENT_143	[p10l420t2734r574b2797],
4	DQ3	NN	O	dq3	npadvmod	5	SENT_143	[p10l420t2734r574b2797],
5	only	RB	O	only	dep	11	SENT_143	[p10l601t2734r728b2799],
6	28	CD	PERCENT	28	num	7	SENT_143	[p10l1540t2733r1624b2786],
7	(	CD	PERCENT	(	dep	5	SENT_143	[p10l1652t2733r1853b2798],
8	O-9	CD	PERCENT	o-9	num	9	SENT_143	[p10l1652t2733r1853b2798],
9	%	NN	PERCENT	%	dep	5	SENT_143	[p10l1652t2733r1853b2798],
10	)	CD	NUMBER	)	num	11	SENT_143	[p10l1652t2733r1853b2798],
11	C4A6	NN	O	c4a6	dep	1	SENT_143	[p10l9t2822r177b2874],
12	only	RB	O	only	prep	11	SENT_143	[p10l202t2822r328b2887],
13	24	CD	PERCENT	24	number	14	SENT_143	[p10l1540t2821r1624b2873],
14	(	CD	PERCENT	(	pobj	12	SENT_143	[p10l1652t2821r1853b2886],
15	O-7	CD	PERCENT	o-7	num	16	SENT_143	[p10l1652t2821r1853b2886],
16	%	NN	PERCENT	%	dep	14	SENT_143	[p10l1652t2821r1853b2886],
17	)	CD	NUMBER	)	num	18	SENT_143	[p10l1652t2821r1853b2886],
18	HLA-DR7	NN	O	hla-dr7	dep	16	SENT_143	[p10l8t2911r305b2971],
19	,	,	O	,	_	0	SENT_143	[p10l8t2911r305b2971],
20	-	:	O	-	_	0	SENT_143	[p10l333t2910r486b2973],
21	DQ3	NN	O	dq3	dep	1	SENT_143	[p10l333t2910r486b2973],
22	only	RB	O	only	quantmod	24	SENT_143	[p10l514t2910r640b2975],
23	37	CD	PERCENT	37	number	24	SENT_143	[p10l1539t2909r1622b2962],
24	(	CD	PERCENT	(	dep	21	SENT_143	[p10l1652t2909r1853b2974],
25	1-2	CD	PERCENT	1-2	num	26	SENT_143	[p10l1652t2909r1853b2974],
26	%	NN	PERCENT	%	dep	1	SENT_143	[p10l1652t2909r1853b2974],
27	)	CD	NUMBER	)	dep	26	SENT_143	[p10l1652t2909r1853b2974],

1	HIV-positive	JJ	O	hiv-positive	amod	3	SENT_144	[p10l12t3120r322b3169],
2	,	,	O	,	_	0	SENT_144	[p10l12t3120r322b3169],
3	HIV-positive	JJ	O	hiv-positive	dep	15	SENT_144	[p10l564t3120r874b3169],
4	,	,	O	,	_	0	SENT_144	[p10l564t3120r874b3169],
5	Abcavir	NNP	O	Abcavir	nn	6	SENT_144	[p10l1141t3120r1329b3160],
6	Abacavir	NNP	O	Abacavir	dep	3	SENT_144	[p10l1637t3120r1857b3160],
7	tolerant	JJ	O	tolerant	amod	8	SENT_144	[p10l1874t3120r2072b3160],
8	abacavir	NN	O	abacavir	dep	6	SENT_144	[p10l10t3186r222b3226],
9	unexposed	JJ	O	unexposed	amod	10	SENT_144	[p10l242t3186r510b3235],
10	abacavir	NN	O	abacavir	nsubj	15	SENT_144	[p10l563t3186r775b3226],
11	exposed	VBN	O	expose	partmod	10	SENT_144	[p10l793t3186r1001b3235],
12	hypersensitive	JJ	O	hypersensitive	amod	14	SENT_144	[p10l1143t3186r1504b3235],
13	(	NN	O	(	nn	14	SENT_144	[p10l1639t3186r1843b3235],
14	n	NN	O	n	dobj	11	SENT_144	[p10l1639t3186r1843b3235],
15	=	JJ	O	=	_	0	SENT_144	[p10l1639t3186r1843b3235],
16	167	CD	NUMBER	167	number	17	SENT_144	[p10l1639t3186r1843b3235],
17	)	CD	NUMBER	)	num	29	SENT_144	[p10l1639t3186r1843b3235],
18	(	NN	O	(	nn	29	SENT_144	[p10l10t3252r214b3301],
19	n	NN	O	n	nn	29	SENT_144	[p10l10t3252r214b3301],
20	=	JJ	O	=	amod	29	SENT_144	[p10l10t3252r214b3301],
21	381	CD	NUMBER	381	number	22	SENT_144	[p10l10t3252r214b3301],
22	)	CD	NUMBER	)	num	29	SENT_144	[p10l10t3252r214b3301],
23	(	NN	O	(	nn	29	SENT_144	[p10l563t3252r766b3301],
24	n	NN	O	n	nn	29	SENT_144	[p10l563t3252r766b3301],
25	=	JJ	O	=	amod	29	SENT_144	[p10l563t3252r766b3301],
26	200	CD	NUMBER	200	number	27	SENT_144	[p10l563t3252r766b3301],
27	)	CD	NUMBER	)	num	29	SENT_144	[p10l563t3252r766b3301],
28	(	NN	O	(	nn	29	SENT_144	[p10l1142t3252r1312b3301],
29	n	NN	O	n	dobj	15	SENT_144	[p10l1142t3252r1312b3301],
30	=	JJ	O	=	amod	29	SENT_144	[p10l1142t3252r1312b3301],
31	18	CD	NUMBER	18	num	32	SENT_144	[p10l1142t3252r1312b3301],
32	)	NN	O	)	dep	30	SENT_144	[p10l1142t3252r1312b3301],

1	8	CD	PERCENT	8	dep	136	SENT_145	[p11l69t83r99b123],
2	(	CD	PERCENT	(	dep	136	SENT_145	[p11l121t83r274b132],
3	2-1	CD	PERCENT	2-1	dep	136	SENT_145	[p11l121t83r274b132],
4	%	NN	PERCENT	%	dep	136	SENT_145	[p11l121t83r274b132],
5	)	CD	NUMBER	)	dep	136	SENT_145	[p11l121t83r274b132],
6	1	CD	NUMBER	1	dep	136	SENT_145	[p11l629t84r657b123],
7	(	NN	O	(	dep	136	SENT_145	[p11l679t83r832b132],
8	O-5	CD	PERCENT	o-5	dep	136	SENT_145	[p11l679t83r832b132],
9	%	NN	PERCENT	%	dep	136	SENT_145	[p11l679t83r832b132],
10	)	CD	NUMBER	)	dep	136	SENT_145	[p11l679t83r832b132],
11	O	NN	O	o	dep	136	SENT_145	[p11l1177t83r1207b123],
12	O	NN	O	o	dep	136	SENT_145	[p11l1712t83r1742b123],
13	2	CD	PERCENT	2	dep	136	SENT_145	[p11l70t149r98b189],
14	(	CD	PERCENT	(	dep	136	SENT_145	[p11l121t149r274b198],
15	O-5	CD	PERCENT	o-5	dep	136	SENT_145	[p11l121t149r274b198],
16	%	NN	PERCENT	%	dep	136	SENT_145	[p11l121t149r274b198],
17	)	CD	PERCENT	)	dep	136	SENT_145	[p11l121t149r274b198],
18	1	CD	PERCENT	1	dep	136	SENT_145	[p11l629t150r657b189],
19	(	NN	PERCENT	(	dep	136	SENT_145	[p11l679t149r832b198],
20	O-5	CD	PERCENT	o-5	dep	136	SENT_145	[p11l679t149r832b198],
21	%	NN	PERCENT	%	dep	136	SENT_145	[p11l679t149r832b198],
22	)	CD	NUMBER	)	dep	136	SENT_145	[p11l679t149r832b198],
23	1	CD	NUMBER	1	dep	136	SENT_145	[p11l1179t150r1207b189],
24	(	NN	O	(	dep	136	SENT_145	[p11l1229t149r1382b198],
25	5-6	CD	PERCENT	5-6	dep	136	SENT_145	[p11l1229t149r1382b198],
26	%	NN	PERCENT	%	dep	136	SENT_145	[p11l1229t149r1382b198],
27	)	CD	NUMBER	)	dep	136	SENT_145	[p11l1229t149r1382b198],
28	o	NN	O	o	dep	136	SENT_145	[p11l1712t149r1742b189],
29	9	CD	PERCENT	9	dep	136	SENT_145	[p11l70t215r99b255],
30	(	NN	PERCENT	(	dep	136	SENT_145	[p11l121t215r274b264],
31	2-4	CD	PERCENT	2-4	dep	136	SENT_145	[p11l121t215r274b264],
32	%	NN	PERCENT	%	dep	136	SENT_145	[p11l121t215r274b264],
33	)	CD	NUMBER	)	dep	136	SENT_145	[p11l121t215r274b264],
34	5	CD	NUMBER	5	dep	136	SENT_145	[p11l628t216r657b255],
35	(	NN	O	(	dep	136	SENT_145	[p11l679t215r832b264],
36	2-5	CD	PERCENT	2-5	dep	136	SENT_145	[p11l679t215r832b264],
37	%	NN	PERCENT	%	dep	136	SENT_145	[p11l679t215r832b264],
38	)	CD	NUMBER	)	dep	136	SENT_145	[p11l679t215r832b264],
39	1	CD	NUMBER	1	dep	136	SENT_145	[p11l1179t216r1207b255],
40	(	NN	O	(	dep	136	SENT_145	[p11l1229t215r1382b264],
41	5-6	CD	PERCENT	5-6	dep	136	SENT_145	[p11l1229t215r1382b264],
42	%	NN	PERCENT	%	dep	136	SENT_145	[p11l1229t215r1382b264],
43	)	CD	NUMBER	)	dep	136	SENT_145	[p11l1229t215r1382b264],
44	4	CD	NUMBER	4	dep	136	SENT_145	[p11l1711t216r1742b255],
45	(	NN	O	(	dep	136	SENT_145	[p11l1763t215r1917b264],
46	2-4	CD	PERCENT	2-4	dep	136	SENT_145	[p11l1763t215r1917b264],
47	%	NN	PERCENT	%	dep	136	SENT_145	[p11l1763t215r1917b264],
48	)	CD	PERCENT	)	dep	136	SENT_145	[p11l1763t215r1917b264],
49	2	CD	PERCENT	2	dep	136	SENT_145	[p11l70t281r98b321],
50	(	CD	PERCENT	(	dep	136	SENT_145	[p11l121t281r274b330],
51	O-5	CD	PERCENT	o-5	dep	136	SENT_145	[p11l121t281r274b330],
52	%	NN	PERCENT	%	dep	136	SENT_145	[p11l121t281r274b330],
53	)	CD	NUMBER	)	dep	136	SENT_145	[p11l121t281r274b330],
54	4	CD	NUMBER	4	dep	136	SENT_145	[p11l627t282r657b321],
55	(	NN	O	(	dep	136	SENT_145	[p11l679t281r832b330],
56	2-0	CD	PERCENT	2-0	dep	136	SENT_145	[p11l679t281r832b330],
57	%	NN	PERCENT	%	dep	136	SENT_145	[p11l679t281r832b330],
58	)	CD	NUMBER	)	dep	136	SENT_145	[p11l679t281r832b330],
59	o	NN	O	o	dep	136	SENT_145	[p11l1177t281r1207b321],
60	3	CD	PERCENT	3	dep	136	SENT_145	[p11l1711t281r1741b321],
61	(	NN	PERCENT	(	dep	136	SENT_145	[p11l1763t281r1917b330],
62	1-8	CD	PERCENT	1-8	dep	136	SENT_145	[p11l1763t281r1917b330],
63	%	NN	PERCENT	%	dep	136	SENT_145	[p11l1763t281r1917b330],
64	)	CD	NUMBER	)	dep	136	SENT_145	[p11l1763t281r1917b330],
65	7	CD	NUMBER	7	dep	136	SENT_145	[p11l71t348r97b387],
66	(	NN	O	(	dep	136	SENT_145	[p11l121t347r274b396],
67	1-8	CD	PERCENT	1-8	dep	136	SENT_145	[p11l121t347r274b396],
68	%	NN	PERCENT	%	dep	136	SENT_145	[p11l121t347r274b396],
69	)	CD	PERCENT	)	dep	136	SENT_145	[p11l121t347r274b396],
70	2	CD	PERCENT	2	dep	136	SENT_145	[p11l628t347r656b387],
71	(	CD	PERCENT	(	dep	136	SENT_145	[p11l679t347r832b396],
72	1-0	CD	PERCENT	1-0	dep	136	SENT_145	[p11l679t347r832b396],
73	%	NN	PERCENT	%	dep	136	SENT_145	[p11l679t347r832b396],
74	)	CD	NUMBER	)	dep	136	SENT_145	[p11l679t347r832b396],
75	o	NN	O	o	dep	136	SENT_145	[p11l1177t347r1207b387],
76	2	CD	PERCENT	2	dep	136	SENT_145	[p11l1712t347r1741b387],
77	(	CD	PERCENT	(	dep	136	SENT_145	[p11l1763t347r1917b396],
78	1-2	CD	PERCENT	1-2	dep	136	SENT_145	[p11l1763t347r1917b396],
79	%	NN	PERCENT	%	dep	136	SENT_145	[p11l1763t347r1917b396],
80	)	CD	PERCENT	)	dep	136	SENT_145	[p11l1763t347r1917b396],
81	9	CD	PERCENT	9	dep	136	SENT_145	[p11l70t413r99b453],
82	(	NN	PERCENT	(	dep	136	SENT_145	[p11l121t413r274b462],
83	2-4	CD	PERCENT	2-4	dep	136	SENT_145	[p11l121t413r274b462],
84	%	NN	PERCENT	%	dep	136	SENT_145	[p11l121t413r274b462],
85	)	CD	NUMBER	)	dep	136	SENT_145	[p11l121t413r274b462],
86	3	CD	NUMBER	3	dep	136	SENT_145	[p11l627t413r657b453],
87	(	NN	O	(	dep	136	SENT_145	[p11l679t413r832b462],
88	1-5	CD	PERCENT	1-5	dep	136	SENT_145	[p11l679t413r832b462],
89	%	NN	PERCENT	%	dep	136	SENT_145	[p11l679t413r832b462],
90	)	CD	NUMBER	)	dep	136	SENT_145	[p11l679t413r832b462],
91	o	NN	O	o	dep	136	SENT_145	[p11l1177t413r1207b453],
92	3	CD	PERCENT	3	dep	136	SENT_145	[p11l1712t413r1741b453],
93	(	NN	PERCENT	(	dep	136	SENT_145	[p11l1763t413r1917b462],
94	1-8	CD	PERCENT	1-8	dep	136	SENT_145	[p11l1763t413r1917b462],
95	%	NN	PERCENT	%	dep	136	SENT_145	[p11l1763t413r1917b462],
96	)	CD	NUMBER	)	dep	136	SENT_145	[p11l1763t413r1917b462],
97	Other	JJ	O	other	dep	136	SENT_145	[p11l88t489r159b510],
98	haplotypes	NNS	O	haplotype	dep	136	SENT_145	[p11l169t489r309b515],
99	2844	CD	DATE	2844	dep	136	SENT_145	[p11l655t489r723b510],
100	(	CD	PERCENT	(	dep	136	SENT_145	[p11l734t489r831b515],
101	88-5	CD	PERCENT	88-5	dep	136	SENT_145	[p11l734t489r831b515],
102	%	NN	PERCENT	%	dep	136	SENT_145	[p11l734t489r831b515],
103	)	CD	NUMBER	)	dep	136	SENT_145	[p11l734t489r831b515],
104	331	CD	NUMBER	331	dep	136	SENT_145	[p11l953t489r1004b510],
105	(	NN	O	(	dep	136	SENT_145	[p11l1015t489r1111b515],
106	86-9	CD	PERCENT	86-9	dep	136	SENT_145	[p11l1015t489r1111b515],
107	%	NN	PERCENT	%	dep	136	SENT_145	[p11l1015t489r1111b515],
108	)	CD	NUMBER	)	dep	136	SENT_145	[p11l1015t489r1111b515],
109	172	CD	NUMBER	172	dep	136	SENT_145	[p11l1242t489r1291b510],
110	(	NN	O	(	dep	136	SENT_145	[p11l1302t489r1373b515],
111	86	CD	PERCENT	86	dep	136	SENT_145	[p11l1302t489r1373b515],
112	%	NN	PERCENT	%	dep	136	SENT_145	[p11l1302t489r1373b515],
113	)	CD	NUMBER	)	dep	136	SENT_145	[p11l1302t489r1373b515],
114	4	CD	NUMBER	4	dep	136	SENT_145	[p11l1559t489r1575b510],
115	(	NN	O	(	dep	136	SENT_145	[p11l1586t489r1683b515],
116	22-2	CD	PERCENT	22-2	dep	136	SENT_145	[p11l1586t489r1683b515],
117	%	NN	PERCENT	%	dep	136	SENT_145	[p11l1586t489r1683b515],
118	)	CD	NUMBER	)	dep	136	SENT_145	[p11l1586t489r1683b515],
119	155	CD	NUMBER	155	dep	136	SENT_145	[p11l1801t489r1850b510],
120	(	NN	O	(	dep	136	SENT_145	[p11l1862t489r1958b515],
121	928	CD	PERCENT	928	dep	136	SENT_145	[p11l1862t489r1958b515],
122	%	NN	PERCENT	%	dep	136	SENT_145	[p11l1862t489r1958b515],
123	)	CD	NUMBER	)	dep	136	SENT_145	[p11l1862t489r1958b515],
124	Table	NNP	O	Table	dep	136	SENT_145	[p11l87t535r165b559],
125	3	CD	NUMBER	3	dep	136	SENT_145	[p11l177t535r203b559],
126	:	:	O	:	_	0	SENT_145	[p11l177t535r203b559],
127	Distribution	NN	O	distribution	dep	136	SENT_145	[p11l218t535r388b559],
128	of	IN	O	of	dep	136	SENT_145	[p11l400t535r428b559],
129	combined	JJ	O	combined	dep	136	SENT_145	[p11l438t535r580b559],
130	and	CC	O	and	dep	136	SENT_145	[p11l592t535r644b559],
131	individual	JJ	O	individual	dep	136	SENT_145	[p11l657t535r794b559],
132	alleles	NNS	O	allele	dep	136	SENT_145	[p11l807t535r902b559],
133	of	IN	O	of	dep	136	SENT_145	[p11l914t535r942b559],
134	57-1	CD	NUMBER	57-1	dep	136	SENT_145	[p11l951t535r1021b559],
135	ancestral	JJ	O	ancestral	dep	136	SENT_145	[p11l1032t535r1169b559],
136	haplotype	NN	O	haplotype	_	0	SENT_145	[p11l1182t535r1325b564],

1	THE	DT	O	the	det	2	SENT_146	[p11l92t667r158b687],
2	LANCET	NN	O	lancet	_	0	SENT_146	[p11l167t667r297b688],
3	-	:	O	-	_	0	SENT_146	[p11l306t674r314b681],
4	Vol	NN	O	vol	dep	2	SENT_146	[p11l323t667r367b688],
5	359	CD	NUMBER	359	dep	4	SENT_146	[p11l377t668r422b688],
6	-	:	O	-	_	0	SENT_146	[p11l434t674r441b681],
7	March	NNP	DATE	March	dep	4	SENT_146	[p11l451t667r535b688],
8	2	CD	DATE	2	num	7	SENT_146	[p11l544t668r566b691],
9	,	,	DATE	,	_	0	SENT_146	[p11l544t668r566b691],
10	2002	CD	DATE	2002	num	7	SENT_146	[p11l577t668r639b688],
11	-	:	O	-	_	0	SENT_146	[p11l650t674r657b681],
12	wwW.the1ancet.com	NN	O	www.the1ancet.com	dep	7	SENT_146	[p11l667t667r917b688],
13	729	CD	NUMBER	729	num	14	SENT_146	[p11l2004t662r2062b688],
14	ARTICLES	NNS	O	article	dep	2	SENT_146	[p11l91t710r244b731],

1	DR7	NN	O	dr7	_	0	SENT_147	[p11l52t885r202b940],
2	/	:	O	/	punct	4	SENT_147	[p11l52t885r202b940],
3	C4A6	NN	O	c4a6	nn	4	SENT_147	[p11l249t884r394b930],
4	B57	NN	O	b57	dep	1	SENT_147	[p11l487t885r601b930],
5	DQ3	NN	O	dq3	dep	1	SENT_147	[p11l58t960r175b1014],

1	DR	NN	O	dr	_	0	SENT_148	[p11l767t885r845b929],
2	7	CD	NUMBER	7	dep	1	SENT_148	[p11l853t885r916b940],
3	/	:	O	/	punct	1	SENT_148	[p11l853t885r916b940],
4	C4A6	CD	NUMBER	c4a6	num	5	SENT_148	[p11l980t884r1124b930],
5	B5	NN	O	b5	dep	1	SENT_148	[p11l1202t885r1277b930],
6	7	CD	NUMBER	7	amod	7	SENT_148	[p11l1285t885r1316b929],
7	DQ3	NN	O	dq3	dep	5	SENT_148	[p11l772t960r889b1014],

1	DR	NN	O	dr	_	0	SENT_149	[p11l1575t885r1653b929],
2	7	CD	NUMBER	7	dep	1	SENT_149	[p11l1662t885r1725b940],
3	/	:	O	/	punct	1	SENT_149	[p11l1662t885r1725b940],
4	C4A6	CD	NUMBER	c4a6	num	5	SENT_149	[p11l1779t884r1924b930],
5	B5	NN	O	b5	dep	1	SENT_149	[p11l1984t885r2059b930],
6	7	CD	NUMBER	7	amod	7	SENT_149	[p11l2067t885r2098b929],
7	DQ3	NN	O	dq3	dep	5	SENT_149	[p11l1581t960r1698b1014],

1	H	NN	O	h	nn	3	SENT_150	[p12l136t3659r257b3703],
2	|	CD	NUMBER	|	num	3	SENT_150	[p12l136t3659r257b3703],
3	V	NN	O	v	dep	8	SENT_150	[p12l136t3659r257b3703],
4	—	CD	NUMBER	—	num	5	SENT_150	[p12l136t3659r257b3703],
5	controls	NNS	O	control	dep	3	SENT_150	[p12l277t3659r495b3703],
6	H	NN	O	h	dep	8	SENT_150	[p12l866t3659r990b3703],
7	|	CD	NUMBER	|	num	6	SENT_150	[p12l866t3659r990b3703],
8	V	NN	O	v	dep	26	SENT_150	[p12l866t3659r990b3703],
9	+	CC	O	+	_	0	SENT_150	[p12l866t3659r990b3703],
10	controls	NNS	O	control	dep	26	SENT_150	[p12l1013t3659r1230b3703],
11	H	NN	O	h	dep	8	SENT_150	[p12l1657t3656r1798b3708],
12	|	CD	NUMBER	|	number	13	SENT_150	[p12l1657t3656r1798b3708],
13	V	NN	O	v	dep	11	SENT_150	[p12l1657t3656r1798b3708],
14	+	CC	O	+	cc	13	SENT_150	[p12l1657t3656r1798b3708],
15	,	,	O	,	_	0	SENT_150	[p12l1657t3656r1798b3708],
16	abacavir	NN	O	abacavir	nn	18	SENT_150	[p12l1825t3656r2054b3701],
17	(	NN	O	(	nn	18	SENT_150	[p12l185t3746r443b3801],
18	n	NN	O	n	appos	11	SENT_150	[p12l185t3746r443b3801],
19	=	JJ	O	=	quantmod	21	SENT_150	[p12l185t3746r443b3801],
20	3212	CD	NUMBER	3212	number	21	SENT_150	[p12l185t3746r443b3801],
21	)	CD	NUMBER	)	num	23	SENT_150	[p12l185t3746r443b3801],
22	(	NN	O	(	nn	23	SENT_150	[p12l947t3746r1166b3801],
23	n	NN	O	n	dep	18	SENT_150	[p12l947t3746r1166b3801],
24	=	JJ	O	=	amod	26	SENT_150	[p12l947t3746r1166b3801],
25	381	CD	NUMBER	381	number	26	SENT_150	[p12l947t3746r1166b3801],
26	)	CD	NUMBER	)	_	0	SENT_150	[p12l947t3746r1166b3801],
27	exposed	VBN	O	expose	partmod	26	SENT_150	[p12l1643t3746r1869b3800],
28	cohort	NN	O	cohort	dobj	27	SENT_150	[p12l1893t3746r2065b3790],

1	(	NN	O	(	nn	2	SENT_151	[p13l1743t23r1962b79],
2	n	NN	O	n	_	0	SENT_151	[p13l1743t23r1962b79],
3	=	JJ	O	=	dep	2	SENT_151	[p13l1743t23r1962b79],
4	200	CD	NUMBER	200	num	5	SENT_151	[p13l1743t23r1962b79],
5	)	NN	O	)	dep	2	SENT_151	[p13l1743t23r1962b79],

1	DR7	NN	O	dr7	_	0	SENT_152	[p13l103t291r326b373],
2	/	:	O	/	punct	3	SENT_152	[p13l103t291r326b373],
3	C4A6	NN	O	c4a6	dep	1	SENT_152	[p13l394t290r610b358],
4	B57	NN	O	b57	nn	5	SENT_152	[p13l744t291r913b358],
5	DR7	NN	O	dr7	dep	3	SENT_152	[p13l1297t291r1521b373],
6	/	:	O	/	punct	3	SENT_152	[p13l1297t291r1521b373],
7	C4A6	NN	O	c4a6	nn	8	SENT_152	[p13l1577t290r1793b358],
8	B5	NN	O	b5	dep	3	SENT_152	[p13l1893t291r2004b358],
9	7	CD	NUMBER	7	amod	11	SENT_152	[p13l2017t291r2062b356],
10	DQ3	NN	O	dq3	nn	11	SENT_152	[p13l113t403r287b483],
11	DQ3	NN	O	dq3	dep	8	SENT_152	[p13l1306t403r1481b483],

1	HlV	NN	O	hlv	dep	13	SENT_153	[p14l207t2099r417b2177],
2	+	CC	O	+	rcmod	1	SENT_153	[p14l207t2099r417b2177],
3	,	,	O	,	_	0	SENT_153	[p14l207t2099r417b2177],
4	abacavir	NN	O	abacavir	nn	5	SENT_153	[p14l456t2099r797b2166],
5	HlV	NN	O	hlv	appos	1	SENT_153	[p14l1219t2103r1429b2181],
6	+	CC	O	+	rcmod	5	SENT_153	[p14l1219t2103r1429b2181],
7	,	,	O	,	_	0	SENT_153	[p14l1219t2103r1429b2181],
8	abacavir	NN	O	abacavir	nn	12	SENT_153	[p14l1468t2103r1809b2170],
9	tolerant	JJ	O	tolerant	amod	12	SENT_153	[p14l1837t2103r2153b2170],
10	hypersensitive	JJ	O	hypersensitive	amod	12	SENT_153	[p14l196t2228r774b2310],
11	(	NN	O	(	nn	12	SENT_153	[p14l1519t2227r1845b2309],
12	n	NN	O	n	appos	1	SENT_153	[p14l1519t2227r1845b2309],
13	=	JJ	O	=	_	0	SENT_153	[p14l1519t2227r1845b2309],
14	167	CD	NUMBER	167	num	15	SENT_153	[p14l1519t2227r1845b2309],
15	)	NN	O	)	dep	13	SENT_153	[p14l1519t2227r1845b2309],

1	(	NN	O	(	nn	2	SENT_154	[p14l363t2354r633b2437],
2	n	NN	O	n	_	0	SENT_154	[p14l363t2354r633b2437],
3	=	JJ	O	=	dep	2	SENT_154	[p14l363t2354r633b2437],
4	18	CD	NUMBER	18	num	5	SENT_154	[p14l363t2354r633b2437],
5	)	NN	O	)	dep	2	SENT_154	[p14l363t2354r633b2437],

1	Figure	NNP	O	Figure	_	0	SENT_155	[p14l96t2481r186b2513],
2	1	CD	NUMBER	1	num	1	SENT_155	[p14l200t2482r223b2506],
3	:	:	O	:	_	0	SENT_155	[p14l200t2482r223b2506],
4	Markers	NNS	O	marker	dep	1	SENT_155	[p14l236t2482r357b2506],
5	of	IN	O	of	_	0	SENT_155	[p14l368t2482r396b2506],
6	57-1	CD	NUMBER	57-1	num	8	SENT_155	[p14l406t2482r475b2506],
7	ancestral	JJ	O	ancestral	amod	8	SENT_155	[p14l486t2482r623b2506],
8	haplotype	NN	O	haplotype	prep_of	4	SENT_155	[p14l636t2482r779b2512],
9	in	IN	O	in	_	0	SENT_155	[p14l792t2482r815b2506],
10	the	DT	O	the	det	12	SENT_155	[p14l827t2482r875b2506],
11	abacavir-hypersensitive	JJ	O	abacavir-hypersensitive	amod	12	SENT_155	[p14l886t2482r1233b2512],
12	group	NN	O	group	prep_in	8	SENT_155	[p14l1244t2485r1336b2512],
13	,	,	O	,	_	0	SENT_155	[p14l1244t2485r1336b2512],
14	abacavir-tolerant	JJ	O	abacavir-tolerant	amod	15	SENT_155	[p14l1349t2482r1599b2506],
15	group	NN	O	group	prep_in	8	SENT_155	[p14l1609t2485r1701b2512],
16	,	,	O	,	_	0	SENT_155	[p14l1609t2485r1701b2512],
17	and	CC	O	and	_	0	SENT_155	[p14l1714t2482r1766b2506],
18	control	NN	O	control	nn	19	SENT_155	[p14l1778t2482r1880b2506],
19	populations	NNS	O	population	prep_in	8	SENT_155	[p14l1894t2482r2064b2511],
20	esence	NN	O	esence	nsubjpass	25	SENT_155	[p14l120t2527r210b2543],
21	of	IN	O	of	_	0	SENT_155	[p14l221t2522r246b2543],
22	indicated	VBN	O	indicate	amod	23	SENT_155	[p14l255t2522r368b2543],
23	markers	NNS	O	marker	prep_of	20	SENT_155	[p14l380t2522r481b2543],
24	is	VBZ	O	be	auxpass	25	SENT_155	[p14l493t2522r512b2543],
25	shown	VBN	O	show	rcmod	8	SENT_155	[p14l523t2522r601b2543],
26	by	IN	O	by	_	0	SENT_155	[p14l614t2522r640b2548],
27	shading	VBG	O	shade	agent	25	SENT_155	[p14l650t2522r755b2548],
28	.	.	O	.	_	0	SENT_155	[p14l650t2522r755b2548],

1	Vertical	JJ	O	vertical	amod	2	SENT_156	[p14l766t2522r858b2543],
2	axes	NNS	O	axis	nsubjpass	5	SENT_156	[p14l870t2527r928b2543],
3	have	VBP	O	have	aux	5	SENT_156	[p14l939t2522r996b2543],
4	been	VBN	O	be	auxpass	5	SENT_156	[p14l1008t2522r1068b2543],
5	sealed	VBN	O	seal	_	0	SENT_156	[p14l1079t2522r1160b2543],
6	for	IN	O	for	_	0	SENT_156	[p14l1170t2522r1204b2543],
7	all	DT	O	all	det	8	SENT_156	[p14l1214t2522r1240b2543],
8	groups	NNS	O	group	prep_for	5	SENT_156	[p14l1251t2525r1337b2548],
9	to	TO	O	to	aux	10	SENT_156	[p14l1346t2524r1371b2543],
10	show	VB	O	show	xcomp	5	SENT_156	[p14l1382t2522r1446b2543],
11	proportion	NN	O	proportion	dobj	10	SENT_156	[p14l1457t2522r1583b2548],
12	of	IN	O	of	_	0	SENT_156	[p14l1594t2522r1619b2543],
13	patients	NNS	O	patient	prep_of	11	SENT_156	[p14l1628t2522r1729b2548],
14	with	IN	O	with	_	0	SENT_156	[p14l1739t2522r1788b2543],
15	various	JJ	O	various	amod	16	SENT_156	[p14l1799t2522r1889b2543],
16	components	NNS	O	component	prep_with	10	SENT_156	[p14l1900t2523r2055b2548],
17	of	IN	O	of	_	0	SENT_156	[p14l8t2565r64b2612],
18	57-1	CD	NUMBER	57-1	num	20	SENT_156	[p14l84t2527r218b2612],
19	ancestral	JJ	O	ancestral	amod	20	SENT_156	[p14l243t2565r503b2612],
20	haplotypes	NNS	O	haplotype	prep_of	16	SENT_156	[p14l533t2565r857b2623],
21	.	.	O	.	_	0	SENT_156	[p14l533t2565r857b2623],

1	Mapping	NN	O	mapping	nsubj	64	SENT_157	[p14l9t2767r319b2841],
2	of	IN	O	of	_	0	SENT_157	[p14l343t2766r416b2826],
3	putative	JJ	O	putative	amod	5	SENT_157	[p14l433t2767r716b2839],
4	susceptibility	NN	O	susceptibility	nn	5	SENT_157	[p14l742t2767r1203b2839],
5	loci	NNS	O	locus	prep_of	1	SENT_157	[p14l1226t2767r1346b2826],
6	within	IN	O	within	_	0	SENT_157	[p14l1373t2767r1576b2825],
7	the	DT	O	the	det	8	SENT_157	[p14l1607t2767r1717b2825],
8	MHC	NN	O	mhc	prep_within	5	SENT_157	[p14l1746t2766r1917b2825],
9	Central	JJ	O	central	amod	11	SENT_157	[p14l11t2857r288b2918],
10	MHC	NN	O	mhc	nn	11	SENT_157	[p14l371t2857r592b2918],
11	markers	NNS	O	marker	dep	22	SENT_157	[p14l678t2857r973b2918],
12	characteristic	JJ	O	characteristic	amod	11	SENT_157	[p14l1059t2857r1553b2918],
13	of	IN	O	of	_	0	SENT_157	[p14l1638t2857r1717b2918],
14	the	DT	O	the	det	19	SENT_157	[p14l1790t2857r1903b2918],
15	57-1	CD	NUMBER	57-1	npadvmod	16	SENT_157	[p14l1990t2860r2143b2918],
16	ancestral	JJ	O	ancestral	amod	19	SENT_157	[p14l9t2950r337b3011],
17	haplotype	NN	O	haplotype	nn	19	SENT_157	[p14l365t2950r730b3026],
18	(	CD	NUMBER	(	num	19	SENT_157	[p14l765t2951r994b3026],
19	D6S1	NN	O	d6s1	prep_of	11	SENT_157	[p14l765t2951r994b3026],
20	014	CD	NUMBER	014	num	21	SENT_157	[p14l1007t2951r1343b3023],
21	*	NN	O	*	dep	22	SENT_157	[p14l1007t2951r1343b3023],
22	137	CD	NUMBER	137	dep	43	SENT_157	[p14l1007t2951r1343b3023],
23	,	,	O	,	_	0	SENT_157	[p14l1007t2951r1343b3023],
24	C4A6	NN	O	c4a6	appos	22	SENT_157	[p14l1379t2951r1608b3023],
25	,	,	O	,	_	0	SENT_157	[p14l1379t2951r1608b3023],
26	D6S273	NN	O	d6s273	appos	22	SENT_157	[p14l1641t2951r2146b3023],
27	*	CD	NUMBER	*	num	26	SENT_157	[p14l1641t2951r2146b3023],
28	]	CD	NUMBER	]	number	29	SENT_157	[p14l1641t2951r2146b3023],
29	35	CD	NUMBER	35	dep	26	SENT_157	[p14l1641t2951r2146b3023],
30	,	,	O	,	_	0	SENT_157	[p14l1641t2951r2146b3023],
31	TNFA	NN	O	tnfa	appos	22	SENT_157	[p14l16t3044r246b3103],
32	238A	NN	O	238a	nn	41	SENT_157	[p14l311t3044r526b3117],
33	,	,	O	,	_	0	SENT_157	[p14l311t3044r526b3117],
34	MICA	NNP	ORGANIZATION	MICA	dep	41	SENT_157	[p14l589t3044r1037b3117],
35	*	CD	NUMBER	*	num	41	SENT_157	[p14l589t3044r1037b3117],
36	I94	NN	O	i94	nn	41	SENT_157	[p14l589t3044r1037b3117],
37	,	,	O	,	_	0	SENT_157	[p14l589t3044r1037b3117],
38	MIB	NN	O	mib	dep	41	SENT_157	[p14l1100t3044r1491b3119],
39	*	NN	O	*	nn	41	SENT_157	[p14l1100t3044r1491b3119],
40	344	CD	NUMBER	344	num	41	SENT_157	[p14l1100t3044r1491b3119],
41	)	NN	O	)	nsubjpass	43	SENT_157	[p14l1100t3044r1491b3119],
42	were	VBD	O	be	auxpass	43	SENT_157	[p14l1557t3063r1730b3104],
43	examined	VBN	O	examine	dep	64	SENT_157	[p14l1794t3044r2152b3104],
44	to	TO	O	to	aux	45	SENT_157	[p14l7t3150r78b3197],
45	conﬁrm	VB	O	conﬁrm	ccomp	43	SENT_157	[p14l129t3136r418b3197],
46	the	DT	O	the	det	47	SENT_157	[p14l465t3136r579b3197],
47	presence	NN	O	presence	dobj	45	SENT_157	[p14l625t3156r950b3212],
48	of	IN	O	of	_	0	SENT_157	[p14l999t3136r1078b3197],
49	the	DT	O	the	det	50	SENT_157	[p14l1115t3136r1229b3197],
50	haplotype	NN	O	haplotype	prep_of	47	SENT_157	[p14l1275t3136r1641b3212],
51	and	CC	O	and	_	0	SENT_157	[p14l1690t3136r1826b3197],
52	to	TO	O	to	aux	53	SENT_157	[p14l1872t3150r1943b3197],
53	map	VB	O	map	ccomp	43	SENT_157	[p14l1991t3156r2150b3212],
54	the	DT	O	the	det	55	SENT_157	[p14l7t3229r121b3290],
55	extent	NN	O	extent	dobj	53	SENT_157	[p14l173t3244r400b3290],
56	of	IN	O	of	_	0	SENT_157	[p14l450t3229r529b3290],
57	the	DT	O	the	det	59	SENT_157	[p14l567t3229r681b3290],
58	non-recombinant	JJ	O	non-recombinant	amod	59	SENT_157	[p14l731t3229r1384b3290],
59	haplotype	NN	O	haplotype	prep_of	55	SENT_157	[p14l1430t3229r1796b3305],
60	in	IN	O	in	_	0	SENT_157	[p14l1846t3230r1916b3289],
61	cases	NNS	O	case	prep_in	59	SENT_157	[p14l1966t3249r2151b3290],
62	and	CC	O	and	_	0	SENT_157	[p14l9t3323r144b3383],
63	controls	NNS	O	control	conj_and	61	SENT_157	[p14l225t3323r522b3383],
64	(	VBP	O	(	_	0	SENT_157	[p14l609t3323r849b3399],
65	ﬁgure	NN	O	ﬁgure	nn	67	SENT_157	[p14l609t3323r849b3399],
66	2	CD	NUMBER	2	num	67	SENT_157	[p14l931t3323r1027b3398],
67	)	NN	O	)	dobj	64	SENT_157	[p14l931t3323r1027b3398],
68	.	.	O	.	_	0	SENT_157	[p14l931t3323r1027b3398],

1	Mapping	NN	O	mapping	nsubj	13	SENT_158	[p14l1112t3323r1452b3399],
2	of	IN	O	of	_	0	SENT_158	[p14l1531t3323r1610b3383],
3	recombinant	JJ	O	recombinant	amod	5	SENT_158	[p14l1679t3323r2153b3383],
4	57-1	CD	NUMBER	57-1	num	5	SENT_158	[p14l10t3418r163b3476],
5	haplotypes	NNS	O	haplotype	prep_of	1	SENT_158	[p14l243t3415r642b3491],
6	among	IN	O	among	_	0	SENT_158	[p14l717t3435r969b3491],
7	abacavir	NN	O	abacavir	prep_among	1	SENT_158	[p14l1040t3415r1348b3476],
8	hypersensitive	JJ	O	hypersensitive	amod	7	SENT_158	[p14l1417t3415r1943b3491],
9	and	CC	O	and	_	0	SENT_158	[p14l2018t3415r2152b3476],
10	abacavir	NN	O	abacavir	nn	12	SENT_158	[p14l9t3508r318b3569],
11	tolerant	JJ	O	tolerant	amod	12	SENT_158	[p14l359t3508r650b3569],
12	patients	NNS	O	patient	conj_and	7	SENT_158	[p14l693t3509r986b3584],
13	identiﬁed	VBD	O	identiﬁed	_	0	SENT_158	[p14l1032t3508r1386b3569],
14	a	DT	O	a	det	16	SENT_158	[p14l1432t3528r1468b3569],
15	candidate	NN	O	candidate	nn	16	SENT_158	[p14l1514t3508r1874b3569],
16	region	NN	O	region	dobj	13	SENT_158	[p14l1919t3509r2153b3584],
17	of	IN	O	of	dep	13	SENT_158	[p14l9t3602r88b3662],
18	about	IN	O	about	_	0	SENT_158	[p14l139t3602r349b3662],
19	300	CD	NUMBER	300	num	20	SENT_158	[p14l409t3604r544b3662],
20	Kb	NN	O	kb	prep_about	13	SENT_158	[p14l606t3602r717b3662],
21	telomeric	JJ	O	telomeric	amod	20	SENT_158	[p14l778t3602r1126b3662],
22	to	TO	O	to	_	0	SENT_158	[p14l1185t3616r1256b3662],
23	the	DT	O	the	det	25	SENT_158	[p14l1316t3602r1430b3662],
24	C4A6	NN	O	c4a6	nn	25	SENT_158	[p14l1492t3602r1703b3662],
25	allele	NN	O	allele	prep_to	21	SENT_158	[p14l1761t3602r1948b3662],
26	that	WDT	O	that	nsubj	28	SENT_158	[p14l2007t3602r2153b3662],
27	was	VBD	O	be	cop	28	SENT_158	[p15l6t43r141b84],
28	unique	JJ	O	unique	rcmod	25	SENT_158	[p15l195t23r452b99],
29	to	TO	O	to	_	0	SENT_158	[p15l505t37r576b84],
30	abacavir	NN	O	abacavir	nn	32	SENT_158	[p15l632t23r940b84],
31	hypersensitive	JJ	O	hypersensitive	amod	32	SENT_158	[p15l990t23r1517b99],
32	patients	NNS	O	patient	prep_to	28	SENT_158	[p15l1569t23r1861b99],
33	in	IN	O	in	_	0	SENT_158	[p15l1916t23r1986b83],
34	the	DT	O	the	det	35	SENT_158	[p15l2038t23r2151b84],
35	cohort	NN	O	cohort	prep_in	32	SENT_158	[p15l9t116r269b177],
36	.	.	O	.	_	0	SENT_158	[p15l9t116r269b177],

1	The	DT	O	the	det	3	SENT_159	[p15l338t116r489b177],
2	telomeric	JJ	O	telomeric	amod	3	SENT_159	[p15l554t116r902b177],
3	boundary	NN	O	boundary	nsubjpass	8	SENT_159	[p15l966t116r1325b192],
4	of	IN	O	of	_	0	SENT_159	[p15l1390t116r1468b177],
5	this	DT	O	this	det	6	SENT_159	[p15l1523t116r1653b177],
6	region	NN	O	region	prep_of	3	SENT_159	[p15l1720t117r1953b192],
7	was	VBD	O	be	auxpass	8	SENT_159	[p15l2016t136r2151b177],
8	marked	VBN	O	mark	_	0	SENT_159	[p15l7t210r287b270],
9	by	IN	O	by	_	0	SENT_159	[p15l342t210r431b286],
10	the	DT	O	the	det	14	SENT_159	[p15l485t210r599b270],
11	D6S273	NN	O	d6s273	nn	14	SENT_159	[p15l656t210r1142b270],
12	*	NN	O	*	nn	14	SENT_159	[p15l656t210r1142b270],
13	135	CD	NUMBER	135	num	14	SENT_159	[p15l656t210r1142b270],
14	microsatellite	NN	O	microsatellite	agent	8	SENT_159	[p15l1196t210r1697b270],
15	present	JJ	DATE	present	amod	14	SENT_159	[p15l1753t224r2027b286],
16	in	IN	O	in	_	0	SENT_159	[p15l2083t210r2152b269],
17	intron	NN	O	intron	prep_in	15	SENT_159	[p15l7t303r235b363],
18	1	CD	NUMBER	1	num	17	SENT_159	[p15l290t305r315b362],
19	of	IN	O	of	_	0	SENT_159	[p15l374t303r452b363],
20	megakaryocyte-enhanced	JJ	O	megakaryocyte-enhanced	amod	22	SENT_159	[p15l488t303r1432b379],
21	gene	NN	O	gene	nn	22	SENT_159	[p15l1479t323r1647b379],
22	transcript	NN	O	transcript	prep_of	17	SENT_159	[p15l1695t303r2053b379],
23	1	CD	NUMBER	1	number	24	SENT_159	[p15l2109t305r2134b362],
24	(	CD	NUMBER	(	num	26	SENT_159	[p15l13t395r580b470],
25	MEGT1/G6d	NN	O	megt1/g6d	nn	26	SENT_159	[p15l13t395r580b470],
26	)	NN	O	)	dep	14	SENT_159	[p15l13t395r580b470],
27	.	.	O	.	_	0	SENT_159	[p15l13t395r580b470],

1	Among	IN	O	among	_	0	SENT_160	[p15l638t396r912b471],
2	the	DT	O	the	det	4	SENT_160	[p15l964t395r1078b456],
3	14	CD	NUMBER	14	num	4	SENT_160	[p15l1141t398r1222b455],
4	patients	NNS	O	patient	prep_among	16	SENT_160	[p15l1276t395r1567b471],
5	with	IN	O	with	_	0	SENT_160	[p15l1621t395r1783b456],
6	abacavir	NN	O	abacavir	nn	7	SENT_160	[p15l1838t395r2145b456],
7	hypersensitivity	NN	O	hypersensitivity	prep_with	4	SENT_160	[p15l6t488r586b564],
8	and	CC	O	and	_	0	SENT_160	[p15l631t488r765b549],
9	the	DT	O	the	det	13	SENT_160	[p15l810t488r923b549],
10	HLA-B	NN	O	hla-b	nn	13	SENT_160	[p15l967t489r1471b549],
11	*	CD	NUMBER	*	num	13	SENT_160	[p15l967t489r1471b549],
12	570I	NN	O	570us	nn	13	SENT_160	[p15l967t489r1471b549],
13	allele	NN	O	allele	conj_and	7	SENT_160	[p15l1523t488r1733b561],
14	,	,	O	,	_	0	SENT_160	[p15l1523t488r1733b561],
15	we	PRP	O	we	nsubj	16	SENT_160	[p15l1779t508r1879b549],
16	found	VBD	O	find	_	0	SENT_160	[p15l1925t488r2143b549],
17	carriage	NN	O	carriage	nsubj	48	SENT_160	[p15l9t582r298b658],
18	of	IN	O	of	_	0	SENT_160	[p15l352t582r431b642],
19	all	DT	O	all	det	20	SENT_160	[p15l474t582r556b642],
20	markers	NNS	O	marker	prep_of	17	SENT_160	[p15l608t582r902b642],
21	between	IN	O	between	_	0	SENT_160	[p15l954t582r1262b642],
22	C4A6	NN	O	c4a6	prep_between	20	SENT_160	[p15l1316t582r1526b642],
23	and	CC	O	and	_	0	SENT_160	[p15l1576t582r1710b642],
24	HLA-Cw6	NN	O	hla-cw6	prep_between	20	SENT_160	[p15l1760t582r2146b642],
25	(	CD	NUMBER	(	num	26	SENT_160	[p15l13t674r123b749],
26	ie	NN	O	ie	dep	17	SENT_160	[p15l13t674r123b749],
27	,	,	O	,	_	0	SENT_160	[p15l13t674r123b749],
28	D6S273	NN	O	d6s273	nn	29	SENT_160	[p15l201t674r704b747],
29	*	NN	O	*	appos	17	SENT_160	[p15l201t674r704b747],
30	135	CD	NUMBER	135	dep	29	SENT_160	[p15l201t674r704b747],
31	,	,	O	,	_	0	SENT_160	[p15l201t674r704b747],
32	TNFA	NN	O	tnfa	appos	17	SENT_160	[p15l792t674r1022b734],
33	238/1	CD	NUMBER	238/1	num	32	SENT_160	[p15l1101t674r1314b747],
34	,	,	O	,	_	0	SENT_160	[p15l1101t674r1314b747],
35	MICA	NNP	ORGANIZATION	MICA	appos	17	SENT_160	[p15l1391t674r1838b747],
36	*	CD	NUMBER	*	num	35	SENT_160	[p15l1391t674r1838b747],
37	194	CD	NUMBER	194	dep	35	SENT_160	[p15l1391t674r1838b747],
38	,	,	O	,	_	0	SENT_160	[p15l1391t674r1838b747],
39	MIB	NNP	O	MIB	appos	17	SENT_160	[p15l1916t675r2136b734],
40	*	CD	NUMBER	*	number	41	SENT_160	[p15l1916t675r2136b734],
41	344	CD	NUMBER	344	dep	39	SENT_160	[p15l8t770r159b840],
42	,	,	O	,	_	0	SENT_160	[p15l8t770r159b840],
43	HLA-B	NN	O	hla-b	nn	46	SENT_160	[p15l252t768r817b843],
44	*	CD	NUMBER	*	num	46	SENT_160	[p15l252t768r817b843],
45	570I	NN	O	570us	nn	46	SENT_160	[p15l252t768r817b843],
46	)	NN	O	)	appos	17	SENT_160	[p15l252t768r817b843],
47	,	,	O	,	_	0	SENT_160	[p15l252t768r817b843],
48	consistent	JJ	O	consistent	xcomp	16	SENT_160	[p15l910t768r1282b828],
49	with	IN	O	with	_	0	SENT_160	[p15l1368t767r1530b828],
50	the	DT	O	the	det	51	SENT_160	[p15l1617t767r1731b828],
51	presence	NN	O	presence	prep_with	48	SENT_160	[p15l1819t787r2142b843],
52	of	IN	O	of	_	0	SENT_160	[p15l9t861r87b921],
53	non-recombinant	JJ	O	non-recombinant	amod	57	SENT_160	[p15l136t861r786b921],
54	57	CD	NUMBER	57	tmod	53	SENT_160	[p15l849t863r933b921],
55	-1	CD	NUMBER	-1	npadvmod	56	SENT_160	[p15l946t863r1001b920],
56	ancestral	JJ	O	ancestral	amod	57	SENT_160	[p15l1072t861r1398b921],
57	haplotype	NN	O	haplotype	prep_of	51	SENT_160	[p15l1458t861r1822b937],
58	in	IN	O	in	_	0	SENT_160	[p15l1882t861r1952b920],
59	this	DT	O	this	det	60	SENT_160	[p15l2011t861r2141b921],
60	region	NN	O	region	prep_in	16	SENT_160	[p15l7t953r259b1029],
61	.	.	O	.	_	0	SENT_160	[p15l7t953r259b1029],

1	Hence	RB	O	hence	advmod	12	SENT_161	[p15l326t954r588b1026],
2	,	,	O	,	_	0	SENT_161	[p15l326t954r588b1026],
3	presence	NN	O	presence	nsubj	12	SENT_161	[p15l650t973r973b1029],
4	of	IN	O	of	_	0	SENT_161	[p15l1036t953r1114b1014],
5	57-1	CD	NUMBER	57-1	num	8	SENT_161	[p15l1168t956r1320b1014],
6	ancestral	JJ	O	ancestral	amod	8	SENT_161	[p15l1392t953r1718b1014],
7	haplotype	NN	O	haplotype	nn	8	SENT_161	[p15l1778t953r2142b1029],
8	alleles	NNS	O	allele	prep_of	3	SENT_161	[p15l9t1046r229b1107],
9	in	IN	O	in	_	0	SENT_161	[p15l310t1047r379b1106],
10	a	DT	O	a	det	11	SENT_161	[p15l459t1066r494b1107],
11	region	NN	O	region	prep_in	8	SENT_161	[p15l573t1047r806b1122],
12	identiﬁed	VBN	O	identiﬁed	_	0	SENT_161	[p15l884t1046r1236b1107],
13	by	IN	O	by	_	0	SENT_161	[p15l1313t1046r1403b1122],
14	the	DT	O	the	det	15	SENT_161	[p15l1479t1046r1592b1107],
15	presence	NN	O	presence	prep_by	12	SENT_161	[p15l1671t1066r1994b1122],
16	of	IN	O	of	_	0	SENT_161	[p15l2075t1046r2153b1107],
17	C4A6	NN	O	c4a6	prep_of	15	SENT_161	[p15l9t1140r220b1200],
18	at	IN	O	at	_	0	SENT_161	[p15l291t1154r356b1200],
19	the	DT	O	the	det	21	SENT_161	[p15l428t1140r541b1200],
20	centromeric	JJ	O	centromeric	amod	21	SENT_161	[p15l617t1140r1060b1200],
21	boundary	NN	O	boundary	prep_at	17	SENT_161	[p15l1132t1140r1510b1216],
22	,	,	O	,	_	0	SENT_161	[p15l1132t1140r1510b1216],
23	and	CC	O	and	_	0	SENT_161	[p15l1588t1140r1723b1200],
24	telomeric	JJ	O	telomeric	conj_and	17	SENT_161	[p15l1795t1140r2142b1200],
25	of	IN	O	of	_	0	SENT_161	[p15l9t1232r87b1293],
26	HLA-Czv6	NN	O	hla-czv6	prep_of	24	SENT_161	[p15l176t1232r580b1305],
27	,	,	O	,	_	0	SENT_161	[p15l176t1232r580b1305],
28	provided	VBN	O	provide	partmod	15	SENT_161	[p15l682t1232r1011b1308],
29	sufﬁcient	JJ	O	sufﬁcient	amod	30	SENT_161	[p15l1113t1232r1453b1293],
30	conditions	NNS	O	condition	dobj	28	SENT_161	[p15l1553t1232r1939b1293],
31	for	IN	O	for	_	0	SENT_161	[p15l2040t1232r2145b1293],
32	abacavir	NN	O	abacavir	nn	34	SENT_161	[p15l9t1325r316b1386],
33	hypersensitivity	NN	O	hypersensitivity	nn	34	SENT_161	[p15l383t1325r963b1401],
34	susceptibility	NN	O	susceptibility	prep_for	28	SENT_161	[p15l1032t1325r1518b1401],
35	in	IN	O	in	_	0	SENT_161	[p15l1587t1326r1656b1385],
36	this	DT	O	this	det	39	SENT_161	[p15l1725t1325r1855b1386],
37	group	NN	O	group	nn	39	SENT_161	[p15l1927t1345r2141b1401],
38	(	CD	NUMBER	(	num	39	SENT_161	[p15l13t1419r252b1495],
39	ﬁgure	NN	O	ﬁgure	prep_in	34	SENT_161	[p15l13t1419r252b1495],
40	2	CD	NUMBER	2	num	41	SENT_161	[p15l283t1419r378b1494],
41	)	NN	O	)	dep	39	SENT_161	[p15l283t1419r378b1494],
42	.	.	O	.	_	0	SENT_161	[p15l283t1419r378b1494],

1	730	CD	NUMBER	730	_	0	SENT_162	[p15l93t1591r152b1617],
2	THE	DT	O	the	det	3	SENT_162	[p15l1238t1596r1305b1616],
3	LANCET	NN	O	lancet	dep	1	SENT_162	[p15l1314t1596r1443b1617],
4	-	:	O	-	_	0	SENT_162	[p15l1453t1603r1460b1610],
5	Vol	NN	O	vol	dep	1	SENT_162	[p15l1470t1596r1514b1617],
6	359	CD	NUMBER	359	num	5	SENT_162	[p15l1524t1597r1569b1617],
7	-	:	O	-	_	0	SENT_162	[p15l1580t1603r1588b1610],
8	March	NNP	DATE	March	dep	5	SENT_162	[p15l1598t1596r1681b1617],
9	2	CD	DATE	2	num	8	SENT_162	[p15l1691t1597r1713b1620],
10	,	,	DATE	,	_	0	SENT_162	[p15l1691t1597r1713b1620],
11	2002	CD	DATE	2002	num	8	SENT_162	[p15l1724t1597r1786b1617],
12	-	:	O	-	_	0	SENT_162	[p15l1796t1603r1804b1610],
13	www.the1ancet.com	CD	NUMBER	www.the1ancet.com	num	14	SENT_162	[p15l1813t1596r2064b1617],
14	ARTICLES	NNS	O	article	dep	8	SENT_162	[p15l1913t1639r2067b1660],

1	I	PRP	O	I	nsubj	2	SENT_163	[p15l110t1767r205b1792],
2	§	VBP	O	§	_	0	SENT_163	[p15l110t1767r205b1792],
3	I	PRP	O	I	nsubj	4	SENT_163	[p15l110t1767r205b1792],
4	§	VBP	O	§	ccomp	2	SENT_163	[p15l110t1767r205b1792],
5	I51E3E	NN	O	i51e3e	nn	8	SENT_163	[p15l110t1767r205b1792],
6	¢	CD	NUMBER	¢	num	8	SENT_163	[p15l110t1767r205b1792],
7	EIE	NNP	O	EIE	nn	8	SENT_163	[p15l110t1767r205b1792],
8	Marker	NNP	O	Marker	dobj	4	SENT_163	[p15l223t1769r310b1790],
9	present	JJ	DATE	present	amod	8	SENT_163	[p15l321t1770r415b1795],
10	but	CC	O	but	_	0	SENT_163	[p15l426t1769r465b1790],
11	explained	VBN	O	explain	amod	8	SENT_163	[p15l475t1769r593b1795],
12	by	IN	O	by	_	0	SENT_163	[p15l605t1769r631b1795],
13	non	JJ	O	non	amod	16	SENT_163	[p15l642t1769r754b1790],
14	—	NN	O	—	nn	16	SENT_163	[p15l642t1769r754b1790],
15	57-1	CD	NUMBER	57-1	num	16	SENT_163	[p15l642t1769r754b1790],
16	haplotype	NN	O	haplotype	prep_by	11	SENT_163	[p15l765t1769r885b1795],

1	D6S10l4	NN	O	d6s10l4	nn	4	SENT_164	[p15l677t1847r893b1871],
2	*	CD	NUMBER	*	num	4	SENT_164	[p15l677t1847r893b1871],
3	l37	NN	O	l37	nn	4	SENT_164	[p15l677t1847r893b1871],
4	D682	NN	O	d682	_	0	SENT_164	[p15l1047t1847r1125b1871],
5	73	CD	NUMBER	73	number	6	SENT_164	[p15l1129t1847r1242b1871],
6	*	CD	NUMBER	*	dep	4	SENT_164	[p15l1129t1847r1242b1871],
7	l35	NN	O	l35	nn	9	SENT_164	[p15l1129t1847r1242b1871],
8	MIB	NN	O	mib	nn	9	SENT_164	[p15l1461t1847r1592b1871],
9	*	NN	O	*	dep	6	SENT_164	[p15l1461t1847r1592b1871],
10	344	CD	NUMBER	344	dep	4	SENT_164	[p15l1461t1847r1592b1871],

1	l	NN	O	l	nn	4	SENT_165	[p15l746t1880r767b1985],
2	1	CD	NUMBER	1	num	4	SENT_165	[p15l1118t1880r1139b1985],
3	MICA	NN	ORGANIZATION	mica	nn	4	SENT_165	[p15l1325t1930r1395b1954],
4	*	NN	O	*	_	0	SENT_165	[p15l1400t1930r1413b1944],
5	194	CD	NUMBER	194	dep	4	SENT_165	[p15l1418t1930r1474b1954],
6	I	PRP	O	I	dep	4	SENT_165	[p15l1511t1880r1531b2018],

1	Chromosome	NN	O	chromosome	nn	4	SENT_166	[p15l100t1995r291b2019],
2	61321.3	CD	NUMBER	61321.3	num	4	SENT_166	[p15l304t1995r409b2024],
3	DQ3/DR7	NN	O	dq3/dr7	nn	4	SENT_166	[p15l524t1995r663b2024],
4	NOTCH4	NN	O	notch4	_	0	SENT_166	[p15l698t1996r813b2019],
5	C4A6	NN	O	c4a6	nn	12	SENT_166	[p15l837t1994r913b2018],
6	HSP	NN	O	hsp	nn	12	SENT_166	[p15l976t1995r1035b2018],
7	MEGTl	NN	O	megtl	nn	12	SENT_166	[p15l1074t1996r1175b2020],
8	TNF	NN	O	tnf	nn	12	SENT_166	[p15l1193t1996r1338b2019],
9	—	NN	O	—	nn	12	SENT_166	[p15l1193t1996r1338b2019],
10	238A	NN	O	238a	nn	12	SENT_166	[p15l1193t1996r1338b2019],
11	l	NN	O	l	nn	12	SENT_166	[p15l1379t1960r1400b2019],
12	B5	NN	O	b5	dep	4	SENT_166	[p15l1590t1996r1627b2019],
13	701	CD	NUMBER	701	num	14	SENT_166	[p15l1632t1995r1685b2019],
14	C6	NN	O	c6	dep	4	SENT_166	[p15l1728t1995r1766b2019],

1	I	PRP	O	I	_	0	SENT_167	[p15l943t2121r947b2133],

1	Abacavir	NNP	O	Abacavir	_	0	SENT_168	[p15l199t2158r320b2182],
2	hypersensitive	JJ	O	hypersensitive	amod	4	SENT_168	[p15l338t2158r543b2187],
3	(	NN	O	(	nn	4	SENT_168	[p15l200t2200r295b2229],
4	n	NN	O	n	dep	1	SENT_168	[p15l200t2200r295b2229],
5	=	JJ	O	=	amod	7	SENT_168	[p15l200t2200r295b2229],
6	14	CD	NUMBER	14	tmod	5	SENT_168	[p15l200t2200r295b2229],
7	)	NN	O	)	dep	4	SENT_168	[p15l200t2200r295b2229],

1	Centromere	NNP	O	Centromere	nn	2	SENT_169	[p15l100t2096r268b2120],
2	Temmere	NNP	O	Temmere	_	0	SENT_169	[p15l1842t2102r1972b2126],

1	Abacavir	NNP	O	Abacavir	nn	4	SENT_170	[p15l199t2658r321b2682],
2	tolerant	JJ	O	tolerant	amod	4	SENT_170	[p15l336t2658r449b2682],
3	(	NN	O	(	nn	4	SENT_170	[p15l200t2700r295b2730],
4	n	NN	O	n	_	0	SENT_170	[p15l200t2700r295b2730],
5	=	JJ	O	=	amod	4	SENT_170	[p15l200t2700r295b2730],
6	:	:	O	:	_	0	SENT_170	[p15l200t2700r295b2730],
7	l.	NN	O	l.	nn	9	SENT_170	[p15l200t2700r295b2730],
8	2	CD	NUMBER	2	num	9	SENT_170	[p15l200t2700r295b2730],
9	)	NN	O	)	dep	4	SENT_170	[p15l200t2700r295b2730],

1	I	PRP	O	I	_	0	SENT_171	[p15l943t2997r947b3009],
2	I	PRP	O	I	dep	1	SENT_171	[p15l943t3018r947b3029],
3	I	PRP	O	I	dep	2	SENT_171	[p15l1067t3017r1072b3030],
4	Possible	JJ	O	possible	amod	6	SENT_171	[p15l952t3040r1071b3063],
5	susceptibility	NN	O	susceptibility	nn	6	SENT_171	[p15l868t3085r1056b3115],
6	region	NN	O	region	dep	1	SENT_171	[p15l1068t3085r1153b3115],

1	Figure	NN	O	figure	_	0	SENT_172	[p15l90t3175r181b3207],
2	2	CD	NUMBER	2	num	1	SENT_172	[p15l192t3176r218b3200],
3	:	:	O	:	_	0	SENT_172	[p15l192t3176r218b3200],
4	Recombinant	JJ	O	recombinant	amod	5	SENT_172	[p15l232t3176r426b3200],
5	mapping	NN	O	mapping	dep	1	SENT_172	[p15l438t3176r564b3206],
6	of	IN	O	of	_	0	SENT_172	[p15l574t3176r602b3200],
7	abacavir	NN	O	abacavir	nn	9	SENT_172	[p15l612t3176r737b3200],
8	hypersensitivity	NN	O	hypersensitivity	nn	9	SENT_172	[p15l749t3176r981b3206],
9	region	NN	O	region	prep_of	5	SENT_172	[p15l993t3176r1083b3206],
10	in	IN	O	in	_	0	SENT_172	[p15l1096t3176r1119b3200],
11	all	DT	O	all	det	13	SENT_172	[p15l1132t3176r1164b3200],
12	abacavir-exposed	JJ	O	abacavir-exposed	amod	13	SENT_172	[p15l1177t3176r1433b3206],
13	patients	NNS	O	patient	prep_in	9	SENT_172	[p15l1446t3176r1566b3206],
14	with	IN	O	with	_	0	SENT_172	[p15l1578t3176r1640b3200],
15	HLA	NN	O	hlum	nn	16	SENT_172	[p15l1653t3176r1711b3200],
16	markers	NNS	O	marker	prep_with	13	SENT_172	[p15l1723t3176r1842b3200],
17	characteristic	JJ	O	characteristic	amod	5	SENT_172	[p15l1853t3176r2060b3200],
18	of	IN	O	of	_	0	SENT_172	[p15l88t3217r117b3241],
19	57-1	CD	NUMBER	57-1	num	21	SENT_172	[p15l127t3217r196b3241],
20	ancestral	JJ	O	ancestral	amod	21	SENT_172	[p15l207t3217r343b3241],
21	haplotype	NN	O	haplotype	prep_of	17	SENT_172	[p15l357t3217r500b3247],
22	For	IN	O	for	_	0	SENT_172	[p15l90t3257r127b3278],
23	each	DT	O	each	det	24	SENT_172	[p15l136t3257r195b3278],
24	individual	NN	O	individual	prep_for	30	SENT_172	[p15l208t3257r332b3281],
25	,	,	O	,	_	0	SENT_172	[p15l208t3257r332b3281],
26	presence	NN	O	presence	nsubjpass	30	SENT_172	[p15l345t3262r459b3283],
27	of	IN	O	of	_	0	SENT_172	[p15l470t3257r494b3278],
28	marker	NN	O	marker	prep_of	26	SENT_172	[p15l504t3257r591b3278],
29	is	VBZ	O	be	auxpass	30	SENT_172	[p15l601t3257r621b3278],
30	indicated	VBN	O	indicate	rcmod	21	SENT_172	[p15l632t3257r745b3278],
31	by	IN	O	by	_	0	SENT_172	[p15l757t3257r783b3283],
32	shading	VBG	O	shade	agent	30	SENT_172	[p15l793t3257r898b3283],
33	.	.	O	.	_	0	SENT_172	[p15l793t3257r898b3283],

1	Vertical	JJ	MISC	vertical	amod	2	SENT_173	[p15l909t3257r1001b3278],
2	axis	NN	O	axis	nsubj	4	SENT_173	[p15l1013t3257r1062b3278],
3	is	VBZ	O	be	cop	4	SENT_173	[p15l1074t3257r1093b3278],
4	proportionate	JJ	O	proportionate	_	0	SENT_173	[p15l1105t3257r1272b3283],
5	to	TO	O	to	_	0	SENT_173	[p15l1282t3258r1306b3278],
6	number	NN	O	number	prep_to	4	SENT_173	[p15l1317t3257r1412b3278],
7	of	IN	O	of	_	0	SENT_173	[p15l1422t3257r1446b3278],
8	patients	NNS	O	patient	prep_of	6	SENT_173	[p15l1456t3257r1564b3282],
9	.	.	O	.	_	0	SENT_173	[p15l1456t3257r1564b3282],

1	Extent	NN	O	extent	nsubj	14	SENT_174	[p15l1578t3257r1655b3278],
2	to	TO	O	to	_	0	SENT_174	[p15l1663t3258r1687b3278],
3	which	WDT	O	which	rel	6	SENT_174	[p15l1697t3257r1767b3278],
4	recombinant	JJ	O	recombinant	amod	5	SENT_174	[p15l1779t3257r1935b3278],
5	haplotype	NN	O	haplotype	nsubj	6	SENT_174	[p15l1946t3257r2066b3283],
6	extends	VBZ	O	extend	rcmod	1	SENT_174	[p15l89t3290r187b3311],
7	into	IN	O	into	_	0	SENT_174	[p15l199t3290r244b3311],
8	putative	JJ	O	putative	amod	9	SENT_174	[p15l256t3290r354b3315],
9	region	NN	O	region	prep_into	6	SENT_174	[p15l366t3290r440b3316],
10	in	IN	O	in	_	0	SENT_174	[p15l453t3290r472b3310],
11	abacavir-tolerant	JJ	O	abacavir-tolerant	amod	12	SENT_174	[p15l483t3290r693b3311],
12	patients	NNS	O	patient	prep_in	9	SENT_174	[p15l704t3290r804b3315],
13	is	VBZ	O	be	cop	14	SENT_174	[p15l816t3290r835b3311],
14	unknown	JJ	O	unknown	_	0	SENT_174	[p15l847t3290r956b3311],
15	and	CC	O	and	_	0	SENT_174	[p15l967t3290r1012b3311],
16	therefore	RB	O	therefore	advmod	17	SENT_174	[p15l1022t3290r1137b3311],
17	illustrated	VBD	O	illustrate	conj_and	14	SENT_174	[p15l1149t3290r1272b3311],
18	with	IN	O	with	_	0	SENT_174	[p15l1283t3290r1332b3311],
19	jagged	JJ	O	jagged	prep_with	17	SENT_174	[p15l1340t3290r1424b3316],
20	shading	VBG	O	shade	amod	19	SENT_174	[p15l1435t3290r1539b3316],
21	.	.	O	.	_	0	SENT_174	[p15l1435t3290r1539b3316],

1	Discussion	NN	O	discussion	_	0	SENT_175	[p15l10t3455r487b3523],
2	The	DT	O	the	det	4	SENT_175	[p15l7t3556r153b3616],
3	major	JJ	O	major	amod	4	SENT_175	[p15l219t3556r429b3631],
4	ﬁnding	NN	O	ﬁnding	dep	1	SENT_175	[p15l491t3556r746b3631],
5	in	IN	O	in	_	0	SENT_175	[p15l809t3556r878b3615],
6	this	DT	O	this	det	7	SENT_175	[p15l942t3556r1067b3616],
7	study	NN	O	study	prep_in	4	SENT_175	[p15l1134t3556r1329b3631],
8	of	IN	O	of	_	0	SENT_175	[p15l1393t3556r1470b3616],
9	200	CD	NUMBER	200	num	12	SENT_175	[p15l1527t3558r1658b3616],
10	consecutive	JJ	O	consecutive	amod	12	SENT_175	[p15l1727t3556r2142b3617],
11	abacavir-treated	JJ	O	abacavir-treated	amod	12	SENT_175	[p15l9t3649r587b3709],
12	individuals	NNS	O	individual	prep_of	7	SENT_175	[p15l613t3649r1002b3709],
13	in	IN	O	in	_	0	SENT_175	[p15l1030t3649r1098b3708],
14	the	DT	O	the	det	17	SENT_175	[p15l1124t3649r1234b3709],
15	Western	JJ	MISC	western	amod	17	SENT_175	[p15l1260t3650r1561b3709],
16	Australian	JJ	MISC	australian	amod	17	SENT_175	[p15l1585t3649r1957b3709],
17	HIV	NN	O	hiv	prep_in	12	SENT_175	[p15l1983t3650r2144b3709],

1	Cohort	NN	O	cohort	nsubj	2	SENT_176	[p16l10t23r268b84],
2	is	VBZ	O	be	dep	24	SENT_176	[p16l310t23r361b84],
3	that	IN	O	that	complm	18	SENT_176	[p16l405t23r546b84],
4	the	DT	O	the	det	5	SENT_176	[p16l589t23r699b84],
5	presence	NN	O	presence	nsubjpass	18	SENT_176	[p16l743t43r1055b99],
6	of	IN	O	of	_	0	SENT_176	[p16l1101t23r1178b84],
7	the	DT	O	the	det	10	SENT_176	[p16l1211t23r1321b84],
8	HLA-B	NN	O	hla-b	nn	10	SENT_176	[p16l1365t24r1882b96],
9	*	CD	NUMBER	*	num	10	SENT_176	[p16l1365t24r1882b96],
10	570I	NN	O	570us	prep_of	5	SENT_176	[p16l1365t24r1882b96],
11	,	,	O	,	_	0	SENT_176	[p16l1365t24r1882b96],
12	HLADR7	NN	O	hladr7	appos	10	SENT_176	[p16l1929t24r2144b83, p16l7t118r193b189],
13	,	,	O	,	_	0	SENT_176	[p16l1929t24r2144b83, p16l7t118r193b189],
14	HLA-DQ3	NN	O	hla-dq3	nn	15	SENT_176	[p16l255t117r645b192],
15	haplotype	NN	O	haplotype	appos	12	SENT_176	[p16l701t117r1053b192],
16	is	VBZ	O	be	auxpass	18	SENT_176	[p16l1112t117r1162b177],
17	strongly	RB	O	strongly	advmod	18	SENT_176	[p16l1224t117r1509b192],
18	associated	VBN	O	associate	ccomp	2	SENT_176	[p16l1568t117r1930b177],
19	with	IN	O	with	_	0	SENT_176	[p16l1986t117r2143b177],
20	susceptibility	NN	O	susceptibility	prep_with	18	SENT_176	[p16l9t210r477b286],
21	to	TO	O	to	_	0	SENT_176	[p16l522t224r590b270],
22	abacavir	NN	O	abacavir	nn	23	SENT_176	[p16l642t210r939b270],
23	hypersensitivity	NN	O	hypersensitivity	prep_to	18	SENT_176	[p16l984t210r1664b286],
24	—	VBD	O	—	_	0	SENT_176	[p16l984t210r1664b286],
25	a	DT	O	a	det	29	SENT_176	[p16l984t210r1664b286],
26	serious	JJ	O	serious	amod	29	SENT_176	[p16l1715t210r1960b270],
27	and	CC	O	and	cc	26	SENT_176	[p16l2011t210r2143b270],
28	potentially	RB	O	potentially	advmod	26	SENT_176	[p16l6t302r388b378],
29	life	NN	O	life	dobj	24	SENT_176	[p16l424t302r974b378],
30	—	CD	NUMBER	—	num	33	SENT_176	[p16l424t302r974b378],
31	threatening	JJ	O	threatening	amod	33	SENT_176	[p16l424t302r974b378],
32	clinical	JJ	O	clinical	amod	33	SENT_176	[p16l1012t302r1262b363],
33	syndrome	NN	O	syndrome	nsubj	24	SENT_176	[p16l1302t302r1654b378],
34	encountered	VBN	O	encounter	dep	24	SENT_176	[p16l1694t302r2143b363],
35	in	IN	O	in	dep	34	SENT_176	[p16l7t396r75b455],
36	about	IN	O	about	_	0	SENT_176	[p16l109t396r313b456],
37	5	CD	PERCENT	5	num	38	SENT_176	[p16l349t396r460b458],
38	%	NN	PERCENT	%	prep_about	34	SENT_176	[p16l349t396r460b458],
39	of	IN	O	of	_	0	SENT_176	[p16l499t395r576b456],
40	abacavir-treated	JJ	O	abacavir-treated	amod	41	SENT_176	[p16l601t396r1178b456],
41	patients	NNS	O	patient	prep_of	38	SENT_176	[p16l1210t396r1511b471],
42	.	.	O	.	_	0	SENT_176	[p16l1210t396r1511b471],

1	The	DT	O	the	det	2	SENT_177	[p16l1548t396r1696b456],
2	presence	NN	O	presence	nsubjpass	8	SENT_177	[p16l1728t415r2041b471],
3	of	IN	O	of	_	0	SENT_177	[p16l2076t395r2153b456],
4	this	DT	O	this	det	6	SENT_177	[p16l7t489r133b549],
5	allelic	JJ	O	allelic	amod	6	SENT_177	[p16l165t489r367b549],
6	combination	NN	O	combination	prep_of	2	SENT_177	[p16l398t489r852b549],
7	is	VBZ	O	be	auxpass	8	SENT_177	[p16l880t489r931b549],
8	associated	VBN	O	associate	_	0	SENT_177	[p16l963t489r1326b549],
9	with	IN	O	with	_	0	SENT_177	[p16l1353t489r1510b549],
10	greatly	RB	O	greatly	advmod	8	SENT_177	[p16l1538t489r1779b565],
11	increased	VBN	O	increase	amod	12	SENT_177	[p16l1806t489r2143b549],
12	risk	NN	O	risk	prep_with	8	SENT_177	[p16l7t581r135b642],
13	of	IN	O	of	_	0	SENT_177	[p16l162t581r239b642],
14	developing	VBG	O	develop	prepc_of	12	SENT_177	[p16l258t581r648b657],
15	the	DT	O	the	det	16	SENT_177	[p16l673t581r784b642],
16	syndrome	NN	O	syndrome	dobj	14	SENT_177	[p16l813t581r1187b657],
17	,	,	O	,	_	0	SENT_177	[p16l813t581r1187b657],
18	with	IN	O	with	_	0	SENT_177	[p16l1216t581r1373b642],
19	an	DT	O	a	det	21	SENT_177	[p16l1401t601r1485b642],
20	odds	NNS	O	odds	nn	21	SENT_177	[p16l1513t581r1682b642],
21	ratio	NN	O	ratio	prep_with	8	SENT_177	[p16l1710t581r1873b642],
22	similar	JJ	O	similar	amod	21	SENT_177	[p16l1903t581r2144b642],
23	to	TO	O	to	_	0	SENT_177	[p16l7t688r76b735],
24	that	DT	O	that	prep_to	22	SENT_177	[p16l128t675r269b735],
25	seen	VBN	O	see	partmod	24	SENT_177	[p16l320t694r476b735],
26	in	IN	O	in	_	0	SENT_177	[p16l526t675r595b734],
27	the	DT	O	the	det	28	SENT_177	[p16l645t675r755b735],
28	association	NN	O	association	prep_in	25	SENT_177	[p16l809t675r1200b735],
29	between	IN	O	between	_	0	SENT_177	[p16l1250t675r1550b735],
30	HLA-B27	NN	O	hla-b27	nn	33	SENT_177	[p16l1599t675r1965b735],
31	and	CC	O	and	_	0	SENT_177	[p16l2011t675r2143b735],
32	ankylosing	NN	O	ankylosing	conj_and	30	SENT_177	[p16l9t768r389b844],
33	spondylitis	NNS	O	spondylitis	prep_between	28	SENT_177	[p16l457t768r911b844],
34	.	.	O	.	_	0	SENT_177	[p16l457t768r911b844],

1	”	NN	O	”	nsubj	5	SENT_178	[p16l457t768r911b844],
2	These	DT	O	these	det	3	SENT_178	[p16l980t768r1199b828],
3	data	NNS	O	datum	dep	1	SENT_178	[p16l1270t768r1421b828],
4	might	MD	O	might	aux	5	SENT_178	[p16l1490t768r1699b844],
5	provide	VB	O	provide	_	0	SENT_178	[p16l1766t768r2036b844],
6	a	DT	O	a	det	8	SENT_178	[p16l2107t788r2142b828],
7	plausible	JJ	O	plausible	amod	8	SENT_178	[p16l6t860r324b936],
8	basis	NN	O	basis	dobj	5	SENT_178	[p16l376t860r548b921],
9	for	IN	O	for	_	0	SENT_178	[p16l601t860r703b921],
10	the	DT	O	the	det	12	SENT_178	[p16l753t860r863b921],
11	observed	VBN	O	observe	amod	12	SENT_178	[p16l917t860r1235b921],
12	differences	NNS	O	difference	conj_and	12	SENT_178	[p16l1289t860r1673b921],
13	in	IN	O	in	_	0	SENT_178	[p16l1726t860r1794b920],
14	abacavir	NN	O	abacavir	nn	15	SENT_178	[p16l1848t860r2145b921],
15	hypersensitivity	NN	O	hypersensitivity	prep_in	12	SENT_178	[p16l6t954r565b1029],
16	between	IN	O	between	_	0	SENT_178	[p16l607t954r906b1014],
17	ethnic	JJ	O	ethnic	amod	18	SENT_178	[p16l952t954r1170b1014],
18	groups	NNS	O	group	prep_between	15	SENT_178	[p16l1216t973r1479b1029],
19	,	,	O	,	_	0	SENT_178	[p16l1216t973r1479b1029],
20	and	CC	O	and	_	0	SENT_178	[p16l1529t954r1660b1014],
21	for	IN	O	for	_	0	SENT_178	[p16l1705t953r1806b1014],
22	cases	NNS	O	case	prep_for	12	SENT_178	[p16l1851t973r2028b1014],
23	of	IN	O	of	_	0	SENT_178	[p16l2076t953r2153b1014],
24	familial	JJ	O	familial	amod	25	SENT_178	[p16l7t1047r272b1107],
25	predisposition	NN	O	predisposition	prep_of	22	SENT_178	[p16l367t1047r895b1123],
26	.	.	O	.	_	0	SENT_178	[p16l367t1047r895b1123],

1	Although	IN	O	although	mark	3	SENT_179	[p16l994t1047r1333b1123],
2	we	PRP	O	we	nsubj	3	SENT_179	[p16l1426t1067r1525b1107],
3	noted	VBD	O	note	advcl	13	SENT_179	[p16l1621t1047r1826b1107],
4	ethnic	JJ	O	ethnic	amod	5	SENT_179	[p16l1924t1047r2142b1107],
5	differences	NNS	O	difference	dobj	3	SENT_179	[p16l9t1139r393b1200],
6	in	IN	O	in	_	0	SENT_179	[p16l448t1139r516b1199],
7	susceptibility	NN	O	susceptibility	prep_in	3	SENT_179	[p16l570t1139r1038b1215],
8	to	TO	O	to	_	0	SENT_179	[p16l1089t1154r1157b1200],
9	abacavir	NN	O	abacavir	nn	10	SENT_179	[p16l1215t1139r1512b1200],
10	hypersensitivity	NN	O	hypersensitivity	prep_to	3	SENT_179	[p16l1561t1139r2140b1215],
11	,	,	O	,	_	0	SENT_179	[p16l1561t1139r2140b1215],
12	there	EX	O	there	expl	13	SENT_179	[p16l7t1233r187b1293],
13	was	VBD	O	be	_	0	SENT_179	[p16l241t1252r373b1293],
14	no	DT	O	no	det	15	SENT_179	[p16l428t1252r518b1293],
15	evidence	NN	O	evidence	nsubj	13	SENT_179	[p16l575t1233r885b1293],
16	that	IN	O	that	complm	21	SENT_179	[p16l940t1233r1080b1293],
17	this	DT	O	this	det	20	SENT_179	[p16l1134t1233r1259b1293],
18	potential	JJ	O	potential	amod	20	SENT_179	[p16l1314t1233r1631b1308],
19	confounding	JJ	O	confounding	amod	20	SENT_179	[p16l1688t1232r2144b1308],
20	factor	NN	O	factor	nsubj	21	SENT_179	[p16l7t1326r216b1386],
21	accounted	VBD	O	account	ccomp	13	SENT_179	[p16l323t1326r692b1386],
22	for	IN	O	for	_	0	SENT_179	[p16l799t1326r901b1386],
23	our	PRP$	O	we	poss	24	SENT_179	[p16l1009t1346r1130b1386],
24	ﬁndings	NNS	O	ﬁndings	prep_for	21	SENT_179	[p16l1236t1326r1541b1402],
25	.	.	O	.	_	0	SENT_179	[p16l1236t1326r1541b1402],

1	Similarly	RB	O	similarly	advmod	12	SENT_180	[p16l1657t1326r1995b1402],
2	,	,	O	,	_	0	SENT_180	[p16l1657t1326r1995b1402],
3	a	DT	O	a	det	5	SENT_180	[p16l2107t1346r2142b1386],
4	comprehensive	JJ	O	comprehensive	amod	5	SENT_180	[p16l9t1418r546b1494],
5	assessment	NN	O	assessment	nsubj	12	SENT_180	[p16l583t1433r978b1479],
6	of	IN	O	of	_	0	SENT_180	[p16l1013t1418r1089b1479],
7	HIV-seronegative	JJ	O	hiv-seronegative	amod	11	SENT_180	[p16l1115t1418r1749b1494],
8	and	CC	O	and	_	0	SENT_180	[p16l1787t1418r1918b1479],
9	HIVinfected	JJ	O	hivinfected	amod	11	SENT_180	[p16l1953t1419r2142b1479, p16l7t1511r294b1572],
10	control	NN	O	control	nn	11	SENT_180	[p16l325t1512r579b1572],
11	populations	NNS	O	population	prep_of	5	SENT_180	[p16l608t1512r1030b1587],
12	provided	VBD	O	provide	conj_or	12	SENT_180	[p16l1061t1512r1380b1587],
13	evidence	NN	O	evidence	dobj	12	SENT_180	[p16l1411t1512r1721b1572],
14	against	IN	O	against	_	0	SENT_180	[p16l1753t1512r2003b1587],
15	the	DT	O	the	det	16	SENT_180	[p16l2032t1512r2142b1572],
16	possibility	NN	O	possibility	prep_against	12	SENT_180	[p16l6t1605r368b1681],
17	of	IN	O	of	_	0	SENT_180	[p16l409t1605r486b1665],
18	a	DT	O	a	det	20	SENT_180	[p16l518t1625r553b1665],
19	biased	VBN	O	bias	amod	20	SENT_180	[p16l593t1605r821b1665],
20	representation	NN	O	representation	prep_of	16	SENT_180	[p16l861t1605r1378b1681],
21	of	IN	O	of	_	0	SENT_180	[p16l1420t1605r1497b1665],
22	the	DT	O	the	det	23	SENT_180	[p16l1527t1605r1637b1665],
23	frequency	NN	O	frequency	prep_of	20	SENT_180	[p16l1679t1605r2035b1681],
24	of	IN	O	of	_	0	SENT_180	[p16l2076t1605r2153b1665],
25	HLA-B	NN	O	hla-b	prep_of	23	SENT_180	[p16l6t1698r523b1770],
26	*	CD	NUMBER	*	number	27	SENT_180	[p16l6t1698r523b1770],
27	5701	CD	NUMBER	5701	num	25	SENT_180	[p16l6t1698r523b1770],
28	,	,	O	,	_	0	SENT_180	[p16l6t1698r523b1770],
29	or	CC	O	or	_	0	SENT_180	[p16l569t1717r643b1758],
30	of	IN	O	of	_	0	SENT_180	[p16l685t1697r761b1758],
31	the	DT	O	the	det	34	SENT_180	[p16l792t1697r903b1758],
32	57-1	CD	NUMBER	57-1	npadvmod	33	SENT_180	[p16l949t1700r1096b1758],
33	ancestral	JJ	O	ancestral	amod	34	SENT_180	[p16l1148t1697r1463b1758],
34	haplotype	NN	O	haplotype	prep_of	12	SENT_180	[p16l1504t1697r1878b1773],
35	,	,	O	,	_	0	SENT_180	[p16l1504t1697r1878b1773],
36	in	IN	O	in	_	0	SENT_180	[p16l1923t1697r1991b1757],
37	the	DT	O	the	det	39	SENT_180	[p16l2032t1697r2142b1758],
38	abacavir-exposed	JJ	O	abacavir-exposed	amod	39	SENT_180	[p16l9t1791r627b1866],
39	cohort	NN	O	cohort	prep_in	12	SENT_180	[p16l654t1791r904b1851],
40	.	.	O	.	_	0	SENT_180	[p16l654t1791r904b1851],

1	Current	JJ	DATE	current	amod	3	SENT_181	[p16l95t1884r381b1944],
2	practice	NN	O	practice	nn	3	SENT_181	[p16l444t1884r727b1960],
3	guidelines	NNS	O	guideline	nsubj	12	SENT_181	[p16l793t1884r1152b1960],
4	for	IN	O	for	_	0	SENT_181	[p16l1219t1884r1320b1944],
5	the	DT	O	the	det	6	SENT_181	[p16l1383t1884r1493b1944],
6	prevention	NN	O	prevention	prep_for	3	SENT_181	[p16l1559t1884r1945b1960],
7	and	CC	O	and	_	0	SENT_181	[p16l2011t1884r2143b1944],
8	management	NN	O	management	prep_for	3	SENT_181	[p16l7t1990r474b2052],
9	of	IN	O	of	_	0	SENT_181	[p16l525t1976r602b2037],
10	abacavir	NN	O	abacavir	nn	11	SENT_181	[p16l643t1976r940b2037],
11	hypersensitivity	NN	O	hypersensitivity	prep_of	6	SENT_181	[p16l987t1976r1546b2052],
12	focus	NN	O	focus	_	0	SENT_181	[p16l1594t1976r1781b2037],
13	on	IN	O	on	_	0	SENT_181	[p16l1834t1996r1923b2037],
14	early	JJ	O	early	amod	15	SENT_181	[p16l1975t1976r2144b2052],
15	recognition	NN	O	recognition	prep_on	12	SENT_181	[p16l7t2070r415b2145],
16	of	IN	O	of	_	0	SENT_181	[p16l472t2069r548b2130],
17	suggestive	JJ	O	suggestive	amod	18	SENT_181	[p16l597t2070r956b2145],
18	symptoms	NNS	O	symptom	prep_of	15	SENT_181	[p16l1014t2083r1380b2145],
19	in	IN	O	in	_	0	SENT_181	[p16l1437t2070r1506b2129],
20	the	DT	O	the	det	22	SENT_181	[p16l1561t2070r1671b2130],
21	appropriate	JJ	O	appropriate	amod	22	SENT_181	[p16l1730t2070r2142b2145],
22	interval	NN	O	interval	prep_in	18	SENT_181	[p16l7t2163r275b2223],
23	after	IN	O	after	_	0	SENT_181	[p16l323t2163r484b2223],
24	initiation	NN	O	initiation	prep_after	22	SENT_181	[p16l529t2163r852b2223],
25	of	IN	O	of	_	0	SENT_181	[p16l900t2163r976b2223],
26	abacavir	NN	O	abacavir	nn	27	SENT_181	[p16l1014t2163r1311b2223],
27	therapy	NN	O	therapy	prep_of	24	SENT_181	[p16l1355t2163r1646b2239],
28	,	,	O	,	_	0	SENT_181	[p16l1355t2163r1646b2239],
29	and	CC	O	and	_	0	SENT_181	[p16l1697t2163r1828b2223],
30	prompt	JJ	O	prompt	amod	31	SENT_181	[p16l1874t2177r2143b2239],
31	cessation	NN	O	cessation	prep_after	22	SENT_181	[p16l9t2255r332b2316],
32	of	IN	O	of	_	0	SENT_181	[p16l387t2255r464b2316],
33	abacavir	NN	O	abacavir	prep_of	31	SENT_181	[p16l509t2255r806b2316],
34	after	IN	O	after	_	0	SENT_181	[p16l860t2255r1021b2316],
35	diagnosis	NN	O	diagnosis	prep_after	12	SENT_181	[p16l1074t2255r1422b2331],
36	.	.	O	.	_	0	SENT_181	[p16l1074t2255r1422b2331],

1	The	DT	O	the	det	6	SENT_182	[p16l1481t2255r1627b2316],
2	positive	JJ	O	positive	amod	6	SENT_182	[p16l1681t2255r1955b2331],
3	and	CC	O	and	_	0	SENT_182	[p16l2011t2255r2143b2316],
4	negative	JJ	O	negative	conj_and	2	SENT_182	[p16l7t2349r302b2424],
5	predictive	JJ	O	predictive	amod	6	SENT_182	[p16l343t2349r696b2424],
6	values	NNS	O	value	nsubj	7	SENT_182	[p16l737t2349r957b2409],
7	(	VBP	O	(	_	0	SENT_182	[p16l1007t2349r1240b2424],
8	100	CD	PERCENT	100	num	9	SENT_182	[p16l1007t2349r1240b2424],
9	%	NN	PERCENT	%	dobj	7	SENT_182	[p16l1007t2349r1240b2424],
10	and	CC	O	and	_	0	SENT_182	[p16l1288t2349r1420b2409],
11	97	CD	PERCENT	97	num	12	SENT_182	[p16l1465t2349r1648b2421],
12	%	NN	PERCENT	%	dobj	7	SENT_182	[p16l1465t2349r1648b2421],
13	,	,	O	,	_	0	SENT_182	[p16l1465t2349r1648b2421],
14	respectively	RB	O	respectively	advmod	7	SENT_182	[p16l1694t2349r2136b2424],
15	)	CD	NUMBER	)	nsubj	33	SENT_182	[p16l1694t2349r2136b2424],
16	associated	VBN	O	associate	partmod	15	SENT_182	[p16l9t2442r372b2502],
17	with	IN	O	with	_	0	SENT_182	[p16l452t2442r610b2502],
18	the	DT	O	the	det	19	SENT_182	[p16l690t2442r801b2502],
19	presence	NN	O	presence	prep_with	16	SENT_182	[p16l883t2462r1196b2518],
20	of	IN	O	of	_	0	SENT_182	[p16l1280t2442r1357b2502],
21	the	DT	O	the	det	24	SENT_182	[p16l1428t2442r1539b2502],
22	HLA-B	NN	O	hla-b	nn	24	SENT_182	[p16l1621t2442r2137b2515],
23	*	CD	NUMBER	*	num	24	SENT_182	[p16l1621t2442r2137b2515],
24	570I	NN	O	570us	prep_of	19	SENT_182	[p16l1621t2442r2137b2515],
25	,	,	O	,	_	0	SENT_182	[p16l1621t2442r2137b2515],
26	HLA-DR7	NN	O	hla-dr7	appos	24	SENT_182	[p16l7t2535r408b2607],
27	,	,	O	,	_	0	SENT_182	[p16l7t2535r408b2607],
28	HLA-DQ3	NN	O	hla-dq3	nn	29	SENT_182	[p16l447t2535r837b2610],
29	haplotype	NN	O	haplotype	appos	26	SENT_182	[p16l869t2534r1222b2610],
30	in	IN	O	in	_	0	SENT_182	[p16l1257t2534r1325b2594],
31	this	DT	O	this	det	32	SENT_182	[p16l1358t2534r1484b2595],
32	study	NN	O	study	prep_in	29	SENT_182	[p16l1522t2534r1715b2610],
33	support	VBP	O	support	ccomp	7	SENT_182	[p16l1750t2549r2025b2610],
34	an	DT	O	a	det	40	SENT_182	[p16l2060t2554r2144b2595],
35	important	JJ	O	important	amod	40	SENT_182	[p16l8t2628r367b2703],
36	and	CC	O	and	_	0	SENT_182	[p16l392t2628r523b2688],
37	immediately	RB	O	immediately	advmod	38	SENT_182	[p16l547t2628r992b2703],
38	applicable	JJ	O	applicable	amod	40	SENT_182	[p16l1015t2628r1376b2703],
39	clinical	JJ	O	clinical	amod	40	SENT_182	[p16l1401t2628r1652b2688],
40	role	NN	O	role	dobj	33	SENT_182	[p16l1675t2628r1810b2688],
41	for	IN	O	for	_	0	SENT_182	[p16l1835t2627r1936b2688],
42	HLA	NN	O	hlum	nn	43	SENT_182	[p16l1958t2629r2145b2687],
43	typing	NN	O	typing	prep_for	40	SENT_182	[p16l8t2721r234b2797],
44	in	IN	O	in	_	0	SENT_182	[p16l259t2721r327b2780],
45	this	DT	O	this	det	46	SENT_182	[p16l353t2721r479b2781],
46	setting	NN	O	setting	prep_in	43	SENT_182	[p16l510t2721r763b2797],
47	.	.	O	.	_	0	SENT_182	[p16l510t2721r763b2797],

1	However	RB	O	however	advmod	17	SENT_183	[p16l797t2722r1142b2794],
2	,	,	O	,	_	0	SENT_183	[p16l797t2722r1142b2794],
3	further	JJ	O	further	amod	4	SENT_183	[p16l1172t2721r1421b2781],
4	studies	NNS	O	study	nsubjpass	17	SENT_183	[p16l1448t2721r1693b2781],
5	in	IN	O	in	_	0	SENT_183	[p16l1722t2721r1790b2780],
6	abacavirexposed	JJ	O	abacavirexposed	amod	7	SENT_183	[p16l1818t2721r2143b2781, p16l10t2813r298b2889],
7	cohorts	NNS	O	cohort	prep_in	4	SENT_183	[p16l370t2813r632b2874],
8	from	IN	O	from	_	0	SENT_183	[p16l704t2813r876b2874],
9	a	DT	O	a	det	10	SENT_183	[p16l947t2833r983b2874],
10	range	NN	O	range	prep_from	7	SENT_183	[p16l1053t2833r1249b2889],
11	of	IN	O	of	_	0	SENT_183	[p16l1322t2813r1398b2874],
12	ethnic	JJ	O	ethnic	amod	15	SENT_183	[p16l1460t2813r1678b2874],
13	and	CC	O	and	_	0	SENT_183	[p16l1750t2813r1882b2874],
14	racial	JJ	O	racial	conj_and	12	SENT_183	[p16l1951t2813r2143b2874],
15	populations	NNS	O	population	prep_of	10	SENT_183	[p16l7t2907r429b2982],
16	are	VBP	O	be	auxpass	17	SENT_183	[p16l463t2926r568b2967],
17	required	VBN	O	require	_	0	SENT_183	[p16l599t2907r901b2982],
18	to	TO	O	to	aux	19	SENT_183	[p16l932t2921r1000b2967],
19	conﬁrm	VB	O	conﬁrm	xcomp	17	SENT_183	[p16l1035t2906r1314b2967],
20	these	DT	O	these	det	21	SENT_183	[p16l1344t2907r1526b2967],
21	ﬁndings	NNS	O	ﬁndings	dobj	19	SENT_183	[p16l1557t2906r1865b2982],
22	,	,	O	,	_	0	SENT_183	[p16l1557t2906r1865b2982],
23	so	RB	O	so	advmod	37	SENT_183	[p16l1899t2926r1972b2967],
24	that	IN	O	that	dep	37	SENT_183	[p16l2003t2907r2144b2967],
25	the	DT	O	the	det	27	SENT_183	[p16l8t3000r118b3060],
26	predictive	JJ	O	predictive	amod	27	SENT_183	[p16l217t3000r571b3076],
27	value	NN	O	value	nsubjpass	37	SENT_183	[p16l670t3000r857b3060],
28	of	IN	O	of	_	0	SENT_183	[p16l960t3000r1036b3060],
29	genetic	JJ	O	genetic	amod	30	SENT_183	[p16l1126t3000r1380b3076],
30	testing	NN	O	testing	prep_of	27	SENT_183	[p16l1480t3000r1719b3076],
31	for	IN	O	for	_	0	SENT_183	[p16l1817t3000r1919b3060],
32	this	DT	O	this	det	34	SENT_183	[p16l2016t3000r2142b3060],
33	hypersensitivity	NN	O	hypersensitivity	nn	34	SENT_183	[p16l7t3092r566b3168],
34	syndrome	NN	O	syndrome	prep_for	30	SENT_183	[p16l673t3092r1025b3168],
35	can	MD	O	can	aux	37	SENT_183	[p16l1134t3112r1258b3153],
36	be	VB	O	be	auxpass	37	SENT_183	[p16l1363t3092r1447b3153],
37	examined	VBN	O	examine	advcl	17	SENT_183	[p16l1556t3092r1903b3153],
38	and	CC	O	and	_	0	SENT_183	[p16l2012t3092r2143b3153],
39	generalised	VBN	O	generalise	advcl	17	SENT_183	[p16l8t3186r409b3261],
40	as	IN	O	as	_	0	SENT_183	[p16l461t3205r528b3246],
41	appropriate	JJ	O	appropriate	prep_as	37	SENT_183	[p16l581t3186r1012b3261],
42	.	.	O	.	_	0	SENT_183	[p16l581t3186r1012b3261],

1	Such	JJ	O	such	amod	3	SENT_184	[p16l1071t3186r1249b3246],
2	transracial	JJ	O	transracial	amod	3	SENT_184	[p16l1298t3186r1670b3246],
3	studies	NNS	O	study	nsubj	7	SENT_184	[p16l1722t3186r1966b3246],
4	will	MD	O	will	aux	7	SENT_184	[p16l2017t3186r2143b3246],
5	also	RB	O	also	advmod	7	SENT_184	[p16l10t3279r144b3339],
6	be	VB	O	be	cop	7	SENT_184	[p16l173t3279r256b3339],
7	essential	JJ	O	essential	_	0	SENT_184	[p16l287t3279r587b3339],
8	to	TO	O	to	_	0	SENT_184	[p16l616t3293r684b3339],
9	the	DT	O	the	det	10	SENT_184	[p16l714t3279r824b3339],
10	characterisation	NN	O	characterisation	prep_to	7	SENT_184	[p16l856t3279r1423b3339],
11	of	IN	O	of	_	0	SENT_184	[p16l1453t3279r1530b3339],
12	the	DT	O	the	det	14	SENT_184	[p16l1547t3279r1658b3339],
13	polymorphic	JJ	O	polymorphic	amod	14	SENT_184	[p16l1686t3279r2143b3355],
14	locus	NN	O	locus	prep_of	10	SENT_184	[p16l8t3371r192b3432],
15	or	CC	O	or	_	0	SENT_184	[p16l258t3391r332b3431],
16	loci	NNS	O	locus	prep_to	7	SENT_184	[p16l393t3371r519b3432],
17	that	WDT	O	that	nsubj	19	SENT_184	[p16l582t3371r722b3432],
18	are	VBP	O	be	cop	19	SENT_184	[p16l786t3391r891b3431],
19	common	JJ	O	common	rcmod	16	SENT_184	[p16l956t3391r1276b3431],
20	to	TO	O	to	_	0	SENT_184	[p16l1338t3385r1406b3431],
21	cases	NNS	O	case	prep_to	19	SENT_184	[p16l1473t3391r1651b3432],
22	of	IN	O	of	_	0	SENT_184	[p16l1717t3371r1794b3431],
23	abacavir	NN	O	abacavir	nn	24	SENT_184	[p16l1848t3371r2145b3432],
24	hypersensitivity	NN	O	hypersensitivity	prep_of	21	SENT_184	[p17l7t23r583b98],
25	.	.	O	.	_	0	SENT_184	[p17l7t23r583b98],

1	On	IN	O	on	_	0	SENT_185	[p17l95t116r206b176],
2	the	DT	O	the	det	3	SENT_185	[p17l250t116r360b176],
3	basis	NN	O	basis	prep_on	11	SENT_185	[p17l403t116r575b176],
4	of	IN	O	of	_	0	SENT_185	[p17l623t116r700b176],
5	these	DT	O	these	det	6	SENT_185	[p17l732t116r915b176],
6	data	NNS	O	datum	prep_of	3	SENT_185	[p17l961t116r1133b189],
7	,	,	O	,	_	0	SENT_185	[p17l961t116r1133b189],
8	our	PRP$	O	we	poss	10	SENT_185	[p17l1182t136r1304b176],
9	current	JJ	DATE	current	amod	10	SENT_185	[p17l1347t129r1608b176],
10	practice	NN	O	practice	nsubj	11	SENT_185	[p17l1650t116r1932b192],
11	is	VBZ	O	be	_	0	SENT_185	[p17l1977t116r2028b176],
12	to	TO	O	to	aux	13	SENT_185	[p17l2073t130r2142b176],
13	withhold	VB	O	withhold	xcomp	11	SENT_185	[p17l7t208r325b269],
14	abacavir	NN	O	abacavir	dobj	13	SENT_185	[p17l352t208r649b269],
15	in	IN	O	in	_	0	SENT_185	[p17l671t208r740b268],
16	patients	NNS	O	patient	prep_in	13	SENT_185	[p17l763t208r1044b284],
17	with	IN	O	with	_	0	SENT_185	[p17l1069t208r1226b269],
18	the	DT	O	the	det	19	SENT_185	[p17l1250t208r1360b269],
19	HLA-B	NN	O	hla-b	prep_with	16	SENT_185	[p17l1384t208r1901b281],
20	*	CD	NUMBER	*	number	21	SENT_185	[p17l1384t208r1901b281],
21	5701	CD	NUMBER	5701	num	19	SENT_185	[p17l1384t208r1901b281],
22	,	,	O	,	_	0	SENT_185	[p17l1384t208r1901b281],
23	HLADR7	NN	O	hladr7	appos	16	SENT_185	[p17l1930t209r2145b268, p17l7t303r193b374],
24	,	,	O	,	_	0	SENT_185	[p17l1930t209r2145b268, p17l7t303r193b374],
25	HLA-DQ3	NN	O	hla-dq3	nn	26	SENT_185	[p17l250t302r640b377],
26	haplotype	NN	O	haplotype	appos	23	SENT_185	[p17l690t302r1062b377],
27	.	.	O	.	_	0	SENT_185	[p17l690t302r1062b377],

1	However	RB	O	however	advmod	27	SENT_186	[p17l1121t303r1466b374],
2	,	,	O	,	_	0	SENT_186	[p17l1121t303r1466b374],
3	in	IN	O	in	_	0	SENT_186	[p17l1522t302r1590b361],
4	four	CD	NUMBER	four	num	5	SENT_186	[p17l1641t301r1791b362],
5	cases	NNS	O	case	prep_in	27	SENT_186	[p17l1843t321r2021b362],
6	of	IN	O	of	_	0	SENT_186	[p17l2077t301r2153b362],
7	abacavir	NN	O	abacavir	nn	8	SENT_186	[p17l10t395r307b455],
8	hypersensitivity	NN	O	hypersensitivity	prep_of	5	SENT_186	[p17l337t395r896b471],
9	(	CD	NUMBER	(	num	8	SENT_186	[p17l934t395r1039b470],
10	ie	FW	O	ie	nsubjpass	27	SENT_186	[p17l934t395r1039b470],
11	,	,	O	,	_	0	SENT_186	[p17l934t395r1039b470],
12	2	CD	PERCENT	2	num	13	SENT_186	[p17l1079t395r1191b457],
13	%	NN	PERCENT	%	dep	19	SENT_186	[p17l1079t395r1191b457],
14	of	IN	O	of	_	0	SENT_186	[p17l1231t395r1308b455],
15	the	DT	O	the	det	16	SENT_186	[p17l1331t395r1441b455],
16	cohort	NN	O	cohort	prep_of	13	SENT_186	[p17l1478t395r1734b470],
17	)	CD	NUMBER	)	dep	19	SENT_186	[p17l1478t395r1734b470],
18	no	DT	O	no	det	19	SENT_186	[p17l1774t415r1863b455],
19	part	NN	O	part	dep	10	SENT_186	[p17l1898t409r2042b471],
20	of	IN	O	of	_	0	SENT_186	[p17l2077t395r2153b455],
21	this	DT	O	this	det	24	SENT_186	[p17l8t487r133b548],
22	putative	JJ	O	putative	amod	24	SENT_186	[p17l176t487r465b563],
23	susceptibility	NN	O	susceptibility	nn	24	SENT_186	[p17l509t487r977b563],
24	haplotype	NN	O	haplotype	prep_of	19	SENT_186	[p17l1016t487r1369b563],
25	could	MD	O	could	aux	27	SENT_186	[p17l1414t487r1612b548],
26	be	VB	O	be	auxpass	27	SENT_186	[p17l1653t487r1737b548],
27	identiﬁed	VBN	O	identiﬁed	_	0	SENT_186	[p17l1780t487r2138b548],
28	.	.	O	.	_	0	SENT_186	[p17l1780t487r2138b548],

1	Two	CD	NUMBER	two	nsubj	5	SENT_187	[p17l7t582r174b641],
2	of	IN	O	of	_	0	SENT_187	[p17l205t580r281b641],
3	these	DT	O	these	det	4	SENT_187	[p17l299t581r481b641],
4	cases	NNS	O	case	prep_of	1	SENT_187	[p17l511t600r689b641],
5	had	VBD	O	have	_	0	SENT_187	[p17l717t581r850b641],
6	concurrent	JJ	O	concurrent	amod	7	SENT_187	[p17l879t594r1272b641],
7	exposure	NN	O	exposure	dobj	5	SENT_187	[p17l1301t600r1619b656],
8	to	TO	O	to	_	0	SENT_187	[p17l1647t595r1716b641],
9	nevirapine	NN	O	nevirapine	prep_to	7	SENT_187	[p17l1745t581r2138b656],
10	.	.	O	.	_	0	SENT_187	[p17l1745t581r2138b656],

1	In	IN	O	in	_	0	SENT_188	[p17l8t675r85b733],
2	this	DT	O	this	det	3	SENT_188	[p17l133t674r258b734],
3	context	NN	O	context	prep_in	13	SENT_188	[p17l311t687r596b747],
4	,	,	O	,	_	0	SENT_188	[p17l311t687r596b747],
5	HLA	NN	O	hlum	nn	6	SENT_188	[p17l649t675r836b733],
6	typing	NN	O	typing	nsubjpass	13	SENT_188	[p17l883t674r1109b750],
7	at	IN	O	at	_	0	SENT_188	[p17l1158t687r1222b734],
8	these	DT	O	these	det	9	SENT_188	[p17l1270t674r1452b734],
9	alleles	NNS	O	allele	prep_at	6	SENT_188	[p17l1503t674r1715b734],
10	can	MD	O	can	aux	13	SENT_188	[p17l1768t687r2012b734],
11	not	RB	O	not	neg	13	SENT_188	[p17l1768t687r2012b734],
12	be	VB	O	be	auxpass	13	SENT_188	[p17l2059t674r2143b734],
13	regarded	VBN	O	regard	_	0	SENT_188	[p17l8t766r323b842],
14	a	DT	O	a	det	16	SENT_188	[p17l372t786r408b827],
15	screening	JJ	O	screening	amod	16	SENT_188	[p17l457t766r796b842],
16	test	NN	O	test	dobj	13	SENT_188	[p17l842t781r987b839],
17	,	,	O	,	_	0	SENT_188	[p17l842t781r987b839],
18	and	CC	O	and	_	0	SENT_188	[p17l1040t766r1171b827],
19	current	JJ	DATE	current	amod	21	SENT_188	[p17l1220t781r1481b827],
20	clinical	JJ	O	clinical	amod	21	SENT_188	[p17l1529t766r1780b827],
21	practices	NNS	O	practice	nsubj	23	SENT_188	[p17l1827t766r2142b842],
22	should	MD	O	should	aux	23	SENT_188	[p17l9t860r248b920],
23	continue	VB	O	continue	conj_and	13	SENT_188	[p17l284t860r597b920],
24	to	TO	O	to	aux	25	SENT_188	[p17l631t873r700b920],
25	underpin	VB	O	underpin	xcomp	23	SENT_188	[p17l736t860r1065b935],
26	the	DT	O	the	det	27	SENT_188	[p17l1098t860r1209b920],
27	management	NN	O	management	dobj	25	SENT_188	[p17l1244t874r1711b935],
28	of	IN	O	of	_	0	SENT_188	[p17l1746t859r1823b920],
29	abacavir	NN	O	abacavir	nn	30	SENT_188	[p17l1848t860r2145b920],
30	hypersensitivity	NN	O	hypersensitivity	prep_of	27	SENT_188	[p17l7t953r583b1029],
31	.	.	O	.	_	0	SENT_188	[p17l7t953r583b1029],

1	These	DT	O	these	det	2	SENT_189	[p17l92t1045r311b1106],
2	ﬁndings	NNS	O	ﬁndings	nsubj	4	SENT_189	[p17l368t1045r652b1121],
3	are	VBP	O	be	cop	4	SENT_189	[p17l711t1065r816b1106],
4	consistent	JJ	O	consistent	_	0	SENT_189	[p17l875t1045r1234b1106],
5	with	IN	O	with	_	0	SENT_189	[p17l1287t1045r1445b1106],
6	a	DT	O	a	det	8	SENT_189	[p17l1501t1065r1536b1106],
7	direct	JJ	O	direct	amod	8	SENT_189	[p17l1595t1045r1798b1106],
8	role	NN	O	role	prep_with	4	SENT_189	[p17l1853t1045r1987b1106],
9	for	IN	O	for	_	0	SENT_189	[p17l2044t1045r2145b1106],
10	MHC-speciﬁc	JJ	O	mhc-speciﬁc	amod	11	SENT_189	[p17l8t1138r524b1214],
11	alleles	NNS	O	allele	prep_for	8	SENT_189	[p17l594t1139r806b1199],
12	in	IN	O	in	_	0	SENT_189	[p17l874t1139r942b1198],
13	the	DT	O	the	det	14	SENT_189	[p17l1007t1139r1118b1199],
14	pathogenesis	NN	O	pathogenesis	prep_in	4	SENT_189	[p17l1184t1139r1644b1214],
15	of	IN	O	of	_	0	SENT_189	[p17l1714t1138r1790b1199],
16	abacavir	NN	O	abacavir	nn	17	SENT_189	[p17l1848t1139r2145b1199],
17	hypersensitivity	NN	O	hypersensitivity	prep_of	14	SENT_189	[p17l7t1232r583b1308],
18	.	.	O	.	_	0	SENT_189	[p17l7t1232r583b1308],

1	The	DT	O	the	det	3	SENT_190	[p17l616t1232r763b1292],
2	susceptibility	NN	O	susceptibility	nn	3	SENT_190	[p17l794t1232r1262b1308],
3	locus	NN	O	locus	nsubj	20	SENT_190	[p17l1289t1232r1472b1292],
4	or	CC	O	or	_	0	SENT_190	[p17l1504t1252r1578b1292],
5	loci	NNS	O	locus	nsubj	20	SENT_190	[p17l1605t1232r1731b1292],
6	marked	VBN	O	mark	partmod	5	SENT_190	[p17l1760t1232r2031b1292],
7	by	IN	O	by	_	0	SENT_190	[p17l2058t1232r2145b1308],
8	the	DT	O	the	det	9	SENT_190	[p17l8t1324r118b1385],
9	presence	NN	O	presence	agent	6	SENT_190	[p17l183t1344r496b1400],
10	of	IN	O	of	_	0	SENT_190	[p17l565t1324r641b1385],
11	HLA-B	NN	O	hla-b	prep_of	9	SENT_190	[p17l696t1325r1213b1397],
12	*	CD	NUMBER	*	number	13	SENT_190	[p17l696t1325r1213b1397],
13	5701	CD	NUMBER	5701	dobj	6	SENT_190	[p17l696t1325r1213b1397],
14	,	,	O	,	_	0	SENT_190	[p17l696t1325r1213b1397],
15	HLA-DR7	NN	O	hla-dr7	appos	13	SENT_190	[p17l1282t1324r1684b1397],
16	,	,	O	,	_	0	SENT_190	[p17l1282t1324r1684b1397],
17	HLA-DQ3	NN	O	hla-dq3	appos	15	SENT_190	[p17l1754t1325r2144b1400],
18	could	MD	O	could	aux	20	SENT_190	[p17l10t1418r208b1478],
19	feasibly	RB	O	feasibly	advmod	20	SENT_190	[p17l280t1417r548b1493],
20	participate	VB	O	participate	_	0	SENT_190	[p17l617t1418r998b1493],
21	directly	RB	O	directly	advmod	20	SENT_190	[p17l1072t1418r1339b1493],
22	in	IN	O	in	_	0	SENT_190	[p17l1409t1418r1478b1477],
23	abacavir-speciﬁc	NN	O	abacavir-speciﬁc	nn	25	SENT_190	[p17l1551t1417r2143b1493],
24	antigen	NN	O	antigen	nn	25	SENT_190	[p17l10t1511r272b1587],
25	recognition	NN	O	recognition	prep_in	20	SENT_190	[p17l297t1511r703b1587],
26	by	IN	O	by	_	0	SENT_190	[p17l727t1511r814b1587],
27	the	DT	O	the	det	28	SENT_190	[p17l836t1511r947b1571],
28	immune	JJ	O	immune	prep_by	20	SENT_190	[p17l972t1511r1271b1571],
29	system	NN	O	system	nn	31	SENT_190	[p17l1298t1524r1539b1587],
30	(	CD	NUMBER	(	num	31	SENT_190	[p17l1570t1511r1675b1586],
31	ie	NN	O	ie	tmod	28	SENT_190	[p17l1570t1511r1675b1586],
32	,	,	O	,	_	0	SENT_190	[p17l1570t1511r1675b1586],
33	oz/B	NN	O	oz/b	conj_or	31	SENT_190	[p17l1704t1511r1823b1588],
34	or	CC	O	or	_	0	SENT_190	[p17l1853t1531r1927b1571],
35	‘	NN	O	‘	nn	38	SENT_190	[p17l1949t1511r2056b1588],
36	y/8	NN	O	y/8	nn	38	SENT_190	[p17l1949t1511r2056b1588],
37	T	NN	O	t	nn	38	SENT_190	[p17l2082t1512r2144b1570],
38	cells	NNS	O	cell	conj_or	31	SENT_190	[p17l10t1603r212b1678],
39	)	CD	NUMBER	)	num	28	SENT_190	[p17l10t1603r212b1678],
40	.	.	O	.	_	0	SENT_190	[p17l10t1603r212b1678],

1	This	DT	O	this	det	2	SENT_191	[p17l257t1603r419b1664],
2	possibility	NN	O	possibility	nsubjpass	4	SENT_191	[p17l459t1603r822b1679],
3	is	VBZ	O	be	auxpass	4	SENT_191	[p17l860t1603r910b1664],
4	supported	VBN	O	support	_	0	SENT_191	[p17l954t1603r1316b1679],
5	by	IN	O	by	_	0	SENT_191	[p17l1355t1603r1442b1679],
6	the	DT	O	the	det	7	SENT_191	[p17l1480t1603r1590b1664],
7	existence	NN	O	existence	agent	4	SENT_191	[p17l1633t1603r1956b1664],
8	of	IN	O	of	_	0	SENT_191	[p17l1999t1603r2076b1664],
9	a	DT	O	a	det	12	SENT_191	[p17l2108t1623r2143b1664],
10	complex	JJ	O	complex	amod	12	SENT_191	[p17l10t1697r314b1772],
11	intracellular	JJ	O	intracellular	amod	12	SENT_191	[p17l380t1697r812b1757],
12	pathway	NN	O	pathway	prep_of	7	SENT_191	[p17l876t1697r1179b1772],
13	for	IN	O	for	_	0	SENT_191	[p17l1244t1696r1346b1757],
14	the	DT	O	the	det	15	SENT_191	[p17l1410t1697r1521b1757],
15	metabolism	NN	O	metabolism	prep_for	12	SENT_191	[p17l1589t1697r2008b1757],
16	of	IN	O	of	_	0	SENT_191	[p17l2077t1696r2153b1757],
17	abacavir	NN	O	abacavir	prep_of	15	SENT_191	[p17l10t1790r325b1863],
18	,	,	O	,	_	0	SENT_191	[p17l10t1790r325b1863],
19	in	IN	O	in	_	0	SENT_191	[p17l375t1790r443b1849],
20	which	WDT	O	which	rel	25	SENT_191	[p17l487t1790r702b1850],
21	this	DT	O	this	det	24	SENT_191	[p17l747t1790r873b1850],
22	carbocyclic	JJ	O	carbocyclic	amod	24	SENT_191	[p17l922t1790r1321b1866],
23	guanine	NN	O	guanine	nn	24	SENT_191	[p17l1368t1790r1652b1866],
24	derivative	NN	O	derivative	nsubj	25	SENT_191	[p17l1700t1790r2044b1850],
25	is	VBZ	O	be	rcmod	7	SENT_191	[p17l2091t1790r2142b1850],

1	THE	DT	O	the	det	2	SENT_192	[p17l92t1967r158b1987],
2	LANCET	NN	O	lancet	_	0	SENT_192	[p17l168t1967r297b1988],
3	-	:	O	-	_	0	SENT_192	[p17l307t1974r314b1981],
4	Vol	NN	O	vol	dep	2	SENT_192	[p17l324t1967r368b1988],
5	359	CD	NUMBER	359	dep	4	SENT_192	[p17l378t1967r423b1988],
6	-	:	O	-	_	0	SENT_192	[p17l434t1974r441b1981],
7	March	NNP	DATE	March	dep	4	SENT_192	[p17l451t1967r535b1988],
8	2	CD	DATE	2	num	7	SENT_192	[p17l545t1968r567b1991],
9	,	,	DATE	,	_	0	SENT_192	[p17l545t1968r567b1991],
10	2002	CD	DATE	2002	num	7	SENT_192	[p17l577t1968r639b1988],
11	-	:	O	-	_	0	SENT_192	[p17l650t1974r658b1981],
12	www.thelancet.com	NN	O	www.thelancet.com	dep	7	SENT_192	[p17l667t1967r918b1988],
13	731	CD	NUMBER	731	num	14	SENT_192	[p17l2004t1962r2060b1988],
14	ARTICLES	NNS	O	article	dep	2	SENT_192	[p17l91t2010r244b2031],

1	converted	VBN	O	convert	_	0	SENT_193	[p17l9t2202r362b2263],
2	to	TO	O	to	_	0	SENT_193	[p17l449t2216r518b2263],
3	carbovir	NN	O	carbovir	nn	4	SENT_193	[p17l609t2202r903b2263],
4	monophosphate	NN	O	monophosphate	prep_to	1	SENT_193	[p17l988t2202r1569b2278],
5	via	IN	O	via	_	0	SENT_193	[p17l1655t2202r1756b2263],
6	multiple	JJ	O	multiple	amod	7	SENT_193	[p17l1844t2202r2142b2278],
7	pathways	NNS	O	pathway	prep_via	4	SENT_193	[p17l6t2295r339b2371],
8	involving	VBG	O	involve	partmod	7	SENT_193	[p17l417t2295r745b2371],
9	deamination	NN	O	deamination	nn	12	SENT_193	[p17l822t2295r1272b2356],
10	and	CC	O	and	_	0	SENT_193	[p17l1350t2295r1482b2356],
11	phosphorylation	NN	O	phosphorylation	nn	12	SENT_193	[p17l1557t2295r2143b2371],
12	steps	NNS	O	step	dobj	8	SENT_193	[p17l9t2403r205b2465],
13	,	,	O	,	_	0	SENT_193	[p17l9t2403r205b2465],
14	before	IN	O	before	_	0	SENT_193	[p17l237t2389r462b2449],
15	undergoing	VBG	O	undergo	prepc_before	1	SENT_193	[p17l492t2389r905b2465],
16	kinase-mediated	JJ	O	kinase-mediated	amod	17	SENT_193	[p17l934t2389r1523b2449],
17	activation	NN	O	activation	dobj	15	SENT_193	[p17l1554t2389r1902b2449],
18	to	TO	O	to	_	0	SENT_193	[p17l1931t2403r2000b2449],
19	the	DT	O	the	det	23	SENT_193	[p17l2032t2389r2142b2449],
20	active	JJ	O	active	amod	23	SENT_193	[p17l9t2481r212b2542],
21	carbovir	NN	O	carbovir	nn	23	SENT_193	[p17l301t2481r595b2542],
22	triphosphate	NN	O	triphosphate	nn	23	SENT_193	[p17l679t2481r1130b2557],
23	form	NN	O	form	prep_to	15	SENT_193	[p17l1217t2481r1458b2542],
24	.	.	O	.	_	0	SENT_193	[p17l1217t2481r1458b2542],

1	”	NN	O	”	nsubj	19	SENT_194	[p17l1217t2481r1458b2542],
2	The	DT	O	the	det	4	SENT_194	[p17l1546t2481r1693b2542],
3	numerous	JJ	O	numerous	amod	4	SENT_194	[p17l1780t2501r2142b2542],
4	metabolites	NNS	O	metabolite	nsubj	6	SENT_194	[p17l7t2574r419b2635],
5	thus	RB	O	thus	advmod	6	SENT_194	[p17l456t2574r608b2635],
6	formed	VBD	O	form	rcmod	1	SENT_194	[p17l645t2574r905b2635],
7	might	MD	O	might	aux	9	SENT_194	[p17l940t2574r1150b2650],
8	then	RB	O	then	advmod	9	SENT_194	[p17l1185t2574r1345b2635],
9	undergo	VB	O	undergo	_	0	SENT_194	[p17l1380t2574r1677b2650],
10	haptenation	NN	O	haptenation	dobj	9	SENT_194	[p17l1713t2574r2144b2650],
11	to	TO	O	to	_	0	SENT_194	[p17l7t2682r76b2728],
12	endogenous	JJ	O	endogenous	amod	13	SENT_194	[p17l127t2668r556b2744],
13	proteins	NNS	O	protein	prep_to	9	SENT_194	[p17l604t2668r894b2744],
14	to	TO	O	to	aux	15	SENT_194	[p17l943t2682r1012b2728],
15	achieve	VB	O	achieve	xcomp	9	SENT_194	[p17l1063t2668r1324b2728],
16	antigenicity	NN	O	antigenicity	dobj	15	SENT_194	[p17l1374t2668r1809b2744],
17	,	,	O	,	_	0	SENT_194	[p17l1374t2668r1809b2744],
18	or	CC	O	or	_	0	SENT_194	[p17l1861t2688r1936b2728],
19	bind	VBP	O	bind	conj_or	9	SENT_194	[p17l1980t2668r2143b2728],
20	directly	RB	O	directly	advmod	19	SENT_194	[p17l9t2760r276b2836],
21	to	TO	O	to	_	0	SENT_194	[p17l330t2774r399b2821],
22	MHC	NN	O	mhc	nn	23	SENT_194	[p17l456t2760r674b2821],
23	molecules	NNS	O	molecule	prep_to	20	SENT_194	[p17l732t2760r1089b2821],
24	to	TO	O	to	aux	25	SENT_194	[p17l1147t2774r1216b2821],
25	elicit	VB	O	elicit	xcomp	19	SENT_194	[p17l1275t2760r1444b2821],
26	T	NN	O	t	dobj	25	SENT_194	[p17l1499t2760r1713b2821],
27	—	JJ	O	—	amod	29	SENT_194	[p17l1499t2760r1713b2821],
28	cell	NN	O	cell	nn	29	SENT_194	[p17l1499t2760r1713b2821],
29	activation	NN	O	activation	tmod	25	SENT_194	[p17l1772t2760r2140b2833],
30	,	,	O	,	_	0	SENT_194	[p17l1772t2760r2140b2833],
31	consistent	JJ	O	consistent	amod	42	SENT_194	[p17l9t2854r368b2914],
32	with	IN	O	with	_	0	SENT_194	[p17l399t2853r556b2914],
33	the	DT	O	the	det	35	SENT_194	[p17l587t2853r698b2914],
34	proposed	VBN	O	propose	amod	35	SENT_194	[p17l730t2853r1064b2929],
35	pathogenesis	NN	O	pathogenesis	prep_with	31	SENT_194	[p17l1095t2853r1555b2929],
36	of	IN	O	of	_	0	SENT_194	[p17l1590t2853r1667b2914],
37	a	DT	O	a	det	38	SENT_194	[p17l1691t2873r1727b2914],
38	number	NN	O	number	prep_of	35	SENT_194	[p17l1759t2853r2045b2914],
39	of	IN	O	of	_	0	SENT_194	[p17l2077t2853r2153b2914],
40	idiosyncratic	JJ	O	idiosyncratic	amod	41	SENT_194	[p17l8t2947r462b3023],
41	drug	NN	O	drug	prep_of	38	SENT_194	[p17l490t2947r656b3023],
42	reactions	NNS	O	reaction	appos	29	SENT_194	[p17l679t2947r1084b3007],
43	.	.	O	.	_	0	SENT_194	[p17l679t2947r1084b3007],

1	“	NN	O	“	_	0	SENT_195	[p17l679t2947r1084b3007],

1	In	IN	O	in	_	0	SENT_196	[p17l93t3040r169b3099],
2	relation	NN	O	relation	prep_in	15	SENT_196	[p17l242t3039r516b3100],
3	to	TO	O	to	_	0	SENT_196	[p17l588t3053r657b3100],
4	recombinant	JJ	O	recombinant	amod	5	SENT_196	[p17l732t3039r1190b3100],
5	mapping	NN	O	mapping	prep_to	2	SENT_196	[p17l1263t3039r1580b3115],
6	of	IN	O	of	_	0	SENT_196	[p17l1654t3039r1731b3100],
7	candidate	NN	O	candidate	nn	9	SENT_196	[p17l1795t3039r2142b3100],
8	susceptibility	NN	O	susceptibility	nn	9	SENT_196	[p17l9t3132r477b3208],
9	regions	NNS	O	region	prep_of	5	SENT_196	[p17l552t3133r831b3208],
10	,	,	O	,	_	0	SENT_196	[p17l552t3133r831b3208],
11	the	DT	O	the	det	14	SENT_196	[p17l912t3132r1023b3193],
12	most	RBS	O	most	advmod	13	SENT_196	[p17l1101t3147r1278b3193],
13	parsimonious	JJ	O	parsimonious	amod	14	SENT_196	[p17l1354t3133r1839b3208],
14	region	NN	O	region	nsubj	15	SENT_196	[p17l1918t3133r2143b3208],
15	identiﬁed	VBD	O	identiﬁed	_	0	SENT_196	[p17l8t3226r347b3286],
16	contains	VBZ	O	contain	ccomp	15	SENT_196	[p17l376t3226r674b3286],
17	several	JJ	O	several	amod	20	SENT_196	[p17l704t3226r944b3286],
18	central	JJ	O	central	amod	20	SENT_196	[p17l973t3226r1216b3286],
19	MHC	NN	O	mhc	nn	20	SENT_196	[p17l1244t3226r1461b3286],
20	genes	NNS	O	gene	dobj	16	SENT_196	[p17l1492t3245r1711b3302],
21	,	,	O	,	_	0	SENT_196	[p17l1492t3245r1711b3302],
22	including	VBG	O	include	_	0	SENT_196	[p17l1741t3226r2079b3302],
23	a	DT	O	a	det	24	SENT_196	[p17l2107t3246r2142b3286],
24	family	NN	O	family	prep_including	20	SENT_196	[p17l7t3318r229b3394],
25	of	IN	O	of	_	0	SENT_196	[p17l263t3318r340b3379],
26	heat-shock-protein	JJ	O	heat-shock-protein	amod	27	SENT_196	[p17l362t3318r1043b3394],
27	genes	NNS	O	gene	prep_of	24	SENT_196	[p17l1076t3338r1273b3394],
28	that	WDT	O	that	nsubjpass	31	SENT_196	[p17l1307t3318r1448b3379],
29	might	MD	O	might	aux	31	SENT_196	[p17l1481t3318r1690b3394],
30	be	VB	O	be	auxpass	31	SENT_196	[p17l1722t3318r1806b3379],
31	involved	VBN	O	involve	rcmod	24	SENT_196	[p17l1841t3318r2143b3379],
32	in	IN	O	in	_	0	SENT_196	[p17l8t3412r75b3471],
33	antigen	NN	O	antigen	prep_in	31	SENT_196	[p17l121t3412r383b3487],
34	chaperoning	VBG	O	chaperon	amod	33	SENT_196	[p17l428t3411r873b3487],
35	and	CC	O	and	_	0	SENT_196	[p17l917t3411r1049b3472],
36	folding	JJ	O	folding	prep_in	31	SENT_196	[p17l1092t3411r1344b3487],
37	as	RB	O	as	_	0	SENT_196	[p17l1388t3431r1455b3472],
38	well	RB	O	well	_	0	SENT_196	[p17l1499t3411r1642b3472],
39	as	IN	O	as	_	0	SENT_196	[p17l1688t3431r1755b3472],
40	providing	VBG	O	provide	rcmod	24	SENT_196	[p17l1799t3411r2144b3487],
41	direct	JJ	O	direct	amod	43	SENT_196	[p17l9t3505r213b3565],
42	immunostimulatory	JJ	O	immunostimulatory	amod	43	SENT_196	[p17l282t3505r1000b3581],
43	signals	NNS	O	signal	dobj	40	SENT_196	[p17l1069t3505r1303b3581],
44	in	IN	O	in	_	0	SENT_196	[p17l1374t3505r1442b3564],
45	the	DT	O	the	det	46	SENT_196	[p17l1511t3505r1621b3565],
46	presence	NN	O	presence	prep_in	40	SENT_196	[p17l1691t3524r2004b3581],
47	of	IN	O	of	_	0	SENT_196	[p17l2076t3505r2153b3565],
48	antigen	NN	O	antigen	prep_of	46	SENT_196	[p17l9t3597r399b3673],
49	.	.	O	.	_	0	SENT_196	[p17l9t3597r399b3673],

1	‘	NN	O	‘	nsubj	19	SENT_197	[p17l9t3597r399b3673],
2	8	CD	NUMBER	8	num	1	SENT_197	[p17l9t3597r399b3673],
3	"	``	O	"	punct	1	SENT_197	[p17l9t3597r399b3673],
4	9	CD	NUMBER	9	dep	1	SENT_197	[p17l9t3597r399b3673],
5	However	RB	O	however	advmod	1	SENT_197	[p17l430t3598r776b3670],
6	,	,	O	,	_	0	SENT_197	[p17l430t3598r776b3670],
7	a	DT	O	a	det	9	SENT_197	[p17l810t3617r846b3658],
8	larger	JJR	O	larger	amod	9	SENT_197	[p17l876t3597r1081b3673],
9	region	NN	O	region	appos	1	SENT_197	[p17l1108t3597r1334b3673],
10	deﬁned	VBN	O	deﬁned	partmod	1	SENT_197	[p17l1364t3597r1630b3658],
11	by	IN	O	by	_	0	SENT_197	[p17l1659t3597r1747b3673],
12	C4A6	NN	O	c4a6	agent	10	SENT_197	[p17l1777t3597r1983b3658],
13	and	CC	O	and	_	0	SENT_197	[p17l2011t3597r2143b3658],
14	HLA-Cw6	NN	O	hla-cw6	agent	10	SENT_197	[p17l6t3691r384b3751],
15	on	IN	O	on	_	0	SENT_197	[p17l452t3710r541b3751],
16	the	DT	O	the	det	18	SENT_197	[p17l610t3690r720b3751],
17	57-1	CD	NUMBER	57-1	num	18	SENT_197	[p17l795t3693r942b3751],
18	haplotype	NN	O	haplotype	prep_on	10	SENT_197	[p17l1020t3690r1372b3766],
19	provides	VBZ	O	provide	_	0	SENT_197	[p17l1441t3690r1744b3766],
20	sufﬁcient	JJ	O	sufﬁcient	amod	21	SENT_197	[p17l1817t3690r2144b3751],
21	conditions	NNS	O	condition	dobj	19	SENT_197	[p18l9t16r382b76],
22	for	IN	O	for	_	0	SENT_197	[p18l432t16r534b76],
23	susceptibility	NN	O	susceptibility	prep_for	21	SENT_197	[p18l583t16r1051b92],
24	to	TO	O	to	_	0	SENT_197	[p18l1097t30r1166b76],
25	abacavir	NN	O	abacavir	nn	26	SENT_197	[p18l1219t16r1516b76],
26	hypersensitivity	NN	O	hypersensitivity	prep_to	19	SENT_197	[p18l1562t16r2140b92],
27	,	,	O	,	_	0	SENT_197	[p18l1562t16r2140b92],
28	raising	VBG	O	raise	partmod	19	SENT_197	[p18l7t108r245b184],
29	the	DT	O	the	det	30	SENT_197	[p18l266t108r377b169],
30	possibility	NN	O	possibility	dobj	28	SENT_197	[p18l401t108r762b184],
31	that	IN	O	that	complm	61	SENT_197	[p18l784t108r925b169],
32	two	CD	NUMBER	two	num	35	SENT_197	[p18l947t122r1078b169],
33	or	CC	O	or	_	0	SENT_197	[p18l1105t128r1179b169],
34	more	JJR	O	more	conj_or	32	SENT_197	[p18l1201t128r1386b169],
35	loci	NNS	O	locus	nsubj	61	SENT_197	[p18l1410t108r1536b169],
36	on	IN	O	on	_	0	SENT_197	[p18l1562t128r1652b169],
37	this	DT	O	this	det	38	SENT_197	[p18l1674t108r1800b169],
38	region	NN	O	region	prep_on	35	SENT_197	[p18l1826t108r2051b184],
39	of	IN	O	of	_	0	SENT_197	[p18l2076t108r2153b169],
40	the	DT	O	the	det	44	SENT_197	[p18l7t201r118b262],
41	57-1	CD	NUMBER	57-1	npadvmod	42	SENT_197	[p18l145t204r292b262],
42	ancestral	JJ	O	ancestral	amod	44	SENT_197	[p18l327t201r642b262],
43	haplotype	NN	O	haplotype	nn	44	SENT_197	[p18l664t201r1017b277],
44	(	NN	O	(	prep_of	38	SENT_197	[p18l1047t201r1412b277],
45	including	VBG	O	include	_	0	SENT_197	[p18l1047t201r1412b277],
46	HLA-B	NN	O	hla-b	prep_including	44	SENT_197	[p18l1432t202r1923b262],
47	*	CD	NUMBER	*	number	48	SENT_197	[p18l1432t202r1923b262],
48	5701	CD	NUMBER	5701	dep	46	SENT_197	[p18l1432t202r1923b262],
49	itself	PRP	O	itself	advmod	48	SENT_197	[p18l1952t201r2140b274],
50	,	,	O	,	_	0	SENT_197	[p18l1952t201r2140b274],
51	as	IN	O	as	_	0	SENT_197	[p18l9t315r76b355],
52	a	DT	O	a	det	54	SENT_197	[p18l156t315r192b355],
53	potential	JJ	O	potential	amod	54	SENT_197	[p18l268t295r585b371],
54	mediator	NN	O	mediator	prep_as	46	SENT_197	[p18l662t295r988b355],
55	of	IN	O	of	_	0	SENT_197	[p18l1064t295r1141b355],
56	class-I-restricted	JJ	O	class-i-restricted	amod	59	SENT_197	[p18l1210t295r1802b355],
57	antigen	NN	O	antigen	nn	59	SENT_197	[p18l1881t295r2143b371],
58	presentation	NN	O	presentation	nn	59	SENT_197	[p18l6t387r478b463],
59	)	NN	O	)	prep_of	54	SENT_197	[p18l6t387r478b463],
60	might	MD	O	might	aux	61	SENT_197	[p18l543t387r753b463],
61	cooperate	VB	O	cooperate	ccomp	28	SENT_197	[p18l813t401r1162b463],
62	to	TO	O	to	aux	63	SENT_197	[p18l1221t401r1290b448],
63	induce	VB	O	induce	xcomp	61	SENT_197	[p18l1351t387r1592b448],
64	susceptibility	NN	O	susceptibility	dobj	63	SENT_197	[p18l1653t387r2137b463],
65	.	.	O	.	_	0	SENT_197	[p18l1653t387r2137b463],

1	Further	JJ	O	further	amod	2	SENT_198	[p18l8t480r286b541],
2	mapping	NN	O	mapping	nsubj	22	SENT_198	[p18l313t480r630b556],
3	of	IN	O	of	_	0	SENT_198	[p18l659t480r736b541],
4	individual	JJ	O	individual	amod	6	SENT_198	[p18l755t480r1113b541],
5	susceptibility	NN	O	susceptibility	nn	6	SENT_198	[p18l1144t480r1612b556],
6	genes	NNS	O	gene	prep_of	2	SENT_198	[p18l1639t500r1836b556],
7	that	WDT	O	that	nsubjpass	9	SENT_198	[p18l1866t480r2007b541],
8	are	VBP	O	be	auxpass	9	SENT_198	[p18l2037t500r2142b541],
9	marked	VBN	O	mark	rcmod	6	SENT_198	[p18l7t574r278b634],
10	by	IN	O	by	_	0	SENT_198	[p18l310t574r398b650],
11	the	DT	O	the	det	12	SENT_198	[p18l428t574r538b634],
12	presence	NN	O	presence	agent	9	SENT_198	[p18l571t593r884b650],
13	of	IN	O	of	_	0	SENT_198	[p18l919t574r996b634],
14	HLA-B	NN	O	hla-b	prep_of	12	SENT_198	[p18l1018t574r1534b647],
15	*	CD	NUMBER	*	num	14	SENT_198	[p18l1018t574r1534b647],
16	5701	CD	NUMBER	5701	dep	14	SENT_198	[p18l1018t574r1534b647],
17	,	,	O	,	_	0	SENT_198	[p18l1018t574r1534b647],
18	HLA-DR7	NN	O	hla-dr7	conj_and	16	SENT_198	[p18l1571t574r1974b647],
19	,	,	O	,	_	0	SENT_198	[p18l1571t574r1974b647],
20	and	CC	O	and	_	0	SENT_198	[p18l2011t574r2143b634],
21	HLA-DQ3	NN	O	hla-dq3	dep	14	SENT_198	[p18l6t666r397b742],
22	requires	VBZ	O	require	_	0	SENT_198	[p18l474t666r761b742],
23	the	DT	O	the	det	24	SENT_198	[p18l841t666r951b727],
24	identiﬁcation	NN	O	identiﬁcation	dobj	22	SENT_198	[p18l1031t666r1506b727],
25	of	IN	O	of	_	0	SENT_198	[p18l1586t666r1663b727],
26	informative	JJ	O	informative	amod	36	SENT_198	[p18l1732t666r2142b727],
27	abacavir	NN	O	abacavir	npadvmod	29	SENT_198	[p18l9t759r841b835],
28	—	CD	NUMBER	—	num	27	SENT_198	[p18l9t759r841b835],
29	hypersensitive	JJ	O	hypersensitive	amod	36	SENT_198	[p18l9t759r841b835],
30	and	CC	O	and	_	0	SENT_198	[p18l900t759r1032b820],
31	abacavir-tolerant	JJ	O	abacavir-tolerant	amod	32	SENT_198	[p18l1089t759r1696b820],
32	cases	NNS	O	case	amod	36	SENT_198	[p18l1752t779r1930b820],
33	with	IN	O	with	_	0	SENT_198	[p18l1986t759r2144b820],
34	recombinant	JJ	O	recombinant	amod	35	SENT_198	[p18l7t853r466b913],
35	57-1	CD	NUMBER	57-1	prep_with	32	SENT_198	[p18l530t855r678b913],
36	haplotypes	NNS	O	haplotype	prep_of	24	SENT_198	[p18l748t853r1153b929],
37	.	.	O	.	_	0	SENT_198	[p18l748t853r1153b929],

1	This	DT	O	this	det	2	SENT_199	[p18l1220t853r1382b913],
2	approach	NN	O	approach	nsubj	5	SENT_199	[p18l1449t853r1781b929],
3	is	VBZ	O	be	cop	5	SENT_199	[p18l1843t853r1894b913],
4	more	RBR	O	more	advmod	5	SENT_199	[p18l1957t872r2142b913],
5	appropriate	JJ	O	appropriate	_	0	SENT_199	[p18l9t945r421b1021],
6	than	IN	O	than	_	0	SENT_199	[p18l454t945r615b1006],
7	multivariate	JJ	O	multivariate	amod	8	SENT_199	[p18l647t945r1077b1006],
8	analyses	NNS	O	analysis	prep_than	5	SENT_199	[p18l1112t945r1401b1021],
9	of	IN	O	of	_	0	SENT_199	[p18l1437t945r1514b1006],
10	individual	JJ	O	individual	amod	11	SENT_199	[p18l1537t945r1894b1006],
11	alleles	NNS	O	allele	prep_of	8	SENT_199	[p18l1930t945r2142b1006],
12	that	WDT	O	that	nsubj	13	SENT_199	[p18l7t1038r148b1099],
13	assume	VBP	O	assume	rcmod	8	SENT_199	[p18l242t1058r503b1099],
14	linkage	NN	O	linkage	nn	15	SENT_199	[p18l597t1038r849b1114],
15	disequilibrium	NN	O	disequilibrium	nsubj	19	SENT_199	[p18l945t1038r1466b1114],
16	to	TO	O	to	aux	19	SENT_199	[p18l1559t1053r1628b1099],
17	be	VB	O	be	cop	19	SENT_199	[p18l1722t1038r1806b1099],
18	mainly	RB	O	mainly	advmod	19	SENT_199	[p18l1900t1038r2145b1114],
19	attributable	JJ	O	attributable	xcomp	13	SENT_199	[p18l9t1132r423b1192],
20	to	TO	O	to	_	0	SENT_199	[p18l466t1146r535b1192],
21	genetic	JJ	O	genetic	amod	22	SENT_199	[p18l579t1132r832b1208],
22	distance	NN	O	distance	prep_to	19	SENT_199	[p18l876t1132r1188b1192],
23	.	.	O	.	_	0	SENT_199	[p18l876t1132r1188b1192],

1	In	IN	O	in	_	0	SENT_200	[p18l1236t1133r1312b1191],
2	multivariate	JJ	O	multivariate	amod	3	SENT_200	[p18l1354t1132r1783b1192],
3	analyses	NNS	O	analysis	prep_in	17	SENT_200	[p18l1828t1132r2140b1208],
4	,	,	O	,	_	0	SENT_200	[p18l1828t1132r2140b1208],
5	markers	NNS	O	marker	nsubj	17	SENT_200	[p18l7t1224r293b1285],
6	that	WDT	O	that	nsubj	8	SENT_200	[p18l346t1224r487b1285],
7	are	VBP	O	be	cop	8	SENT_200	[p18l540t1244r646b1285],
8	haplospeciﬁc	NN	O	haplospeciﬁc	rcmod	5	SENT_200	[p18l697t1224r1164b1300],
9	but	CC	O	but	prep	8	SENT_200	[p18l1216t1224r1338b1285],
10	distant	JJ	O	distant	dep	9	SENT_200	[p18l1391t1224r1634b1285],
11	from	IN	O	from	_	0	SENT_200	[p18l1685t1224r1858b1285],
12	a	DT	O	a	det	15	SENT_200	[p18l1912t1244r1947b1285],
13	true	JJ	O	true	amod	15	SENT_200	[p18l1999t1238r2142b1285],
14	susceptibility	NN	O	susceptibility	nn	15	SENT_200	[p18l9t1317r477b1393],
15	locus	NN	O	locus	prep_from	10	SENT_200	[p18l513t1317r697b1378],
16	can	MD	O	can	aux	17	SENT_200	[p18l738t1337r861b1378],
17	display	VB	O	display	_	0	SENT_200	[p18l900t1317r1150b1393],
18	stronger	JJR	O	stronger	amod	19	SENT_200	[p18l1188t1332r1483b1393],
19	associations	NNS	O	association	dobj	17	SENT_200	[p18l1521t1318r1943b1378],
20	than	IN	O	than	_	0	SENT_200	[p18l1983t1317r2143b1378],
21	non-haplospeciﬁc	JJ	O	non-haplospeciﬁc	amod	22	SENT_200	[p18l7t1411r645b1487],
22	markers	NNS	O	marker	prep_than	17	SENT_200	[p18l675t1411r960b1471],
23	that	WDT	O	that	nsubj	25	SENT_200	[p18l992t1411r1132b1471],
24	are	VBP	O	be	cop	25	SENT_200	[p18l1163t1430r1268b1471],
25	close	JJ	O	close	rcmod	22	SENT_200	[p18l1301t1411r1474b1471],
26	to	TO	O	to	_	0	SENT_200	[p18l1504t1425r1574b1471],
27	it	PRP	O	it	prep_to	25	SENT_200	[p18l1605t1411r1671b1471],
28	.	.	O	.	_	0	SENT_200	[p18l1605t1411r1671b1471],

1	Recognition	NN	O	recognition	nsubj	6	SENT_201	[p18l1708t1411r2143b1487],
2	of	IN	O	of	_	0	SENT_201	[p18l9t1503r86b1564],
3	these	DT	O	these	det	4	SENT_201	[p18l110t1503r293b1564],
4	effects	NNS	O	effect	prep_of	1	SENT_201	[p18l330t1503r553b1564],
5	has	VBZ	O	have	aux	6	SENT_201	[p18l588t1503r705b1564],
6	prompted	VBN	O	prompt	_	0	SENT_201	[p18l739t1503r1096b1579],
7	the	DT	O	the	det	8	SENT_201	[p18l1130t1503r1240b1564],
8	development	NN	O	development	dobj	6	SENT_201	[p18l1277t1503r1741b1579],
9	of	IN	O	of	_	0	SENT_201	[p18l1777t1503r1854b1564],
10	speciﬁc	NN	O	speciﬁc	nn	11	SENT_201	[p18l1880t1503r2142b1579],
11	methods	NNS	O	method	prep_of	8	SENT_201	[p18l7t1596r316b1657],
12	to	TO	O	to	aux	13	SENT_201	[p18l341t1611r410b1657],
13	adjust	VB	O	adjust	xcomp	6	SENT_201	[p18l438t1596r652b1672],
14	for	IN	O	for	_	0	SENT_201	[p18l676t1596r778b1657],
15	the	DT	O	the	det	17	SENT_201	[p18l800t1596r910b1657],
16	confounding	JJ	O	confounding	amod	17	SENT_201	[p18l937t1596r1394b1672],
17	effects	NNS	O	effect	prep_for	13	SENT_201	[p18l1418t1596r1642b1657],
18	of	IN	O	of	_	0	SENT_201	[p18l1669t1596r1746b1657],
19	haplotypeassociated	JJ	O	haplotypeassociated	amod	21	SENT_201	[p18l1759t1596r2143b1672, p18l9t1690r372b1750],
20	linkage	NN	O	linkage	nn	21	SENT_201	[p18l398t1690r650b1766],
21	disequilibrium	NN	O	disequilibrium	prep_of	17	SENT_201	[p18l677t1690r1268b1766],
22	.	.	O	.	_	0	SENT_201	[p18l677t1690r1268b1766],

1	”	NN	O	”	_	0	SENT_202	[p18l677t1690r1268b1766],

1	Abacavir	NNP	O	Abacavir	nsubj	4	SENT_203	[p18l91t1782r411b1843],
2	is	VBZ	O	be	cop	4	SENT_203	[p18l481t1782r532b1843],
3	a	DT	O	a	det	4	SENT_203	[p18l608t1802r643b1843],
4	member	NN	O	member	_	0	SENT_203	[p18l715t1782r1017b1843],
5	of	IN	O	of	_	0	SENT_203	[p18l1088t1782r1165b1843],
6	the	DT	O	the	det	8	SENT_203	[p18l1226t1782r1337b1843],
7	nucleoside	NN	O	nucleoside	nn	8	SENT_203	[p18l1409t1782r1790b1843],
8	reversetranscriptase	NN	O	reversetranscriptase	prep_of	4	SENT_203	[p18l1862t1802r2142b1843, p18l7t1876r462b1951],

1	inhibitor	NN	O	inhibitor	nn	3	SENT_204	[p18l490t1875r802b1936],
2	(	NN	O	(	nn	3	SENT_204	[p18l833t1876r1108b1951],
3	NRTI	NN	O	nrtus	nsubj	30	SENT_204	[p18l833t1876r1108b1951],
4	)	CD	NUMBER	)	num	5	SENT_204	[p18l833t1876r1108b1951],
5	class	NN	O	class	nsubj	24	SENT_204	[p18l1143t1875r1304b1936],
6	of	IN	O	of	dep	5	SENT_204	[p18l1335t1875r1411b1936],
7	antiretroviral	JJ	O	antiretroviral	amod	8	SENT_204	[p18l1430t1875r1893b1936],
8	drugs	NNS	O	drug	pobj	6	SENT_204	[p18l1921t1875r2140b1951],
9	,	,	O	,	_	0	SENT_204	[p18l1921t1875r2140b1951],
10	and	CC	O	and	_	0	SENT_204	[p18l9t1969r141b2029],
11	has	VBZ	O	have	dep	5	SENT_204	[p18l192t1969r309b2029],
12	a	DT	O	a	det	14	SENT_204	[p18l365t1989r400b2029],
13	favourable	JJ	O	favourable	amod	14	SENT_204	[p18l453t1969r828b2029],
14	proﬁle	NN	O	proﬁle	dobj	11	SENT_204	[p18l880t1969r1110b2045],
15	in	IN	O	in	_	0	SENT_204	[p18l1164t1969r1232b2028],
16	relation	NN	O	relation	prep_in	14	SENT_204	[p18l1284t1969r1557b2029],
17	to	TO	O	to	_	0	SENT_204	[p18l1609t1983r1678b2029],
18	the	DT	O	the	det	19	SENT_204	[p18l1732t1969r1842b2029],
19	risk	NN	O	risk	prep_to	11	SENT_204	[p18l1896t1969r2024b2029],
20	of	IN	O	of	_	0	SENT_204	[p18l2076t1969r2153b2029],
21	mitochondrial	JJ	O	mitochondrial	amod	23	SENT_204	[p18l7t2061r515b2122],
22	toxic	JJ	O	toxic	amod	23	SENT_204	[p18l540t2061r713b2122],
23	effects	NNS	O	effect	prep_of	19	SENT_204	[p18l741t2061r1163b2122],
24	—	VBP	O	—	rcmod	3	SENT_204	[p18l741t2061r1163b2122],
25	the	DT	O	the	det	29	SENT_204	[p18l741t2061r1163b2122],
26	major	JJ	O	major	amod	29	SENT_204	[p18l1189t2061r1399b2137],
27	duration-dependent	JJ	O	duration-dependent	amod	29	SENT_204	[p18l1423t2061r2144b2137],
28	toxic	JJ	O	toxic	amod	29	SENT_204	[p18l7t2155r180b2215],
29	effect	NN	O	effect	dobj	24	SENT_204	[p18l234t2154r427b2215],
30	associated	VBN	O	associate	_	0	SENT_204	[p18l480t2154r843b2215],
31	with	IN	O	with	_	0	SENT_204	[p18l892t2154r1050b2215],
32	NRTI	NN	ORGANIZATION	nrtus	nn	33	SENT_204	[p18l1099t2155r1324b2215],
33	use	NN	O	use	prep_with	30	SENT_204	[p18l1376t2156r1621b2215],
34	.	.	O	.	_	0	SENT_204	[p18l1376t2156r1621b2215],

1	“’	NN	O	“’	nsubj	14	SENT_205	[p18l1376t2156r1621b2215],
2	22	CD	NUMBER	22	num	1	SENT_205	[p18l1376t2156r1621b2215],
3	The	DT	O	the	det	4	SENT_205	[p18l1673t2155r1820b2215],
4	drug	NN	O	drug	dep	1	SENT_205	[p18l1874t2155r2040b2231],
5	is	VBZ	O	be	auxpass	7	SENT_205	[p18l2091t2155r2141b2215],
6	commonly	RB	O	commonly	advmod	7	SENT_205	[p18l9t2248r392b2324],
7	incorporated	VBN	O	incorporate	_	0	SENT_205	[p18l434t2248r895b2324],
8	into	IN	O	into	_	0	SENT_205	[p18l938t2248r1076b2308],
9	triple	JJ	O	triple	amod	11	SENT_205	[p18l1121t2248r1307b2324],
10	NRTI	NN	O	nrtus	nn	11	SENT_205	[p18l1349t2249r1575b2308],
11	regimens	NNS	O	regimen	prep_into	7	SENT_205	[p18l1618t2248r1963b2324],
12	,	,	O	,	_	0	SENT_205	[p18l1618t2248r1963b2324],
13	and	CC	O	and	_	0	SENT_205	[p18l2011t2248r2143b2308],
14	has	VBZ	O	have	conj_and	7	SENT_205	[p18l6t2340r123b2401],
15	the	DT	O	the	det	16	SENT_205	[p18l153t2340r264b2401],
16	advantage	NN	O	advantage	dobj	14	SENT_205	[p18l296t2340r654b2416],
17	of	IN	O	of	_	0	SENT_205	[p18l686t2340r762b2401],
18	presentation	NN	O	presentation	prep_of	16	SENT_205	[p18l780t2340r1227b2416],
19	in	IN	O	in	_	0	SENT_205	[p18l1256t2340r1324b2400],
20	a	DT	O	a	det	23	SENT_205	[p18l1354t2360r1389b2401],
21	co	NN	O	co	nn	23	SENT_205	[p18l1420t2340r1959b2401],
22	—	NN	O	—	nn	23	SENT_205	[p18l1420t2340r1959b2401],
23	formulation	NN	O	formulation	prep_in	18	SENT_205	[p18l1420t2340r1959b2401],
24	with	IN	O	with	_	0	SENT_205	[p18l1986t2340r2143b2401],
25	zidovudine	NN	O	zidovudine	prep_with	23	SENT_205	[p18l7t2433r401b2494],
26	and	CC	O	and	_	0	SENT_205	[p18l466t2433r598b2494],
27	lamivudine	NN	O	lamivudine	conj_and	25	SENT_205	[p18l660t2433r1078b2494],
28	.	.	O	.	_	0	SENT_205	[p18l660t2433r1078b2494],

1	In	IN	O	in	_	0	SENT_206	[p18l1146t2434r1223b2493],
2	this	DT	O	this	det	3	SENT_206	[p18l1284t2433r1410b2494],
3	context	NN	O	context	prep_in	14	SENT_206	[p18l1476t2448r1760b2506],
4	,	,	O	,	_	0	SENT_206	[p18l1476t2448r1760b2506],
5	a	DT	O	a	det	8	SENT_206	[p18l1828t2453r1863b2494],
6	highly	RB	O	highly	advmod	8	SENT_206	[p18l1924t2433r2145b2509],
7	predictive	JJ	O	predictive	amod	8	SENT_206	[p18l6t2527r359b2603],
8	test	NN	O	test	nsubjpass	14	SENT_206	[p18l427t2541r552b2587],
9	for	IN	O	for	_	0	SENT_206	[p18l618t2527r720b2587],
10	abacavir	NN	O	abacavir	nn	11	SENT_206	[p18l787t2527r1083b2587],
11	hypersensitivity	NN	O	hypersensitivity	prep_for	8	SENT_206	[p18l1147t2527r1706b2603],
12	would	MD	O	would	aux	14	SENT_206	[p18l1769t2527r1993b2587],
13	be	VB	O	be	auxpass	14	SENT_206	[p18l2058t2527r2142b2587],
14	predicted	VBN	O	predict	_	0	SENT_206	[p18l6t2619r346b2695],
15	to	TO	O	to	aux	16	SENT_206	[p18l392t2633r460b2680],
16	provide	VB	O	provide	xcomp	14	SENT_206	[p18l507t2619r777b2695],
17	a	DT	O	a	det	19	SENT_206	[p18l826t2639r861b2680],
18	signiﬁcant	JJ	O	signiﬁcant	amod	19	SENT_206	[p18l909t2619r1276b2695],
19	reduction	NN	O	reduction	dobj	16	SENT_206	[p18l1320t2619r1667b2680],
20	in	IN	O	in	_	0	SENT_206	[p18l1712t2619r1781b2679],
21	the	DT	O	the	det	23	SENT_206	[p18l1826t2619r1936b2680],
22	total	JJ	O	total	amod	23	SENT_206	[p18l1982t2619r2143b2680],
23	burden	NN	O	burden	prep_in	16	SENT_206	[p18l6t2712r266b2773],
24	of	IN	O	of	_	0	SENT_206	[p18l310t2712r387b2773],
25	toxic	JJ	O	toxic	amod	26	SENT_206	[p18l419t2713r592b2773],
26	effects	NNS	O	effect	prep_of	23	SENT_206	[p18l638t2712r861b2773],
27	associated	VBN	O	associate	partmod	26	SENT_206	[p18l907t2712r1270b2773],
28	with	IN	O	with	_	0	SENT_206	[p18l1311t2712r1468b2773],
29	abacavir	NN	O	abacavir	nn	30	SENT_206	[p18l1512t2712r1809b2773],
30	therapy	NN	O	therapy	prep_with	27	SENT_206	[p18l1850t2712r2140b2788],
31	,	,	O	,	_	0	SENT_206	[p18l1850t2712r2140b2788],
32	and	CC	O	and	_	0	SENT_206	[p18l9t2806r141b2866],
33	allow	VB	O	allow	xcomp	14	SENT_206	[p18l219t2806r406b2866],
34	for	IN	O	for	_	0	SENT_206	[p18l481t2806r582b2866],
35	the	DT	O	the	det	37	SENT_206	[p18l655t2806r766b2866],
36	safer	JJR	O	safer	amod	37	SENT_206	[p18l844t2806r1011b2866],
37	use	NN	O	use	prep_for	33	SENT_206	[p18l1084t2826r1201b2866],
38	of	IN	O	of	_	0	SENT_206	[p18l1280t2806r1356b2866],
39	this	DT	O	this	det	40	SENT_206	[p18l1422t2806r1548b2866],
40	drug	NN	O	drug	prep_of	37	SENT_206	[p18l1627t2806r1793b2882],
41	without	IN	O	without	_	0	SENT_206	[p18l1865t2806r2144b2866],
42	inappropriate	JJ	O	inappropriate	amod	43	SENT_206	[p18l8t2898r491b2974],
43	denial	NN	O	denial	prep_without	33	SENT_206	[p18l554t2898r769b2959],
44	of	IN	O	of	_	0	SENT_206	[p18l831t2898r908b2959],
45	access	NN	O	access	prep_of	43	SENT_206	[p18l960t2918r1177b2959],
46	to	TO	O	to	_	0	SENT_206	[p18l1238t2912r1308b2959],
47	its	PRP$	O	its	poss	48	SENT_206	[p18l1370t2898r1448b2959],
48	use	NN	O	use	prep_to	33	SENT_206	[p18l1509t2918r1646b2959],
49	.	.	O	.	_	0	SENT_206	[p18l1509t2918r1646b2959],

1	The	DT	O	the	det	3	SENT_207	[p18l1711t2898r1858b2959],
2	strong	JJ	O	strong	amod	3	SENT_207	[p18l1921t2912r2144b2974],
3	association	NN	O	association	nsubj	32	SENT_207	[p18l9t2992r401b3052],
4	between	IN	O	between	_	0	SENT_207	[p18l448t2991r749b3052],
5	abacavir	NN	O	abacavir	nn	6	SENT_207	[p18l799t2991r1096b3052],
6	hypersensitivity	NN	O	hypersensitivity	prep_between	3	SENT_207	[p18l1142t2991r1701b3067],
7	and	CC	O	and	_	0	SENT_207	[p18l1750t2991r1882b3052],
8	HLAB	NN	O	hlab	prep_between	3	SENT_207	[p18l1929t2992r2144b3051, p18l6t3086r308b3158],
9	*	CD	NUMBER	*	number	10	SENT_207	[p18l1929t2992r2144b3051, p18l6t3086r308b3158],
10	5701	CD	NUMBER	5701	dep	6	SENT_207	[p18l1929t2992r2144b3051, p18l6t3086r308b3158],
11	,	,	O	,	_	0	SENT_207	[p18l1929t2992r2144b3051, p18l6t3086r308b3158],
12	HLA-DR7	NN	O	hla-dr7	prep_between	3	SENT_207	[p18l374t3085r776b3158],
13	,	,	O	,	_	0	SENT_207	[p18l374t3085r776b3158],
14	and	CC	O	and	_	0	SENT_207	[p18l843t3085r974b3145],
15	HLA-DQ3	NN	O	hla-dq3	conj_and	6	SENT_207	[p18l1034t3085r1425b3161],
16	identiﬁed	VBN	O	identiﬁed	partmod	15	SENT_207	[p18l1486t3085r1825b3145],
17	in	IN	O	in	_	0	SENT_207	[p18l1887t3085r1955b3144],
18	this	DT	O	this	det	19	SENT_207	[p18l2016t3085r2141b3145],
19	study	NN	O	study	prep_in	16	SENT_207	[p18l9t3177r222b3253],
20	,	,	O	,	_	0	SENT_207	[p18l9t3177r222b3253],
21	although	IN	O	although	mark	22	SENT_207	[p18l268t3177r583b3253],
22	requiring	VBG	O	require	dep	3	SENT_207	[p18l623t3177r953b3253],
23	conﬁrmation	NN	O	conﬁrmation	dobj	22	SENT_207	[p18l994t3177r1457b3238],
24	in	IN	O	in	_	0	SENT_207	[p18l1498t3177r1566b3237],
25	further	JJ	O	further	amod	26	SENT_207	[p18l1607t3177r1856b3238],
26	studies	NNS	O	study	prep_in	22	SENT_207	[p18l1896t3177r2141b3238],
27	involving	VBG	O	involve	partmod	26	SENT_207	[p18l8t3270r336b3346],
28	racially	RB	O	racially	advmod	29	SENT_207	[p18l368t3270r624b3346],
29	diverse	JJ	O	diverse	amod	30	SENT_207	[p18l657t3270r904b3331],
30	populations	NNS	O	population	dobj	27	SENT_207	[p18l937t3270r1382b3346],
31	,	,	O	,	_	0	SENT_207	[p18l937t3270r1382b3346],
32	provides	VBZ	O	provide	_	0	SENT_207	[p18l1417t3270r1720b3346],
33	a	DT	O	a	det	35	SENT_207	[p18l1756t3290r1791b3331],
34	plausible	JJ	O	plausible	amod	35	SENT_207	[p18l1824t3270r2142b3346],
35	basis	NN	O	basis	dobj	32	SENT_207	[p18l6t3364r178b3424],
36	for	IN	O	for	_	0	SENT_207	[p18l213t3364r315b3424],
37	the	DT	O	the	det	38	SENT_207	[p18l346t3364r457b3424],
38	development	NN	O	development	prep_for	32	SENT_207	[p18l492t3364r957b3440],
39	of	IN	O	of	_	0	SENT_207	[p18l991t3364r1068b3424],
40	such	PDT	O	such	predet	42	SENT_207	[p18l1092t3364r1256b3424],
41	a	DT	O	a	det	42	SENT_207	[p18l1291t3384r1326b3424],
42	test	NN	O	test	prep_of	38	SENT_207	[p18l1359t3378r1505b3437],
43	,	,	O	,	_	0	SENT_207	[p18l1359t3378r1505b3437],
44	as	RB	O	as	_	0	SENT_207	[p18l1544t3384r1610b3424],
45	well	RB	O	well	_	0	SENT_207	[p18l1644t3364r1787b3424],
46	as	IN	O	as	_	0	SENT_207	[p18l1823t3384r1890b3424],
47	for	IN	O	for	_	0	SENT_207	[p18l1924t3364r2026b3424],
48	an	DT	O	a	det	50	SENT_207	[p18l2059t3383r2143b3424],
49	increased	VBN	O	increase	amod	50	SENT_207	[p18l8t3456r345b3517],
50	understanding	NN	O	understanding	conj_and	38	SENT_207	[p18l418t3456r940b3532],
51	of	IN	O	of	_	0	SENT_207	[p18l1014t3456r1090b3517],
52	the	DT	O	the	det	53	SENT_207	[p18l1154t3456r1265b3517],
53	pathogenesis	NN	O	pathogenesis	prep_of	50	SENT_207	[p18l1338t3456r1798b3532],
54	of	IN	O	of	_	0	SENT_207	[p18l1875t3456r1952b3517],
55	this	DT	O	this	det	59	SENT_207	[p18l2015t3456r2141b3517],
56	potentially	RB	O	potentially	advmod	57	SENT_207	[p18l6t3549r388b3625],
57	life-threatening	JJ	O	life-threatening	amod	59	SENT_207	[p18l412t3549r961b3625],
58	clinical	JJ	O	clinical	amod	59	SENT_207	[p18l987t3549r1237b3610],
59	syndrome	NN	O	syndrome	prep_of	53	SENT_207	[p18l1265t3549r1636b3625],
60	.	.	O	.	_	0	SENT_207	[p18l1265t3549r1636b3625],

1	Contributors	NNS	O	contributor	nsubjpass	7	SENT_208	[p19l9t78r390b131],
2	MHC	NN	O	mhc	nn	3	SENT_208	[p19l7t159r176b207],
3	typing	NN	O	typing	dep	1	SENT_208	[p19l197t159r373b218],
4	was	VBD	O	be	auxpass	5	SENT_208	[p19l391t175r493b206],
5	supervised	VBN	O	supervise	_	0	SENT_208	[p19l515t159r808b218],
6	and	CC	O	and	_	0	SENT_208	[p19l829t159r931b207],
7	analysed	VBN	O	analyse	conj_and	5	SENT_208	[p19l952t159r1190b218],
8	by	IN	O	by	_	0	SENT_208	[p19l1208t159r1276b218],
9	C	NN	O	c	nn	10	SENT_208	[p19l1297t159r1342b207],
10	Witt	NN	PERSON	witt	agent	5	SENT_208	[p19l1362t159r1502b207],
11	.	.	O	.	_	0	SENT_208	[p19l1362t159r1502b207],

1	D	NN	O	d	nn	2	SENT_209	[p19l1526t160r1577b206],
2	Sayer	NN	PERSON	sayer	nsubj	3	SENT_209	[p19l1601t159r1754b218],
3	designed	VBN	O	design	_	0	SENT_209	[p19l1773t159r2018b218],
4	and	CC	O	and	_	0	SENT_209	[p19l2039t159r2142b206],
5	supervised	VBN	O	supervise	conj_and	3	SENT_209	[p19l8t234r301b293],
6	sequence-based	JJ	O	sequence-based	amod	8	SENT_209	[p19l322t234r761b293],
7	HLA	NN	O	hlum	nn	8	SENT_209	[p19l781t234r927b280],
8	typing	NN	O	typing	dobj	5	SENT_209	[p19l945t234r1134b293],
9	.	.	O	.	_	0	SENT_209	[p19l945t234r1134b293],

1	A	DT	O	a	det	2	SENT_210	[p19l1157t234r1205b280],
2	Castley	NN	O	castley	nsubj	8	SENT_210	[p19l1226t234r1430b293],
3	and	CC	O	and	_	0	SENT_210	[p19l1450t234r1552b281],
4	C	NN	PERSON	c	nsubj	6	SENT_210	[p19l1575t234r1619b281],
5	Mamotte	JJ	PERSON	mamotte	amod	4	SENT_210	[p19l1641t234r1901b281],
6	designed	VBN	O	design	_	0	SENT_210	[p19l8t309r253b368],
7	and	CC	O	and	_	0	SENT_210	[p19l274t309r377b357],
8	carried	VBN	O	carry	conj_and	6	SENT_210	[p19l398t309r589b357],
9	out	RP	O	out	prt	8	SENT_210	[p19l610t320r702b357],
10	TNF	NN	O	tnf	nn	11	SENT_210	[p19l720t310r866b357],
11	genotyping	NN	O	genotyping	dobj	8	SENT_210	[p19l886t309r1210b368],
12	.	.	O	.	_	0	SENT_210	[p19l886t309r1210b368],

1	Microsatellite/SNP	NN	O	microsatellite/snp	nn	3	SENT_211	[p19l1234t309r1771b357],
2	MHC	NN	O	mhc	nn	3	SENT_211	[p19l1791t309r1959b357],
3	mapping	NN	O	mapping	nsubjpass	12	SENT_211	[p19l7t384r254b443],
4	and	CC	O	and	_	0	SENT_211	[p19l274t384r376b432],
5	calculation	NN	O	calculation	nsubjpass	12	SENT_211	[p19l397t384r701b431],
6	of	IN	O	of	_	0	SENT_211	[p19l721t384r781b431],
7	allele	NN	O	allele	nn	10	SENT_211	[p19l795t384r934b431],
8	and	CC	O	and	_	0	SENT_211	[p19l956t384r1059b431],
9	haplotype	NN	O	haplotype	nn	10	SENT_211	[p19l1077t384r1352b443],
10	frequencies	NNS	O	frequency	prep_of	5	SENT_211	[p19l1372t384r1688b443],
11	was	VBD	O	be	auxpass	12	SENT_211	[p19l1708t400r1810b432],
12	done	VBN	O	do	_	0	SENT_211	[p19l1833t384r1969b432],
13	by	IN	O	by	_	0	SENT_211	[p19l1989t384r2057b443],
14	A	DT	O	a	det	16	SENT_211	[p19l6t459r54b505],
15	M	NN	O	m	nn	16	SENT_211	[p19l72t459r137b505],
16	Martin	NNP	PERSON	Martin	agent	12	SENT_211	[p19l155t459r366b506],
17	.	.	O	.	_	0	SENT_211	[p19l155t459r366b506],

1	D	NN	O	d	nn	2	SENT_212	[p19l390t459r442b505],
2	Maxwell	NNP	PERSON	Maxwell	nsubj	18	SENT_212	[p19l462t459r703b506],
3	collected	VBN	O	collect	partmod	2	SENT_212	[p19l724t459r971b506],
4	data	NNS	O	datum	dobj	3	SENT_212	[p19l992t459r1126b515],
5	,	,	O	,	_	0	SENT_212	[p19l992t459r1126b515],
6	C	NN	O	c	appos	4	SENT_212	[p19l1151t459r1195b506],
7	Moore	NNP	PERSON	Moore	nsubj	8	SENT_212	[p19l1217t459r1406b506],
8	did	VBD	O	do	rcmod	6	SENT_212	[p19l1427t459r1516b506],
9	statistical	JJ	O	statistical	amod	10	SENT_212	[p19l1537t459r1793b506],
10	analysis	NN	O	analysis	dobj	8	SENT_212	[p19l1815t459r2026b518],
11	and	CC	O	and	_	0	SENT_212	[p19l8t534r111b582],
12	database	NN	O	database	nn	13	SENT_212	[p19l132t534r373b582],
13	management	NN	O	management	conj_and	10	SENT_212	[p19l393t545r771b593],
14	,	,	O	,	_	0	SENT_212	[p19l393t545r771b593],
15	and	CC	O	and	_	0	SENT_212	[p19l795t534r898b582],
16	I	PRP	O	I	dep	17	SENT_212	[p19l917t535r939b581],
17	James	NNP	PERSON	James	rcmod	6	SENT_212	[p19l955t535r1122b592],
18	did	VBD	O	do	_	0	SENT_212	[p19l1144t534r1233b582],
19	statistical	JJ	O	statistical	amod	20	SENT_212	[p19l1254t534r1511b582],
20	analysis	NN	O	analysis	dobj	18	SENT_212	[p19l1532t534r1760b593],
21	.	.	O	.	_	0	SENT_212	[p19l1532t534r1760b593],

1	Clinical	JJ	O	clinical	amod	2	SENT_213	[p19l1786t534r2001b582],
2	assessment	NN	O	assessment	nsubjpass	9	SENT_213	[p19l8t620r315b657],
3	and	CC	O	and	_	0	SENT_213	[p19l336t609r438b656],
4	application	NN	O	application	nsubjpass	9	SENT_213	[p19l459t609r768b668],
5	of	IN	O	of	_	0	SENT_213	[p19l788t609r848b656],
6	diagnostic	JJ	O	diagnostic	amod	7	SENT_213	[p19l861t609r1143b668],
7	criteria	NNS	O	criterion	prep_of	2	SENT_213	[p19l1165t609r1358b657],
8	were	VBD	O	be	auxpass	9	SENT_213	[p19l1376t625r1508b656],
9	done	VBN	O	do	_	0	SENT_213	[p19l1529t609r1665b657],
10	by	IN	O	by	_	0	SENT_213	[p19l1685t609r1753b668],
11	G	NN	PERSON	g	nn	12	SENT_213	[p19l1773t609r1825b657],
12	Masel	NN	PERSON	masel	agent	9	SENT_213	[p19l1843t609r2026b657],
13	.	.	O	.	_	0	SENT_213	[p19l1843t609r2026b657],

1	The	DT	O	the	det	2	SENT_214	[p19l6t684r121b731],
2	paper	NN	O	paper	nsubjpass	4	SENT_214	[p19l141t699r300b743],
3	was	VBD	O	be	auxpass	4	SENT_214	[p19l317t699r419b731],
4	prepared	VBN	O	prepare	_	0	SENT_214	[p19l439t684r689b743],
5	by	IN	O	by	_	0	SENT_214	[p19l707t684r776b743],
6	D	NN	PERSON	d	nn	7	SENT_214	[p19l794t684r845b730],
7	Nolan	NNP	PERSON	Nolan	agent	4	SENT_214	[p19l865t684r1057b740],
8	,	,	O	,	_	0	SENT_214	[p19l865t684r1057b740],
9	S	NNP	O	S	nn	10	SENT_214	[p19l1081t684r1114b731],
10	Mallal	NNP	O	Mallal	agent	4	SENT_214	[p19l1135t684r1330b740],
11	,	,	O	,	_	0	SENT_214	[p19l1135t684r1330b740],
12	and	CC	O	and	_	0	SENT_214	[p19l1354t684r1456b731],
13	F	NN	O	f	nn	14	SENT_214	[p19l1476t684r1517b730],
14	Christiansen	NN	PERSON	christiansen	conj_and	7	SENT_214	[p19l1539t684r1904b731],
15	.	.	O	.	_	0	SENT_214	[p19l1539t684r1904b731],

1	The	DT	O	the	det	3	SENT_215	[p19l1927t684r2042b731],
2	research	NN	O	research	nn	3	SENT_215	[p19l7t759r238b807],
3	project	NN	O	project	nsubjpass	12	SENT_215	[p19l257t759r451b818],
4	was	VBD	O	be	auxpass	5	SENT_215	[p19l469t775r571b807],
5	conceived	VBN	O	conceive	_	0	SENT_215	[p19l593t759r887b816],
6	,	,	O	,	_	0	SENT_215	[p19l593t759r887b816],
7	designed	VBN	O	design	conj_and	5	SENT_215	[p19l910t759r1171b818],
8	,	,	O	,	_	0	SENT_215	[p19l910t759r1171b818],
9	implemented	VBN	O	implement	dep	7	SENT_215	[p19l1193t759r1579b818],
10	,	,	O	,	_	0	SENT_215	[p19l1193t759r1579b818],
11	and	CC	O	and	_	0	SENT_215	[p19l1603t759r1705b807],
12	overseen	VBN	O	oversee	conj_and	5	SENT_215	[p19l1726t775r1968b807],
13	by	IN	O	by	_	0	SENT_215	[p19l1986t759r2054b818],
14	S	NN	PERSON	s	nn	15	SENT_215	[p19l9t834r42b882],
15	Mallal	NN	PERSON	mallal	prep_by	12	SENT_215	[p19l64t834r256b881],
16	.	.	O	.	_	0	SENT_215	[p19l64t834r256b881],

1	D	NN	O	d	nn	2	SENT_216	[p19l281t835r332b881],
2	Nolan	NNP	PERSON	Nolan	nsubj	4	SENT_216	[p19l352t834r528b881],
3	also	RB	O	also	advmod	4	SENT_216	[p19l548t834r653b881],
4	contributed	VBD	O	contribute	_	0	SENT_216	[p19l676t834r1001b882],
5	to	TO	O	to	aux	6	SENT_216	[p19l1021t845r1074b881],
6	study	VB	O	study	xcomp	4	SENT_216	[p19l1096t834r1248b893],
7	design	NN	O	design	dobj	6	SENT_216	[p19l1267t834r1444b893],
8	and	CC	O	and	_	0	SENT_216	[p19l1465t834r1568b882],
9	analysis	NN	O	analysis	dobj	6	SENT_216	[p19l1589t834r1816b893],
10	.	.	O	.	_	0	SENT_216	[p19l1589t834r1816b893],

1	Conflict	NN	O	conflict	nsubj	8	SENT_217	[p19l11t918r244b971],
2	of	IN	O	of	_	0	SENT_217	[p19l267t918r332b971],
3	interest	NN	O	interest	nn	6	SENT_217	[p19l349t919r587b971],
4	statement	NN	O	statement	nn	6	SENT_217	[p19l607t922r929b971],
5	S	NN	O	s	nn	6	SENT_217	[p19l11t1000r44b1047],
6	Mallal	NN	PERSON	mallal	prep_of	1	SENT_217	[p19l65t999r244b1047],
7	has	VBZ	O	have	aux	8	SENT_217	[p19l263t999r355b1047],
8	spoken	VBN	O	speak	_	0	SENT_217	[p19l377t999r572b1059],
9	at	IN	O	at	_	0	SENT_217	[p19l593t1010r644b1047],
10	meetings	NNS	O	meeting	prep_at	8	SENT_217	[p19l662t1000r912b1059],
11	sponsored	VBN	O	sponsor	partmod	10	SENT_217	[p19l933t999r1219b1059],
12	by	IN	O	by	_	0	SENT_217	[p19l1237t999r1306b1058],
13	GlaxoSmithK1ine	NN	O	glaxosmithk1ine	agent	11	SENT_217	[p19l1325t999r1835b1056],
14	,	,	O	,	_	0	SENT_217	[p19l1325t999r1835b1056],
15	and	CC	O	and	_	0	SENT_217	[p19l1859t999r1962b1047],
16	has	VBZ	O	have	aux	17	SENT_217	[p19l1980t999r2071b1047],
17	sat	VBN	O	sit	conj_and	8	SENT_217	[p19l10t1085r86b1122],
18	on	IN	O	on	_	0	SENT_217	[p19l107t1090r176b1122],
19	the	DT	O	the	det	22	SENT_217	[p19l195t1074r282b1122],
20	HIV	NN	MISC	hiv	nn	22	SENT_217	[p19l302t1075r428b1122],
21	advisory	JJ	O	advisory	amod	22	SENT_217	[p19l448t1074r680b1133],
22	boards	NNS	O	board	prep_on	17	SENT_217	[p19l697t1074r885b1122],
23	for	IN	O	for	_	0	SENT_217	[p19l906t1074r985b1122],
24	GlaxoSmithK1ine	NN	O	glaxosmithk1ine	prep_for	22	SENT_217	[p19l1005t1074r1498b1122],
25	and	CC	O	and	_	0	SENT_217	[p19l1520t1074r1622b1122],
26	Merck	NNP	PERSON	Merck	nn	27	SENT_217	[p19l1642t1074r1826b1122],
27	Sharpe	NNP	PERSON	Sharpe	prep_on	17	SENT_217	[p19l1847t1074r2040b1133],
28	and	CC	O	and	_	0	SENT_217	[p19l10t1149r113b1196],
29	Dohme	NNP	O	Dohme	conj_and	27	SENT_217	[p19l133t1149r360b1196],
30	.	.	O	.	_	0	SENT_217	[p19l133t1149r360b1196],

1	Acknowledgments	NNS	O	acknowledgment	nsubj	3	SENT_218	[p19l6t1295r579b1361],
2	We	PRP	O	we	nsubj	3	SENT_218	[p19l7t1376r103b1422],
3	thank	VBP	O	thank	_	0	SENT_218	[p19l123t1375r283b1422],
4	Martyn	NNP	PERSON	Martyn	nn	5	SENT_218	[p19l301t1376r511b1434],
5	French	NNP	PERSON	French	dobj	3	SENT_218	[p19l530t1375r747b1432],
6	,	,	O	,	_	0	SENT_218	[p19l530t1375r747b1432],
7	Patricia	NNP	PERSON	Patricia	nn	8	SENT_218	[p19l770t1375r982b1422],
8	Martinez	NNP	PERSON	Martinez	dobj	3	SENT_218	[p19l1001t1375r1273b1432],
9	,	,	O	,	_	0	SENT_218	[p19l1001t1375r1273b1432],
10	and	CC	O	and	_	0	SENT_218	[p19l1296t1375r1399b1422],
11	Ric	NNP	PERSON	Ric	nn	12	SENT_218	[p19l1420t1375r1511b1422],
12	Chaney	NNP	PERSON	Chaney	dobj	3	SENT_218	[p19l1534t1375r1749b1434],
13	for	IN	O	for	_	0	SENT_218	[p19l1767t1375r1847b1422],
14	providing	VBG	O	provide	prepc_for	3	SENT_218	[p19l1864t1375r2134b1434],
15	clinical	JJ	O	clinical	amod	16	SENT_218	[p19l10t1448r206b1496],
16	information	NN	O	information	dobj	14	SENT_218	[p19l226t1448r572b1496],
17	.	.	O	.	_	0	SENT_218	[p19l226t1448r572b1496],

1	References	NNS	O	reference	_	0	SENT_219	[p19l12t1704r358b1754],

1	1	CD	NUMBER	1	num	3	SENT_220	[p19l16t1811r36b1856],
2	Hetherington	NNP	PERSON	Hetherington	nn	3	SENT_220	[p19l114t1809r492b1868],
3	S	NN	O	s	_	0	SENT_220	[p19l514t1809r565b1866],
4	,	,	O	,	_	0	SENT_220	[p19l514t1809r565b1866],
5	McGuirk	NNP	PERSON	McGuirk	nn	6	SENT_220	[p19l587t1809r850b1856],
6	S	NNP	O	S	appos	3	SENT_220	[p19l871t1809r922b1866],
7	,	,	O	,	_	0	SENT_220	[p19l871t1809r922b1866],
8	Powell	NNP	PERSON	Powell	nn	9	SENT_220	[p19l944t1809r1132b1856],
9	G	NNP	PERSON	G	appos	3	SENT_220	[p19l1153t1809r1220b1866],
10	,	,	O	,	_	0	SENT_220	[p19l1153t1809r1220b1866],
11	et	FW	O	et	nn	12	SENT_220	[p19l1244t1820r1293b1856],
12	al.	FW	O	al.	appos	3	SENT_220	[p19l1314t1809r1374b1856],
13	.	.	O	.	_	0	SENT_220	[p19l1314t1809r1374b1856],

1	Hypersensitivity	NN	O	hypersensitivity	nn	2	SENT_221	[p19l1398t1809r1852b1868],
2	reactions	NNS	O	reaction	_	0	SENT_221	[p19l1870t1809r2121b1856],
3	during	IN	O	during	_	0	SENT_221	[p19l114t1884r299b1943],
4	therapy	NN	O	therapy	prep_during	2	SENT_221	[p19l317t1884r528b1943],
5	with	IN	O	with	_	0	SENT_221	[p19l546t1884r669b1931],
6	the	DT	O	the	det	11	SENT_221	[p19l688t1884r774b1931],
7	nucleoside	JJ	O	nucleoside	amod	11	SENT_221	[p19l793t1884r1091b1931],
8	reverse	JJ	O	reverse	amod	11	SENT_221	[p19l1111t1899r1306b1931],
9	transcriptase	NN	O	transcriptase	nn	11	SENT_221	[p19l1326t1884r1681b1943],
10	inhibitor	NN	O	inhibitor	nn	11	SENT_221	[p19l1701t1884r1944b1931],
11	abacavir	NN	O	abacavir	prep_with	2	SENT_221	[p19l115t1958r359b2006],
12	.	.	O	.	_	0	SENT_221	[p19l115t1958r359b2006],

1	Clin	NNP	O	Clin	nn	2	SENT_222	[p19l385t1958r495b2006],
2	Ther	NNP	DATE	Ther	_	0	SENT_222	[p19l521t1958r642b2006],
3	2001	CD	DATE	2001	num	2	SENT_222	[p19l659t1960r815b2015],
4	,	,	O	,	_	0	SENT_222	[p19l659t1960r815b2015],
5	23	CD	NUMBER	23	num	2	SENT_222	[p19l839t1960r922b2006],
6	:	:	O	:	_	0	SENT_222	[p19l839t1960r922b2006],
7	1603-14	CD	NUMBER	1603-14	dep	2	SENT_222	[p19l953t1960r1207b2006],
8	.	.	O	.	_	0	SENT_222	[p19l953t1960r1207b2006],

1	2	CD	NUMBER	2	num	3	SENT_223	[p19l10t2044r41b2089],
2	Escaut	NN	ORGANIZATION	escaut	nn	3	SENT_223	[p19l113t2043r302b2090],
3	L	NN	ORGANIZATION	l	nsubj	19	SENT_223	[p19l321t2043r380b2099],
4	,	,	O	,	_	0	SENT_223	[p19l321t2043r380b2099],
5	Liotier	NNP	PERSON	Liotier	nn	7	SENT_223	[p19l402t2042r593b2090],
6	]	CD	NUMBER	]	num	7	SENT_223	[p19l607t2043r695b2100],
7	Y	NN	O	y	appos	3	SENT_223	[p19l607t2043r695b2100],
8	,	,	O	,	_	0	SENT_223	[p19l607t2043r695b2100],
9	Albengres	NNP	PERSON	Albengres	nn	10	SENT_223	[p19l716t2042r996b2101],
10	E	NNP	PERSON	E	appos	3	SENT_223	[p19l1017t2043r1075b2099],
11	,	,	O	,	_	0	SENT_223	[p19l1017t2043r1075b2099],
12	Cheminot	NNP	ORGANIZATION	Cheminot	nn	13	SENT_223	[p19l1100t2042r1383b2090],
13	N	NNP	ORGANIZATION	N	appos	3	SENT_223	[p19l1401t2043r1472b2099],
14	,	,	O	,	_	0	SENT_223	[p19l1401t2043r1472b2099],
15	Vittecoq	NNP	ORGANIZATION	Vittecoq	nn	18	SENT_223	[p19l1492t2042r1732b2101],
16	D.	NNP	ORGANIZATION	D.	nn	18	SENT_223	[p19l1752t2043r1820b2090],
17	Abacavir	NNP	ORGANIZATION	Abacavir	nn	18	SENT_223	[p19l1842t2042r2092b2090],
18	rechallenge	NN	O	rechallenge	appos	3	SENT_223	[p19l113t2117r429b2176],
19	has	VBZ	O	have	_	0	SENT_223	[p19l449t2117r540b2164],
20	to	TO	O	to	aux	22	SENT_223	[p19l561t2128r614b2164],
21	be	VB	O	be	auxpass	22	SENT_223	[p19l634t2117r700b2164],
22	avoided	VBN	O	avoid	xcomp	19	SENT_223	[p19l722t2117r939b2164],
23	in	IN	O	in	_	0	SENT_223	[p19l959t2117r1012b2164],
24	case	NN	O	case	_	0	SENT_223	[p19l1033t2132r1147b2164],
25	of	IN	O	of	_	0	SENT_223	[p19l1168t2117r1228b2164],
26	hypersensitivity	NN	O	hypersensitivity	nn	27	SENT_223	[p19l1239t2117r1675b2176],
27	reaction	NN	O	reaction	prep_in_case_of	22	SENT_223	[p19l1693t2117r1934b2164],
28	.	.	O	.	_	0	SENT_223	[p19l1693t2117r1934b2164],

1	AIDS	NN	MISC	aid	_	0	SENT_224	[p19l1953t2117r2122b2164],
2	1999	CD	DATE	1999	num	1	SENT_224	[p19l120t2193r272b2249],
3	;	:	O	;	_	0	SENT_224	[p19l120t2193r272b2249],
4	13	CD	NUMBER	13	num	6	SENT_224	[p19l299t2193r378b2239],
5	:	:	O	:	_	0	SENT_224	[p19l299t2193r378b2239],
6	1419-20	CD	NUMBER	1419-20	dep	1	SENT_224	[p19l409t2193r663b2239],
7	.	.	O	.	_	0	SENT_224	[p19l409t2193r663b2239],

1	3	CD	NUMBER	3	num	3	SENT_225	[p19l10t2278r40b2323],
2	Hetherington	NNP	PERSON	Hetherington	nn	3	SENT_225	[p19l114t2276r492b2335],
3	S	NN	O	s	_	0	SENT_225	[p19l514t2276r565b2332],
4	,	,	O	,	_	0	SENT_225	[p19l514t2276r565b2332],
5	Cutrell	NN	O	cutrell	nn	6	SENT_225	[p19l590t2276r784b2323],
6	A	NN	O	a	appos	3	SENT_225	[p19l803t2276r866b2332],
7	,	,	O	,	_	0	SENT_225	[p19l803t2276r866b2332],
8	Edwards	NNP	ORGANIZATION	Edwards	nn	9	SENT_225	[p19l888t2276r1133b2323],
9	M	NNP	ORGANIZATION	M	appos	3	SENT_225	[p19l1154t2276r1235b2332],
10	,	,	O	,	_	0	SENT_225	[p19l1154t2276r1235b2332],
11	Spreen	NNP	PERSON	Spreen	nn	12	SENT_225	[p19l1259t2276r1453b2335],
12	W	NNP	O	W	appos	3	SENT_225	[p19l1471t2276r1553b2332],
13	,	,	O	,	_	0	SENT_225	[p19l1471t2276r1553b2332],
14	Steel	NNP	PERSON	Steel	nn	15	SENT_225	[p19l1577t2276r1711b2323],
15	H.	NNP	PERSON	H.	appos	3	SENT_225	[p19l1732t2276r1800b2323],
16	Risk	NN	PERSON	risk	nn	18	SENT_225	[p19l1825t2276r1947b2323],
17	factor	NN	O	factor	nn	18	SENT_225	[p19l1965t2275r2127b2323],
18	analysis	NN	O	analysis	dep	15	SENT_225	[p19l115t2351r327b2410],
19	of	IN	O	of	_	0	SENT_225	[p19l349t2351r409b2399],
20	hypersensitivity	NN	O	hypersensitivity	nn	21	SENT_225	[p19l420t2351r856b2410],
21	reactions	NNS	O	reaction	prep_of	3	SENT_225	[p19l874t2351r1125b2399],
22	to	TO	O	to	_	0	SENT_225	[p19l1146t2362r1200b2399],
23	abacavir	NN	O	abacavir	prep_to	21	SENT_225	[p19l1222t2351r1467b2399],
24	:	:	O	:	_	0	SENT_225	[p19l1222t2351r1467b2399],
25	retrospective	JJ	O	retrospective	amod	26	SENT_225	[p19l1490t2351r1848b2410],
26	analysis	NN	O	analysis	dep	3	SENT_225	[p19l1869t2351r2082b2410],
27	of	IN	O	of	_	0	SENT_225	[p19l114t2426r174b2473],
28	25	CD	NUMBER	25	num	30	SENT_225	[p19l188t2428r253b2474],
29	clinical	JJ	O	clinical	amod	30	SENT_225	[p19l277t2426r473b2473],
30	trials	NNS	O	trial	prep_of	26	SENT_225	[p19l493t2426r643b2473],
31	.	.	O	.	_	0	SENT_225	[p19l493t2426r643b2473],

1	Program	NN	O	program	_	0	SENT_226	[p19l667t2427r911b2485],
2	and	CC	O	and	_	0	SENT_226	[p19l932t2426r1034b2474],
3	abstracts	NNS	O	abstract	conj_and	1	SENT_226	[p19l1056t2426r1299b2473],
4	of	IN	O	of	_	0	SENT_226	[p19l1321t2426r1381b2473],
5	the	DT	O	the	det	8	SENT_226	[p19l1393t2426r1479b2473],
6	1st	CD	ORDINAL	1st	num	8	SENT_226	[p19l1507t2428r1581b2473],
7	IAS	NNP	O	IAS	nn	8	SENT_226	[p19l1600t2426r1707b2474],
8	Conference	NN	O	conference	prep_of	1	SENT_226	[p19l1731t2426r2053b2474],
9	on	IN	O	on	_	0	SENT_226	[p19l2075t2442r2145b2473],
10	HIV	NN	O	hiv	nn	11	SENT_226	[p19l114t2501r239b2548],
11	Pathogenesis	NN	O	pathogenesis	prep_on	1	SENT_226	[p19l258t2501r620b2560],
12	and	CC	O	and	_	0	SENT_226	[p19l642t2501r745b2548],
13	Treatment	NN	O	treatment	prep_on	1	SENT_226	[p19l764t2501r1082b2557],
14	;	:	O	;	_	0	SENT_226	[p19l764t2501r1082b2557],
15	8-11	CD	NUMBER	8-11	dep	1	SENT_226	[p19l1107t2502r1236b2548],
16	July	NNP	DATE	July	tmod	15	SENT_226	[p19l1259t2501r1371b2560],
17	2001	CD	DATE	2001	num	16	SENT_226	[p19l1391t2503r1548b2557],
18	;	:	O	;	_	0	SENT_226	[p19l1391t2503r1548b2557],
19	Argentina	NNP	LOCATION	Argentina	dep	15	SENT_226	[p19l1568t2501r1862b2560],
20	.	.	O	.	_	0	SENT_226	[p19l1568t2501r1862b2560],

1	Stockholm	NNP	LOCATION	Stockholm	_	0	SENT_227	[p19l115t2576r431b2624],
2	:	:	O	:	_	0	SENT_227	[p19l115t2576r431b2624],
3	International	NNP	MISC	International	nn	5	SENT_227	[p19l455t2576r819b2624],
4	AIDS	NNP	MISC	AIDS	nn	5	SENT_227	[p19l838t2576r1001b2624],
5	Society	NNP	O	Society	dep	1	SENT_227	[p19l1025t2576r1227b2635],
6	2001	CD	DATE	2001	dep	5	SENT_227	[p19l1247t2578r1402b2624],
7	.	.	O	.	_	0	SENT_227	[p19l1247t2578r1402b2624],

1	4	LS	NUMBER	4	dep	2	SENT_228	[p19l10t2661r42b2706],
2	Peyrieere	NN	O	peyrieere	_	0	SENT_228	[p19l114t2659r371b2718],
3	H	NN	O	h	dobj	2	SENT_228	[p19l392t2660r462b2716],
4	,	,	O	,	_	0	SENT_228	[p19l392t2660r462b2716],
5	Nicolas	NNP	PERSON	Nicolas	nn	6	SENT_228	[p19l483t2659r752b2717],
6	]	NNP	O	]	appos	3	SENT_228	[p19l483t2659r752b2717],
7	,	,	O	,	_	0	SENT_228	[p19l483t2659r752b2717],
8	Siffert	NNP	PERSON	Siffert	nn	9	SENT_228	[p19l776t2659r946b2707],
9	M	NNP	O	M	appos	3	SENT_228	[p19l964t2660r1045b2716],
10	,	,	O	,	_	0	SENT_228	[p19l964t2660r1045b2716],
11	et	FW	O	et	nn	12	SENT_228	[p19l1069t2670r1118b2707],
12	al.	FW	O	al.	appos	3	SENT_228	[p19l1138t2659r1198b2707],
13	.	.	O	.	_	0	SENT_228	[p19l1138t2659r1198b2707],

1	Hypersensitivity	NN	O	hypersensitivity	nsubj	2	SENT_229	[p19l1222t2659r1677b2718],
2	related	JJ	O	related	_	0	SENT_229	[p19l1695t2659r1886b2707],
3	to	TO	O	to	_	0	SENT_229	[p19l1905t2670r1959b2707],
4	abacavir	NN	O	abacavir	prep_to	2	SENT_229	[p19l115t2734r346b2781],
5	in	IN	O	in	_	0	SENT_229	[p19l364t2734r418b2781],
6	two	CD	NUMBER	two	num	7	SENT_229	[p19l437t2745r538b2781],
7	members	NNS	O	member	prep_in	2	SENT_229	[p19l559t2734r817b2782],
8	of	IN	O	of	_	0	SENT_229	[p19l839t2734r899b2781],
9	a	DT	O	a	det	10	SENT_229	[p19l913t2750r940b2781],
10	family	NN	O	family	prep_of	7	SENT_229	[p19l960t2734r1147b2793],
11	.	.	O	.	_	0	SENT_229	[p19l960t2734r1147b2793],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_230	[p19l1166t2734r1286b2781],
2	Pharmacother	NNP	PERSON	Pharmacother	_	0	SENT_230	[p19l1304t2734r1677b2781],
3	2001	CD	DATE	2001	num	5	SENT_230	[p19l1694t2736r1850b2791],
4	;	:	O	;	_	0	SENT_230	[p19l1694t2736r1850b2791],
5	35	CD	NUMBER	35	dep	2	SENT_230	[p19l1874t2735r1957b2782],
6	:	:	O	:	_	0	SENT_230	[p19l1874t2735r1957b2782],
7	1	CD	NUMBER	1	number	8	SENT_230	[p19l120t2809r140b2854],
8	29	CD	NUMBER	29	dep	2	SENT_230	[p19l151t2809r216b2854],
9	1-92	CD	NUMBER	1-92	dep	8	SENT_230	[p19l228t2809r374b2854],
10	.	.	O	.	_	0	SENT_230	[p19l228t2809r374b2854],

1	5	CD	NUMBER	5	num	7	SENT_231	[p19l12t2892r40b2938],
2	Park	NNP	O	Park	nn	7	SENT_231	[p19l114t2891r243b2938],
3	BK	NNP	O	BK	nn	7	SENT_231	[p19l261t2891r373b2947],
4	,	,	O	,	_	0	SENT_231	[p19l261t2891r373b2947],
5	Naisbitt	NNP	PERSON	Naisbitt	appos	7	SENT_231	[p19l394t2891r620b2938],
6	D	NNP	O	D	nn	7	SENT_231	[p19l640t2891r732b2948],
7	]	NN	O	]	_	0	SENT_231	[p19l640t2891r732b2948],
8	,	,	O	,	_	0	SENT_231	[p19l640t2891r732b2948],
9	Gordon	NNP	PERSON	Gordon	nn	10	SENT_231	[p19l756t2891r977b2938],
10	SF	NNP	PERSON	SF	dep	7	SENT_231	[p19l999t2891r1092b2947],
11	,	,	O	,	_	0	SENT_231	[p19l999t2891r1092b2947],
12	Kitteringham	NNP	O	Kitteringham	nn	13	SENT_231	[p19l1115t2891r1492b2950],
13	NR	NNP	O	NR	appos	10	SENT_231	[p19l1511t2891r1629b2947],
14	,	,	O	,	_	0	SENT_231	[p19l1511t2891r1629b2947],

1	Pirmohamed	NNP	O	Pirmohamed	nn	2	SENT_232	[p19l114t2966r479b3014],
2	M.	NNP	O	M.	_	0	SENT_232	[p19l498t2967r577b3014],
3	Metabolic	JJ	O	metabolic	amod	4	SENT_232	[p19l601t2966r886b3014],
4	activation	NN	O	activation	dep	2	SENT_232	[p19l907t2966r1178b3014],
5	in	IN	O	in	_	0	SENT_232	[p19l1198t2966r1251b3013],
6	drug	NN	O	drug	nn	7	SENT_232	[p19l1271t2966r1402b3025],
7	allergies	NNS	O	allergy	prep_in	4	SENT_232	[p19l1421t2966r1660b3025],
8	.	.	O	.	_	0	SENT_232	[p19l1421t2966r1660b3025],

1	Toxicology	NN	O	toxicology	_	0	SENT_233	[p19l1690t2966r1964b3025],
2	2001	CD	DATE	2001	num	1	SENT_233	[p19l1984t2968r2141b3023],
3	,	,	O	,	_	0	SENT_233	[p19l1984t2968r2141b3023],
4	158	CD	NUMBER	158	num	6	SENT_233	[p19l118t3042r231b3089],
5	:	:	O	:	_	0	SENT_233	[p19l118t3042r231b3089],
6	11-23	CD	DATE	11-23	appos	1	SENT_233	[p19l262t3043r444b3089],
7	.	.	O	.	_	0	SENT_233	[p19l262t3043r444b3089],

1	6	CD	NUMBER	6	num	3	SENT_234	[p19l12t3127r41b3173],
2	Zanni	NNP	ORGANIZATION	Zanni	nn	3	SENT_234	[p19l114t3125r279b3172],
3	MP	NN	O	mp	_	0	SENT_234	[p19l298t3126r421b3182],
4	,	,	O	,	_	0	SENT_234	[p19l298t3126r421b3182],
5	Greyez	NNP	PERSON	Greyez	nn	7	SENT_234	[p19l444t3125r641b3184],
6	S	NNP	PERSON	S	nn	7	SENT_234	[p19l662t3125r695b3173],
7	Von	NNP	PERSON	Von	appos	3	SENT_234	[p19l715t3141r835b3182],
8	,	,	O	,	_	0	SENT_234	[p19l715t3141r835b3182],
9	Schnyder	NNP	PERSON	Schnyder	nn	10	SENT_234	[p19l859t3125r1123b3184],
10	B	NNP	O	B	appos	3	SENT_234	[p19l1142t3126r1201b3182],
11	,	,	O	,	_	0	SENT_234	[p19l1142t3126r1201b3182],
12	et	FW	O	et	nn	13	SENT_234	[p19l1225t3136r1274b3172],
13	al.	FW	O	al.	appos	3	SENT_234	[p19l1294t3125r1354b3172],
14	.	.	O	.	_	0	SENT_234	[p19l1294t3125r1354b3172],

1	HLA-restricted	JJ	O	hla-restricted	amod	2	SENT_235	[p19l1379t3125r1810b3173],
2	processingand	NN	O	processingand	_	0	SENT_235	[p19l1829t3125r2147b3184, p19l115t3200r217b3247],

1	metabolism	NN	O	metabolism	_	0	SENT_236	[p19l236t3200r942b3259],
2	—	CD	NUMBER	—	num	4	SENT_236	[p19l236t3200r942b3259],
3	independent	JJ	O	independent	amod	4	SENT_236	[p19l236t3200r942b3259],
4	pathway	NN	O	pathway	dep	1	SENT_236	[p19l960t3200r1196b3259],
5	of	IN	O	of	_	0	SENT_236	[p19l1216t3199r1276b3247],
6	drug	NN	O	drug	nn	7	SENT_236	[p19l1289t3200r1419b3259],
7	recognition	NN	O	recognition	prep_of	4	SENT_236	[p19l1437t3200r1755b3259],
8	by	IN	O	by	_	0	SENT_236	[p19l1773t3200r1842b3259],
9	human	JJ	O	human	amod	12	SENT_236	[p19l1859t3200r2058b3247],
10	OLB	NN	O	olb	nn	12	SENT_236	[p19l114t3277r189b3335],
11	T	NN	O	t	nn	12	SENT_236	[p19l210t3276r259b3322],
12	lymphocytes	NNS	O	lymphocyte	prep_by	7	SENT_236	[p19l279t3275r644b3334],
13	.	.	O	.	_	0	SENT_236	[p19l279t3275r644b3334],

1	3	CD	NUMBER	3	num	3	SENT_237	[p19l662t3275r703b3334],
2	‘	NN	O	‘	nn	3	SENT_237	[p19l662t3275r703b3334],
3	Clin	NNP	O	Clin	_	0	SENT_237	[p19l719t3275r829b3323],
4	Invest	NNP	O	Invest	dep	3	SENT_237	[p19l848t3276r1009b3323],
5	1998	CD	DATE	1998	num	4	SENT_237	[p19l1032t3277r1183b3332],
6	;	:	O	;	_	0	SENT_237	[p19l1032t3277r1183b3332],
7	102	CD	NUMBER	102	num	9	SENT_237	[p19l1210t3277r1324b3323],
8	:	:	O	:	_	0	SENT_237	[p19l1210t3277r1324b3323],
9	1591-98	CD	NUMBER	1591-98	dep	3	SENT_237	[p19l1355t3277r1609b3323],
10	.	.	O	.	_	0	SENT_237	[p19l1355t3277r1609b3323],

1	7	CD	NUMBER	7	num	3	SENT_238	[p19l11t3360r40b3405],
2	Schnyder	NN	O	schnyder	nn	3	SENT_238	[p19l115t3358r379b3417],
3	B	NN	O	b	_	0	SENT_238	[p19l398t3359r457b3415],
4	,	,	O	,	_	0	SENT_238	[p19l398t3359r457b3415],
5	Burkhart	NNP	PERSON	Burkhart	nn	6	SENT_238	[p19l480t3358r731b3406],
6	C	NNP	O	C	appos	3	SENT_238	[p19l753t3358r816b3415],
7	,	,	O	,	_	0	SENT_238	[p19l753t3358r816b3415],
8	Schnyder-Frutig	NNP	O	Schnyder-Frutig	nn	9	SENT_238	[p19l840t3358r1303b3417],
9	K	NNP	O	K	appos	3	SENT_238	[p19l1322t3359r1389b3415],
10	,	,	O	,	_	0	SENT_238	[p19l1322t3359r1389b3415],
11	et	FW	O	et	nn	12	SENT_238	[p19l1412t3369r1462b3406],
12	al.	FW	O	al.	appos	3	SENT_238	[p19l1482t3358r1542b3406],
13	.	.	O	.	_	0	SENT_238	[p19l1482t3358r1542b3406],

1	Recognition	NN	O	recognition	_	0	SENT_239	[p19l1567t3358r1907b3417],
2	of	IN	O	of	_	0	SENT_239	[p19l1927t3358r1987b3406],
3	sulfamethoxazole	NN	O	sulfamethoxazole	prep_of	1	SENT_239	[p19l114t3433r598b3480],
4	and	CC	O	and	_	0	SENT_239	[p19l620t3433r722b3481],
5	its	PRP$	O	its	poss	7	SENT_239	[p19l742t3433r804b3480],
6	reactive	JJ	O	reactive	amod	7	SENT_239	[p19l824t3433r1039b3481],
7	metabolites	NNS	O	metabolite	prep_of	1	SENT_239	[p19l1059t3433r1380b3480],
8	by	IN	O	by	_	0	SENT_239	[p19l1400t3433r1469b3492],
9	drug-speciﬁc	JJ	O	drug-speciﬁc	amod	10	SENT_239	[p19l1488t3433r1848b3492],
10	CD4	NN	O	cd4	prep_by	7	SENT_239	[p19l1871t3433r2050b3481],
11	+	CC	O	+	_	0	SENT_239	[p19l1871t3433r2050b3481],
12	T	NN	O	t	nn	13	SENT_239	[p19l2071t3434r2120b3480],
13	cells	NNS	O	cell	conj_and	3	SENT_239	[p19l115t3508r231b3555],
14	from	IN	O	from	_	0	SENT_239	[p19l252t3507r387b3555],
15	allergic	JJ	O	allergic	amod	16	SENT_239	[p19l408t3508r605b3567],
16	individuals	NNS	O	individual	prep_from	13	SENT_239	[p19l626t3508r945b3555],
17	.	.	O	.	_	0	SENT_239	[p19l626t3508r945b3555],

1	3	CD	NUMBER	3	num	2	SENT_240	[p19l962t3508r1004b3567],
2	‘	NN	O	‘	_	0	SENT_240	[p19l962t3508r1004b3567],
3	Immunol	NNP	O	Immunol	dep	2	SENT_240	[p19l1017t3508r1260b3555],
4	2000	CD	DATE	2000	num	3	SENT_240	[p19l1277t3510r1434b3564],
5	,	,	O	,	_	0	SENT_240	[p19l1277t3510r1434b3564],
6	164	CD	NUMBER	164	num	3	SENT_240	[p19l1461t3510r1574b3555],
7	:	:	O	:	_	0	SENT_240	[p19l1461t3510r1574b3555],
8	6647-54	CD	NUMBER	6647-54	dep	2	SENT_240	[p19l1600t3510r1859b3555],
9	.	.	O	.	_	0	SENT_240	[p19l1600t3510r1859b3555],

1	8	CD	NUMBER	8	num	3	SENT_241	[p19l11t3593r41b3638],
2	Dawkins	NNP	ORGANIZATION	Dawkins	nn	3	SENT_241	[p19l113t3591r358b3638],
3	RL	NNP	ORGANIZATION	RL	_	0	SENT_241	[p19l379t3591r485b3647],
4	,	,	O	,	_	0	SENT_241	[p19l379t3591r485b3647],
5	Christiansen	NNP	ORGANIZATION	Christiansen	nn	6	SENT_241	[p19l509t3591r861b3638],
6	FT	NNP	ORGANIZATION	FT	appos	3	SENT_241	[p19l881t3591r988b3647],
7	,	,	O	,	_	0	SENT_241	[p19l881t3591r988b3647],
8	Kay	NNP	PERSON	Kay	nn	9	SENT_241	[p19l1010t3591r1124b3650],
9	PH	NNP	O	PH	appos	3	SENT_241	[p19l1143t3591r1254b3647],
10	,	,	O	,	_	0	SENT_241	[p19l1143t3591r1254b3647],
11	et	FW	O	et	nn	12	SENT_241	[p19l1278t3601r1327b3638],
12	al.	FW	O	al.	appos	3	SENT_241	[p19l1348t3591r1408b3638],
13	.	.	O	.	_	0	SENT_241	[p19l1348t3591r1408b3638],

1	Disease	NN	O	disease	nn	2	SENT_242	[p19l1432t3591r1645b3638],
2	associations	NNS	O	association	_	0	SENT_242	[p19l1667t3591r1996b3638],
3	with	IN	O	with	_	0	SENT_242	[p19l2016t3591r2139b3638],
4	complotypes	NNS	O	complotype	prep_with	2	SENT_242	[p19l115t3666r485b3725],
5	,	,	O	,	_	0	SENT_242	[p19l115t3666r485b3725],
6	supratypes	NNS	O	supratype	prep_with	2	SENT_242	[p19l508t3677r804b3725],
7	and	CC	O	and	_	0	SENT_242	[p19l826t3666r929b3714],
8	haplotypes	NNS	O	haplotype	prep_with	2	SENT_242	[p19l948t3666r1264b3725],
9	.	.	O	.	_	0	SENT_242	[p19l948t3666r1264b3725],

1	Immunol	NNP	O	Immunol	nn	2	SENT_243	[p19l1287t3666r1530b3714],
2	Rev	NN	O	rev	_	0	SENT_243	[p19l1544t3667r1648b3714],
3	1983	CD	DATE	1983	num	2	SENT_243	[p19l1674t3668r1825b3723],
4	,	,	O	,	_	0	SENT_243	[p19l1674t3668r1825b3723],
5	70	CD	NUMBER	70	num	7	SENT_243	[p19l1850t3668r1932b3714],
6	:	:	O	:	_	0	SENT_243	[p19l1850t3668r1932b3714],
7	1-22	CD	NUMBER	1-22	appos	2	SENT_243	[p19l1963t3668r2109b3714],
8	.	.	O	.	_	0	SENT_243	[p19l1963t3668r2109b3714],

1	9	CD	NUMBER	9	_	0	SENT_244	[p20l11t21r40b67],
2	Daly	NNP	PERSON	Daly	nn	3	SENT_244	[p20l113t19r248b78],
3	MJ	NNP	PERSON	MJ	dep	1	SENT_244	[p20l266t20r369b77],
4	,	,	O	,	_	0	SENT_244	[p20l266t20r369b77],
5	Rioux	NNP	PERSON	Rioux	nn	6	SENT_244	[p20l393t19r560b67],
6	JD	NNP	O	JD	appos	3	SENT_244	[p20l575t20r672b77],
7	,	,	O	,	_	0	SENT_244	[p20l575t20r672b77],
8	Schafﬁuer	NNP	O	Schafﬁuer	nn	9	SENT_244	[p20l696t19r963b67],
9	SF	NNP	O	SF	appos	3	SENT_244	[p20l983t19r1077b76],
10	,	,	O	,	_	0	SENT_244	[p20l983t19r1077b76],
11	Hudson	NNP	ORGANIZATION	Hudson	nn	12	SENT_244	[p20l1100t19r1327b67],
12	TJ	NNP	ORGANIZATION	TJ	appos	3	SENT_244	[p20l1346t20r1434b77],
13	,	,	O	,	_	0	SENT_244	[p20l1346t20r1434b77],
14	Lander	NNP	O	Lander	nn	15	SENT_244	[p20l1455t19r1660b67],
15	ES	NN	O	e	appos	3	SENT_244	[p20l1678t19r1774b67],
16	.	.	O	.	_	0	SENT_244	[p20l1678t19r1774b67],

1	Highresolution	NN	O	highresolution	_	0	SENT_245	[p20l1799t19r1961b78, p20l113t94r393b141],

1	haplotype	NN	O	haplotype	nn	2	SENT_246	[p20l412t94r687b153],
2	structure	NN	O	structure	_	0	SENT_246	[p20l708t105r958b141],
3	in	IN	O	in	_	0	SENT_246	[p20l978t94r1032b141],
4	the	DT	O	the	det	6	SENT_246	[p20l1051t94r1137b141],
5	human	JJ	O	human	amod	6	SENT_246	[p20l1156t94r1355b141],
6	genome	NN	O	genome	prep_in	2	SENT_246	[p20l1374t110r1610b153],
7	.	.	O	.	_	0	SENT_246	[p20l1374t110r1610b153],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_247	[p20l1632t95r1742b141],
2	Genet	NNP	PERSON	Genet	_	0	SENT_247	[p20l1762t94r1915b141],
3	2001	CD	DATE	2001	num	2	SENT_247	[p20l1933t96r2089b151],
4	;	:	O	;	_	0	SENT_247	[p20l1933t96r2089b151],
5	29	CD	NUMBER	29	num	7	SENT_247	[p20l114t170r198b214],
6	:	:	O	:	_	0	SENT_247	[p20l114t170r198b214],
7	229-32	CD	NUMBER	229-32	dep	2	SENT_247	[p20l223t169r446b214],
8	.	.	O	.	_	0	SENT_247	[p20l223t169r446b214],

1	10	CD	NUMBER	10	num	7	SENT_248	[p20l16t253r77b298],
2	Dawkins	NNP	ORGANIZATION	Dawkins	nn	7	SENT_248	[p20l113t251r358b298],
3	RL	NNP	ORGANIZATION	RL	nn	7	SENT_248	[p20l379t251r485b307],
4	,	,	O	,	_	0	SENT_248	[p20l379t251r485b307],
5	Zhang	NNP	PERSON	Zhang	appos	7	SENT_248	[p20l507t251r688b310],
6	W	NNP	O	W	nn	7	SENT_248	[p20l705t251r809b308],
7	]	NN	O	]	_	0	SENT_248	[p20l705t251r809b308],
8	,	,	O	,	_	0	SENT_248	[p20l705t251r809b308],
9	Degli	NNP	PERSON	Degli	appos	7	SENT_248	[p20l832t251r1213b310],
10	.	.	O	.	_	0	SENT_248	[p20l832t251r1213b310],

1	—	NN	O	—	_	0	SENT_249	[p20l832t251r1213b310],
2	.	.	O	.	_	0	SENT_249	[p20l832t251r1213b310],

1	Esposti	NNP	PERSON	Esposti	nn	2	SENT_250	[p20l832t251r1213b310],
2	MA	NNP	PERSON	MA	_	0	SENT_250	[p20l1232t251r1360b307],
3	,	,	O	,	_	0	SENT_250	[p20l1232t251r1360b307],
4	et	FW	O	et	nn	5	SENT_250	[p20l1384t261r1433b298],
5	al.	FW	O	al.	appos	2	SENT_250	[p20l1454t251r1513b298],
6	.	.	O	.	_	0	SENT_250	[p20l1454t251r1513b298],

1	Studies	NNS	O	study	_	0	SENT_251	[p20l1540t251r1742b298],
2	of	IN	O	of	_	0	SENT_251	[p20l1765t250r1825b298],
3	MHC	NN	O	mhc	prep_of	1	SENT_251	[p20l1837t251r2006b298],

1	haplotypes	NNS	O	haplotype	_	0	SENT_252	[p20l112t326r412b385],
2	by	IN	O	by	_	0	SENT_252	[p20l432t326r501b385],
3	pulsed	JJ	O	pulsed	amod	6	SENT_252	[p20l518t326r702b385],
4	ﬁeld	JJ	O	ﬁeld	amod	6	SENT_252	[p20l721t326r842b374],
5	gel	NN	O	gel	nn	6	SENT_252	[p20l862t326r940b385],
6	electrophoresis	NN	O	electrophoresis	prep_by	1	SENT_252	[p20l961t326r1395b385],
7	.	.	O	.	_	0	SENT_252	[p20l961t326r1395b385],

1	Baillieres	NNP	O	Baillieres	nn	4	SENT_253	[p20l1417t326r1657b374],
2	Clin	NNP	O	Clin	nn	4	SENT_253	[p20l1677t326r1788b374],
3	Endocrinol	NNP	O	Endocrinol	nn	4	SENT_253	[p20l1806t326r2093b374],
4	Metabol1991	NN	O	metabol1991	_	0	SENT_253	[p20l110t400r506b457],
5	;	:	O	;	_	0	SENT_253	[p20l110t400r506b457],
6	5	CD	NUMBER	5	num	8	SENT_253	[p20l531t401r579b448],
7	:	:	O	:	_	0	SENT_253	[p20l531t401r579b448],
8	285-97	CD	NUMBER	285-97	dep	4	SENT_253	[p20l604t402r828b448],
9	.	.	O	.	_	0	SENT_253	[p20l604t402r828b448],

1	11	CD	NUMBER	11	_	0	SENT_254	[p20l16t486r72b531],
2	Wilson	NNP	ORGANIZATION	Wilson	nn	3	SENT_254	[p20l111t484r310b532],
3	AG	NNP	ORGANIZATION	AG	dep	1	SENT_254	[p20l328t484r444b532],
4	.	.	O	.	_	0	SENT_254	[p20l328t484r444b532],

1	di	FW	O	di	_	0	SENT_255	[p20l469t484r520b532],
2	Giovine	FW	O	giovine	nn	3	SENT_255	[p20l542t484r762b532],
3	FS	FW	O	fs	dep	1	SENT_255	[p20l782t484r878b541],
4	,	,	O	,	_	0	SENT_255	[p20l782t484r878b541],
5	Blakemore	NNP	PERSON	Blakemore	nn	6	SENT_255	[p20l901t484r1202b531],
6	AIH	NNP	PERSON	AIH	appos	3	SENT_255	[p20l1221t485r1364b541],
7	,	,	O	,	_	0	SENT_255	[p20l1221t485r1364b541],
8	Duff	NNP	PERSON	Duff	nn	9	SENT_255	[p20l1386t484r1525b531],
9	GW	NNP	O	GW	appos	3	SENT_255	[p20l1538t484r1670b532],
10	:	:	O	:	_	0	SENT_255	[p20l1538t484r1670b532],
11	Single	JJ	O	single	amod	13	SENT_255	[p20l1696t484r1865b543],
12	base	NN	O	base	nn	13	SENT_255	[p20l1884t484r2007b531],
13	change	NN	O	change	dep	1	SENT_255	[p20l115t559r309b618],
14	in	IN	O	in	_	0	SENT_255	[p20l330t559r383b605],
15	the	DT	O	the	det	24	SENT_255	[p20l402t559r488b606],
16	human	JJ	O	human	amod	24	SENT_255	[p20l508t559r706b606],
17	tumour	NN	O	tumour	nn	24	SENT_255	[p20l725t569r938b606],
18	necrosis	NN	O	necrosis	nn	24	SENT_255	[p20l956t559r1179b606],
19	factor	NN	O	factor	nn	24	SENT_255	[p20l1200t558r1363b606],
20	alpha	NN	O	alpha	nn	24	SENT_255	[p20l1382t559r1531b618],
21	(	CD	NUMBER	(	num	24	SENT_255	[p20l1556t559r1790b617],
22	TNFA	NN	O	tnfa	nn	24	SENT_255	[p20l1556t559r1790b617],
23	)	NN	O	)	nn	24	SENT_255	[p20l1556t559r1790b617],
24	gene	NN	O	gene	prep_in	13	SENT_255	[p20l1815t574r1943b618],
25	detectable	JJ	O	detectable	amod	24	SENT_255	[p20l114t634r398b682],
26	by	IN	O	by	_	0	SENT_255	[p20l417t634r486b693],
27	NcoI	NN	O	ncous	nn	28	SENT_255	[p20l503t635r647b682],
28	restriction	NN	O	restriction	prep_by	25	SENT_255	[p20l667t634r951b682],
29	of	IN	O	of	_	0	SENT_255	[p20l972t634r1032b682],
30	PCR	NN	O	pcr	nn	31	SENT_255	[p20l1044t634r1185b682],
31	product	NN	O	product	prep_of	28	SENT_255	[p20l1201t634r1437b693],
32	.	.	O	.	_	0	SENT_255	[p20l1201t634r1437b693],

1	Hum	NNP	O	Hum	nn	3	SENT_256	[p20l1460t635r1597b682],
2	Mol	NNP	O	Mol	nn	3	SENT_256	[p20l1615t634r1729b682],
3	Genet	NNP	O	Genet	_	0	SENT_256	[p20l1749t634r1901b682],
4	1992	CD	DATE	1992	num	3	SENT_256	[p20l1925t636r2076b691],
5	;	:	O	;	_	0	SENT_256	[p20l1925t636r2076b691],
6	1	CD	NUMBER	1	num	8	SENT_256	[p20l118t710r164b754],
7	:	:	O	:	_	0	SENT_256	[p20l118t710r164b754],
8	353	CD	NUMBER	353	dep	3	SENT_256	[p20l189t710r308b755],
9	.	.	O	.	_	0	SENT_256	[p20l189t710r308b755],

1	12	CD	NUMBER	12	num	3	SENT_257	[p20l16t793r77b838],
2	Cheong	NNP	O	Cheong	nn	3	SENT_257	[p20l116t791r336b850],
3	KY	NNP	O	KY	_	0	SENT_257	[p20l355t792r468b848],
4	,	,	O	,	_	0	SENT_257	[p20l355t792r468b848],
5	Allcock	NNP	PERSON	Allcock	nn	6	SENT_257	[p20l489t791r702b838],
6	RJN	NNP	O	RJN	appos	3	SENT_257	[p20l721t792r859b849],
7	,	,	O	,	_	0	SENT_257	[p20l721t792r859b849],
8	Eerligh	NNP	O	Eerligh	nn	9	SENT_257	[p20l882t791r1083b850],
9	P	NN	O	p	appos	3	SENT_257	[p20l1103t792r1158b848],
10	,	,	O	,	_	0	SENT_257	[p20l1103t792r1158b848],
11	et	FW	O	et	nn	12	SENT_257	[p20l1182t802r1231b838],
12	al.	FW	O	al.	appos	3	SENT_257	[p20l1252t791r1311b839],
13	.	.	O	.	_	0	SENT_257	[p20l1252t791r1311b839],

1	Localization	NN	O	localization	_	0	SENT_258	[p20l1335t791r1681b838],
2	of	IN	O	of	_	0	SENT_258	[p20l1701t791r1762b838],
3	central	JJ	O	central	amod	5	SENT_258	[p20l1775t791r1964b839],
4	MHC	NN	O	mhc	nn	5	SENT_258	[p20l113t866r282b913],
5	genes	NNS	O	gene	prep_of	1	SENT_258	[p20l304t881r458b925],
6	inﬂuencing	VBG	O	inﬂuencing	partmod	1	SENT_258	[p20l479t865r794b925],
7	type	NN	O	type	nn	9	SENT_258	[p20l812t876r929b925],
8	I	CD	NUMBER	i	num	9	SENT_258	[p20l950t866r972b912],
9	diabetes	NN	O	diabetes	dobj	6	SENT_258	[p20l992t866r1235b913],
10	.	.	O	.	_	0	SENT_258	[p20l992t866r1235b913],

1	Hum	NNP	O	Hum	nn	2	SENT_259	[p20l1258t866r1395b913],
2	Immunol	NNP	O	Immunol	_	0	SENT_259	[p20l1415t866r1658b913],
3	2001	CD	DATE	2001	num	2	SENT_259	[p20l1674t868r1831b922],
4	;	:	O	;	_	0	SENT_259	[p20l1674t868r1831b922],
5	62	CD	NUMBER	62	num	7	SENT_259	[p20l1853t868r1938b913],
6	:	:	O	:	_	0	SENT_259	[p20l1853t868r1938b913],
7	1363-70	CD	NUMBER	1363-70	dep	2	SENT_259	[p20l120t942r374b987],
8	.	.	O	.	_	0	SENT_259	[p20l120t942r374b987],

1	13	CD	NUMBER	13	num	3	SENT_260	[p20l16t1025r76b1071],
2	Ota	NN	O	ota	nn	3	SENT_260	[p20l115t1024r217b1071],
3	M	NN	O	m	_	0	SENT_260	[p20l236t1024r318b1080],
4	,	,	O	,	_	0	SENT_260	[p20l236t1024r318b1080],
5	Katsuyama	NNP	PERSON	Katsuyama	nn	6	SENT_260	[p20l340t1024r656b1082],
6	Y	NN	PERSON	y	appos	3	SENT_260	[p20l675t1024r737b1080],
7	,	,	O	,	_	0	SENT_260	[p20l675t1024r737b1080],
8	Mizuki	NNP	PERSON	Mizuki	nn	9	SENT_260	[p20l759t1023r957b1071],
9	N	NNP	PERSON	N	appos	3	SENT_260	[p20l976t1024r1047b1080],
10	,	,	O	,	_	0	SENT_260	[p20l976t1024r1047b1080],
11	et	FW	O	et	nn	12	SENT_260	[p20l1071t1034r1120b1071],
12	al.	FW	O	al.	appos	3	SENT_260	[p20l1141t1023r1200b1071],
13	.	.	O	.	_	0	SENT_260	[p20l1141t1023r1200b1071],

1	Trinucleotide	NN	MISC	trinucleotide	_	0	SENT_261	[p20l1223t1023r1608b1071],
2	repeat	NN	O	repeat	nn	3	SENT_261	[p20l1629t1034r1802b1083],
3	polymorphism	NN	O	polymorphism	dep	1	SENT_261	[p20l112t1098r521b1157],
4	within	IN	O	within	_	0	SENT_261	[p20l539t1098r717b1146],
5	exon	NN	O	exon	prep_within	3	SENT_261	[p20l738t1114r870b1145],
6	5	CD	NUMBER	5	num	5	SENT_261	[p20l893t1100r921b1146],
7	of	IN	O	of	_	0	SENT_261	[p20l945t1098r1005b1145],
8	the	DT	O	the	det	10	SENT_261	[p20l1017t1098r1103b1145],
9	MICA	NNP	ORGANIZATION	MICA	nn	10	SENT_261	[p20l1123t1098r1311b1146],
10	gene	NN	O	gene	prep_of	5	SENT_261	[p20l1330t1114r1458b1157],
11	(	CD	NUMBER	(	num	13	SENT_261	[p20l1483t1098r1673b1156],
12	MHC	NN	O	mhc	nn	13	SENT_261	[p20l1483t1098r1673b1156],
13	class	NN	O	class	dep	1	SENT_261	[p20l1696t1098r1822b1145],
14	I	CD	NUMBER	i	num	16	SENT_261	[p20l1843t1099r1865b1145],
15	chain-related	JJ	O	chain-related	amod	16	SENT_261	[p20l132t1173r499b1220],
16	gene	NN	O	gene	dep	13	SENT_261	[p20l518t1188r646b1232],
17	A	DT	O	a	det	18	SENT_261	[p20l665t1173r752b1231],
18	)	NN	O	)	dep	1	SENT_261	[p20l665t1173r752b1231],
19	:	:	O	:	_	0	SENT_261	[p20l665t1173r752b1231],
20	allele	NN	O	allele	nn	22	SENT_261	[p20l777t1173r917b1220],
21	frequency	NN	O	frequency	nn	22	SENT_261	[p20l937t1172r1215b1232],
22	data	NNS	O	datum	dep	18	SENT_261	[p20l1235t1173r1353b1220],
23	in	IN	O	in	_	0	SENT_261	[p20l1373t1173r1426b1219],
24	the	DT	O	the	det	27	SENT_261	[p20l1445t1173r1531b1220],
25	nine	CD	NUMBER	nine	num	27	SENT_261	[p20l1551t1173r1672b1220],
26	population	NN	O	population	nn	27	SENT_261	[p20l1691t1173r1997b1232],
27	groups	NNS	O	group	prep_in	22	SENT_261	[p20l113t1264r301b1308],
28	Japanese	JJ	MISC	japanese	dep	1	SENT_261	[p20l319t1249r583b1308],
29	,	,	O	,	_	0	SENT_261	[p20l319t1249r583b1308],
30	Northern	JJ	LOCATION	northern	amod	31	SENT_261	[p20l604t1248r869b1296],
31	Han	NNP	LOCATION	Han	dep	1	SENT_261	[p20l888t1249r1027b1305],
32	,	,	O	,	_	0	SENT_261	[p20l888t1249r1027b1305],
33	Hui	NNP	PERSON	Hui	nn	42	SENT_261	[p20l1050t1248r1174b1305],
34	,	,	O	,	_	0	SENT_261	[p20l1050t1248r1174b1305],
35	Uygur	NNP	O	Uygur	appos	42	SENT_261	[p20l1196t1249r1391b1308],
36	,	,	O	,	_	0	SENT_261	[p20l1196t1249r1391b1308],
37	Kazakhstan	NNP	LOCATION	Kazakhstan	appos	42	SENT_261	[p20l1413t1248r1756b1305],
38	,	,	O	,	_	0	SENT_261	[p20l1413t1248r1756b1305],
39	Iranian	NNP	MISC	Iranian	appos	42	SENT_261	[p20l1778t1249r1995b1305],
40	,	,	O	,	_	0	SENT_261	[p20l1778t1249r1995b1305],
41	Saudi	NNP	LOCATION	Saudi	appos	42	SENT_261	[p20l115t1323r273b1371],
42	Arabian	NNP	LOCATION	Arabian	dep	1	SENT_261	[p20l292t1323r533b1380],
43	,	,	O	,	_	0	SENT_261	[p20l292t1323r533b1380],
44	Greek	JJ	MISC	greek	conj_and	28	SENT_261	[p20l556t1323r727b1371],
45	and	CC	O	and	_	0	SENT_261	[p20l747t1323r849b1371],
46	Italian	JJ	MISC	italian	conj_and	28	SENT_261	[p20l869t1323r1062b1370],
47	.	.	O	.	_	0	SENT_261	[p20l869t1323r1062b1370],

1	Tissue	NN	O	tissue	nn	2	SENT_262	[p20l1092t1323r1249b1370],
2	Antigens	NNS	O	antigen	_	0	SENT_262	[p20l1263t1323r1495b1382],
3	1997	CD	DATE	1997	dep	2	SENT_262	[p20l1522t1325r1673b1380],
4	,	,	O	,	_	0	SENT_262	[p20l1522t1325r1673b1380],
5	49	CD	NUMBER	49	num	7	SENT_262	[p20l1695t1325r1779b1371],
6	:	:	O	:	_	0	SENT_262	[p20l1695t1325r1779b1371],
7	448-54	CD	NUMBER	448-54	appos	3	SENT_262	[p20l1803t1325r2028b1371],
8	.	.	O	.	_	0	SENT_262	[p20l1803t1325r2028b1371],

1	14	CD	NUMBER	14	num	3	SENT_263	[p20l16t1408r78b1453],
2	Svejgaard	NN	O	svejgaard	nn	3	SENT_263	[p20l101t1406r370b1465],
3	A	NN	O	a	_	0	SENT_263	[p20l389t1407r452b1463],
4	,	,	O	,	_	0	SENT_263	[p20l389t1407r452b1463],
5	Ryder	NNP	O	Ryder	nn	6	SENT_263	[p20l475t1406r644b1465],
6	LP	NN	O	lp	appos	3	SENT_263	[p20l662t1407r761b1453],
7	.	.	O	.	_	0	SENT_263	[p20l662t1407r761b1453],

1	HLA	NN	O	hlum	nn	4	SENT_264	[p20l785t1407r931b1453],
2	and	CC	O	and	_	0	SENT_264	[p20l951t1406r1054b1454],
3	disease	NN	O	disease	nn	4	SENT_264	[p20l1075t1406r1269b1454],
4	associations	NNS	O	association	_	0	SENT_264	[p20l1291t1406r1636b1453],
5	:	:	O	:	_	0	SENT_264	[p20l1291t1406r1636b1453],
6	detecting	VBG	O	detect	dep	4	SENT_264	[p20l1661t1406r1918b1465],
7	the	DT	O	the	det	9	SENT_264	[p20l1936t1406r2023b1453],
8	strongest	JJS	O	strongest	amod	9	SENT_264	[p20l114t1491r366b1540],
9	association	NN	O	association	dobj	6	SENT_264	[p20l387t1481r706b1528],
10	.	.	O	.	_	0	SENT_264	[p20l387t1481r706b1528],

1	Tissue	NN	O	tissue	nn	2	SENT_265	[p20l737t1481r893b1528],
2	Antigens	NNS	O	antigen	_	0	SENT_265	[p20l907t1481r1139b1540],
3	1994	CD	DATE	1994	dep	2	SENT_265	[p20l1166t1482r1317b1537],
4	;	:	O	;	_	0	SENT_265	[p20l1166t1482r1317b1537],
5	43	CD	NUMBER	43	num	7	SENT_265	[p20l1339t1483r1423b1528],
6	:	:	O	:	_	0	SENT_265	[p20l1339t1483r1423b1528],
7	18-27	CD	DATE	18-27	dep	2	SENT_265	[p20l1454t1483r1636b1528],
8	.	.	O	.	_	0	SENT_265	[p20l1454t1483r1636b1528],

1	15	CD	NUMBER	15	num	3	SENT_266	[p20l16t1565r75b1611],
2	Pirmohamed	NNP	O	Pirmohamed	nn	3	SENT_266	[p20l114t1564r478b1611],
3	M	NN	O	m	_	0	SENT_266	[p20l498t1564r579b1620],
4	,	,	O	,	_	0	SENT_266	[p20l498t1564r579b1620],
5	Lin	NNP	PERSON	Lin	nn	6	SENT_266	[p20l601t1564r699b1610],
6	K	NNP	PERSON	K	appos	3	SENT_266	[p20l718t1564r785b1620],
7	,	,	O	,	_	0	SENT_266	[p20l718t1564r785b1620],
8	Chadwick	NNP	PERSON	Chadwick	nn	9	SENT_266	[p20l810t1564r1092b1611],
9	D	NNP	O	D	appos	3	SENT_266	[p20l1110t1564r1180b1620],
10	,	,	O	,	_	0	SENT_266	[p20l1110t1564r1180b1620],
11	Park	NNP	O	Park	nn	12	SENT_266	[p20l1203t1564r1332b1611],
12	BK	NNP	O	BK	appos	3	SENT_266	[p20l1351t1564r1460b1611],
13	.	.	O	.	_	0	SENT_266	[p20l1351t1564r1460b1611],

1	TNFalpha	NN	O	tnfalpha	nn	3	SENT_267	[p20l1483t1564r1783b1623],
2	promoter	NN	O	promoter	nn	3	SENT_267	[p20l1802t1574r2067b1623],
3	region	NN	O	region	_	0	SENT_267	[p20l113t1639r289b1699],
4	gene	NN	O	gene	nn	5	SENT_267	[p20l309t1655r437b1699],
5	polymorphisms	NNS	O	polymorphism	dep	3	SENT_267	[p20l456t1639r889b1699],
6	in	IN	O	in	_	0	SENT_267	[p20l910t1640r964b1686],
7	carbamazepine	NN	O	carbamazepine	npadvmod	9	SENT_267	[p20l984t1639r1822b1699],
8	—	CD	NUMBER	—	num	7	SENT_267	[p20l984t1639r1822b1699],
9	hypersensitive	JJ	O	hypersensitive	amod	10	SENT_267	[p20l984t1639r1822b1699],
10	patients	NNS	O	patient	prep_in	5	SENT_267	[p20l1842t1640r2077b1699],
11	.	.	O	.	_	0	SENT_267	[p20l1842t1640r2077b1699],

1	Neurology	NNP	O	Neurology	_	0	SENT_268	[p20l111t1714r382b1773],
2	2001	CD	DATE	2001	num	1	SENT_268	[p20l402t1716r558b1771],
3	;	:	O	;	_	0	SENT_268	[p20l402t1716r558b1771],
4	10	CD	NUMBER	10	num	6	SENT_268	[p20l585t1716r665b1762],
5	:	:	O	:	_	0	SENT_268	[p20l585t1716r665b1762],
6	890-96	CD	NUMBER	890-96	dep	1	SENT_268	[p20l691t1716r914b1762],
7	.	.	O	.	_	0	SENT_268	[p20l691t1716r914b1762],

1	16	CD	NUMBER	16	num	3	SENT_269	[p20l16t1799r77b1845],
2	Brewerton	NNP	ORGANIZATION	Brewerton	nn	3	SENT_269	[p20l114t1798r408b1845],
3	DA	NNP	ORGANIZATION	DA	_	0	SENT_269	[p20l428t1798r544b1854],
4	,	,	O	,	_	0	SENT_269	[p20l428t1798r544b1854],
5	Hart	NNP	PERSON	Hart	nn	6	SENT_269	[p20l567t1798r698b1844],
6	FD	NNP	O	FD	dep	3	SENT_269	[p20l717t1798r830b1854],
7	,	,	O	,	_	0	SENT_269	[p20l717t1798r830b1854],
8	Nicholls	NNP	PERSON	Nicholls	nn	9	SENT_269	[p20l850t1797r1084b1844],
9	A	NNP	O	A	appos	6	SENT_269	[p20l1103t1798r1167b1854],
10	,	,	O	,	_	0	SENT_269	[p20l1103t1798r1167b1854],
11	Caffrey	NNP	PERSON	Caffrey	nn	12	SENT_269	[p20l1191t1797r1396b1856],
12	M	NNP	O	M	appos	6	SENT_269	[p20l1415t1798r1496b1854],
13	,	,	O	,	_	0	SENT_269	[p20l1415t1798r1496b1854],
14	James	NNP	PERSON	James	nn	15	SENT_269	[p20l1514t1798r1681b1855],
15	DC	NNP	PERSON	DC	appos	6	SENT_269	[p20l1703t1797r1824b1854],
16	,	,	O	,	_	0	SENT_269	[p20l1703t1797r1824b1854],

1	Sturrock	NNP	O	Sturrock	nn	2	SENT_270	[p20l115t1872r358b1919],
2	RD.	NNP	O	RD.	_	0	SENT_270	[p20l377t1872r491b1919],
3	.	.	O	.	_	0	SENT_270	[p20l377t1872r491b1919],

1	Ankylosing	VBG	O	ankylose	_	0	SENT_271	[p20l513t1872r829b1931],
2	spondylitis	NNS	O	spondylitis	dobj	1	SENT_271	[p20l848t1872r1147b1931],
3	and	CC	O	and	_	0	SENT_271	[p20l1169t1872r1272b1919],
4	HLA-B27	NN	O	hla-b27	dobj	1	SENT_271	[p20l1292t1872r1592b1919],
5	.	.	O	.	_	0	SENT_271	[p20l1292t1872r1592b1919],

1	Lancet	NNP	O	Lancet	_	0	SENT_272	[p20l1616t1872r1797b1919],
2	1973	CD	DATE	1973	num	1	SENT_272	[p20l1821t1873r1972b1928],
3	,	,	O	,	_	0	SENT_272	[p20l1821t1873r1972b1928],
4	1	CD	NUMBER	1	num	1	SENT_272	[p20l1999t1874r2044b1919],
5	:	:	O	:	_	0	SENT_272	[p20l1999t1874r2044b1919],
6	904-07	CD	NUMBER	904-07	dep	1	SENT_272	[p20l115t1948r320b1993],
7	.	.	O	.	_	0	SENT_272	[p20l329t1985r338b1993],

1	17	CD	NUMBER	17	num	3	SENT_273	[p20l16t2031r76b2076],
2	Faletto	NNP	O	Faletto	nn	3	SENT_273	[p20l113t2029r310b2077],
3	MB	NNP	O	MB	_	0	SENT_273	[p20l331t2030r457b2086],
4	,	,	O	,	_	0	SENT_273	[p20l331t2030r457b2086],
5	Miller	NNP	PERSON	Miller	nn	6	SENT_273	[p20l479t2029r652b2077],
6	WH	NNP	PERSON	WH	appos	3	SENT_273	[p20l669t2030r806b2086],
7	,	,	O	,	_	0	SENT_273	[p20l669t2030r806b2086],
8	Garvey	NNP	PERSON	Garvey	nn	9	SENT_273	[p20l830t2030r1031b2088],
9	EP	NNP	O	EP	appos	3	SENT_273	[p20l1049t2030r1149b2086],
10	,	,	O	,	_	0	SENT_273	[p20l1049t2030r1149b2086],
11	et	FW	O	et	nn	12	SENT_273	[p20l1172t2040r1222b2077],
12	al.	FW	O	al.	appos	3	SENT_273	[p20l1243t2029r1302b2077],
13	.	.	O	.	_	0	SENT_273	[p20l1243t2029r1302b2077],

1	Unique	JJ	O	unique	amod	3	SENT_274	[p20l1326t2030r1537b2089],
2	intracellular	JJ	O	intracellular	amod	3	SENT_274	[p20l1558t2029r1895b2077],
3	activation	NN	O	activation	_	0	SENT_274	[p20l115t2104r386b2152],
4	of	IN	O	of	_	0	SENT_274	[p20l406t2104r467b2151],
5	the	DT	O	the	det	11	SENT_274	[p20l478t2104r564b2151],
6	potent	JJ	O	potent	amod	11	SENT_274	[p20l584t2115r766b2163],
7	anti-human	JJ	O	anti-human	amod	11	SENT_274	[p20l787t2104r1114b2151],
8	immunodeﬁciency	NN	O	immunodeﬁciency	nn	11	SENT_274	[p20l1134t2104r1656b2163],
9	virus	NN	O	virus	nn	11	SENT_274	[p20l1673t2104r1807b2152],
10	agent	NN	O	agent	nn	11	SENT_274	[p20l1830t2115r1980b2163],
11	1592U89	NN	O	1592u89	prep_of	3	SENT_274	[p20l120t2179r396b2226],
12	.	.	O	.	_	0	SENT_274	[p20l120t2179r396b2226],

1	Antimicrob	NNP	O	Antimicrob	nn	3	SENT_275	[p20l415t2179r712b2226],
2	Agents	NNPS	O	Agents	nn	3	SENT_275	[p20l726t2179r907b2238],
3	Chemother	NNP	O	Chemother	_	0	SENT_275	[p20l928t2179r1213b2226],
4	1997	CD	DATE	1997	dep	3	SENT_275	[p20l1236t2181r1387b2235],
5	;	:	O	;	_	0	SENT_275	[p20l1236t2181r1387b2235],
6	41	CD	NUMBER	41	num	8	SENT_275	[p20l1410t2181r1494b2226],
7	:	:	O	:	_	0	SENT_275	[p20l1410t2181r1494b2226],
8	1099-107	CD	NUMBER	1099-107	dep	3	SENT_275	[p20l1524t2180r1814b2226],
9	.	.	O	.	_	0	SENT_275	[p20l1524t2180r1814b2226],

1	18	CD	NUMBER	18	num	3	SENT_276	[p20l16t2264r77b2309],
2	Multhoff	JJ	O	multhoff	amod	3	SENT_276	[p20l113t2261r374b2309],
3	G	NN	O	g	_	0	SENT_276	[p20l387t2262r454b2318],
4	,	,	O	,	_	0	SENT_276	[p20l387t2262r454b2318],
5	Botzler	NN	PERSON	botzler	nn	6	SENT_276	[p20l477t2262r679b2309],
6	C	NN	PERSON	c	appos	3	SENT_276	[p20l699t2262r762b2318],
7	,	,	O	,	_	0	SENT_276	[p20l699t2262r762b2318],
8	Issels	NNP	O	Issels	nn	11	SENT_276	[p20l784t2262r930b2309],
9	R.	NNP	O	R.	nn	11	SENT_276	[p20l952t2262r1011b2309],
10	The	NNP	O	The	nn	11	SENT_276	[p20l1034t2262r1149b2309],
11	role	NN	O	role	appos	3	SENT_276	[p20l1169t2262r1275b2309],
12	of	IN	O	of	_	0	SENT_276	[p20l1296t2261r1356b2309],
13	heat	NN	O	heat	nn	15	SENT_276	[p20l1367t2262r1487b2309],
14	shock	NN	O	shock	nn	15	SENT_276	[p20l1507t2262r1667b2309],
15	proteins	NNS	O	protein	prep_of	11	SENT_276	[p20l1684t2262r1910b2321],
16	in	IN	O	in	_	0	SENT_276	[p20l1931t2262r1984b2308],
17	the	DT	O	the	det	18	SENT_276	[p20l2003t2262r2090b2309],
18	stimulation	NN	O	stimulation	prep_in	15	SENT_276	[p20l114t2337r430b2385],
19	of	IN	O	of	_	0	SENT_276	[p20l451t2337r511b2385],
20	an	DT	O	a	det	22	SENT_276	[p20l524t2353r590b2385],
21	immune	JJ	O	immune	amod	22	SENT_276	[p20l609t2338r843b2385],
22	response	NN	O	response	prep_of	18	SENT_276	[p20l863t2353r1122b2397],
23	.	.	O	.	_	0	SENT_276	[p20l863t2353r1122b2397],

1	Biol	NNP	ORGANIZATION	Biol	nn	2	SENT_277	[p20l1144t2338r1256b2385],
2	Chem	NNP	ORGANIZATION	Chem	_	0	SENT_277	[p20l1273t2338r1424b2385],
3	1998	CD	DATE	1998	num	2	SENT_277	[p20l1452t2339r1603b2394],
4	;	:	O	;	_	0	SENT_277	[p20l1452t2339r1603b2394],
5	379	CD	NUMBER	379	num	7	SENT_277	[p20l1626t2339r1744b2385],
6	:	:	O	:	_	0	SENT_277	[p20l1626t2339r1744b2385],
7	295-300	CD	NUMBER	295-300	dep	2	SENT_277	[p20l1769t2339r2028b2385],
8	.	.	O	.	_	0	SENT_277	[p20l1769t2339r2028b2385],

1	19	CD	NUMBER	19	num	14	SENT_278	[p20l16t2422r76b2468],
2	More	JJR	O	more	amod	14	SENT_278	[p20l113t2421r267b2468],
3	SH	NN	O	sh	nn	14	SENT_278	[p20l290t2421r396b2477],
4	,	,	O	,	_	0	SENT_278	[p20l290t2421r396b2477],
5	Breloer	NNP	O	Breloer	dep	14	SENT_278	[p20l419t2420r626b2468],
6	M	NNP	O	M	nn	14	SENT_278	[p20l644t2421r724b2477],
7	,	,	O	,	_	0	SENT_278	[p20l644t2421r724b2477],
8	von	NNP	O	von	appos	14	SENT_278	[p20l745t2436r849b2468],
9	Bonin	NNP	PERSON	Bonin	nn	14	SENT_278	[p20l869t2421r1039b2468],
10	A.	NNP	PERSON	A.	nn	14	SENT_278	[p20l1057t2421r1118b2468],
11	Eukaryotic	NNP	PERSON	Eukaryotic	nn	14	SENT_278	[p20l1142t2420r1446b2480],
12	heat	NN	O	heat	nn	14	SENT_278	[p20l1465t2420r1585b2468],
13	shock	NN	O	shock	nn	14	SENT_278	[p20l1605t2420r1765b2468],
14	proteins	NNS	O	protein	_	0	SENT_278	[p20l1782t2421r2008b2480],
15	as	IN	O	as	_	0	SENT_278	[p20l2030t2436r2083b2468],
16	molecular	JJ	O	molecular	amod	17	SENT_278	[p20l113t2495r393b2542],
17	links	NNS	O	link	prep_as	14	SENT_278	[p20l412t2495r539b2542],
18	in	IN	O	in	_	0	SENT_278	[p20l560t2495r613b2542],
19	innate	JJ	O	innate	amod	23	SENT_278	[p20l633t2495r805b2542],
20	and	CC	O	and	_	0	SENT_278	[p20l827t2495r930b2543],
21	adaptive	JJ	O	adaptive	conj_and	19	SENT_278	[p20l951t2495r1184b2554],
22	immune	JJ	O	immune	amod	23	SENT_278	[p20l1204t2495r1438b2542],
23	responses	NNS	O	response	prep_in	17	SENT_278	[p20l1458t2511r1742b2554],
24	:	:	O	:	_	0	SENT_278	[p20l1458t2511r1742b2554],
25	Hsp60mediated	JJ	O	hsp60mediated	amod	26	SENT_278	[p20l1767t2496r1977b2554, p20l113t2570r374b2617],
26	activation	NN	O	activation	dep	14	SENT_278	[p20l395t2570r666b2617],
27	of	IN	O	of	_	0	SENT_278	[p20l687t2569r747b2617],
28	cytotoxic	JJ	O	cytotoxic	amod	30	SENT_278	[p20l760t2570r1012b2629],
29	T	NN	O	t	nn	30	SENT_278	[p20l1032t2570r1081b2616],
30	cells	NNS	O	cell	prep_of	26	SENT_278	[p20l1101t2570r1234b2617],
31	.	.	O	.	_	0	SENT_278	[p20l1101t2570r1234b2617],

1	Int	NNP	O	Int	nn	2	SENT_279	[p20l1257t2570r1337b2617],
2	Immunol	NNP	O	Immunol	_	0	SENT_279	[p20l1353t2570r1596b2617],
3	2001	CD	DATE	2001	num	5	SENT_279	[p20l1612t2572r1769b2626],
4	;	:	O	;	_	0	SENT_279	[p20l1612t2572r1769b2626],
5	13	CD	NUMBER	13	dep	2	SENT_279	[p20l1795t2572r1875b2617],
6	:	:	O	:	_	0	SENT_279	[p20l1795t2572r1875b2617],
7	1	CD	NUMBER	1	number	8	SENT_279	[p20l120t2646r140b2690],
8	1	CD	NUMBER	1	dep	2	SENT_279	[p20l156t2646r175b2690],
9	2	CD	NUMBER	2	num	10	SENT_279	[p20l186t2646r217b2690],
10	1-27	CD	NUMBER	1-27	dep	8	SENT_279	[p20l228t2646r357b2690],
11	.	.	O	.	_	0	SENT_279	[p20l365t2682r374b2691],

1	20	CD	NUMBER	20	num	3	SENT_280	[p20l10t2729r77b2775],
2	Johnson	NNP	ORGANIZATION	Johnson	nn	3	SENT_280	[p20l109t2727r342b2785],
3	GC	NN	ORGANIZATION	gc	_	0	SENT_280	[p20l363t2728r482b2784],
4	,	,	O	,	_	0	SENT_280	[p20l363t2728r482b2784],
5	Esposito	NNP	PERSON	Esposito	nn	6	SENT_280	[p20l504t2728r742b2787],
6	L	NNP	O	L	appos	3	SENT_280	[p20l763t2728r822b2784],
7	,	,	O	,	_	0	SENT_280	[p20l763t2728r822b2784],
8	Barratt	NNP	ORGANIZATION	Barratt	nn	9	SENT_280	[p20l844t2728r1042b2775],
9	BJ	NNP	ORGANIZATION	BJ	appos	3	SENT_280	[p20l1061t2728r1143b2785],
10	,	,	O	,	_	0	SENT_280	[p20l1061t2728r1143b2785],
11	et	FW	O	et	nn	12	SENT_280	[p20l1167t2738r1216b2775],
12	al.	FW	O	al.	appos	3	SENT_280	[p20l1236t2727r1296b2775],
13	.	.	O	.	_	0	SENT_280	[p20l1236t2727r1296b2775],

1	Haplotype	NN	O	haplotype	nn	2	SENT_281	[p20l1321t2727r1614b2787],
2	tagging	NN	O	tagging	_	0	SENT_281	[p20l1634t2728r1839b2787],
3	for	IN	O	for	_	0	SENT_281	[p20l113t2802r192b2849],
4	the	DT	O	the	det	5	SENT_281	[p20l210t2802r296b2849],
5	identiﬁcation	NN	O	identiﬁcation	prep_for	2	SENT_281	[p20l317t2802r687b2850],
6	of	IN	O	of	_	0	SENT_281	[p20l708t2802r768b2849],
7	common	JJ	O	common	amod	9	SENT_281	[p20l781t2818r1030b2849],
8	disease	NN	O	disease	nn	9	SENT_281	[p20l1051t2802r1245b2850],
9	genes	NNS	O	gene	prep_of	2	SENT_281	[p20l1266t2818r1435b2861],
10	.	.	O	.	_	0	SENT_281	[p20l1266t2818r1435b2861],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_282	[p20l1457t2803r1567b2849],
2	Genet	NNP	PERSON	Genet	_	0	SENT_282	[p20l1587t2802r1740b2849],
3	2001	CD	DATE	2001	num	2	SENT_282	[p20l1758t2804r1915b2859],
4	;	:	O	;	_	0	SENT_282	[p20l1758t2804r1915b2859],
5	29	CD	NUMBER	29	num	7	SENT_282	[p20l1937t2804r2021b2849],
6	:	:	O	:	_	0	SENT_282	[p20l1937t2804r2021b2849],
7	233-37	CD	NUMBER	233-37	dep	2	SENT_282	[p20l115t2878r338b2922],
8	.	.	O	.	_	0	SENT_282	[p20l115t2878r338b2922],

1	21	CD	NUMBER	21	num	3	SENT_283	[p20l10t2961r72b3006],
2	Johnson	NNP	ORGANIZATION	Johnson	nn	3	SENT_283	[p20l109t2959r342b3017],
3	AA	NNP	ORGANIZATION	AA	_	0	SENT_283	[p20l360t2960r470b3016],
4	,	,	O	,	_	0	SENT_283	[p20l360t2960r470b3016],
5	Ray	NNP	PERSON	Ray	nn	6	SENT_283	[p20l493t2960r601b3018],
6	AS	NNP	O	AS	appos	3	SENT_283	[p20l618t2959r719b3016],
7	,	,	O	,	_	0	SENT_283	[p20l618t2959r719b3016],
8	Hanes	NNP	PERSON	Hanes	nn	9	SENT_283	[p20l742t2960r919b3006],
9	J	NNP	PERSON	J	appos	3	SENT_283	[p20l936t2960r977b3017],
10	,	,	O	,	_	0	SENT_283	[p20l936t2960r977b3017],
11	et	FW	O	et	nn	12	SENT_283	[p20l1001t2970r1050b3006],
12	al.	FW	O	al.	appos	3	SENT_283	[p20l1071t2959r1131b3006],
13	.	.	O	.	_	0	SENT_283	[p20l1071t2959r1131b3006],

1	Toxicity	NN	O	toxicity	_	0	SENT_284	[p20l1154t2959r1390b3018],
2	of	IN	O	of	_	0	SENT_284	[p20l1409t2959r1469b3006],
3	antiviral	JJ	O	antiviral	amod	5	SENT_284	[p20l1482t2959r1707b3006],
4	nucleoside	NN	O	nucleoside	nn	5	SENT_284	[p20l1727t2959r2025b3006],
5	analogs	NNS	O	analog	prep_of	1	SENT_284	[p20l115t3034r320b3094],
6	and	CC	O	and	_	0	SENT_284	[p20l343t3034r445b3082],
7	the	DT	O	the	det	11	SENT_284	[p20l465t3034r551b3082],
8	human	JJ	O	human	amod	11	SENT_284	[p20l571t3034r769b3082],
9	mitochondrial	JJ	O	mitochondrial	amod	11	SENT_284	[p20l789t3034r1185b3082],
10	DNA	NN	O	dna	nn	11	SENT_284	[p20l1205t3035r1362b3082],
11	polymerase	NN	O	polymerase	prep_of	1	SENT_284	[p20l1379t3034r1712b3094],
12	.	.	O	.	_	0	SENT_284	[p20l1379t3034r1712b3094],

1	3	CD	NUMBER	3	num	3	SENT_285	[p20l1729t3035r1771b3093],
2	‘	NN	O	‘	nn	3	SENT_285	[p20l1729t3035r1771b3093],
3	Biol	NNP	O	Biol	_	0	SENT_285	[p20l1784t3035r1896b3082],
4	Chem	NNP	O	Chem	dep	3	SENT_285	[p20l1912t3035r2064b3082],
5	2001	CD	DATE	2001	num	4	SENT_285	[p20l115t3110r272b3164],
6	;	:	O	;	_	0	SENT_285	[p20l115t3110r272b3164],
7	276	CD	NUMBER	276	num	9	SENT_285	[p20l294t3110r412b3155],
8	:	:	O	:	_	0	SENT_285	[p20l294t3110r412b3155],
9	40845-57	CD	NUMBER	40845-57	dep	3	SENT_285	[p20l436t3110r732b3155],
10	.	.	O	.	_	0	SENT_285	[p20l436t3110r732b3155],

1	22	CD	NUMBER	22	_	0	SENT_286	[p20l10t3193r77b3238],
2	White	NNP	O	White	nn	3	SENT_286	[p20l111t3191r282b3239],
3	AJ	NNP	O	AJ	dep	1	SENT_286	[p20l301t3192r385b3249],
4	.	.	O	.	_	0	SENT_286	[p20l301t3192r385b3249],

1	Mitochondrial	JJ	O	mitochondrial	amod	2	SENT_287	[p20l409t3191r814b3239],
2	toxicity	NN	O	toxicity	_	0	SENT_287	[p20l834t3191r1041b3250],
3	and	CC	O	and	_	0	SENT_287	[p20l1061t3191r1164b3238],
4	HIV	NN	MISC	hiv	conj_and	2	SENT_287	[p20l1184t3192r1310b3239],
5	therapy	NN	O	therapy	dep	2	SENT_287	[p20l1328t3191r1552b3250],
6	.	.	O	.	_	0	SENT_287	[p20l1328t3191r1552b3250],

1	Sex	NN	O	sex	nn	2	SENT_288	[p20l1576t3191r1672b3238],
2	Transm	NN	O	transm	_	0	SENT_288	[p20l1697t3192r1894b3238],
3	Infect	VB	O	infect	dep	2	SENT_288	[p20l1914t3191r2062b3250],

1	732	CD	NUMBER	732	_	0	SENT_289	[p20l93t3443r152b3469],
2	THE	DT	O	the	det	3	SENT_289	[p20l1238t3448r1305b3468],
3	LANCET	NN	O	lancet	dep	1	SENT_289	[p20l1314t3448r1443b3469],
4	-	:	O	-	_	0	SENT_289	[p20l1453t3455r1460b3462],
5	Vol	NN	O	vol	dep	1	SENT_289	[p20l1470t3448r1514b3469],
6	359	CD	NUMBER	359	num	5	SENT_289	[p20l1524t3449r1569b3469],
7	-	:	O	-	_	0	SENT_289	[p20l1580t3455r1588b3462],
8	March	NNP	DATE	March	dep	5	SENT_289	[p20l1598t3448r1681b3469],
9	2	CD	DATE	2	num	8	SENT_289	[p20l1691t3449r1713b3472],
10	,	,	DATE	,	_	0	SENT_289	[p20l1691t3449r1713b3472],
11	2002	CD	DATE	2002	num	8	SENT_289	[p20l1724t3449r1786b3469],
12	-	:	O	-	_	0	SENT_289	[p20l1796t3455r1804b3462],
13	www.the1ancet.com	NN	O	www.the1ancet.com	dep	8	SENT_289	[p20l1813t3448r2064b3469],

